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Abstract 
Muscular dystrophies are inherited disorders that cause progressive muscle 
deterioration and weakness. Impaired walking and mental challenges are also 
recognised clinically, but there is little quantification of these in the literature. 
Resistance training was historically believed to be detrimental in this population, 
but the evidence for this is limited to anecdote and murine investigation. 
Potentially, as in healthy adults, resistance training could improve muscle strength 
in this population, together with physical function, gait and mental health.  
Part A of this thesis aimed to describe lower-limb muscle strength, physical function, 
gait patterns and mental health profiles of adults with Facioscapulohumeral (9), 
Limb-girdle (6) and Becker (7) Muscular Dystrophy, compared to an age-matched 
control group (10). Part B of this thesis aimed to examine the effect of 12-weeks’ 
resistance training on lower-limb muscle strength, kinematics and kinetics of gait 
and mental health in 17 ambulatory adults with muscular dystrophy.  
Muscle strength, physical function, gait and mental health were impaired in the 
muscular dystrophy groups compared to controls. Mean adherence to the training 
programme was 96%. Isometric maximum voluntary contraction torque increased 
in 6 muscle groups by between 13% and 65%, along with improvements in 
functional movements such as a 23% decrease in stair descent time. Gait speed 
increased by 8% with additional improvements in gait abnormalities, such as a 4° 
reduction in the severity of knee hyperextension, a 2° increase in mean dorsi-flexion 
in the swing phase and a 9% increase in peak plantarflexion generation power in 
late stance. Perceived quality of life improved, with a 19% and 11% reduction in the 
severity of depression and trait anxiety and a 10% and 15% increase in self-esteem 
and physical self-worth.  
This thesis described areas of predominant muscle weakness, gait abnormalities 
and poor mental health, previously un-reported in these muscular dystrophies. 
Resistance training was feasible and highly beneficial to muscle strength, gait and 
mental health. Thus, resistance training is an innovative approach to improving 
muscle strength and managing the physical and mental challenges of muscular 
dystrophy and in doing so, helping to maintain independence in this population.
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Chapter 1 
Introduction to  
Muscular Dystrophy 
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1.1 Introduction 
Muscular dystrophy (MD) embodies a broad collection of inherited muscle diseases 
which progressively weaken the muscles of the body to variable extents (Huml, 
2015). MD is rare, relative to other neuromuscular diseases, with a collective 
prevalence between 19.8 and 25.1 per 100,000 individuals (Theadom et al., 2014; 
Norwood et al., 2009). However, this prevalence is ambiguous given that in excess 
of thirty subtypes of MD exist, all of which can be grouped into nine major types of 
MD (Terrill et al., 2013). These nine major types are Duchenne, Becker, Congenital, 
Distal, Emery-Dreifuss, Myotonic, Facioscapulohumeral, Limb-girdle and 
Oculopharyngeal MD (Huml, 2015), each of which differs by genetic phenotype, 
clinical signs and pathological criteria. 
The discovery of MD is hard to pinpoint, as a direct consequence of the 
heterogeneous nature of MD. Various individuals have been credited with the initial 
description of MD. Some of these earliest descriptions were put forward by 
Giovanni Semmola, a physician at the Hospital of Incurables, who in 1834 presented 
a lecture on two boys with enlarged calf muscles. Sir Charles Bell wrote of muscle 
weakness in young boys in 1830 and Conte and Gioja documented cases of 
increasing muscle weakness in boys in 1836 (Huml, 2015). Importantly, MD was 
officially termed in 1886; it was named Duchenne MD after the French neurologist 
Guillaume Benjamin Armand Duchenne who was well known within the medical 
field. He documented 13 boys with progressive muscle weakness all of whom  were 
unable to walk and died prematurely in their teenage years (Parent, 2014). Soon 
after this, the medical profession recognised that MD is not a homogenous 
condition and that in fact different types of MD exist, which are not exclusive to 
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young boys and differ in terms of weakness severity, location and rate of 
progression (Huml, 2015). 
The variety of MD subtypes exhibit a diverse range of genetic mutations, yet all MDs 
ultimately cause progressive muscle deterioration and weakness that is detrimental 
to physical ability (Mercuri and Muntoni, 2013). Although the various types and 
subtypes of MD do not share the same genotype, they do share some common 
muscle histological features, including variation in myofiber size, myofiber 
degeneration and renewal, fibrosis (the replacement of muscle with connective 
tissue) and fat infiltration (Terrill et al., 2013). The exact mechanism of pathogenesis 
for every type of MD has not yet been described but it is known that each genetic 
defect results in either a problem with, or a lack of, one of the many proteins that 
are associated with muscles (Cohn and Campbell, 2000). These proteins are 
essential during different cellular functions in the muscle and therefore, each 
genetic mutation ultimately results in muscle cell and tissue death (Cohn and 
Campbell, 2000), albeit through a different pathway. The location of each protein 
deficiency can occur at a variety of molecular levels within the muscle, including the 
extracellular matrix, sarcolemma, cytoplasm, sarcomere and nuclear membrane, 
dependant on the protein in question (Terrill et al., 2013). Many of these MD related 
protein deficiencies, along with their location within a myocyte, are highlighted in 
Figure 1.1 (Murphy and Straub, 2015).
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Figure 1.1: Molecular diagram of a myocyte, showing the proteins that are implicated in 
subtypes of MD. Diagram taken from Murphy and Straub (2015). 
MD is notably variable in characteristics such as age of onset, pathway of 
inheritance and distribution of muscle weakness (Terrill et al., 2013), both within 
and between the different types of MD. In addition, MD can weaken the muscles to 
varying extents and severities. The age of onset of MD can vary between childhood 
and adulthood, with some cases of MD appearing in the third, fourth or even fifth 
decade of life (Mercuri and Muntoni, 2013). With regard to how MD is inherited, 
there are three potential pathways. The first, autosomal dominant inheritance 
occurs when one normal gene is inherited from one parent and one faulty gene is 
inherited from the other parent. Alternatively, autosomal recessive inheritance 
happens when both parents pass on the faulty gene and X-linked recessive 
inheritance arises when the mother carries and passes on the faulty gene (Huml, 
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2015). Alternatively, MD can also result from a de novo mutation. The distribution 
of muscle weakness is typically categorised per type of MD, but this will be discussed 
at length later within this review. It is important to note that the prognosis of MD 
also varies greatly, symptom expression can be mild, although progressive, or result 
in substantial disability and early death (Theadom et al., 2014).  
Progressive muscle weakness is the main symptom of MD, but other symptoms can 
include reduced range of motion, pain, joint stiffness, cramps, fasciculation and 
pseudo-hypertrophy, whilst in certain forms of MD the respiratory muscles, 
swallowing muscles and cardiac muscles can also be affected (Mercuri and Muntoni, 
2013). MD can be devastating for both the individual and their family, because 
despite its first description 15 decades ago, there remains no cure for MD (Huml, 
2015). The current treatment options do however aim to manage symptoms, slow 
progression and prevent complications (Birkrant et al., 2018). In recent years, the 
clinical management of MD has led to improved patient outcomes. In particular, life 
expectancy in young boys with Duchenne MD has improved from the teenage years 
to survival well into the twenties and possibly thirties nowadays (Birkrant et al., 
2018). To achieve this, a multitude of therapies including glucocorticoid steroid 
medication, cardiac management, respiratory management, sleep management 
and rehabilitation are employed (Huml, 2015). Physiotherapy is an important tool 
in this multidisciplinary approach, which helps maintain functional mobility and 
independence for those individuals living with MD. 
One of the major defining stages in the progression of MD is the loss of physical 
function or ability to walk, and with that the individual’s independence. This is 
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especially true for Duchenne MD, one of the most common types of childhood MD, 
with a reported prevalence of 8.2 per 100,000 individuals (Mercuri and Muntoni, 
2013). Duchenne MD affects mostly males but on rare occasions x inactivation or 
other genetic modifications can mean that females present with Duchenne MD.  It 
is of childhood onset and renders boys wheelchair bound by, on average, the age of 
12 years old (Huml, 2015). However, adults with other types of MD are often able 
to remain ambulatory. The most common of these forms are Myotonic MD, Becker 
MD (BMD), Facioscapulohumeral MD (FSHD) and Limb-girdle MD (LGMD), which 
have a reported  prevalence of 8.3, 7.0, 3.9 and 1.6 per 100,000 individuals, 
respectively (Mercuri and Muntoni, 2013; Di Fruscio et al., 2016; Mah et al., 2016). 
Myotonic MD is the most common overall, but it differs widely from the other eight 
MDs as the disorder affects nearly every system in body, even the endocrine and 
central nervous system (Hilbert et al., 2012). As the present thesis is concerned with 
ambulatory adults with MD, it will focus largely on the three most common types of 
MD where individuals are often able to remain ambulatory into adulthood (FSHD, 
LGMD and BMD), disregarding Myotonic MD due to the additional complications 
associated with it. 
1.1.1 FSHD 
The genetic mutation responsible for FSHD is unknown, but the site of the genetic 
defect is believed to be located in the D4Z4 DNA region (Emery, 2002). Two types 
of FSHD exist, the most common is termed type 1 and the second is termed type 2. 
Although not fully understood, a widely accepted explanation for both types of 
FSHD is incorrect expression of a retrogene named DUX4 (Sacconi et al., 2015). 
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DUX4 is typically supressed in healthy muscle tissue as it is harmful to the muscle 
cells, but mis-expressed in cases of FSHD (Yao et al., 2014). Type 1 FSHD accounts 
for 95% of cases, which are transmitted as an autosomal dominant trait and the 
remaining 5% are inherited as type 2 FSHD (Huml, 2015). Type 1 FSHD exhibits a loss 
of microsatellite repeat arrays at chromosome 4 in the D4Z4 region (Yao et al., 
2014), resulting in mis-expression of DUX4. Type 2 FSHD is due to a mutation in the 
SMCHD 1 gene on chromosome 18, leading to mis-expression of DUX4 (Statland and 
Tawil, 2014). Despite this knowledge, the consequence of DUX4 expression in 
skeletal muscle has not been established definitively. There are however, numerous 
propositions including cell apoptosis, altered expression of genes that are involved 
in RNA splicing and processing, obstruction of normal muscle regeneration and the 
possible inducement of an immune response (Tawil et al., 2014). A detailed 
explanation of each of these proposed mechanisms for the pathogenesis of FSHD is 
provided by Tawil et al. (2014). 
FSHD is generally of adult onset with slow progressive manifestations commencing 
in the second or third decade of life; an earlier onset is largely accompanied by more 
rapid progression and severity (Sacconi et al., 2015). FSHD is described clinically as 
a primary weakness of the facial, scapula and humeral muscles (Emery, 2002), with 
weakness in the foot extensors accepted as a common characteristic (Huml, 2015), 
yet there is limited quantitative assessment of muscle strength in FSHD. Asymmetric 
muscle weakness, which is uncommon in other MDs, is recognised in clinical 
descriptions of FSHD as a possible characteristic (Sacconi et al., 2015). In rare cases, 
FSHD can also cause visual abnormalities, hearing loss and cardiac arrhythmias 
(Huml, 2015). In most cases the use of a wheelchair is only needed later in life, 
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although experimental descriptions of walking in this population are scarce. Indeed, 
the majority of wheelchair dependant FSHD individuals will express an early 
childhood onset (Sacconi et al., 2015).  
1.1.2 LGMD 
The LGMDs are a diverse group of at least thirty-four disorders (Nigro and Savarese, 
2014; Liewluck and Milone, 2018) that are described clinically as sharing a weakness 
of the proximal limb musculature (Emery, 2002), although experimental 
descriptions of muscle weakness in theses adults are extremely limited (Jacques et 
al., 2018; Lokken et al., 2016). Two main types of LGMD exist, which are further 
categorised into various sub classifications. LGMD type 1 is relatively rare and 
represents an autosomal dominant inheritance, whereas LGMD type 2 is much 
more common and is inherited through a recessive pathway (Vieira et al., 2014). 
Both types of LGMD are sub classified further according to the precise genetic 
defect: LGMD1 includes eight subtypes ranging from A-H and LGMD2 includes 
twenty-six subtypes ranging from A-Z (Liewluck and Milone, 2018).  
A comprehensive list of the genetic mutation and associated protein deficiency for 
each subtype of LGMD has been provided by Liewluck and Milone (2018). The thirty-
four LGMDs give rise to a complex network of genetic defects and consequential 
protein deficiencies. Thus it is currently extremely challenging to manage and to 
understand the pathogenesis of LGMD. To combat this, Liewluck and Milone (2018) 
resourcefully grouped all LGMDs into seven alternative subgroups, as a function of 
the defective protein or shared location. This simplifies the understanding of where 
on a molecular level each LGMD subtype influences skeletal muscle cells. These 
9 
 
seven subgroups include protein deficiencies that are located in the extracellular 
matrix, sarcolemma, cytoplasm, nucleus and sarcomere, the majority of which are 
demonstrated in Figure 1.1 and described below: 
 1) α-Dystroglycanopathies (LGMD 2I, 2K, 2M, 2N, 2O, 2P, 2S, 2T, 2U and 2Z) are due 
to a mutation in the DAG1 gene that encodes for a protein named α-Dystroglycan, 
or in genes that encode for other proteins that work together with α-Dystroglycan, 
such as Fukutin and Protein-O-mannosyl transferase-1. These proteins are located 
in the sarcolemma and help to maintain integrity of the sarcolemma and link the 
dystrophin-associated glycoprotein complex to the extracellular matrix.  
2) Caveolae associated, which includes LGMD1C and is due to a mutated Caveolin-
3 gene. This mutation causes a deficiency in the Caveolin and/or Cavin proteins that 
play a major role in maintaining the stability of the sarcolemma membrane. 
3) LGMD2B and LGMD2L with defective membrane repair. These are due to a 
mutation in the DYSF and ANO5 gene that typically encode for the Dsyferlin and 
Anoctamin-5 protein and are both critical for the repair of the muscle membrane 
following disruption and are located in the sarcolemma and cytoplasm.  
4) LGMDs caused by a protein deficiency in the nuclear envelope. These include 
LGMD1B, LGMD1F, LGMD2X and LGMD2Z, which are due to a mutation in the LMNA 
gene that encodes for the protein LAMIN A/C, TNPO3 gene that encodes for the 
protein Transportin-3, POPDC1 gene that encodes for the Popeye domain 
containing protein 1 and TOR1AIP1 that encodes for the Lamin-associated protein 
1, respectively.  
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5) Sarcoglycanopathies (LGMB 2C, 2D, 2E and 2F), which are due to mutations in 
gene loci that encode for Sarcoglycan proteins. These Sarcoglycan proteins are 
located in the sarcolemma within in a sub-complex of the dystrophin-associated 
glycoprotein complex. The role of Sarcoglycan proteins is similar to many other 
defected proteins in LGMD, which is to maintain the integrity of the sarcolemma 
and to connect the sarcolemma to the extracellular matrix.  
6) Z-disk Proteinopathies (LGMD 1A, 1D, 1E, 2G, 2J, 2Q and 2R) are due to a mutation 
in genes that encode for proteins located in the Z-disk or proteins that facilitate the 
function of the Z-disk, such as Titin, Telethonin and Desmin.  The z-disk defines the 
border of a sarcomere and is important for mechanical stability.  
7) Other LGMDs (LGMD 1G, 1H, 2G, 2H, 2V and 2W) in which the exact protein 
deficiency and/or cellular location is currently unknown.  
In short, it is difficult to outline one common pathway of pathophysiology for LGMD 
due to the variety of locations and functions of the defected proteins. However, 
Murphy and Straub (2015) highlight that the mechanism of pathogenesis for the 
majority of LGMDs is ultimately through sarcolemma membrane instability, which 
consequently leads to muscle fibre degeneration. Murphy and Straub (2015) also 
highlight two other mechanisms including a dysfunctional dystroglycan complex 
and errors in muscle repair, but they stress that these two additional mechanisms 
are also likely to lead to sarcolemma membrane instability and in turn muscle fibre 
degeneration, in the end.  
 The LGMDs have a far less uniform progression rate than other MDs, such as FSHD. 
They can progress rapidly resulting in a severe loss of independence, or at a much 
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slower rate allowing an ordinary life expectancy and activity capability (Di Fruscio et 
al., 2016). Interestingly, the severity and rate of progression can range between 
mild, moderate and severe even within individuals of the same family, due to the 
severity of the individual mutation affecting the gene (Nigro and Savarese, 2014). 
LGMD can manifest in early childhood, late childhood/adolescence after ambulation 
has been attained or milder variants may not appear until adulthood (Mercuri and 
Muntoni, 2013). Invariably, the milder adult onset variants are typically associated 
with the autosomal dominant forms (LGMD1), whilst the more severe childhood 
onset variants are generally caused by the more common recessive forms (LGMD2). 
According to clinical descriptions, muscle weakness primarily occurs in the proximal 
shoulder and/or pelvic girdle muscles (Vieira et al., 2014) and in some forms (1B, 
1D, 2C, 2D, 2E, 2F, 2G, 2I, 2K, 2L, 2M, 2N and 2O) the disorder is associated with 
cardiac involvement (Mercuri and Muntoni, 2013). In instances of childhood onset, 
ambulation will be achieved but invariably lost by adolescence. Conversely, 
ambulation will generally be maintained at least until later life, in cases of adult 
onset (Mercuri and Muntoni, 2013), but experimental descriptions of gait are yet to 
emerge in this condition. 
1.1.3 BMD 
BMD is allelic with Duchenne MD, meaning that it is caused by a different mutation 
in the same gene as Duchenne MD, which is located on the Xp21 chromosome 
(Mercuri and Muntoni, 2013). Both disorders are inherited via the x-linked recessive 
pathway, rendering the conditions male oriented, unlike FSHD or LGMD (Coote et 
al., 2018). Whilst females who carry the condition usually present as asymptomatic, 
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roughly 2-8% can endure mild to moderate symptoms (Huml, 2015) or in rare cases 
symptoms as severe as boys with Duchenne MD, and are therefore labelled as 
manifesting carriers.   
As the Duchenne MD gene is one of the largest recognised human genes, 
information on the pathogenesis of Duchenne and BMD is ample. In essence, 
dystrophin, which is a protein usually located in the sarcolemma and cytoplasm, is 
completely absent in those with Duchenne and either reduced or abnormal in those 
with BMD (Mercuri and Muntoni, 2013). Dystrophin is essential for muscle fibre 
cohesion , as it bonds to the dystroglycan proteins to form a physical link for actin 
fibres across the sarcolemma to connect the extracellular matrix to the cytoplasm 
(Figure 1.1) (Winder, 1997). This is termed the dystrophin glycoprotein complex and 
is essential for sarcolemma membrane function in order to cope with contractile 
stress (Robinson-Hamm and Gersbach, 2016). Absent or reduced dystrophin 
destabilises this dystrophin complex, and consequently results in muscle 
degeneration with a diminished or reduced regenerative capacity (Lapidos et al., 
2004). 
In BMD, the pattern of muscle weakness mimics that of Duchenne MD but with a 
lesser severity and rate of progression. Clinical descriptions of muscle weakness in 
BMD describe a predominantly proximal to distal muscle weakness pattern, 
impairing the proximal knee and hip extensor muscles first followed by the more 
distal leg muscles, and pseudohypertrophy of the gastrocnemius muscle is often 
evident (Emery, 2002; Huml, 2015). However, experimental investigations of muscle 
strength in adults with BMD are limited to grip strength, the knee extensors, the 
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plantar-flexors and the dorsi-flexors (Lokken et al., 2016; Jacques et al., 2018). The 
clinical characteristics of BMD are more variable than Duchenne MD, due to 
variability in the severity of the genetic defect (Coote et al., 2018). The age of onset 
in BMD is later than Duchenne MD, occurring anytime between childhood and 
adulthood. Loss of ambulation is also variable in BMD, ranging from adolescence 
onwards and in many cases ambulation is  sustained well into adulthood (Mercuri 
and Muntoni, 2013), although experimental descriptions of ambulation do not exist. 
Cardiomyopathy occurs in some cases of BMD, with 70% of the combined Duchenne 
and BMD cases presenting with it (Coote et al., 2018). In addition, respiratory 
weakness typically parallels the severity of skeletal muscle weakness and is 
therefore more severe in Duchenne than BMD. 
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2.1 Literature Review Aims 
Previous research studies have investigated the muscular, biomechanical and/or 
psychological characteristics of individuals with muscular dystrophy (MD), 
compared to non-dystrophic individuals: no review has pooled this evidence. 
Accordingly, this literature review aims to identify, review, and synthesise the 
research surrounding MD, with a specific emphasis on Facioscapulohumeral MD 
(FSHD), Limb-girdle MD (LGMD) and Becker MD (BMD) in the following areas: 
1. Muscle strength and physical function 
2. Gait pattern characteristics 
3. Mental health and wellbeing 
This review also aims to unravel the evidence surrounding the role of resistance 
exercise training in individuals with MD, with a specific emphasis on FSHD, LGMD 
and BMD. This review will summarise what is known, identify knowledge gaps and 
outline where future research is required.  
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2.2 Muscle Strength in MD 
Decreased skeletal muscle strength is a well-recognised feature of all MDs, to 
varying degrees and distributions of muscle involvement, and is a detriment to 
physical function (Huml, 2015). Previous investigations of muscle strength, the 
parameters associated with muscle weakness and physical function in MD, exist 
mostly in children with Duchenne MD (Mathur et al., 2010) or are limited to clinical 
assessment through manual muscle testing rather than quantitative measurement. 
2.2.1 Muscle Weakness Distribution 
The distribution of muscles that are weakened in the different forms of MD have 
been classified clinically and schematics that demonstrate these classifications, such 
as Figure 2.1 presented by Mercuri and Muntoni (2013), are often utilised to 
describe MD. Furthermore, these weakness patterns are often used, in combination 
with the suspected pathway of inheritance, during early medical consultations 
(Tawil et al., 2010; Mercuri and Muntoni, 2013). However, although clinical 
descriptions of weakness distribution in FSHD, LGMD and BMD are readily available, 
they are not based on quantitative data presenting muscle strength in these 
populations. Such data do not exist to any great extent or depth within the 
literature, rendering clinical classifications of FSHD, LGMD and BMD ambiguous. 
This is an important consideration given that subtype-specific patterns of muscle 
weakness are often used to inform and facilitate an initial MD classification, to 
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subsequently direct further diagnostic testing, and to inform the ongoing clinical 
management of MD subtypes.  
Scientific quantification of muscle strength in the various forms of MD will either 
support or challenge the pre-existing clinical classifications, and in doing so facilitate 
rehabilitation or clinical management programmes. In particular, scientific 
quantification of lower-body muscle strength could help to direct interventions 
aimed at maintaining walking and/or functional ability. However, the majority of 
studies that have previously quantified muscle strength in MD have been 
undertaken in children with Duchenne MD. The results of these studies cannot be 
related to ambulatory adults with other forms of MD, given the reduced severity 
and progression rate compared to Duchenne MD. In other forms of MD, specifically 
those relevant to this thesis: BMD, LGMD and FSHD, only five studies have 
scientifically quantified lower-limb muscle strength in these populations (Bachasson 
et al., 2014; Jacques et al., 2018; Lokken et al., 2016; Skalsky et al., 2008; Marra et 
al., 2018), in four muscle groups (knee extensors, knee flexors, dorsi-flexors and 
plantar-flexors). Of these studies, two measured isometric maximum voluntary 
contraction (MVC) strength using the gold standard technique of isokinetic 
Figure 2.1: Patterns of predominant muscle weakness in six types of MD: 
Duchenne and Becker (A), Emery-Dreifuss (B), Limb-girdle (C), 
Facioscapulohumeral (D), Distal (E) and Oculopharyngeal (F). Shading = involved 
muscles. Taken from Mercuri and Muntoni (2013). 
18 
 
dynamometry (Skalsky et al., 2008; Lokken et al., 2016), and the other three 
completed isometric quantitative muscle strength assessments using a strain-gauge 
(Jacques et al., 2018; Bachasson et al., 2014; Marra et al., 2018).  
2.2.1.1 Quantitative Strength Data in FSHD 
In FSHD, the weakness distribution is classified clinically as a primary muscle 
weakness in the facial, scapula and humeral muscles, along with distal weakness of 
the lower body (Figure 2.1) (Emery, 2002; Tawil et al., 2010; Mercuri and Muntoni, 
2013). In accordance with this, Jacques et al. (2018) reported a 35% reduction in 
isometric MVC strength of the plantar-flexor muscles, in adults with FSHD compared 
to an age-matched control group.  However, higher percentages of weakness have 
been reported in the proximal muscle groups, relative to matched control groups in 
this population. The strength of the knee extensor muscles in individuals with FSHD 
were reportedly  41.6% (Skalsky et al., 2008), 44.9% (Bachasson et al., 2014), 65.6% 
(Marra et al., 2018) and 24.9% (Jacques et al., 2018) lower than non-dystrophic 
control groups. In a second proximal muscle group, knee flexor strength was 
reportedly 56% lower in a group of children and adults with FSHD (10-64 years), 
compared to a sex, height and weight matched control group (Skalsky et al., 2008). 
However, the pre-existing clinical classifications (Figure 2.1) do not signify a 
predominant weakness of these proximal muscles in FSHD. The differences in the 
severity of knee extensor weakness between the experimental studies may be 
explained by differences in testing procedure, ambulatory status, participant ages 
and the variables used to match participant groups. Concerning the latter point, 
Marra et al. (2018) did not age-match the experimental to the control group, 
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rendering the control group an average 20.5 years younger, which may explain the 
greater differences in muscle strength.  At the lower end of the scale, the 
differences are likely due to a combination of sex differences and measurement 
technique, as Jacques et al. (2018) studied an all-male group. 
2.2.1.2 Quantitative Strength Data in LGMD 
Clinical descriptions of LGMD demonstrate a predominantly proximal muscle 
weakness pattern (Figure 2.1) (Emery, 2002; Wicklund and Kissel, 2014; Mercuri and 
Muntoni, 2013). This is in part supported by experimental data, as Jacques et al. 
(2018) reported knee extensor muscle strength values that were 43% weaker than 
an age-matched control group. However Jacques et al. (2018) also reported a more 
severe relative weakness in the distal plantar-flexor muscles of 58%. Further 
evidence supports this distal muscle weakness in LGMD, with an approximate 42% 
reduction in plantar-flexor muscle strength and an approximate 31% reduction in 
dorsi-flexor muscle strength of adults with LGMD, compared to an age-matched 
control group (Lokken et al., 2016). Despite this evidence, distal muscle weakness is 
not represented as a predominant clinical classification of LGMD (see Figure 2.1). 
2.2.1.3 Quantitative Strength Data in BMD 
Clinical descriptions of BMD often group it together with Duchenne MD (Emery, 
2002) (Mercuri and Muntoni, 2013) and whilst BMD is a less severe variant of 
Duchenne MD, the specific weakness distribution in BMD may differ due to the 
extended period of ambulation in BMD (Huml, 2015). Nevertheless, clinical 
classifications of BMD allude to a proximal followed by distal muscle weakness 
pattern, similar to children with Duchenne MD (Emery, 2002). That is, the proximal 
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leg muscles such as the knee and hip extensors weaken first, followed by the more 
distally located leg muscles such as the dorsi flexors. Jacques et al. (2018) reported 
strength reductions of 41% and 51% in the knee extensor and plantar-flexor muscles 
of adults with BMD, respectively, compared to an age-matched control group. The 
more severe relative weakness of the plantar-flexor muscles in comparison to the 
knee extensor muscles does not support the classic proximal to distal weakness 
distribution that is described clinically. In addition, Lokken et al. (2016) reported a 
similar reduction of 53% in plantar-flexor muscle strength and a reduction of 43% in 
dorsi-flexor muscle strength, of adults with BMD compared to an age-matched 
control group. It is possible that the prolonged ambulatory capacity of adults with 
BMD (Huml, 2015) may help to preserve strength in the proximal muscles and 
therefore explain the limited agreement with the classic proximal to distal muscle 
weakness distribution that has been described clinically.  
2.2.2 Parameters Associated with Muscle Weakness 
Limited insight exists into the parameters that are associated with muscle weakness 
in FSHD, LGMD and BMD. The production of strength encompasses both central 
(neural) and peripheral (muscular) mechanisms, both of which have received 
limited attention within these populations.   
At the muscle level, disparity between research studies exists. Skalsky et al. (2008) 
demonstrated a direct association between reduced isometric MVC strength, and 
smaller lean muscle mass in the knee extensor muscle region of children and adults 
with FSHD, measured using a dual-energy x-ray absorptiometry body scanner.  
Marra et al. (2018) reported a significant association between physiological cross-
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sectional area, measured using magnetic resonance imaging, and MVC strength in 
the quadriceps of adults with FSHD. In addition, Lokken et al. (2016) established a 
direct relationship MVC strength and muscle size (cross-sectional area) of the 
plantar-flexor muscle group, in adults with LGMD but not BMD. In partial agreement 
with the latter study, Jacques et al. (2018) reported no association between plantar-
flexor isometric MVC strength and lean body mass or medial gastrocnemius muscle 
size (anatomical cross-sectional area), in adults with BMD, LGMD or FSHD. These 
differences are most likely confounded by use of whole body (bioelectrical 
impedance analysis) versus regional (dual-energy x-ray absorptiometry) 
composition measures, and by the use of ultrasound versus magnetic resonance 
imaging to assess muscle size. Although the measure of anatomical cross-sectional 
area via ultrasound allows investigation with the most severely affected MD 
individuals, due to the portability and accessibility of such equipment, the results 
may be confounded by the inclusion of non-contractile muscle tissue within this 
measure. 
One known study has investigated the association between central mechanisms of 
muscle function to muscle strength, in adults with FSHD, LGMD or BMD. 
Interestingly, Bachasson et al. (2014) presented a higher voluntary activation 
percentage in individuals with FSHD (95.6%) compared to an age-matched control 
group (90.6%), which was inversely related to quadriceps MVC strength. This finding 
may reflect a potential compensatory mechanism of the central nervous system to 
increase muscle strength where peripheral limitations exist in FSHD. 
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Similar to an ageing population, disuse atrophy may also contribute towards muscle 
weakness and reduced functional ability in adults with MD. Jacques et al. (2018) 
recently established a direct link between current physical activity levels, measured 
using accelerometers, and knee extension isometric MVC strength and physical 
function (10 m walk time), in adults with BMD. Importantly, this highlights a 
potential direct translation of lifetime physical activity levels on parameters such as 
progression of muscle weakness in MD, and it may help to explain some of the 
striking differences seen in the amount and progression of muscle weakness 
between individuals with identical genetic mutations.  
Overall, the precise parameters that are associated with muscle weakness in these 
populations of MD are most likely multi-fold, but investigations into these 
parameters remain relatively vague and confounded by differences in 
measurement techniques. 
2.2.3 Physical Function  
In this thesis, physical function describes an individual’s ability to perform normal 
daily household tasks, work related and recreational activities. It is often assessed 
by timed functional tests such as the time taken to rise from a seated position, the 
time taken to walk a given distance or the time taken to ascend and/or descend 
stairs. A person’s physical function can also be associated with their ability to 
ambulate safely without falling, which is important given the high risk of injury, 
fractures, hospitalisation and even death that is associated with falls in other 
populations (Gill et al., 2013; Spaniolas et al., 2010). Ultimately, physical function 
offers an insight into a person’s level of physical independence and a meaningful 
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measure of how the condition is progressing. It can be presumed that muscle 
strength influences, to a considerable extent, the capacity to perform physical tasks, 
as demonstrated in ageing populations (Byrne et al., 2016). Therefore, investigation 
of physical function together with muscle strength may help to better understand 
the factors that put adults with MD at risk of losing their physical independence. 
Direct relationships between muscle strength and functional ability have not been 
demonstrated to any great extent in BMD, LGMD or FSHD specifically, but studies 
have demonstrated associations in paediatric Duchenne MD and adult Myotonic 
MD populations. Lindeman et al. (1998) established a strong inverse relationship 
between knee extensor MVC strength and timed motor performances, including 
time to walk 50 m, time to rise from a chair, time to ascend stairs and time to 
descend stairs, in adults with Myotonic MD. Hammaren et al. (2014) reported a 
negative association between number of falls and ankle dorsi-flexor MVC strength, 
in Myotonic MD. Beenakker et al. (2005) established a negative correlation between 
time to run 9 m and the sum of the MVC strength of 4 proximal leg muscles (knee 
flexors, knee extensors, hip flexors and hip abductors), in children with Duchenne 
MD. However, given the differences in age and ambulation duration along with 
weakness severity, progression and distribution between these types of MD and 
those relevant to this thesis (Huml, 2015), the exact same associations cannot be 
assumed to exist in FSHD, LGMD and BMD. 
In FSHD, LGMD and BMD specifically, only one study has investigated associations 
between muscle strength and functional performance. Jacques et al. (2018) 
presented a significant inverse relationship between both knee extensor and 
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plantar-flexor MVC strength and 10 m walk time. However, multiple linear 
regression analyses demonstrated that total time spent being physically active was 
the greatest predictor of 10 m walk time, indicating that an active lifestyle may 
better predict physical function than muscle strength itself, in these forms of MD. 
Investigation into the independent and synergist role of lower-limb muscle 
weakness on common functional tasks, such as standing up from a seated position, 
ascending the stairs and walking, in addition to number of falls may help to identify 
functionally important muscle weakness and therefore facilitate rehabilitation 
and/or management programmes in FSHD, LGMD and BMD. This information will 
help to inform future therapies which muscles have the greatest influence over fall 
risk and loss of physical function and independence in adults with MD. 
2.2.4 Recommendations 
Few studies have quantified muscle strength in BMD, LGMD and FSHD and in those 
that have, only four muscle groups were measured. No quantification of muscle 
strength has been reported in the muscle groups of the hips (e.g. hip abductors, hip 
adductors, hip flexors and hip extensors). Furthermore, limited agreement exists 
between the pre-existing clinical classifications of weakness distribution and the 
quantified muscle strength data that do exist.  
Previous studies that have quantified muscle strength in BMD, LGMD and FSHD are 
subject to some key limitations. Firstly, the methods of matching control groups to 
MD groups were overall well established but variable. Three studies did match 
(Bachasson et al., 2014; Lokken et al., 2016), or accounted for statistically (Jacques 
et al., 2018), the age of participants between the experimental and control groups, 
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whilst one study matched these groups by sex, height and weight (Skalsky et al., 
2008), and another study failed to match the participant groups entirely (Marra et 
al., 2018). Due to the progressive nature of MD and the decline in muscle strength 
typical with ageing, the use of appropriately age-matched control groups within MD 
research is of paramount importance. Secondly, measurement technique of 
isometric MVC strength was variable. 40% of studies utilised an isokinetic 
dynamometer (Skalsky et al., 2008; Lokken et al., 2016); the gold standard in 
strength measurement, and the remaining studies utilised a portable strain gauge 
(Jacques et al., 2018; Bachasson et al., 2014; Marra et al., 2018). The latter 
technique is more practical to use within a MD population, but it is important to 
show that this measurement technique and the specific protocol used are reliable, 
which was only demonstrated in one study (Jacques et al., 2018). Finally, the 
maximum number of lower-limb muscles that were measured per study was two, 
which limits comparisons of relative muscle strength between different muscle 
groups in the same individuals. Thus, it is difficult to decipher which muscles are 
more severely affected than others, per subtype of MD. 
The relationship between muscle weakness and physical function has received little 
attention in BMD, LGMD and FSHD. Investigation into potential associations 
between lower-limb muscle strength and functional ability may provide an insight 
into which muscles have the largest influence on functional ability in these forms of 
MD, along with parameters such as walking capacity and more stringent gait 
parameters. Ideally, the establishment of full or lower-body strength profiles may 
help to identify weakness thresholds or weakness patterns that dispose these 
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individuals to reduced functional ability, an increased risk of falling and/or loss of 
ambulation.  
In summary, MD is repeatedly defined as a condition characterized by lower skeletal 
muscle strength, smaller muscle mass, and lower physical performance; yet the 
precise details and nuances of these parameters for FSHD, LGMD and BMD are not 
clearly quantified. Detailed investigations into the specific weakness patterns of 
these ambulatory forms of MD, together with physical function would benefit both 
classification endeavours and condition specific management approaches.  
2.3 Gait in MD 
It has been suggested clinically that the ability to walk in individuals with MD often 
diminishes in conjunction with disease progression, and in many cases the ability to 
walk is eventually lost (Huml, 2015). Children with Duchenne MD typically become 
wheelchair bound by the age of 12 years old (Bushby et al., 2010), whilst individuals 
with FSHD, LGMD and BMD may remain ambulatory (Emery, 2002) but precise 
measures of age at loss of ambulation are not available. Ambulation may be 
maintained in adults with FSHD, BMD and LGMD but it is recognised that walking 
abnormalities are often observable. A major goal of individuals with MD and their 
physiotherapists is for them to remain ambulant and preserve function for as long 
as possible. In order to facilitate this, the gait patterns of adults with MD must be 
measured and analysed quantitatively, and the primary causes of the abnormalities 
understood.  
In clinical environments, walking ability in individuals with MD is typically assessed 
using the 6-minute walk test, an outcome measure that is often utilised to inform 
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the effectiveness of clinical trials in MD (McDonald et al., 2010). Although this test 
demonstrates reduced walking speed in adults with MD (Bachasson et al., 2016), it 
offers no insight into the detailed gait abnormalities that exist. Investigation of 
spatial-temporal variables, joint kinematics, joint kinetics, muscular activity and the 
energetics of gait may facilitate the understanding of the biomechanical 
mechanisms behind reduced walking speed in MD. However, investigation of these 
parameters is currently limited to children with Duchenne MD, adults with 
Myotonic MD and minimal studies of adults with FSHD. 
The number of studies that have assessed at least one detailed gait parameter 
(kinematic, kinetic, muscle activity or energetics) in individuals with MD compared 
to a control population or with increasing disease progression amount to seven 
observations of children with Duchenne MD, five of adults with Myotonic MD and 
four of adults with FSHD. Although sustained walking ability is equally important in 
individuals with LGMD and BMD, quantitative analysis of gait in theses populations 
compared to non-dystrophic control participants are yet to emerge.  
Before discussing the aforementioned studies, the following section of this review 
will briefly describe the phases of gait and important terminology for reference.  
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2.3.1 The Gait Cycle 
Human walking is the bipedal movement that occurs due to the forward progression 
of the feet. Support and propulsion are provided by alternative movements of the 
feet. The term gait is used to refer to the manner of walking. One gait cycle (Figure 
2.2) consists of two successive instances of initial foot contact with the ground, on 
the same side (ipsilateral; Figure 2.2). Two phases make up the gait cycle: the stance 
phase and the swing phase. The stance phase is when the foot is in contact with the 
ground (typically around 60% of the gait cycle) and it begins with initial contact and 
ends with toe-off. The swing phase is when the foot is in the air and passes the 
support leg ready to contact the ground again (around 40% of the gait cycle). 
 
 
 
 
 
 
 
Figure 2.2: One gait cycle from initial contact to the next contact on the same side (Whittle, 
1991) 
Spatial-temporal variables and kinematic and kinetic variables are most often used 
to describe gait in research. Spatial-temporal variables describe parameters of 
distance and time, kinematics describe the angular displacement of joints and 
kinetics describes forces, joint moments and joint powers.  
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2.3.2 Spatial-Temporal Variables 
Authors consistently report slower self-selected walking speed and reduced stride 
length in children with Duchenne MD (D'Angelo et al., 2009; Doglio et al., 2011; 
Gaudreault et al., 2009; Gaudreault et al., 2010; McDonald et al., 2010; Ropars et 
al., 2016; Sutherland et al., 1981), adults with FSHD  (Aprile et al., 2012; Iosa et al., 
2007; Iosa et al., 2010; Rijken, van Engelen, de Rooy, et al., 2015; Rijken, van 
Engelen, Geurts, et al., 2015) and adults with type 1 Myotonic MD (Bachasson et al., 
2016; Galli et al., 2012; Radovanovic et al., 2016; Tiffreau et al., 2012; Wright et al., 
1995), compared to control participants or with increasing disease severity. In 
addition, increased step width (Galli et al., 2012; Sutherland et al., 1981) and stance 
duration (Iosa et al., 2007) have also been reported in individuals with MD. Variable 
results have been reported for walking cadence, with some studies reporting no 
difference (D'Angelo et al., 2009; Gaudreault et al., 2010; Gaudreault et al., 2009) 
and others reporting either reduced (Ropars et al., 2016; Sutherland et al., 1981; 
Iosa et al., 2010; Bachasson et al., 2016) or increased walking cadence (Doglio et al., 
2011).  
In general, the research indicates that reduced walking speed in MD is primarily a 
function of reduced stride length, at least in the 3 types of MD mentioned above 
(Duchenne, FSHD and type 1 Myotonic MD). However, a study that included an 
additional type of MD, other than those mentioned above, contradicts this. 
Radovanovic et al. (2016) observed slower walking speed in both type 1 and type 2 
Myotonic MD, yet those with type 2 did not differ in stride length compared to 
healthy controls. Unfortunately, cadence was not reported, but it can be deduced 
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that reduced speed must instead be due to reduced cadence in these participants. 
This discrepancy in stride characteristics is perhaps the result of different lower-
limb weakness distributions between type 1 and type 2 Myotonic MD, which was 
confirmed via manual muscle testing in the study (significantly weaker distal 
muscles in type 1 and weaker proximal muscles in type 2). Hence, the current author 
suggests that the mechanism behind reduced walking speed in MD is a direct 
function of weakness distribution. It could be theorised that lower extremity distal 
muscle weakness causes an inability to fully weight-bear over the forefoot and 
create adequate progression during late stance, resulting in shorter strides, whilst 
predominantly proximal lower extremity muscle weakness may, or may not, 
preserve this function. To clarify this, future descriptions of spatial-temporal 
variables during gait in MD should be undertaken in additional types of MD, those 
that may exhibit a predominantly proximal muscle weakness distribution pattern in 
the lower extremities, such as LGMD. Although weakness distribution patterns may 
be unpredictable, given the limited quantitative assessment of muscle strength 
already discussed in section 1.2.  
2.3.3 Kinematics and Kinetics 
Several techniques have been employed to assess the kinematics and kinetics of MD 
gait, including 2D and 3D motion analysis, ground reaction force measurements and 
accelerometery. Assessments have taken place in adults with Myotonic MD, 
children with Duchenne MD and adults with FSHD. To date there appear to be no 
published studies that have measured the kinematics and kinetics of gait in humans 
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with LGMD or BMD. The data will be discussed separately for the individual types of 
MD. 
2.3.3.1 Myotonic MD 
In individuals with Myotonic MD (type 1), joint motion abnormalities have been 
reported at all levels (pelvis, hip, knee and ankle). Galli et al. (2012) reported an 
excessive anterior pelvic tilt throughout the entire gait cycle, inadequate hip 
extension during terminal stance, hyperextension of the knee during mid-stance, 
additional knee flexion during swing and reduced plantarflexion during terminal 
stance. Similarly, Wright et al. (1995) also observed abnormal hip motion during the 
stance phase (irregular oscillations compared to a smooth continuous hip motion 
typical of healthy gait), but the total range of motion at the hip, knee and ankle were 
not significantly different between Myotonic MD and control participants. This 
apparent discrepancy is likely due to the comparison of overall range of motion 
throughout the gait cycle rather than within specific phases or at key moments, such 
as the stance phase or at initial contact. In addition, using triaxle accelerometers on 
the trunk, Bachasson et al. (2016) observed greater trunk acceleration in the medial-
lateral direction during the 6-minute walk test, in individuals with Myotonic MD 
compared to a healthy control group. 
Regarding gait kinetics in adults with Myotonic MD (type 1), Galli et al. (2012) 
established that maximum plantarflexion power generation, representative of 
push-off ability, was lower in MD than control participants, but that maximum hip 
power generation  during loading was higher in the MD than the control group, with 
no difference in maximum knee power generation. This highlights a predominant 
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contribution of hip power during gait in this disorder. Regarding joint moments, 
Tiffreau et al. (2012) reported differences in the knee extension joint moment 
between MD and control participants, but the direction of this difference was not 
stated. It is important to note that this assessment was completed on a treadmill. 
The influence of a moving treadmill belt on the gait of individuals with MD has not 
yet been established and as such, the differences presented by Tiffreau et al. (2012) 
may diminish or increase during over-ground gait.  
2.3.3.2 Duchenne MD 
In children with Duchenne MD, assessments of gait kinematics have typically been 
conducted in the sagittal plane, but some investigation of frontal and transverse 
plane motion has also taken place. Postural abnormalities of lumbar lordosis and 
excessive anterior pelvic tilt are evident throughout the whole gait cycle (Doglio et 
al., 2011; D'Angelo et al., 2009; Sutherland et al., 1981). At the hip joint, extension 
is reduced during the stance phase (Sutherland et al., 1981; Gaudreault et al., 2010) 
with excessive flexion during the swing phase (D'Angelo et al., 2009; Gaudreault et 
al., 2010; Sutherland et al., 1981) compared to control participants. The latter 
appears to be a compensatory mechanism for reduced dorsi-flexion observed in the 
swing phase and at initial contact (D'Angelo et al., 2009; Doglio et al., 2011; 
Sutherland et al., 1981). At the knee joint, there is a lack of flexion during initial 
stance (D'Angelo et al., 2009) and in some children hyperextension of the knee is 
evident (D'Angelo et al., 2009), along with excessive knee flexion in the swing phase 
(D'Angelo et al., 2009; Doglio et al., 2011). Doglio et al. (2011) also assessed pelvic 
and hip motion in the frontal and transverse plane, reporting increased external 
33 
 
pelvic rotation, increased pelvic obliquity and early abduction of the hip during the 
stance phase. Furthermore, Gaudreault et al. (2010) found that hip abduction 
started much earlier during the stance phase in children with Duchenne MD, 
compared to control children. This motion signifies that the contralateral pelvis was 
lifted by the hip abductor muscles in combination with a lateral trunk lean towards 
the supporting limb, which the authors reported was confirmed via video. 
Abnormalities in gait kinetics in Duchenne MD reflect both proximal and distal 
muscle weakness in the lower body. Smaller joint powers compared to control 
populations have been reported at all levels, including a smaller hip flexor power 
generation in late stance, sometimes referred to as the pull-off,  (Gaudreault et al., 
2010), a smaller knee power absorption in late swing (Gaudreault et al., 2009) and 
smaller plantar flexion power generations at push-off (D'Angelo et al., 2009; 
Gaudreault et al., 2009; Gaudreault et al., 2010). In terms of ground reaction forces, 
the magnitudes of the vertical, anterior and posterior peak forces were found to be 
lower in children with Duchenne MD than a control group walking at a self-selected 
pace, but no differences were evidence when the controls walked at a slow pace 
(Gaudreault et al., 2010). On the other hand, medial peak forces were significantly 
higher in the MD than the control group regardless of walking pace. 
2.3.3.3 FSHD 
Research into FSHD gait is far less comprehensive than that conducted on Duchenne 
MD. Two research studies have described lower-limb joint kinematics and/or 
kinetics during gait in adults with FSHD (Iosa et al., 2007; Rijken, van Engelen, de 
Rooy, et al., 2015) but only one of those compared gait to a control population (Iosa 
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et al., 2007). Additionally, two studies measured dynamic stability during gait in 
FSHD (Iosa et al., 2010; Rijken, van Engelen, Geurts, et al., 2015). Lower-limb 
kinematics and kinetics will be discussed first, followed by those studies that 
focused on dynamic stability. 
2.3.3.3.1 Lower-limb kinematics and kinetics 
Iosa et al. (2007) assessed sagittal plane kinematics and kinetics of the hip, knee and 
ankle joint during self-selected walking in 12 adults with FSHD, compared to 12 non-
dystrophic control participants; it is unknown whether the groups were matched. In 
addition, MRI images of various lower-limb muscles were scored according to the 
quantity of fat infiltration present (ranging from no infiltration at 0 to whole muscle 
replacement at 3). The authors reported reduced ankle dorsi flexion at initial 
contact which was positively correlated with the MRI score in the tibialis anterior 
muscle, indirectly alluding to a relationship between tibialis anterior muscle 
strength and ankle angle during gait. Furthermore, insufficient knee flexion during 
the stance phase was reported and reduced hip extension at push-off. The latter 
abnormality was positively correlated with the MRI score in the hip extensor 
muscle, again alluding to an indirect association between hip extensor muscle 
strength and hip angle during gait. In some participants, a reduction in the knee 
flexion moment after foot-strike, reduction in hip extensor moment before toe-off 
and smaller peak plantarflexion power generation were evident, but none of these 
kinetic variables reached significance. The study was limited to participants with 
mild-moderate FSHD, which was evidenced by all MRI scores less than 1.5 and that 
no participants required the use of walking aids. The latter point was not directly 
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reported but is assumed based on the Ricci clinical severity scale scores, which were 
all less than or equal to 3.5 (use of walking aids is associated with a score of 4 or 
above). Thus, it is unclear whether differences in joint moments and/or powers may 
exist in more severe presentations of FSHD.  
Rijken, van Engelen, de Rooy, et al. (2015) assessed gait in a group of adults with 
FSHD that included a wide range of severities, including 3, 3.5, 4 and 4.5 on the same 
Ricci clinical severity scale. Self-selected and maximum walking speed, joint powers 
and the percentage of contractile tissue left within the gastrocnemius, iliopsoas and 
gluteus maximus muscles (measured using MRI) were assessed. Reportedly, self-
selected walking speed was 29% lower than normal values for healthy control 
populations. From self-selected to maximum walking speed, peak plantarflexion 
power at push-off increased by 28% and peak hip flexor power at push-off increased 
by 66%. This suggests that individuals with FSHD utilise hip power to a greater 
extent than ankle power to generate greater propulsive forces at push-off in order 
to walk at a fast pace, but it is unclear if this strategy differs to that used by control 
populations. At self-selected walking speeds, a positive correlation was established 
with ankle power at push-off (i.e. faster walkers generated more ankle power) but 
not with hip-power at push-off, despite greater contractile tissue remaining in the 
iliopsoas muscle (89%) than the gastrocnemius muscle (57%). Thus, the participants 
utilised an ankle push-off strategy for propulsion rather than a hip push or pull-off 
strategy, at a comfortable walking pace. 
Comparison of kinematic and kinetic gait abnormalities in FSHD to control groups 
are limited in depth and numerous gaps in the literature are apparent. Investigation 
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of angular displacements and joint moments at the hip, knee and ankle joint are 
limited to the sagittal plane and adults with mild-moderate presentations of FSHD. 
In addition, ground reaction forces and joint powers in FSHD compared to control 
populations remain unreported. A more comprehensive description of joint 
kinematics and kinetics across a wider range of FSHD severities would be 
advantageous in this population. 
In addition to the research gaps identified above in FSHD, several other points 
should be considered by researchers. Firstly, previous assessments of gait have 
taken place during barefoot ambulation. Whilst this is standard in laboratory-based 
gait analysis, it introduces significant practical issues (health and safety) in a MD 
population and gait abnormalities between MD and control participants may vary 
between barefoot and shod walking. Adults with MD are usually habituated to 
walking with shoes on, so walking without shoes goes against what is normal in this 
population. Future research should consider gait assessments whilst shod in MD as 
this better represents everyday life for these individuals. Secondly, it is often 
assumed that muscle weakness is the main contributor to gait alterations in MD, 
and although this reasoning is logical it has not been directly veriﬁed. Associations 
between joint angles and fat infiltration do not directly verify a relationship 
between joint angles and muscle strength. Whilst muscle strength may be 
associated with the severity of fat infiltration in that muscle it is not a direct measure 
of muscle strength. Future investigations interested in these potential relationships 
should utilise a direct measure of muscle strength.  
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2.3.3.3.2 Postural Control 
Maintaining postural control is imperative to avoid falling over, a hazard that has 
been shown to increase 5-fold in individuals with FSHD (Horlings et al., 2009), with 
the majority of falls occurring in the forward direction. Although it seems likely that 
individuals with BMD and LGMD are also at an increased risk of falling over, this is 
yet to be confirmed.  
Postural control in standing and during ambulation have previously been measured 
in adults with FSHD, whilst nothing is known about the postural control of adults 
with LGMD or BMD during gait. Postural control during barefoot stance was 
assessed in 15 adults with FSHD (Aprile et al., 2012). Centre of pressure data were 
collected over 30 seconds of quite standing with eyes closed and eyes open, via a 
baropodometric platform. Compared to a healthy control population, FSHD 
participants exhibited significantly greater centre of pressure sway in both the eyes 
closed and eyes open condition, and centre of pressure sway velocity was greater 
in both the anterior-posterior and medial-lateral directions. Whilst this supports the 
notion of reduced postural control in adults with FSHD in stance, assessment during 
gait itself may provide greater insight into the loss of stability whilst walking.  
With regards to postural control during the task of walking, two studies have 
considered this in adults with FSHD. Iosa et al. (2010) tracked the movement 
trajectories of the head and upper trunk during a stride, in the medial-lateral and 
anterior-poster directions. Wider displacements of both the head and trunk were 
found in both directions compared to a control group, suggesting that the control 
of upper body and head movement during gait is reduced in adults with FSHD. 
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However, this finding does not directly represent stability with regards to 
controlling the body centre of mass. Alternatively, Rijken, van Engelen, Geurts, et 
al. (2015) calculated the margin of stability during walking, in adults with FSHD. The 
margin of stability refers to the distance between the centre of mass and the edge 
of the base of support (Hof et al., 2005) during single limb stance phases of gait. 
Thus, the distance represents how close a person is to falling over. The margins of 
stability in the anterior-posterior direction and medial-lateral direction are visually 
demonstrated in Figure 2.2 (Rijken, van Engelen, Geurts, et al., 2015).  
 
 
 
 
 
 
 
 
 
Figure 2.3: Schematic of the measurement of the medial-lateral margin of stability (L MoS) 
and the anterior-posterior margin of stability (F MoS), adapted from Rijken, van Engelen, 
Geurts, et al. (2015). * represents heel-strike. The grey line represents the centre of mass 
trajectory and the black represents the extrapolated centre of mass trajectory.   
Rijken, van Engelen, Geurts, et al. (2015) calculated the margins of stability in adults 
with FSHD, compared to a non-dystrophic control group. In the anterior-posterior 
direction this was calculated as the anterior distance between the heel marker and 
the centre of mass at heel strike. In the medial-lateral direction it was calculated as 
the lateral distance between the centre of mass and the ankle marker throughout 
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the stance phase (Figure 2.2). The authors found no difference in either the 
anterior-posterior or the medial-lateral margin of stability during level walking 
between the FSHD and non-dystrophic control group (Rijken, van Engelen, Geurts, 
et al., 2015). This finding does not reflect the increased frequency of falls that has 
previously been reported in adults with FSHD (Horlings et al., 2009). 
The previous research in MD suggests that no limitation in postural control during 
gait exists in adults with FSHD, but this may be due to the method used for 
calculating postural control. As already mentioned, to calculate of the margin of 
stability Rijken, van Engelen, Geurts, et al. (2015) utilised the distance between the 
centre of mass and the edge of the base of support (i.e. the position of the heel and 
ankle marker). However, Terry et al. (2014) proposed a technique that utilises the 
position of the measured centre of pressure to define the base of support instead 
of the position of markers on the foot. This technique considers the position and 
movement of the centre of pressure which varies as stance progresses, therefore 
allowing for adjustments in the position of the base of support with movement 
progression. This method has previously demonstrated deficient stability in a 
clinical population of adults with diabetic neuropathy (Brown et al., 2015). Thus, this 
technique may also prove useful in detecting postural control deficits in adults with 
FSHD, LGMD and BMD. 
2.3.4 Muscle Activation 
Investigation of muscle activation during gait in MD is limited to adults with 
Myotonic MD and children with Duchenne MD. Abnormalities in the timing of 
muscle activation have been established in each phase of the gait cycle. Galli et al. 
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(2012) reported no abnormality in the activity of the rectus femoris muscle in 
Myotonic MD, whereas Ropars et al. (2016) reported increased co-contraction of 
the rectus femoris with the  medial hamstring muscle throughout the entire gait 
cycle, in DMD children. Furthermore, Galli et al. (2012) found prolonged activity of 
the tibialis anterior and delayed activity in the semitendinosus and gastrocnemius-
soleus muscles during the stance phase in Myotonic MD. Additionally, both Galli et 
al. (2012) and Ropars et al. (2016) observed excessive co-contraction of the distal 
leg muscles during the swing and stance phase of gait, respectively, in Myotonic and 
Duchenne MD children compared to control populations. This research implies that 
different compensatory movement strategies may be utilised between the MDs, 
which is likely related to differing weakness distributions. However, there are 
limited data available to support this assertion and as such, further exploration of 
this is required.  
In addition to the timing of EMG signals, the relative magnitude of EMG signals are 
important in gait analysis (Rosati et al., 2017) . Only one study has measured this in 
MD, reporting a higher percentage of activation in the rectus femoris, medial 
hamstrings and tibialis anterior muscles in children with Duchenne MD compared 
to a control group (Ropars et al., 2016). However, to compare the magnitude of 
EMG signals between different participants, different muscles and/or different 
testing sessions, normalisation of the EMG signal is paramount (Burden, 2010; 
Lehman and McGill, 1999). This is because technical, anatomical and physiological 
elements are known to influence EMG magnitude (De Luca, 1997). Normalisation is 
achieved by dividing the EMG signal of the task (e.g. gait) by the mean or maximum 
EMG signal of a reference contraction in the same muscle (Burden, 2010). Ropars 
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et al. (2016) normalised EMG signals collected during gait, to a percentage of the 
maximum EMG signal that occurred during that same gait cycle. Arguably, this 
method does not permit comparison between different participants, as the EMG 
signal used as the denominator was obtained during the task under investigation 
(gait) and not a standardised reference contraction (Burden, 2010). For this reason, 
a valid comparison of the magnitude of muscle activation during gait between MD 
and control participants has not been undertaken. Future research should seek to 
rectify this. 
There are numerous recognised methods to normalise EMG signals during gait. The 
Journal of Electromyography and Kinesiology and the SENIAM project (Merletii et 
al., 1999) both advocate the use of EMG associated with either an isometric or a 
dynamic MVC for normalisation purposes, in healthy participants. However, there 
is no precedent for EMG normalisation in pathological populations. Normalisation 
of EMG using a MVC may not be appropriate in individuals with neuromuscular 
disorders, due to potential problems with muscle fibre recruitment. Although, MD 
may not come under this bracket as it is characterised by muscle weakness rather 
than complications at the level of nerve cells. Consequently, individuals with MD 
may be able to elicit a maximum voluntary muscle contraction close to their 
maximum possible activation level, as in healthy individuals. It should firstly be 
established if a MVC is feasible in individuals with MD and if not, an alternative 
method of normalisation should be established that will allow comparison of muscle 
activation magnitude between MD and healthy control individuals. 
2.3.5 Energetics of Gait 
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Walking capacity is essential for independent living and the completion of everyday 
activities. Deficits in the biomechanics of gait, such as reduced stride length or 
cadence, may increase the energy requirements of walking (Katzel et al., 2012), 
which presents as a higher oxygen consumption. Reduced economy of gait is often 
witnessed in other clinical disorders such as Parkinson’s Disease (Katzel et al., 2012). 
Given the gait abnormalities previously presented in individuals with MD (as 
described above), the assessment of the energy requirement of gait is of particular 
interest, yet only one study has measured this in adults with MD compared to a 
control group.  Tiffreau et al. (2012) reported no difference in oxygen consumption 
between adults with Myotonic MD and a healthy control group whilst walking on a 
treadmill.  However, it was not clear if walking speed was matched between the 
participant groups and as Myotonic MD differs vastly from the other types of MD, 
these results cannot be generalised to other types of MD.   
2.3.6 Recommendations  
Despite the previous research that has investigated gait in individuals with MD, 
more research is required. Future studies should assess additional types of MD, a 
broader range of severities within the participant groups and examine gait in more 
depth and breadth. The current author suggests the following recommendations: 
Additional types of MD, such as LGMD and BMD, require investigation. Kinematic 
and kinetic gait abnormalities in these conditions may be similar to those already 
described in other types of MD, but this is yet to be confirmed. In addition, in FSHD, 
kinematic and kinetic analysis is limited to the sagittal plane and to the less severe 
presentations of FSHD. Future research should include participants who rely on 
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walking aids to facilitate the understanding of gait in more severe presentations of 
FSHD. 
There is relatively limited research concerning muscle activation patterns during 
gait in individuals with MD. There remains no investigation into participants with 
FSHD, LGMD or BMD. Future research should seek to establish both the timing and 
magnitude of the individual muscle activations during gait, in all types of MD. 
However, it must first be established whether normalisation of EMG signals to MVC 
are appropriate in individuals with MD and if not, an alternative normalisation 
technique sought. 
There is a clear lack of research concerning the energetics of walking in all types of 
MD. Given the importance this review places on ambulation and physical function 
in everyday life, the economy of walking is of interest. Indeed, to minimise fall risk, 
metabolic gait assessments in MD should be completed during over-ground 
ambulation, opposed to the typical method of treadmill ambulation which more 
easily enables investigators to standardise walking speed. To enable metabolic 
assessments at a self-selected speed in MD, the calculation of walking cost should 
be employed by future studies. Walking cost is the amount of oxygen consumed per 
minute (ml/kg/min) normalised to the distance walked (ml/kg/m).   
Relationships between muscle weakness and specific gait abnormalities in MD are 
unknown. Some investigations presented relationships between measures of fat 
infiltration within a muscle and specific gait abnormalities, but such relationships 
are indirect and only allude to an association between muscle strength and gait 
abnormalities. Future research should seek to identify direct relationships between 
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gait abnormalities and muscle strength, ensuring quantitative measures of muscle 
strength are utilised. 
Finally, the assessment of dynamic stability in adults with FSHD, LGMD and BMD is 
limited to one study in FSHD. Future investigations should seek to examine dynamic 
stability during gait in these populations.  
 2.4 Quality of Life and Mental Health in MD 
Individuals living with long-term clinical conditions are often faced with additional 
physical and mental challenges, as a direct consequence of their chronic disease. 
These additional challenges may have an impact on their quality of life and 
psychological state.   
Quality of life is a notion that is hard to describe but on a subjective level it is 
instinctively understood. The World Health Organisation defines global quality of 
life as “an individual’s perception of their position in life in the context of the culture 
and value systems in which they live and in relation to their goals, expectations, 
standards and concerns” (Khanna and Tsevat, 2007) In the framework of health and 
illness, health-related quality of life (hereafter referred to as QoL) is “the extent to 
which one’s usual or expected physical, emotional and social well-being are affected 
by a medical condition or its treatment” (Khanna and Tsevat, 2007). An individual’s 
psychological state is concerned with aspects of his or her mental health and is 
inclusive of psychological concepts such as depression, anxiety and self-esteem.  
In comparison to other chronic diseases, relatively few studies have assessed QoL 
or concepts of mental health in individuals with MD (Winter et al., 2010). Most 
studies that have, were conducted in children or adults with Duchenne MD, whilst 
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individuals with FSHD, LGMD and BMD have received little attention. The results of 
studies in children and adults with Duchenne MD cannot be generalised to adults 
living with other types of MD. This is because of the severe childhood onset and 
early loss of ambulation in Duchenne compared to other MDs, in which individuals 
may have lived any number of years unaffected by, or unaware of, their MD 
condition and in many cases are able to remain ambulatory. 
2.4.1 Quality of Life in MD 
In recent years, improving QoL has become a major goal of long-term disease 
management. This is because chronic conditions can impact on QoL, as shown in 
individuals with a variety of different muscle diseases  (Graham et al., 2011).  
In MD specifically, a limited number of studies have assessed QoL, and most studies 
that have were conducted in individuals with Duchenne MD (Davis et al., 2010; 
Uzark et al., 2012; Landfeldt et al., 2016; Lue et al., 2016; Kohler et al., 2005; 
Elsenbruch et al., 2013; Pangalila, van den Bos, Bartels, Bergen, Kampelmacher, et 
al., 2015). In any case, the literature is controversial. Some studies have reported 
reduced QoL in MD, compared to control groups or normative reference values. 
Whereas other studies report that whilst physical aspects of QoL are impaired, QoL 
in the mental health domain is similar between individuals with MD and control 
groups or normative reference values. Accordingly, reduced QoL in both physical 
and mental health subscales have been found in children with Duchenne MD (Davis 
et al., 2010; Uzark et al., 2012; Landfeldt et al., 2016),  children and young men with 
Duchenne MD (Lue et al., 2016), a combined group of children and adults with 
Duchenne MD, BMD and LGMD (Grootenhuis et al., 2007), adults with Myotonic MD 
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(Antonini et al., 2006) and adults with FSHD (Winter et al., 2010; Padua et al., 2009). 
On the other hand, several authors report no difference in QoL, although 
interestingly these studies included no examinations of FSHD, LGMD or BMD. These 
studies included a mixed group of children and adults with Duchenne MD (Kohler et 
al., 2005) and adults with Duchenne MD (Pangalila, van den Bos, Bartels, Bergen, 
Kampelmacher, et al., 2015; Elsenbruch et al., 2013).  
Those research studies discussed above, that report a positive QoL in individuals 
with Duchenne MD, concur with the disability paradox phenomenon (Albrecht and 
Devlieger, 1999). This occurs when individuals report a good QoL in spite of long-
term disease and disability, which often seems counterintuitive to healthy 
individuals (Pangalila, 2016). However, these studies are limited to Duchenne MD, 
and therefore, the disability paradox is potentially exclusive to Duchenne MD. This 
is important to note, as boys with Duchenne MD are subject to a severe childhood 
onset and early loss of ambulation, leaving them little to no experience of a life 
without disability. This may influence how they perceive their QoL both in the 
physical and mental health domains, compared to other types of MD with a much 
later disease onset. Thus, the disability paradox, and therefore a high perceived 
QoL, may be exclusive to Duchenne MD or it may exist in adults with other types of 
MD, such as FSHD, LGMD and BMD, but more research studies quantifying QoL in 
these populations are required to determine this.  
The relationship between disease and QoL in people with MD is clearly complicated 
and may be related to additional factors. These could include disease-specific 
parameters such as age at onset, disease severity, disease duration or specific 
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muscle involvement or it could be related to more personal factors, such as self-
perceptions and aspects of mental health. This would be expected as in other 
neuromuscular disorders, QoL has shown a strong relationship to disease-specific 
parameters, such as disease severity, pain and fatigue, in addition to aspects of 
mental health, such as mood (Graham et al., 2011). In MD specifically, investigation 
into the factors associated with QoL has been limited, but some studies have 
investigated this. However, the focus of these studies is on disease-specific 
parameters, with little consideration of mental health.   
2.4.2 Parameters Associated to QoL in MD 
Disease-specific parameters that may be associated with QoL in individuals with MD 
have been investigated in Duchenne MD mainly, but some studies have included 
FSHD. These studies have shown that numerous parameters are negatively related 
to QoL, mainly in the physical domains. These include, age (Uzark et al., 2012), 
disease severity (Landfeldt et al., 2016; Padua et al., 2009; Otto et al., 2017), 
functional status (Lue et al., 2016) and wheelchair use (Wei et al., 2016). Other 
parameters are negatively associated with all domains of QoL, inclusive of pain 
(Padua et al., 2009; Abresch et al., 2002) and fatigue (Wei et al., 2016; Kalkman, 
2005; Pangalila, van den Bos, Bartels, Bergen, Stam, et al., 2015).  A more recent 
study did investigate individuals with LGMD (Peric et al., 2018) and reported 
negative associations between age at disease onset, current age, fatigue and use of 
assistive walking devices, with overall QoL score. Additionally, and of most interest, 
the authors assessed the strength of various muscle groups (shoulder abductors, 
elbow flexors, wrist extensors, hip flexors, knee extensors and dorsi-flexors) and 
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reported a positive correlation between hip flexor strength and overall QoL. This 
study is unique in its assessment of QoL in LGMD and it is the only study to assess 
potential relationships between the strength of various muscle groups and overall 
QoL. This is extremely practical, as unlike other parameters such as graded disease 
severity, the results can be used directly to inform future intervention programmes, 
such as which muscles to target during an exercise training programme. 
Interestingly, the influence of mental health on QoL in MD has only been considered 
in three studies, in individuals with Myotonic MD, Duchenne MD and LGMD. 
Antonini et al. (2006) not only established a negative association between disease 
severity and duration with the physical domain of QoL, but also a negative 
association between depression and anxiety to QoL, in both the physical and mental 
health domains. Similarly, in Duchenne MD, Pangalila, van den Bos, Bartels, Bergen, 
Stam, et al. (2015) also found an inverse relationship between anxiety and both 
domains of QoL and between depression and the physical domain of QoL. What is 
more, the frequency of fatigue, anxiety and depression was higher in those 
categorised as having poor QoL, than those categorised as having a good QoL. More 
recently, Peric et al. (2018) established a negative association between depression 
and total QoL score, in adults with LGMD. Unfortunately, the only psychological 
variable that the authors considered was depression and details regarding which 
specific QoL domains depression was associated with were not provided.  
Thus, it appears that depression and anxiety are related to QoL in MD. However, 
other aspects of mental health, such as self-esteem, may also influence QoL in MD 
and should be considered by future investigators in all types of MD.  
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2.4.3 Recommendations 
Overall, quantification of QoL in MD is controversial, and dominated by studies 
investigating Duchenne MD. The disability paradox may or may not be present in 
adults with other types of MD, but more quantifications of QoL in other types of MD 
are required to know this definitively. 
It is clear that numerous disease-specific parameters influence QoL in MD, but more 
specific measures related to the disease, such as muscle strength in various muscle 
groups, may prove more useful. Furthermore, investigation into psychological 
concepts that may be related to QoL is limited to three studies. Nevertheless, the 
available evidence does suggest that both depression and anxiety can influence QoL 
in Duchenne and Myotonic MD, and that depression is associated with QoL in 
LGMD. Thus, both depression and anxiety may influence QoL in individuals with 
FSHD and BMD too, and anxiety may also with associated to QoL in LGMD, but 
investigations into these specific populations are required. Additional aspects of 
mental health, such as self-esteem, may also be associated with QoL and therefore, 
investigation of this is warranted in all types of MD.  
Understanding QoL and the factors associated with QoL, will facilitate treatment 
and management programmes and potentially reduce the burden of disease on 
health. Future research should seek to quantify QoL in individuals with FSHD, LGMD 
and BMD specifically, and to investigate the association between muscle strength 
in various muscle groups and psychological state with QoL in these populations. In 
particular, the psychological parameters that may represent barriers to physical 
activity, such as depression, self-esteem and anxiety are of interest.  
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2.4.4 Mental Health in MD  
The prevalence of poor mental health is considerably higher in individuals with a 
long-term physical disease (Katon, 2011). Specifically, patients with a physical 
disease are three times more likely to experience depression and/or anxiety, 
compared to individuals without disease (Moussavi et al., 2007). Hence, it is 
unsurprising that between 9.3% and 18.1% of patients with a physical condition 
present with depression, which is significantly higher than the 4.4% of the general 
population with no physical condition (Moussavi et al., 2007). Interestingly, the 
evidence suggests that those with a long-term disease in combination with 
depression and/or anxiety, have an inferior health status to those with depression 
or anxiety alone, or those with multiple physical diseases (Panagioti et al., 2014). 
What’s more, a study of more than 30,000 patients with a physical disease in 
combination with depression, found reduced functional capacity in these 
individuals, signifying a relationship between mental health and physical function 
(Egede, 2007).  
It is often recognised subjectively, that the physical burden of MD may have an 
impact on the psychological health of both the individual and, in many cases, their 
families (Huml, 2015). Yet the investigation of psychological health in individuals 
with MD is scarce, compared to other long-term clinical conditions, such as stroke 
(Burton et al., 2013) , multiple sclerosis (Marrie et al., 2015) and cerebral palsy (Van 
Der Slot et al., 2012).  Indeed, the progressive nature of MD prioritises medical and 
rehabilitation interventions over psychological management, to maintain the 
physical autonomy of patients. However, as stated by the World Health 
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Organisation ‘there can be no health without mental health’ (World Health 
Organisation, 2005). Thus, investigation of psychological health should be a priority 
and will help to ascertain the necessity for psychological intervention/management 
in MD. This is especially pertinent, given that (as discussed above) mental health 
may be related to perceived QoL and functional disability. 
Mental health management is encouraged as part of the primary care and disease 
management for children with Duchenne MD, as discussed in the US Centres for 
Disease Control and Prevention clinical care recommendations (Bushby et al., 2010). 
However, investigation into the different components of mental health, risk factors 
and subsequently, potential interventions for poor mental health remain under-
investigated in MD. In contrast, no such guidelines or framework for the 
management of adults with Duchenne MD or other types of MD were provided, 
other than the recommendation for a  transition into the usual mental health care 
pathway , together with the general population (Bushby et al., 2010). This is despite 
the likely heightened occurrence of poor mental health in MD and the additional 
burden of the primary disease in these individuals too.  
The psychological characteristics of individuals with FSHD, LGMD and BMD are 
relatively unknown, but three psychological concepts that have received some 
attention in individuals with MD are depression, anxiety and self-esteem. These are 
explored in the following sections.  
2.4.4.1 Depression and Anxiety  
The World Health Organisation classifies common mental disorders into two main 
categories; depressive disorders and anxiety disorders, with symptoms ranging 
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from mild to moderate to severe (World Health Organisation., 2017). Depression is 
defined as “a mental health disorder characterised by sadness, loss of interest or 
pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feeling of 
tiredness, and poor concentration. Depression can be long lasting or recurrent, 
substantially impairing an individual’s ability to function at work or school or cope 
with daily life” (World Health Organisation., 2017). Anxiety on the other hand, is 
characterised by excessive and inappropriate worrying, intrusive thoughts, tension 
and concerns, along with physical symptoms such as sweating and trembling 
(American Psychological Association, 2019). In research, anxiety is often separated 
into two distinct constructs (state and trait anxiety), which were originally proposed 
by Cattell and Scheier (1961). State anxiety is a temporary state of anxiety that is 
related to a particular situation, whereas trait anxiety is a predisposition to long-
lasting and persistent feelings of anxiety that are not restricted to particular 
circumstances (Spielberger et al., 1983).  
 Globally, it is estimated that 4.4% and 3.6% of the world population suffer with 
depression and anxiety disorders respectively, and many individuals suffer with 
them both together (World Health Organisation., 2017). The increased presence of 
depression and anxiety in individuals with chronic disease (Moussavi et al., 2007) ( 
between 9.3 and 18.1%) may stem from several origins. The burden of the disease 
itself may cause enough stress to prompt or exacerbate a psychiatric disorder or 
conversely, there may be a joint pathway between the pathogenesis of a disease 
and psychiatric disorders. In MD, both options are viable and may be 
interchangeable between the different types of MD, due to the varying 
pathogenesis between them.  
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Research studies investigating anxiety and/or depression in individuals with MD, 
compared to control or normative reference data are sparse. Investigation has 
taken place in children and adults with Duchenne MD (Pangalila, van den Bos, 
Bartels, Bergen, Stam, et al., 2015; Elsenbruch et al., 2013). In FSHD, BMD and LGMD 
specifically, one study utilised assessments of mental health from caregivers of non-
ambulatory males with BMD (Latimer et al., 2017), and two studies compared levels 
of depression between different MD populations. This was between BMD and 
LGMD  (Melo et al., 1995) and between Myotonic MD and FSHD (Alschuler et al., 
2012). Finally, only one study assessed depression in one of the target populations 
(FSHD) independently. Padua et al. (2009) investigated factors that may be 
associated with depression (inclusive of age, clinical severity and muscle region 
involvement), in individuals with FSHD.  
Pangalila, van den Bos, Bartels, Bergen, Stam, et al. (2015) found that depression 
and anxiety were present in 19% and 24% of adults with Duchenne MD respectively, 
and that the severity of both concepts were negatively associated with QoL. The 
frequency of anxiety and severe depression were in line with the reference 
population, but moderate depression was higher than in the reference population 
(18% versus 8%). In contrast, Elsenbruch et al. (2013) reported that a small 
proportion of adults with Duchenne MD presented mild-moderate depressive 
symptoms (between 11-17 on The Beck Depression Inventory) but the mean score 
was not clinically relevant (4.1). 
In FSHD, LGMD and BMD, depression and anxiety may or may not have an increased 
frequency, but the research is inconclusive. In a study relating to children and adults 
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with Duchenne and BMD (Latimer et al., 2017), 209 caregivers completed a survey 
examining secondary conditions. Depression and anxiety were reported in 26% and 
18% of BMD participants, respectively. However, incongruity between caregivers 
and MD patient reports have previously been demonstrated in ratings of perceived 
QoL (Wei et al., 2016) and therefore, these results may not represent the 
perceptions of the individuals with BMD themselves. Melo et al. (1995) reported no 
difference in the frequency of anxiety and depression between adults with BMD and 
LGMD, indicating no effect of genotype on mental health in these conditions, but 
comparison to a non-dystrophic control group or reference values was not 
conducted. In contrast, however, Alschuler et al. (2012) did report significantly less 
depression in adults with FSHD compared to adults with Myotonic MD, despite 
significantly higher levels of pain and lower physical functioning, with no difference 
in fatigue or age between the groups. Thus, depression may be higher in particular 
genotypes of MD, but this is hard to determine as other variables such as age at 
onset and disease duration may have differed between the groups. Furthermore, it 
is well known that Myotonic MD differs from the other 8 types of MD, as nearly 
every system in the body is involved (Huml, 2015). Hence, the increased frequency 
of depression within this population compared to FSHD is fairly meaningless. Finally, 
Padua et al. (2009) established that depression was positively associated with age 
in adults with FSHD, and that participants with both upper and lower limb 
involvement had significantly higher depression scores than those with upper limb 
involvement only. This type of information could direct the design of future 
intervention programmes aimed at increasing muscle strength. However, it is 
unclear whether the accumulation of having more muscles involved was the 
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mediating factor in depression, or whether lower limb muscle involvement 
specifically was more important. For this reason, investigation towards the 
influence of individual muscle groups would facilitate the design of future 
intervention programmes, particularly those designed to target muscle strength. 
Overall, numerous problems with the research are evident. The frequency of 
depression and anxiety compared to non-dystrophic control or normative reference 
data is limited to investigations in Duchenne MD, which cannot be generalised to 
adults with FSHD, LGMD and BMD. This is because boys with Duchenne MD typically 
become wheelchair bound by the age of 12 years old.  Therefore, their psychological 
characteristics may differ to adults with FSHD, LGMD and BMD, who are able to 
remain ambulatory into adulthood and have often experienced many years without 
disability. In addition, individuals with Duchenne MD are often treated with 
corticosteroids, which may influence aspects of mood, as discussed by Poysky 
(2007).  Secondly, the factors that may be associated with depression and anxiety 
in FSHD, LGMD and BMD are largely unknown. Investigation has been limited to the 
parameters of age, clinical severity and muscle region involvement, in FSHD. 
Whereas other factors, particularly those that have the potential to directly inform 
future intervention programmes (such as the strength of individual muscle groups 
or physical activity levels) have not been investigated. 
2.4.4.2 Self-esteem  
Global self-esteem (hereafter referred to as self-esteem) has been defined as “an 
individual’s global, subjective and emotional evaluation of their perceived worth as 
a person” (Rosenberg, 1965). The presence or development of a chronic clinical 
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condition may be a driving force behind changes in self-esteem, as although reports 
of self-esteem before and after diagnosis are typically not possible, lower self-
esteem has been reported in numerous clinical conditions, such as multiple sclerosis 
(Sarisoy et al., 2013), cerebral palsy (Riad et al., 2013), obesity (Abiles et al., 2010) 
and acquired brain injury (Kelly et al., 2013), compared to age-matched control 
populations. This is important given that self-esteem has been shown to be highly 
associated with measures of health-related QoL, in clinical conditions such as 
multiple sclerosis (Mikula et al., 2017). Furthermore, self-esteem has been 
identified as a crucial mediator in adherence to treatment programmes, such as 
exercise in diabetic patients (Kneckt et al., 2001). Interestingly, it is well established 
within cross-sectional and longitudinal research studies that age is positively 
associated with self-esteem, from adolescence to adulthood (Huang, 2010), 
followed by a subsequent reduction in old age (Orth and Robins, 2014).  
The assessment of self-esteem in MD is extremely limited. Only two studies, to this 
author’s knowledge, have investigated self-esteem in individuals with MD. 
Specifically, these studies assessed children with LGMD (Miladi et al., 1999) and 
adults with Myotonic MD (Bertrand et al., 2015), compared to control and 
normative reference data, respectively. At present, no studies have investigated 
levels of self-esteem in adults with LGMD, BMD and FSHD. Miladi et al. (1999) 
measured self-esteem subjectively, in children and young adults (ranging from 10-
22 years old) with LGMD, compared to an age and sex-matched control group of 
children referred to an outpatient clinic for emotional and behavioural difficulties. 
The children were shown projective cards that elicited realistic common 
interpersonal events with children and adults, and their self-esteem was scored 
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based on stories told by them in response to these cards. Overall, lower self-esteem 
was reported in children with LGMD than the control group. However, the 
investigator scoring self-esteem was not blinded to the groups, which is important 
given the subjective nature of this investigation. In adults with Myotonic MD, 
Bertrand et al. (2015) assessed self-esteem using the Rosenberg Self-esteem Scale. 
The authors reported no difference in self-esteem compared to normative 
reference data. However, there was a significantly lower self-esteem in the more 
severe MD group compared to the mild group, suggesting a potential relationship 
with disease severity or genotype.  
The disparity in findings between the two studies that investigated self-esteem in 
MD, are perhaps a consequence of the different forms of MD and therefore the 
different pathogenesis of each disease, but there are multiple other potential 
explanations. The discrepancy may be due to the different measures of self-esteem 
utilised or the difference in age between the populations. As mentioned earlier, self-
esteem increases from adolescence to adulthood across many different populations 
(Orth and Robins, 2014). Although the participants in both studies were compared 
to age-matched control or normative reference data, the additional impact of MD 
may be evident in children (due to the already inferior and vulnerable self-esteem), 
but dissipated in adults with MD. Alternatively, disease severity or duration may 
have influenced self-esteem in both studies, as naturally, the children and young 
adults in the former study had less time since MD onset. More MD research studies 
assessing global self-esteem, along with the factors that are associated with this are 
required. Global self-esteem may be lower, equal or even higher in adults with 
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LGMD, BMD and FSHD compared to age-matched controls, but research in these 
individuals specifically is required to determine this.  
A major limitation of these studies is that investigation was limited to measures of 
global self-esteem. However, self-esteem is now considered to be 
multidimensional, with global self-esteem influenced by various domain levels of 
self-esteem, which are associated with different areas of the self (Raustorp et al., 
2005), such as physical, academic, cognitive and social self-worth (Raustorp et al., 
2005).  
Self-esteem in individuals with a disease compared to individuals with no disease 
may differ in specific domains of the self, particularly those domains that are 
impacted by the disease. In MD for example, physical self-worth is of particular 
interest due to the characteristic effects of MD on physical function. The 
investigation of global self-esteem alone may conceal variances in self-esteem 
within this area. Hence, it is important to study self-esteem from this multifactorial 
perspective. This is particularly important when examining changes in self-esteem 
through a physical exercise intervention. The Physical Self-Perception Profile was 
developed by Fox and Corbin to enable measurement of physical self-worth in 
adults, and therefore this might be a useful measure in such studies (Fox and Corbin, 
1989).  
2.4.5 Recommendations 
The degenerative aspects of MD mean that researchers prioritise medical 
interventions to maintain the physical autonomy of patients. However, 
psychological profiles of adults with MD, specifically FSHD, LGMD and BMD, would 
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be highly advantageous to discern the need for increased psychosocial support and 
counselling. Furthermore, previous psychological assessment has focused on the 
construct of depression, whilst there has been less investigation of other constructs 
such as anxiety and self-esteem. Furthermore, future researchers should look more 
deeply into domain levels of self-esteem in MD, with specific emphasis on self-
esteem at the physical level.  
Investigation into factors that may be associated with, and mediate, mental health 
in FSHD, LGMD and BMD would be highly beneficial to future interventions and 
management programmes, particularly those parameters that could be tackled 
directly by interventions, such as physical activity levels or muscle strength. In 
addition, the relationship between depression, anxiety and self-esteem with QoL in 
these populations is of interest.  
2.5 Resistance Training in MD 
Resistance training (RT) is a type of exercise that is endorsed by numerous health 
organisations, including the American College of Sports Medicine (Kraemer et al., 
2002), who recognise that developing or maintaining muscular strength is pertinent 
for physical health and functional ability. In healthy populations, it is well 
established that RT increases skeletal muscle strength and lean body mass (Kraemer 
and Ratamess, 2004; Williams et al., 2007). These benefits are also evident in many 
other clinical populations often characterised with muscle weakness, such as stroke 
patients (Pak and Patten, 2008), elderly individuals (Morse et al., 2005), cerebral 
palsy children (Scholtes et al., 2010) and adults with multiple sclerosis (White et al., 
2004), to name a few. Thus, RT may also benefit individuals living with a muscle 
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condition that progressively weakens and diminishes their skeletal muscle: namely, 
individuals with FSHD, LGMD and BMD, whose primary affliction is muscle 
deterioration and progressive weakness (Huml, 2015). However, investigation into 
the role of RT in MD has been extremely limited, due to historical fears that it may 
be detrimental to individuals with MD (Gianola et al., 2013). Specifically, for many 
years the medical domain believed that muscular effort might exacerbate the loss 
of muscle tissue and strength in individuals with MD (Ansved, 2001). This dated 
perspective has received limited scientific scrutiny and therefore, the value of RT in 
MD remains controversial, despite the arguments for a harmful effect being based 
on murine assessment of only one type of MD and anecdotal evidence (Ansved, 
2001).  
The murine evidence for a harmful effect of RT exists in mouse models of Duchenne 
MD, named mdx mice (Petrof, 1998). Weller et al. (1990) found that the mdx mice 
demonstrated more muscle fibres containing IgG, which is described as a biomarker 
for acute necrosis, following a bout of electrically stimulated eccentric contractions, 
compared to non-mdx mice. In addition, Petrof et al. (1993) reported an increased 
degree of sarcolemma membrane rupture in response to a range of in-vitro 
electrically stimulated maximal muscle contractions, in mdx compared to normal 
mice. However, multiple problems arise from generalising this evidence to both 
humans with Duchenne MD and other types of MD. Firstly, each type and subtype 
of MD differs via genetic mutation and subsequently, the defected protein or 
pathogenesis of the disease; It cannot be assumed that each type of MD will react 
to a stimulus such as RT in the same way. In addition, biological factors are present 
in-vivo that are most likely absent when muscles tissues are examined in-vitro, 
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which may influence the function and stability of the muscle cells.  Furthermore, 
although mdx mice have the same genetic defect as humans with Duchenne MD (a 
mutated dystrophin gene), numerous differences exist between mdx mice and 
humans. Some of the most obvious differences include scale, tissue growth and 
development, and arguably one of the most important differences, that is often 
ignored, is that the mdx myopathy is not a precise replication of Duchenne MD 
(Partridge, 2013). Therefore, although suggestive, mdx mouse evidence should be 
treated circumspectly and a direct extrapolation to humans with MD should not be 
assumed.  
An organisation heavily associated with MD recently recognised that some muscular 
exercise might benefit adults with some forms of MD (Muscular Dystrophy UK, 
2014). However, due to the lack of research investigating RT in MD their guidelines 
are understandably, extremely vague. Thus, RT in MD remains underplayed, 
rendering it a potentially huge missed opportunity in the management of MD. The 
continuation of this limited research is likely due to how challenging this type of 
research is to undertake. There are an abundance of barriers to designing and 
implementing a RT study, for individuals with MD. These barriers include limited 
access to adults with MD, as a direct result of the rarity of the conditions. This forces 
researchers to employ less stringent controls over participant inclusion criteria 
concerning age, sex, condition severity, condition duration and rate of progression. 
Other barriers include the labour-intensive requirement for participant supervision 
to ensure movement quality, and the need to adapt regular exercises to allow 
completion by individuals with severe disabilities. Despite these barriers, research 
in this area is warranted. 
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Aside from the muscular adaptations typically associated with RT, there are other 
benefits of RT. Positive effects of RT on mental health and wellbeing are well 
documented in a variety of clinical populations. Perhaps of most interest are those 
studies demonstrating improved mental health in older adults, who similar to adults 
with MD, often experience inadequate muscle mass, strength and physical function 
(von Haehling et al., 2010). QoL has been shown to consistently improve post 
completion of a RT programme in a variety of clinical populations, including  adults 
with Parkinson’s disease (Ferreira et al., 2018), older adults (Kekalainen et al., 2018) 
and patients with chronic heart failure (Lans et al., 2018). With regards to the more 
detailed parameters of mental health, several reviews have been conducted into 
the effects of RT in numerous populations. O' Connor et al. (2010) conducted a 
systematic review and meta-analysis into the effects of RT on various aspects of 
mental health, including anxiety, depression and global self-esteem. Furthermore, 
Mead et al. (2010) meta-analysed studies that had measured the effects of RT in 
clinically depressed individuals and Spence et al. (2005) meta-analysed the influence 
of RT on global measures of self-esteem.  
The effects of RT on the reduction of anxiety symptoms are positive. O' Connor et 
al. (2010) revealed a moderate effect (0.19 SD) of RT on the reduction of anxiety 
symptoms across older adults, breast cancer patients and adults with osteoarthritis, 
but a large effect of RT (0.54 SD) was established when those studies that included 
only older adults were meta-analysed (Tsutsumi et al., 1998; Jette et al., 1996; 
Damush and Damush, 1999; Cassilhas et al., 2007). Importantly, Strickland and 
Smith (2014) highlighted the importance of an intensity threshold, with the largest 
reductions in anxiety associated with RT programmes of moderate intensity. 
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 The evidence with regards to the effect of RT on depression is supportive, on the 
whole. Mead et al. (2010) reported large reductions in the severity of depressive 
symptoms (1.34 SMD) amongst clinically depressed patients. Furthermore, 
consistent reductions in depressive symptoms amongst individuals with 
fibromyalgia (Jones et al., 2002; Hakkinen et al., 2001), spinal cord injury (Hicks et 
al., 2003) and osteoarthritis (O' Reilly et al., 1999) have been established, whilst 
results in older adults are inconclusive. Some studies have found a positive effect of 
RT in older adults, with reductions to the severity of depression (Cassilhas et al., 
2007; Timonen et al., 2002; Singh et al., 1997), whilst other studies have reported 
no change to depression with RT in elderly populations (Jette et al., 1996; Sims et 
al., 2006; Chin A Paw et al., 2004; Penninx et al., 2002). It is unclear exactly which 
variables mediate the effect of RT on depression in older adults as many similarities 
in study design exist between the two groups, such as an age range from 68 to the 
mid 80’s, programme durations between 10 and 24 weeks on both sides and 
exercise frequencies of 2 or 3 times per week on both sides. Logically, it could be 
assumed that the baseline severity of depression likely mediates the effect of RT in 
elderly adults, however, Penninx et al. (2002) showed no effect of RT in both highly 
depressed and non-depressed older adults. On closer inspection, it appears that 
adherence and compliance to RT programmes are the key mediators in whether RT 
influences depression in older adults. Adherence was reportedly high in those 
studies that reported a positive effect of RT (reported as above 75%, on average 
90% and on average 93%) and low in those that reported no effect of RT (ranging 
from 58 % to 71%). What is more, after finding no effect of RT between depressed 
and non-depressed elderly adults, Penninx et al. (2002) found a significant effect of 
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RT when participants were re-grouped by compliance percentage, reporting a 
reduction in depression in the high compliance group only (≥ 79 %).  Thus, it appears 
that RT does positively influence depression in elderly adults, as long as adherence 
to the programme is sufficient.  
Investigation into the effects of exercise on self-esteem are typically focused on 
global measures of self-esteem. Spence et al. (2005) found a small effect (0.24 SD) 
of RT on improvements in self-esteem and O' Connor et al. (2010) concluded that 
randomised control trials exhibited a consistently positive effects of RT on global 
self-esteem across a range of populations, including elderly men and women 
(Tsutsumi et al., 1998; Singh et al., 1997), cancer patients (Courneya et al., 2007) 
and clinically depressed individuals (Ossip-Klein et al., 1989). More recently, 
improvements in global self-esteem together with larger improvements in physical 
self-perceptions have been demonstrated in a population of obese women, post 12-
weeks of RT (Megakli et al., 2015). Physical self-perceptions may have a higher 
sensitivity to change than global measures of self-esteem following a programme of 
RT specifically, given the focus of RT on physical aspects and the multidimensional 
nature of self-esteem. Overall, RT may also elicit beneficial effects on aspects of 
mental health and QoL in individuals with MD.  
In addition to the potential psychological health benefits of RT discussed above, RT 
might also influence the walking ability of individuals with MD. Evidence to suggest 
this stems from a positive relationship found between lower limb muscle strength 
and self-selected walking speed in older adults (Buchner et al., 1996). Habitual gait 
speed increased with leg muscle strength up to a threshold, after which no 
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advantage of muscle strength was evident (Buchner et al., 1996). This highlights the 
important role of lower limb muscle strength on gait performance, in individuals 
with initially weaker muscles. Further to this, in MD participants specifically, 
Lindeman et al. (1998) reported a strong correlation between quadriceps muscle 
strength and timed motor performances (the 6-minute walk test, descending and 
ascending stairs and rising from a chair), in Myotonic MD. RT programmes have 
proved successful in influencing a number of gait parameters, in other disorders 
that commonly exhibit gait deficiencies. For example, in individuals with multiple 
sclerosis, increased walking speed, increased stride length and decreased double 
support duration has been reported (Manca et al., 2017; Kierkegaard et al., 2016; 
Gutierrez et al., 2005). In children with cerebral palsy, positive effects of RT include 
increased ankle power at push-off and reduced minimum knee angle during the 
stance phase (Eek et al., 2008; Engsberg et al., 2006). Thus, RT may also influence 
walking speed and gait parameters in individuals with MD.  
Essentially, there is viable potential for RT to improve muscle strength in MD, as 
shown in healthy individuals and other clinical populations, or for RT to stabilise the 
inherent decline in muscle mass and strength in MD. Furthermore, the benefits of 
RT in MD may go beyond muscle strength, yielding functional benefits in the 
physical and/or psychological domain. RT may be able to improve physical function 
and walking ability in MD, along with psychological health and wellbeing. Few 
research studies have considered the role of RT on muscle strength in MD, and even 
fewer studies have considered the potential for additional benefits of RT in 
individuals with MD.  
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2.5.1 RT on Muscle Strength in MD 
Few research studies have investigated the influence of RT programmes on 
variables of muscle strength in MD. In FSHD, LGMD and BMD specifically, only one 
study has examined adults with FSHD (Van der Kooi et al., 2004) and another study 
has investigated a combined cohort of individuals with LGMD and BMD (Sveen et 
al., 2013). Gianola et al. (2013) conducted a systematic review and meta-analysis 
into RT in individuals with MD, in which only five studies were retrieved overall. The 
participants in those studies consisted of children with Duchenne MD (de Lateur 
and Giaconi, 1979), adults with Myotonic MD (Kierkegaard et al., 2011; Lindeman 
et al., 1995; Tollback et al., 1999) and adults with FSHD (Van der Kooi et al., 2004). 
Four of the studies measured isometric maximum voluntary contraction (MVC) 
torque (Lindeman et al., 1995; Tollback et al., 1999; Van der Kooi et al., 2004; de 
Lateur and Giaconi, 1979). The authors conducted a meta-analysis on those studies 
that measured MVC torque of the knee extensor muscles and found no significant 
effect of RT, but the direction of the effect was positive in all of them (Gianola et al., 
2013). This non-significant outcome is likely due to the small number of participants 
that could be used in the meta-analysis (total of 37), which highlights the need for 
further research. It is pertinent to note that within these progressive conditions that 
the ability to maintain rather than significantly increase strength may be equally as 
meaningful, and future research should recognise this. The meta-analysis also 
considered the influence of RT on physical function (Gianola et al., 2013). Two 
studies that included multiple measures of physical function (Kierkegaard et al., 
2011; Lindeman et al., 1995), such as time to ascend the stairs, time to descend the 
stairs and time to stand up from a seated position, were meta-analysed, but no 
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significant effect of RT was found. However shortly after this review, Sveen et al. 
(2013) demonstrated a ~60% and ~35% increase in elbow flexor and knee extensor 
muscle strength, respectively, following 24-weeks of RT in adults with LGMD and 
BMD. This latter study offers support for RT in adults with MD and justifies the need 
for continued research in this area to determine an outcome unequivocally. 
The previous studies of RT on muscle strength in individuals with MD share some 
common drawbacks. Firstly, authors typically did not include any further 
physiological measures of muscle mass or function within their investigations. 
Secondly, only a limited number of skeletal muscles were measured (the knee 
extensors, knee flexors, elbow flexors and ankle flexors), which limits comparisons 
of strength between different muscles in the same individuals. Furthermore, limited 
subtypes of MD were considered, with the majority conducted in participants with 
Myotonic MD, and measures of physical function were rare. Finally, a major barrier 
to detecting a significant effect of RT in previous studies is that the progressive 
nature of MD was sometimes overlooked. Appropriate control groups or periods 
allow comparisons between RT programme effects and the muscular changes that 
typically occur during the degenerative progression of the disease. This is possible 
by utilising control groups who have a similar disease type, severity and progression 
rate or by measuring a control period before participants complete the RT 
programme. Some of the previous studies either failed to include a control 
group/condition or utilised the participant’s contralateral limb as a control 
condition. This overlooks the possibility that unilateral RT can cause cross-education 
(strength gain in the opposite untrained limb) and therefore may mask the normal 
progression of MD. 
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Of all the previous RT studies in MD presented above, exercise duration ranged from 
12-52 weeks, with significant gains in knee extensor one-rep maximum strength 
reported after a 12-week programme (Tollback et al., 1999). More RT studies are 
required to establish whether RT is beneficial in various types of MD. 
2.5.2 RT on Gait in MD 
Few studies have investigated the influence of RT on gait in MD and those that have, 
combined RT with aerobic exercise. Furthermore, in adults with FSHD, LGMD and 
BMD specifically, only one study included adults with LGMD and BMD. A study 
focused on balance and gait in Myotonic MD, investigated the effects of a 6-week 
rehabilitation-training programme. This program consisted of stretching exercises, 
balance training on a wobble board, resistance exercise on an isokinetic 
dynamometer and aerobic treadmill training (Missaoui et al., 2010). Increases of 
18% and 32% in peak knee extension and knee flexion torques, respectively, were 
reported. These strength increases were accompanied by an improvement in 
balance, measured via the berg balance scale, functional reach test and timed up 
and go test, along with a 6% increase in fast walking speed but not self-selected 
walking speed. Whilst this evidence offers some support for the use of RT towards 
improving gait speed and stability in MD, the more detailed gait parameters were 
not measured and the sole influence of RT cannot be separated from the additional 
elements of the exercise programme. In addition, Berthelsen et al. (2014) 
investigated the combined effect of aerobic (walking or running) and RT (squats, calf 
raises and lunges) in individuals with LGMD and BMD, using an anti-gravity 
treadmill. Participants underwent a 10-week control period followed immediately 
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by the exercise programme, which was completed three times per week for a total 
of ten weeks. All exercises were completed on a treadmill within a lower body 
reduced pressure compartment. This allowed participants to exercise at a reduced 
proportion of their bodyweight, which was progressive and individualised to each 
participant. The RT consisted of squats, calf raises and lunge exercises whilst the 
treadmill was at a standstill. Post training, an 8% improvement in the distance 
walked over 6 minutes was reported, compared to the control period. In addition, 
after completion of the exercise programme a 13% improvement in dynamic 
balance measured using an AMTI force platform was reported. Both the 
improvement in walking speed and dynamic balance in this study offer support for 
RT in individuals with MD, but a deeper insight into the mechanism behind the 
increased walking speed, and whether these balance improvements were 
transferred during the task of walking remain unknown.  
The biomechanical mediators of increased walking speed associated with exercise 
interventions in MD remain unknown. To combat this, detailed gait parameters, 
such as joint kinematics, joint kinetics and powers, muscle activity, energetics and 
stability require investigation. Future work is required to explore the possibility that 
RT can firstly, increase muscle strength in the legs of individuals with MD, and 
subsequently induce improvements in the detailed gait deficits and functional 
capacity of individuals with MD.  
2.5.3 RT on QoL and Mental Health in MD 
The few studies that have investigated RT in individuals with MD have been 
generally limited to physiological and biomechanical outcome measures. 
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Investigations into mental health have been limited to measures of QoL. 
Kierkegaard et al. (2011) measured QoL via the Short-Form 36 Health Survey, 
following 14-weeks of RT in adults with Myotonic MD, but no change was found. In 
addition, Berthelsen et al. (2014) observed QoL in adults with LGMD and BMD, 
before completion of a 10-week combined aerobic and RT programme, but 
unfortunately the authors failed to measure it post RT, reporting it as a baseline 
characteristic only. The more detailed variables of psychological health (e.g. anxiety, 
depression and self-esteem) are yet to be investigated following a programme of RT 
in MD. This is a disappointing since mental health and wellbeing are an extremely 
important part of an individual’s global health. 
2.5.4 Recommendations 
Overall, there is an insufficient number and quality of research studies investigating 
the effect of RT on muscular, biomechanical and psychological variables in adults 
with FSHD, LGMD and BMD. The clinical implications of this are that there remains 
no answer to whether RT is beneficial, null or detrimental to individuals with MD. 
The collection of previous research studies that have measured muscle strength 
post RT have numerous limitations, and future research should make certain to 
include a range of muscle groups, include additional physiological and functional 
measures and importantly, ensure that appropriate control groups or control 
periods are utilised. Furthermore, investigation into the effect of RT on walking 
ability in MD is extremely scant and the biomechanical mechanisms of how, if at all, 
RT improves gait in MD are completely unknown. Therefore, future research should 
prioritise more sophisticated biomechanical variables of gait as outcome measures. 
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Finally, the effect of RT on psychological health in MD is yet to be investigated to 
any great depth. Regardless of whether RT is beneficial to muscle strength in MD, 
as long as it is not harmful, RT may positively influence psychological health, which 
in itself is extremely important to health and warrants investigation.  
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2.6 Thesis Aims and Objectives 
The overarching aims of the current thesis are: 
1) To contribute towards the understanding of muscle strength, gait and 
psychological limitations in individuals with FSHD, LGMD and BMD. 
2) To enhance the understanding of the potential role of RT as an intervention 
in adults with FSHD, LGMD and BMD. 
More specifically, the thesis objectives are: 
1) To compare the lower-limb muscle strength and function of ambulatory 
adults with FSHD, LGMD and BMD, versus non-dystrophic age-matched 
control adults. 
2) To examine the effect of a 12-week RT programme on lower-limb muscle 
strength and function in ambulatory adults with FSHD, LGMD and BMD. 
3) To compare gait, including spatial-temporal, kinematic and kinetic variables, 
of ambulatory adults with FSHD, LGMD and BMD versus non-dystrophic 
control individuals. 
4) To examine the effect of a 12-week RT programme on gait in adults with 
FSHD, LGMD and BMD. 
5) To compare the mental health of adults with MD (FSHD, LGMD and BMD) to 
non-dystrophic control adults, and to assess the relationship of these 
parameters to quality of life in MD. 
6) To examine the effect of as 12-week RT programme on QoL and mental 
health in adults with FSHD, LGMD and BMD. 
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2.7 Thesis Outline 
This thesis will present each data chapter in two parts. Part A is a between 
participant design that examines differences between a MD group and an age-
matched control group, or between three MD groups (FSHD, BMD and LGMD) and 
an age-matched control group. Part B is a within participant design that examines 
the influence of a 12-week RT programme compared to a 12-week control period, 
in a MD population.  
Chapter 3 examines MVC torque in eight lower-body muscles and physical function 
via a 6-minute walk test, in adults with FSHD, BMD and LGMD compared to a 
matched control group. Part B examines the influence of a 12-week RT programme 
on MVC torque in eight lower-body muscle groups and timed tests of physical 
function, inclusive of a 6-minute walk test, a sit to stand test, a balance test, a stair 
ascent and a stair descent test, compared to a 12-week control period in a group of 
adults with MD (FSHD, BMD and LGMD). 
Chapter 4 describes joint kinematics during gait and the metabolic cost of walking 
in adults with FSHD, BMD and LGMD, compared to a matched control group. Part B 
of this chapter examines the effect of a 12-week RT programme on these variables 
compared to a 12-week control period, in a group of adults with MD (FSHD, BMD 
and LGMD).  
Chapter 5 describes joint kinetics (joint moments, joint powers and ground reaction 
forces) during gait in three groups of adults with FSHD, BMD and LGMD, compared 
to a matched control group. Part B of this chapter examines the effect of a 12-week 
74 
 
RT programme on these variables compared to a 12-week control period, in a group 
of adults with MD.  
Chapter 6 investigates the mental health and QoL profiles of a group of adults with 
MD, compared to a matched control group, along with the severity of kinesiophobia 
in adults with MD. In addition, associations between physical activity and numerous 
mental health factors to QoL were examined in the MD population. Part B examines 
the influence of a 12-week RT programme on mental health and QoL, compared to 
a 12-week control period in a MD population.   
Chapter 7 provides an overall summary of the principal findings, the clinical 
implications, the main limitations, the recommended future research and the 
overarching conclusions from this thesis.
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Chapter 3 
Influence of resistance training on muscle 
strength and physical function in adults 
with Facioscapulohumeral, Limb-girdle and 
Becker muscular dystrophy 
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3.1 Introduction 
3.1.1 Part A 
MD encompasses a range of myogenic conditions, which are caused by a variety of 
genetic mutations (Huml, 2015). Such mutations give rise to a reduced or absent 
expression of intra-muscular proteins, which ultimately cause progressive 
weakening and deterioration of the muscles (Mercuri and Muntoni, 2013). 
Duchenne MD is the most severe form of MD, characterised by an absence of the 
protein dystrophin (Koenig et al., 1989), early childhood onset, rapid progression, 
cardiac and respiratory complications, loss of ambulation during childhood and 
premature death (Bushby et al., 2010). Other types of MD vary between childhood 
and adult onset, progress slower and do not typically lose the ability to walk, at least 
until later in adulthood (Emery, 2002). Three common types of MD that match the 
latter description are FSHD, LGMD and BMD (Emery, 2002). Similar to Duchenne 
MD, BMD is also due to a defect in the dystrophin protein, but the protein is reduced 
or dysfunctional rather than absent (Koenig et al., 1989). BMD is described as a less 
severe variant of Duchenne MD, with the loss in ability to walk typically occurring 
from the second decade of life onwards (Mercuri and Muntoni, 2013). FSHD and 
LGMD are both heterogeneous conditions, with various subtypes in each condition 
affecting different proteins at several molecular levels of the muscle cell (Sacconi et 
al., 2015; Liewluck and Milone, 2018). FSHD and LGMD typically occur in adulthood, 
with the loss in ability to walk occurring much later in life (Emery, 2002), if at all. 
Despite differences in genotype between FSHD, LGMD and BMD, they all ultimately 
gives rise to progressive weakening and deterioration of the skeletal muscles 
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(Mercuri and Muntoni, 2013). Alongside this, individuals experience a worsening 
ability to perform daily functional tasks (Emery, 2002) such as, standing up from a 
seated position, walking, climbing stairs, descending stairs and many more.   
Distribution patterns of muscle weakness in MD have been described clinically and 
schematics, such as that presented by Mercuri and Muntoni (2013) in Figure 3.1, 
are often referred to within the literature to describe predominant weakness 
patterns. Although clinical descriptions of weakness distribution in FSHD, LGMD and 
BMD are readily available, they are not based on quantitative data presenting 
muscle strength in these populations. Such data does not exist to any great extent 
or depth within the literature, which is important as subtype-specific patterns of 
muscle weakness are often used to inform an initial MD classification, to direct 
diagnostic testing, and to inform the clinical management of a patient.  
Figure 3.1: Pattern of predominant muscle weakness in MD: Duchenne and Becker (A), 
Emery-Dreifuss (B), Limb-girdle (C), Facioscapulohumeral (D), Distal (E) and 
Oculopharyngeal (F). Shading = involved muscles. Taken from Mercuri and Muntoni (2013). 
In BMD, LGMD and FSHD only five studies have actively quantified lower-limb MVC 
torque (Bachasson et al., 2014; Jacques et al., 2018; Lokken et al., 2016; Skalsky et 
al., 2008; Marra et al., 2018), in four muscle groups: knee extensors, knee flexors, 
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dorsi-flexors and plantar-flexors. The number of investigations that have taken 
place for each muscle group per type of MD are demonstrated in Figure 3.2. From 
these five studies, some agreement with the pre-existing clinical classifications of 
muscle weakness distribution is evident (Figure 3.1). Accordingly, plantar flexor 
MVC torque was reportedly 35% weaker in adults with FSHD, and knee extensor 
MVC torque was 43% weaker in adults with LGMD, compared to non-dystrophic 
control adults (Jacques et al., 2018). These findings parallel the pre-existing clinical 
classifications of weakness distribution in FSHD and LGMD (Figure 3.1). However, 
numerous experimental studies have reported data that do not support such clinical 
descriptions.   
Numerous experimental studies present results that challenge certain aspects of 
clinical classifications of muscle weakness distribution in FSHD, BMD and LGMD 
(Figure 3.1). Firstly, the knee extensor and knee flexor muscles are not recognised 
as a predominant region of muscle weakness in individuals with FSHD (Figure 3.1), 
yet studies have revealed knee extension MVC torques that were 41.6% (Skalsky et 
al., 2008), 44.9% (Bachasson et al., 2014) and 65.6% (Marra et al., 2018) weaker 
than non-dystrophic control groups, in these individuals. In addition, knee flexion 
MVC torque was found to be 56% weaker in FSHD than a non-dystrophic control 
group (Skalsky et al., 2008). Secondly, LGMD is described as presenting a primarily 
proximal muscle weakness pattern (Mercuri and Muntoni, 2013) (Figure 3.1), yet 
numerous studies have found significantly reduced muscle strength in the distal 
muscles of these individuals. In the plantar flexor muscles, MVC torque was found 
to be  58% weaker (Jacques et al., 2018) and 42% weaker (Lokken et al., 2016) than 
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a healthy control group, and in the dorsi flexor muscles MVC torque was 31% 
weaker (Lokken et al., 2016) than a control group. Finally, BMD is described clinically 
as presenting with descending proximal to distal muscle weakness (Emery, 2002). 
Jacques et al. (2018) reported that knee extensor MVC torque was 42% weaker in 
adults with BMD than a non-dystrophic control group, but Jacques et al. (2018) also 
reported a greater weakness, relative to the control group, of 51% in the distal 
plantar flexor muscles of the same individuals. This does not match with the 
proximal to distal muscle weakness classification that is described clinically for BMD 
(Emery, 2002). Thus, the clinical classifications of muscle weakness distribution in 
MD exhibit numerous discrepancies to the published strength data in FSHD, BMD 
and LGMD. 
The MVC torque averaged from all previous investigations that have measured MVC 
torque of the knee extensors, knee flexors, plantar flexors or dorsi flexors, in 
individuals with FSHD, BMD and LGMD are presented in Figure 3.2, relative to non-
dystrophic control groups. Within this schematic, the discrepancies between the 
pre-existing clinical descriptions of weakness distribution in MD and the 
quantitative data that are discussed above are evident. 
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Figure 3.2: MVC torque per MD type in the knee extensors (green), knee flexors (blue), 
plantar flexors (red) and dorsi flexors (grey), as a percentage of MVC torque in control 
participants. Data was averaged from previously published data (Bachasson et al., 2014; 
Jacques et al., 2018; Lokken et al., 2016; Skalsky et al., 2008; Marra et al., 2018). Shading 
represents clinical classifications of weakness distribtuion (taken from Mercuri and 
Muntoni (2013). Dashed lines represent the range across multiple studies. The number of 
assesments per muscle group are presented above or below the corresponding rectangle.   
It is important to note that although experimental data in FSHD, BMD and LGMD 
highlight some discrepancies with the clinical classifications of weakness 
distribution, the previous studies are subject to numerous limitations. Firstly, only 
four muscle groups have been quantified overall, and no quantification of MVC 
torque has been reported in the muscle groups of the hips (e.g. hip abductors). The 
maximum number of muscles measured per study was two, which limits 
comparisons of relative muscle strength between different muscle groups in the 
same individuals. Three studies utilised a portable strain-guage to measure MVC 
torque (Jacques et al., 2018; Bachasson et al., 2014; Marra et al., 2018), which is far 
more practical in this population than an isokinetic dynamometer; the gold standard 
of strength assessment. However, only one of those studies (Jacques et al., 2018) 
also demonstrated the reliability of their measurement technique and protocol. 
Finally, a major flaw of the previous research in this area is related to the method 
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of matching control groups to experimental groups. Three studies did match 
(Bachasson et al., 2014; Lokken et al., 2016) or accounted for statistically (Jacques 
et al., 2018) the age of participants between the groups. However, Skalsky et al. 
(2008) matched participants by sex, height and weight and Marra et al. (2018) did 
not match the participant groups, resulting in a difference of 20.5 years in the 
median age between the experimental and control group. Due to the progressive 
nature of MD and the decline in muscle strength with typical ageing, the use of 
appropriately age-matched control groups within MD research is of paramount 
importance.  
Overall, five studies have quantified MVC torque in BMD, LGMD and FSHD and in 
those studies numerous limitations are evident. Therefore, the first aim of this study 
is to quantify the MVC torque of eight lower-body muscle groups and physical 
function in the form of a six-minute walk test, of adults with FSHD, BMD and LGMD, 
and compare to an age-matched control group. 
3.1.2 Part B 
In healthy populations it is well established that RT increases skeletal muscle 
strength and lean body mass (Kraemer and Ratamess, 2004; Williams et al., 2007). 
Furthermore, RT has proved highly beneficial in increasing MVC torque in older 
adults (Morse et al., 2005), a population that often presents with muscle weakness 
similar to MD. It would be highly valuable if RT offered similar benefits to adults 
with MD, but this is yet to be established.  
For many years RT in adults living with MD was discouraged or disregarded by the 
medical domain. This was due to reservations that RT may damage muscle cells in 
82 
 
individuals with MD (Ansved, 2001). However, the evidence for this is limited to 
anecdotal case reports of overwork weakness in FSHD (Johnson and Braddom, 
1971) and scapuloperoneal MD (Wagner et al., 1986) and murine evidence in MDX 
mice (Weller et al., 1990; Petrof et al., 1993). MDX mice represent one type of MD 
only (Duchenne) and in any case,  the replicability of the MDX mutation to Duchenne 
MD is limited (Partridge, 2013) . Given the stark differences in genotype and severity 
of Duchenne MD to other types of MD, along with questionable applicability of MDX 
mice results to humans, it is illogical to assume that RT should be avoided in all types 
of MD. Yet, there remains a lack of experimental investigation into RT in individuals 
with MD.  
A meta-analysis conducted by Gianola et al. (2013) was unable to determine 
whether RT was beneficial or not in MD, as only four studies had previously 
measured MVC torque following a period of RT in individuals with MD (Lindeman et 
al., 1995; Tollback et al., 1999; Van der Kooi et al., 2004; de Lateur and Giaconi, 
1979). Nevertheless, the authors did establish that despite no overall effect of RT, 
the direction of the effect in each of those studies was positive (Gianola et al., 2013). 
Shortly afterwards, Sveen et al. (2013) reported an approximate 60% and 35% 
increase in elbow flexor and knee extensor muscle strength (one-repetition 
maximum), following 24-weeks of RT in adults with LGMD and BMD. This research 
provides support for a beneficial effect of RT on muscle strength in adults with 
LGMD and BMD. However, more research, in more muscles, is required to 
determine this unequivocally. 
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It is pertinent to note that within this progressive condition (MD), the ability to 
maintain rather than increase muscle strength may be equally as meaningful. A 
major flaw of previous investigations into RT in MD is the lack of appropriate control 
groups or control periods within study designs. This limits comparison between the 
RT programme and the typical deterioration that may occur over an equal time 
period, due to the progressive condition. One possible approach to combat this is 
through the use of a within participant control design. These have previously been 
adopted to account for participant variance within small cohort training studies. In 
addition, limited attention has previously been paid to the influence of RT on 
functional performance in adults with FSHD, BMD or LGMD (Gianola et al., 2013). 
Whilst muscle strength is an important variable, the influence of RT on everyday life 
and physical function is of particular importance to prolonging independence in this 
population.  
Therefore, the second aim of the present investigation was to determine the effect 
of a 12-week, twice a week, RT programme, compared to a 12-week control period, 
on isometric MVC torque and timed functional tasks.
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3.2 Method 
3.2.1 Study Design  
The experimental design for this study was based around two parts. Part A was 
conducted to allow group comparisons between adults with muscular dystrophy (MD) 
and adults without MD (hereafter referred to as controls). Part B was a within-
participant design involving a subgroup of adults with MD, and included 12 weeks of 
observation, followed by 12 weeks of resistance training (RT). 
In part A, ten control and twenty-two MD participants attended the laboratory at 
MMU to complete one baseline testing session (PRE1). Data from this testing session 
correspond to baseline comparisons. A subset of 17 MD participants also completed 
part B. In total, part B participants completed three testing sessions including PRE1, 
followed by a second testing session 12-weeks after a control period (PRE2) and a 
third testing session within two weeks of completing a 12-week RT programme 
(POST, Figure 3.1). During the 12-week control period, MD participants were asked to 
maintain their habitual physical activity levels. The 12-week supervised RT programme 
took place at the Neuromuscular Centre (NMC), twice a week. Data collection at each 
testing session (i.e. PRE1, PRE2 and POST) remained identical.  One additional testing 
session, MID-Train, took place halfway through the RT programme, which consisted 
of functional test measures.  
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Figure 3.1. Schematic of study design. CTRL= control, MD = muscular dystrophy, 
PRE1 = testing session 1, PRE2 = testing session 2, POST = testing session 3. 
3.2.2 Participants 
Twenty-two adults with three distinct variants of MD; 7 with Becker (BMD), 9 with 
Facioscapulohumeral (FSHD) and 6 with Limb-girdle (LGMD) completed part A, 
along with 10 controls matched by age, stature and body mass (Table 3.1). 
Seventeen adults with three distinct variants of MD: 5 with BMD, 6 with FSHD and 
6 with LGMD completed part B (Table 3.2).  
All participants were between 26 and 64 years old, had not previously undertaken 
structured RT and were of sound intellectual status. All participants were untrained 
but functionally active (ambulatory) and self-reported that they did not undertake 
more than one hour of intense physical activity or three hours of low-moderate 
physical activity each week. Control participants were free from any known significant 
health problems, illness or musculoskeletal injuries. MD participants were able to 
walk at least seven metres with or without assistive walking devices, were in otherwise 
good health and without any uncontrolled co-morbidity or cardiac issues. All MD 
participants had previously received a laboratory confirmed diagnosis of MD via 
genetic testing at specialist clinics. MD participants were recruited from the NMC 
12-weeks control period  
(n = 17) 
12-weeks resistance training 
(n = 17) 
PRE1 
CTRL: (n =10) 
MD: (n =22) 
PRE2 
MD: (n =17) 
POST 
MD: (n =17) 
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(Cheshire, UK), a centre of excellence for adults with MD, where they regularly 
(weekly, bi-weekly or monthly) receive physiotherapy to maintain function and 
independence. 
Manchester Metropolitan University (MMU) Ethics Committee granted ethical 
approval and all participants provided written informed consent, prior to participation. 
Table 3.1: Participant characteristics for part A, presented as mean ± SD.  
 CTRL MD BMD FSHD LGMD 
n 10 22 7 9 6 
Male/Female 5/5 16/6 7/0 6/3 3/3 
Age (years) 46.8 ± 10.2 45.5 ± 9.4 42.1 ± 7.6 46.7 ± 11.2 47.3 ± 11.3  
Stature (cm) 174.4 ± 7.5 178.1 ± 9.0 179.9 ± 9.4 181.4 ± 6.3 170.9 ± 9.0 
Mass (kg) 79.4 ± 12.3 88.0 ± 17. 93.0 ± 16.7 88.2 ± 18.4 82.0 ± 19.4 
CTRL= control, MD= muscular dystrophy, BMD= Becker, FSHD= Facioscapulohumeral, 
LGMD= Limb-girdle. 
 
Table 3.2: Participant characteristics for part B, presented as mean ± SD.  
 MD BMD FSHD LGMD 
n 17 5 6 6 
Age (years) 43.6 ± 10.8 40.0 ± 8.0 43.3 ± 12.8 47.0 ± 11.5 
Stature (cm) 176.8 ± 8.3 180.2 ± 8.1 179.9 ± 4.4  170.9 ± 8.2 
Mass (kg) 87.9 ± 16.7  92.3 ± 17.0 90.1 ± 13.6 82.0 ± 17.7 
MD= muscular dystrophy, BMD= Becker, FSHD= Facioscapulohumeral, LGMD= Limb-girdle.
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3.2.3 Procedures 
All participants were screened for eligibility during a face-to-face meeting or via email. 
All testing sessions were identical, as time of day, equipment and order of data 
collection remained consistent, both between participants and between testing 
sessions. Participants attended the laboratories at MMU for a total of four hours per 
testing session, having refrained from consuming caffeine and alcohol in the 12 hours 
prior to the start of testing. Anthropometric and body composition measures were 
taken first, followed by strength tests in the knee flexor and knee extensor muscles 
using a Cybex dynamometer and six additional lower-limb strength tests measured 
using a load-cell, gait analysis and finally, a 6-minue walk test was completed. 
Participants also completed four timed functional tests at the NMC and seven 
questionnaires, within one week of each testing session. 
3.2.3.1 Anthropometry 
Stature (m) and body mass (kg) were measured using a stadiometer that was wall 
mounted and digital scales (Seca model 873, Germany). The dominant limb was 
determined via self-report, in answer to the following question: which leg would 
you use to stop a football that was rolling towards you? Leg length (mm; measured 
from the anterior superior iliac spine to the medial malleolus) was measured using 
a tape measure whilst the participant stood up. Knee width (mm; width of the knee 
from the medial to the lateral epicondyles of the femur) and ankle width (mm; 
medial-lateral distance across the malleoli) were measured bilaterally using 
callipers, whilst the participant stood up. Sole delta (mm; the difference in thickness 
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of the sole of the shoe at the toe and at the heel – positive indicates that the heel is 
raised compared to the toe) was measured whilst participants were seated. 
3.2.3.2 Body Composition 
Body composition, including fat mass and lean mass were measured using a 
bioelectrical impedance (BIA) device (Model 1500: Bodystat, Isle of Man, UK), whilst 
participants lay supine on a physiotherapy treatment bed. They were positioned 
with their arms slightly abducted from their sides and their legs separated 
marginally. Adhesive surface electrodes were placed on the right limb: on the dorsal 
surface of the hand at the metacarpals and at the distal prominences of the radius 
and ulna and on the dorsal surface of the foot at the metatarsals and between the 
medial and lateral malleoli. BIA was used as a substitute to a dual energy x-ray 
absorptiometry scan, because of the reduced functional movement ability in MD 
participants. BIA has previously been reported as a valid and reliable measure 
compared to dual-energy X-ray absorptiometry in adults with a wide range (19-38 
kg/m2) of body mass indices (von Hurst et al., 2016).  
Lean mass was determined using the following equation: 
𝐿𝑒𝑎𝑛 𝑚𝑎𝑠𝑠 (𝑘𝑔) = 𝑏𝑜𝑑𝑦 𝑚𝑎𝑠𝑠 (𝑘𝑔) − 𝑓𝑎𝑡 𝑚𝑎𝑠𝑠 (𝑘𝑔) 
3.2.3.3 Knee Extensor and Knee Flexor Torque 
Isometric maximal voluntary contraction (MVC) torque during knee extension and 
knee flexion were measured using an isokinetic dynamometer (Cybex Norm, Cybex 
International Inc., NY, USA). Participants sat on the dynamometer chair with a hip 
angle of 85° and were secured with straps around the shoulders, hips and thigh 
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(Figure 3.2). The axis of rotation of the dynamometer was aligned with the knee 
joint centre of rotation by visual inspection and the dynamometer and chair settings 
(lever arm length, back angle, chair fore-after position, dynamometer rotation and 
dynamometer height) were noted and remained consistent between testing 
sessions. The cuff of the lever arm was attached proximal to the medial malleolus 
on the dominant leg. 
Participants completed a set of five submaximal warm-up contractions of knee 
flexion, followed by a set of five submaximal warm-up contractions of knee 
extension. Subsequently, at an angle of 70° knee flexion, participants completed 
two maximal contractions of knee flexion, followed by two maximal contractions of 
knee extension, on the dominant leg. Participants were instructed to contract 
maximally for approximately 4 seconds, until verbally cued to relax. Verbal 
encouragement was given during MVCs and a three-minute rest period was given 
between each MVC. MVC torque was visible to participants during the contraction 
on a computer (Macintosh) and was recorded on an Apple computer (Cupertino, 
CA, USA) via an A/D converter (Biopac Systems, Santa Barbara, CA).  
Torque measurements were processed offline using Acknowledge software 
(Version 3.9.2). Baseline torque was removed from the trace and then peak torque 
was measured. The highest torque produced during Knee extension and knee 
flexion was taken as MVC peak torque.  
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Figure 3.2: Example of participant set-up for measurement of knee extension and 
knee flexion MVC torque.  
3.2.3.4 Strength Tests 
The research team developed seven isometric strength tests, which were initially 
piloted in individuals with MD. Due to the limited mobility, fatigue and severe 
muscle weakness associated with MD, all of the test protocols were developed to 
ensure that completion was possible by the most severe participants. The seven 
tests measured isometric force during hip flexion, hip adduction, hip abduction, 
ankle dorsi-flexion, ankle plantar-flexion, hip extension and elbow flexion, using an 
S Beam strain-gauge (SGA/A; Load Cell Shop, Richmond Industries Ltd., Reading, UK) 
that collected force-time data in newtons (N). The load cell was calibrated using 
known loads ranging from 5 g -5 kg, at 500 g increments. 
The strength tests were completed on the dominant limb with participants in one 
of three positions: lay prone, lay supine or seated on a physiotherapy treatment 
bed. Assessment of hip flexion, hip adduction and hip abduction was measured in a 
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supine position with the leg horizontal. Ankle dorsi-flexion was measured whilst 
participants lay supine with the long axis of the foot vertical. Elbow flexion and ankle 
plantar flexion were measured whilst participants were seated with the forearm 
and long axis of the foot horizontal. Hip extension was measured whilst participants 
lay prone with the leg horizontal. Straps were secured to both ends of the load-cell, 
with one strap secured to a stable base to ensure that an isometric contraction 
occurred. The opposite end, the cuff, was secured around the participant’s ankle 
during hip flexion, hip adduction, hip abduction and hip extension, around the 
participant’s forefoot during ankle plantar-flexion and ankle dorsi-flexion or within 
the participant’s hand during elbow flexion. The strap was tightened until it was 
taught, without altering the position of the limb. A detailed description of the testing 
protocol for each MVC is provided in Table 3.3. 
Participants completed practise trials followed by two MVCs. Participants were 
instructed to contract maximally for approximately 4 seconds until verbally cued to 
relax and encouragement was given throughout each MVC. Force (N) was accessible 
instantaneously using MyLabView software on a HP computer (Elite Book 850 G3) via 
an A/D converter (National Instruments Berkshire, UK). The moment arm of the MVC 
force was measured from the joint axis of rotation (anterior superior iliac spine, lateral 
malleolus or lateral epicondyle of the elbow) to the line of action of the force (the 
distance from the axis of rotation to the centre of the cuff) with a tape measure, to 
enable the calculation of torque (N.m) during data analysis.  
Force traces were processed and analysed using Microsoft Excel. The baseline force, 
due to the initial tension on the load-cell, was removed by subtracting the average 
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force over the first 3 seconds from the entire force trace. Subsequently, the highest 
force produced during MVC was taken as peak force with the higher of both trials 
used for further analysis.  
Torque, presented as MVC, was calculated using the following calculation: 
𝑇𝑜𝑟𝑞𝑢𝑒 (𝑁. 𝑚) = 𝑓𝑜𝑟𝑐𝑒 (𝑁) 𝑥 𝐸𝑥𝑡𝑒𝑟𝑛𝑎𝑙 𝑀𝑜𝑚𝑒𝑛𝑡 𝐴𝑟𝑚 (𝑚) 
3.2.3.4.1 Reliability 
This method of strength assessment is similar to those previously utilised within clinical 
research to assess muscle strength, including hand-held dynamometry and 
quantitative strength testing, which have been reported as reliable in healthy 
populations (Hogrel et al., 2007; Mentiplay et al., 2015), weaker populations with 
muscle myopathy (Baschung Pfister et al., 2018) and MD (Brussock et al., 1991).  
Test-retest reliability of the strength tests was determined in five healthy individuals 
(Mean ± SD: age: 29.4 ± 9.5 years, mass: 84.7 ± 17.5 kg, height: 175.5 ± 13.3 cm). 
Between day reliability was assessed by measuring MVC (as described above) on 
two different days, separated by an average of 48 hours. The data were checked for 
a normal distribution via the Shapiro-Wilk test, and then paired sample t-tests were 
conducted to detect any significant change in MVC between the two measures and 
Intraclass correlation coefficients were calculated to provide a complete 
assessment of reliability (Hopkins, 2000).  
Reliability tests indicated that all strength tests were reliable. There was no 
significant change in MVC between the two days in any of the seven MVC tests and 
Intraclass correlation coefficients showed good test-retest reliability across all 
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seven MVCs, ranging from .86 to .99 (Table 3.4). The absolute and relative change 
in MVC between the two days ranged from -9.7 ± 24.5 to 1.8 ± 11.5 N and -4 ± 6.6 
to 1.1 ± 7.4 %, respectively. 
94 
 
 
 
   ICC = Intraclass correlation coefficient, CI = confidence interval. 
 Day 1 
Mean ± SD 
(N) 
Day 2 
Mean ± SD  
(N) 
∆ D2-D1 
Mean ± SD 
 (N) 
∆ D2-D1 
Mean ± SD  
(%) 
ICC 
(95% CI) 
Plantar Flexion 294.7 ± 150.1 288.4 ± 139.5 -6.3 ± 12.2 -1.3 ± 2.9 
.96 
(.95 -.99) 
Dorsi Flexion 246.8 ± 86.4 237.1 ± 65.8 -9.7 ± 24.5 - 4.0 ± 6.6 
.94 
(.60 -.99) 
Hip Flexion 192.3 ± 63.6 186.8 ± 69.1 -5.6 ± 29.7 - 2.9 ± 12.0 
.90 
(.33 -.99) 
Hip Extension 195.8 ± 72.2 195.7 ± 72.9 - 0.2 ± 3.9 < 0.1  ± 2.0 
.99 
(.98 -1.00) 
Hip Abduction 141.7 ± 32.0 143.5 ± 34.7 1.8 ± 11.5 1.1 ± 7.4 
.94 
(.55 - .99) 
Hip Adduction 145.7 ± 46.3 142.8 ± 41.1 -3.0 ± 23.4 - 0.8 ± 14.3 
.86 
(.17 -.98) 
Elbow Flexion 155.7 ± 61.2 155.9 ± 61.3 0.2 ± 2.4 < 0.1 ± 1.7 
.99 
(.99 -1.00) 
 
Table 3.4: Reliability of muscle strength tests using the S Beam load cell in healthy individuals. 
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Table 3.3: Description of protocol for the measurement of MVC at the hip, ankle and elbow joint.  
MVC Position Instruction  
Hip Flexion The participant lay supine with the hip and 
knee extended at 0° (straight), 0° of hip 
abduction and neutral hip rotation with the 
foot hanging freely over the plinth. The cuff 
was secured around the ankle, 2 cm proximal 
to the medial malleolus. The load cell was 
parallel to line of gravity and secured by 
sufficient weight so that it was taut when the 
hip and knee of the leg were horizontal. 
Maximally lift the leg 
upwards, by flexing at the 
hip without bending the 
knee. 
 
 
Hip Adduction 
The participant lay supine with the hip and 
knee extended at 0° (straight), 10° of hip 
abduction and neutral hip rotation, with the 
foot hanging freely over the plinth. The cuff 
was secured around the ankle, 2cm proximal to 
the medial malleolus. The load cell was at the 
same height as the plinth, perpendicular to the 
leg and to the line of gravity, in the opposite 
direction to the pending force and secured by 
sufficient weight so that it was taut. 
 
 
Maximally pull the leg 
inwards, towards the 
opposite leg. Do not bend 
at the knee or rotate the 
foot. 
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MVC Position Instruction  
Hip Abduction 
The participant lay supine with the hip and 
knee extended at 0°, 0° of hip abduction and 
neutral hip rotation, with the foot hanging 
freely over the plinth. The cuff was secured 
around the ankle, 2cm proximal to the medial 
malleolus. The load cell was at the same 
height as the plinth, perpendicular to the leg 
and to the line of gravity, in the opposite 
direction to the pending force and secured by 
sufficient weight so that it was taut. 
Maximally push the leg 
outwards away from the 
body. Do not bend at the 
knee or rotate the foot. 
 
 
Plantar Flexion 
 
Participants sat upright on the edge of the 
plinth with their hands resting on the bed at 
either side. The knee was flexed at 90°, with 
the ankle dorsi-flexed at 90° to the shank.  The 
cuff was secured around the dorsal surface of 
the foot with the load cell directly above, 
perpendicular to the foot and parallel to the 
line of gravity, so that the strap was taut when 
the ankle was at 90° to the shank.  
 
Maximally pull your heel 
upwards, without lifting 
your knees from the 
surface of the bed. 
 
Note: If 90° of ankle 
dorsi-flexion could not 
be achieved due to 
limited range of motion, 
the closest possible 
angle to 90° was used 
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MVC Position Instruction  
Dorsi-Flexion Participants lay supine with the hip and knee 
extended at 0°, 0° of hip abduction and 
neutral hip rotation, with the foot hanging 
freely over the plinth and the ankle flexed at 
90° to the shank. The cuff was secured around 
the forefoot with the load cell positioned 
perpendicular to the foot and to the line of 
gravity, in the opposing direction to the 
pending force and secured by sufficient 
weight so that the strap was taut when the 
ankle was at 90° to the shank.                       
Maximally pull your foot 
towards your lower leg, 
without bending at the 
knee or moving the 
pelvis. 
Note: If 90° ankle dorsi-
flexion could not be 
achieved due to limited 
range of motion, the 
closest possible angle to 
0° was used. 
 
Hip Extension Participants lay prone with the hip and knee 
extended at 0° (straight), 0° of hip abduction 
and neutral hip rotation with the foot hanging 
freely over the plinth. The cuff was secured 
around the ankle, 2cm proximal to the medial 
malleolus. The load cell was parallel to line of 
gravity and secured by sufficient weight so 
that it was taut when the hip and knee of the 
leg were horizontal. 
Maximally lift the leg 
upwards, without 
bending the knee. 
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MVC Position Instruction  
Elbow Flexion 
 
The participant sat upright on the edge of the 
plinth, with their feet firmly on the ground. 
The elbow was flexed at 90° with the hand in 
supination and the shoulder adducted by 10°. 
The cuff was held in the hand with the load 
cell positioned below, parallel to the line of 
gravity and secured by sufficient weight so 
that the straps were taut when the elbow was 
at 90° flexion. 
Maximally pull the lower 
arm upwards, with no 
movement of the torso. 
 
 
 
 
 
 
 
 
MVC = maximum voluntary contraction.
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3.2.3.5 Adapted Six-Minute Walk Test  
A six-minute walk test was conducted with participants who self-reported confidence 
in their ability to walk for 6 minutes. An adapted version of the protocol set out by the 
American Thoracic Society (2002) was utilised. Participants were instructed to walk at 
their self-selected walking pace, instead of as far as possible as prescribed by the 
American Thoracic Society (2002), due to safety concerns in the current population. 
The test took place along a flat, straight corridor that was rarely used. Each end of the 
25 m course was marked with tape on the ground. Participants were instructed to turn 
clockwise at each end and walk in a straight path of movement. One investigator timed 
the walk with a stopwatch and kept count of the laps completed on each minute and 
overall. A second investigator walked behind the participant, keeping at least a 2 m 
distance, to provide encouragement (in accordance with The American Thoracic 
Society guidelines), to assess fall risk and to place markers on the course at each 
minute to enable the calculation of minute-distance splits. Participants were 
instructed to use their walking aids during the six-minute walk test if they would 
typically use them to walk for a time period of six-minutes. If walking aids were used, 
this remained constant throughout the study.   
A five-minute seated rest period was provided before completion of the walking test. 
To start the test, participants were readied at the start line and the timer was started 
once they began to walk. Participants were instructed to stop walking at six minutes 
and were subsequently seated until fully recovered. 
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3.2.3.6 Functional Tests  
Four timed functional tests were completed at the NMC: a sit-to-stand, a stair 
ascent, a stair descent and a 30 s maximum balance test. The sit-to-stand movement 
required participants to rise from a seated position to a standing position, from a 
standardised chair that measured approximately 45 cm from the floor to the seat. 
The stair ascent test required participants to climb four steps with an approximate 
rise of 15 cm between the steps. The stair descent test required participants to 
climb down the same set of four steps. The balance test required participants to 
stand on one leg with the other leg raised from the floor, for as long as possible up 
to a maximum of 30 s.  
Participants were instructed to complete all tasks as fast but as safely as possible 
and were initially given a practise trial before PRE1. Participants were encouraged 
not to use the arms of the chair during the sit to stand test or the handrails during 
the stair ascend/descent test, unless it was not possible to complete the test 
without using them, in which case this remained consistent throughout the study. 
Each test was timed using a stopwatch and recorded using a video camera.  
3.2.4 Resistance Exercise Training Programme  
The RT programme consisted of two supervised gym sessions at the NMC gym each 
week, for a total of 12 weeks. Collectively, previous research highlights that a 
frequency of 2 training days per week is sufficient to induce muscular adaptations 
in novice resistance trainers  (Bird et al., 2005) whilst also requiring minimal time 
commitments and therefore promoting adherence. The 12-week duration was 
extended where necessary so that everyone performed 24 gym sessions in total. 
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Participants received a personalised training plan that was progressive and designed 
specifically to their individual needs and capabilities. To do this the research team, 
using muscle strength and 3D gait analysis data collected at PRE1, conducted an 
individual needs analysis. The muscles that were most weak, along with the most 
pronounced gait pattern abnormalities (e.g. excessive knee extension/hyper-
extension or limited plantar flexion during the late stance phase of a gait cycle) were 
identified. Subsequently, a training programme was designed that included two 
warm-up and four consistent exercises across all participants, in addition to six 
individualised resistance exercises. Training sessions ranged between 45 minutes to 
90 minutes depending on the functional ability of the participant.  
3.2.4.1 Exercise Selection 
All exercises consisted of dynamic repetitions of concentric and eccentric muscle 
actions. Single-joint exercises formed the majority of the exercise programme, to 
ensure isolation of specific muscle groups and to ensure ease of learning a safe 
technique in novice lifters. Multi-joint exercises are more neurally and coordination 
demanding than single-joint exercises (Bird et al., 2005; Kraemer and Ratamess, 
2004) and therefore two multi-joint exercises were included within every 
programme; squat and step-up. These specific exercises were chosen due to the 
simplicity of their technique for a group of novice exercisers with muscle weakness. 
The two warm-up and 4 consistent exercises across all exercise programmes are 
described as follows. All training sessions commenced with a 5-minute warm up, 
which was completed on a cycle ergometer, rowing machine or seated cross trainer, 
followed by 5-10 minutes of balance training on a Wii Fit video game balance board 
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(Nintendo of America Inc, Redmond, WA). Specific balance games on the Wii Fit 
video game system, that required participants to transfer their centre of pressure 
in an anterior-posterior and a medial-lateral direction, were chosen. Subsequently, 
all participants then completed two multi-joint exercises: freestanding squats or 
assisted squats (further details on assisted squats are provided in 3.2.4.2 Load and 
Volume) and a step-up exercise onto a box of various and progressive heights. The 
final two exercises included within all programmes were two seated resistance 
exercises (knee flexion and knee extension) completed on a seated leg curl and 
extension machine (Pro Heavy Duty, XS Sports). Descriptions and examples of these 
exercises are provided in Appendix 2.2. Participants then completed 6 additional 
single-joint resistance exercises, based on the needs analysis completed at PRE1. 
The potential muscle groups targeted within the individual exercises included 8 
muscle groups of the lower body (dorsi-flexors, plantar-flexors, hip flexors, hip 
extensors, hip adductors, hip abductors, hip internal rotators and hip external 
rotators), along with the abdominals and/or lower back muscles. The research 
team, who have expertise in resistance exercise, movement analysis and muscle 
physiology, selected the target muscle groups using an impairment-based 
approach. Where required, the physiotherapists at the NMC were also involved in 
this process. The impairment-based approach utilised firstly, gait data to highlight 
the most pronounced gait deviations (compared to the control data) and then 
secondly, combined this information with muscle strength data to decipher which 
gait deviations were primary (due to a muscle weakness) or secondary (a 
compensatory mechanism for a weakness/gait deviation elsewhere). Thus, 6 
resistance exercises were selected, to specifically target those muscle groups that 
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were deemed responsible for the primary gait deviations. Gait deviations within the 
sagittal plane held the highest priority, given that walking occurs primarily in this 
sagittal plane. 
Once the target muscle groups had been identified, the selection of exercises to 
train each muscle group was completed by the research team, with the help of the 
NMC physiotherapists where required. Several variations of exercises to train the 
same muscle group were developed, to enable exercises to be completed in various 
positions (standing, seated and/or lying), depending on the functional ability and 
initial strength of the participant. Descriptions and examples of exercises for each 
muscle group are presented in Appendix 2.3.  
3.2.4.2 Load and Volume 
Initially, two sets of 10 repetition maximums (RM) per exercise were performed. 
Participants lifted enough weight so that they could only lift it ten times before 
experiencing fatigue. The initial starting weight for each exercise was ascertained in 
the first week of the exercise programme. The number of sets increased to three 
after 3 weeks. The training weight of 10RM was reviewed and adjusted (if the 
current load could be lifted for two repetitions over the desired amount) every 
three weeks. This training load and volume are in line with those recommended by 
the American College of Sport Medicine to increase muscle strength in previously 
untrained adults (Tawil et al., 1994; Kraemer et al., 2002). In addition, this training 
load and volume are similar to those previously shown to be achievable in adults 
with MD. For example,  adults with Myotonic MD lifted 3 sets of 8-10 repetitions at 
80% of their 1RM (Tollback et al., 1999; Lindeman et al., 1995), adults with FSHD 
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and LGMD lifted a 12RM load and a second group lifted 3 sets at 85% of 1RM, with 
no change in plasma creatine kinase levels (Sveen et al., 2013). 
Training load was provided through various pieces of equipment, which was 
dependent upon the initial strength of the participant and, as a consequence of that, 
the position that the movement was completed in (standing, seated or lay). Load 
was provided through the use of resistive rubber bands, ankle weights and 
dumbbells and once a certain degree of strength was attained, load was provided 
through a cable machine (Bodymax CF820 Functional Trainer), plate weights or 
weighted barbells. In circumstances where participants were unable to complete an 
exercise with resistance, their body or limb weight was used as the initial resistance. 
In circumstances where participants could not complete an exercise through a 
complete range of motion, due to the weight of their body or limb, the investigator 
provided assistance manually or with rubber bands or the movement was 
completed in a gravity neutral/assisted position (e.g. bent knee hip flexion in a side 
lying position). The degree of assistance provided was reviewed and adjusted (if 
appropriate) every three weeks.  
In order to provide assistance during the squat exercise, in circumstances where 
participants could not safely lower or lift their body weight in a freestanding 
position, two alternative options were developed. Option one comprised of a squat 
exercise with a Swiss ball placed between the participant’s lower back and the wall, 
to aid balance in the posterior direction. The second alternative involved a 
physiotherapy treatment bed that was modified into a piece of equipment, named 
a squat bed. This enabled a movement similar to that of a squat (simultaneous 
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flexion and extension of the ankle, knee and hip joint) to be completed with a 
reduced amount of body weight involved in the movement. Details of this 
modification are provided in 3.2.4.4 Squat Bed Modification. The angle of the plinth, 
and therefore the proportion of body weight involved in the movement, was 
reviewed and increased (if appropriate) every three weeks.   
Descriptions and examples of the squat modifications are provided in Appendix 2.2. 
In addition, descriptions of training load variations for both the consistent exercises 
and each muscle group are provided in Appendix 2.2 and Appendix 2.3, respectively. 
3.2.4.3 Rest and Velocity  
One-minute rest was given between exercise sets, but in cases where participants 
felt heavily fatigued, due to the nature of MD, they were offered a further rest 
period up to a total of three-minutes between exercise sets. Participants were 
instructed to complete exercises at a moderate repetition velocity (2 second 
concentric: 4 second eccentric), a protocol previously shown to induce greater 1RM 
strength gains (39% versus 15%) than slower repetition velocity protocols (Keeler et 
al., 2011).  
3.2.4.4 Squat Bed Modification  
The aim of the physiotherapy treatment bed modification was to create a piece of 
equipment that enabled participants with significant muscle deterioration and 
weakness to complete supported squat like movements, at progressive proportions 
of their bodyweight. This was achieved by modifying a physiotherapy treatment bed 
(Huntleigh Healthcare, Akron Products Division, model: A9622/2/THS), which 
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already had the function to move up and down mechanically and incline between a 
horizontal and vertical position. Whilst participants lay on the bed, the gradient of 
the plinth could be increased from a horizontal position to a full, but supported, 
standing position or any gradient in-between. This function is visually demonstrated 
in Figure 3.5 
Figure 3.5: Representation of the physiotherapy treatment bed demonstrating the 
pre-existing incline function. 
The modification involved raising the plinth onto two metal bars with runners; this 
allowed the plinth of the bed to slide forwards and backwards with external force. 
Additionally, the existing footplate was enlarged to enable participants to push with 
their feet during the squat movement. Furthermore, a mechanism to disable this 
sliding function was installed to ensure participant safety whilst getting onto and off 
the equipment. The sliding function is visually demonstrated in Figure 3.6. 
 
Figure 3.6: Representation of the physiotherapy treatment bed demonstrating the 
sliding function modification. 
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The squat bed enabled participants to complete a movement that replicates a 
freestanding squat (triple flexion and extension at the ankle, knee and hip joints) 
whilst lying supine on the plinth or at any gradient in-between supine and vertical. 
As the plinth inclined from a horizontal to a vertical position, the proportion of body 
weight involved in the movement increased with the angle of the plinth. The 
proportion of body weight involved in the movement can be calculated using vector 
components for an object on a slope, via the following equation: 
𝑊 =   𝑚𝑔 × 𝑠𝑖𝑛 𝜃 
Where W is the component of weight acting parallel to the plinth angle, m is body 
mass (kg), g is gravity and 𝜃 is plinth angle to the horizontal. 
To convert W to a percentage of body mass, the following equation was used: 
(𝑊 ÷ 𝑔)/𝑚 × 100 = % 
For example, an object with a mass of 78 kg sliding down a slope of 30° to the 
horizontal has 39 kg of mass acting parallel to the slope (Figure 3.7).  
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78 𝑥 9.81 𝑥 sin 30 ° =  383.3 N 
383.3 ÷ 9.8 = 39 𝑘𝑔 
39 ÷ 78 𝑥 100 = 50% 
Figure 3.7: Example of the vector components of weight for an object sliding at an 
incline to the horizontal.  
3.2.5 Data Analysis  
All data were stored and analysed in Microsoft Excel. Data are presented as means 
and standard deviations for the control group, FSHD, BMD and LGMD group, for part 
A. For part B, data are presented as means and standard deviations for the overall 
MD group, at each time point. In addition, all MVC torque measures are presented 
relative to the matched control group, but statistical analysis was not completed on 
these data, they were instead described. 
3.2.6 Statistical Analysis  
All statistical analysis were completed using IBM SPSS Statistics 25 software. The 
critical level of significance was set at p ≤ .05. 
3.2.6.1 Part A – MD versus Controls 
All data was checked against the parametric assumptions. For parametric data, 
differences between the groups (control, FSHD, BMD and LGMD) were assessed 
 
30° 
mg 
30° 
mg Sin 𝜃 
mg Cos 𝜃 
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using a one-way ANOVA with Tukey post-hoc tests where appropriate. The following 
data did not satisfy one or more of the parametric assumptions: knee extension and 
knee flexion MVC torque, lean body mass, six-minute walk distance, dorsi flexion 
MVC torque, hip abduction MVC torque, hip adduction MVC torque, plantar flexion 
MVC torque, hip flexion MVC torque and hip extension MVC torque. In these cases, 
Kruskall Wallis tests were conducted with Mann-Whitney U post-hoc comparisons 
(least significant difference) where necessary. Statistical analysis of hip extension 
MVC torque was not undertaken in the LGMD group, as data was limited to one 
participant in this group due to issues with the testing position (lay prone). For 
analysis of the six-minute walk data a subgroup of MD participants was utilised. This 
comprised of eighteen MD participants (7 FSHD, 5 BMD and 6 LGMD). 
3.2.6.2 Part B – Effects of RT 
All data were checked against the parametric assumptions and the following data 
were parametric: six-minute walk test, sit to stand time, stair ascend time, elbow 
flexion and hip abduction MVC torque. For parametric data, differences between 
the time points (PRE1, PRE2 and POST or PRE1, PRE2, Mid-Train and POST) were 
assessed using a one-way repeated measures ANOVA. If the data did not pass 
Mauchly’s test of sphericity (P < .05), a Greenhouse-Geisser correction was applied. 
From the ANOVA, both the retrospective observed power and the effect size, 
calculated as partial eta squared (Ꞃp2), were reported. Post hoc analysis was 
completed using the least significant difference pairwise comparisons, where 
appropriate. Non-parametric data were analysed using a Friedman’s ANOVA, 
followed by post-hoc analysis using Wilcoxon-signed rank tests (least significant 
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difference), where required. For analysis of the six-minute walk test data, a 
subgroup of 15 MD participants was utilised (5 FSHD, 4 BMD and 6 LGMD). For 
analysis of the hip extension MVC torque, a subgroup of 9 MD participants was 
assessed, which included 3 FSHD, 5 BMD and 1 LGMD participant.  
3.3 Results 
3.3.1 Part A – MD versus Controls 
3.3.1.1 Participant Characteristics 
There were no differences between any of the participant groups for age, body 
mass, stature or lean body mass (p > .05; Table 3.5). 
Table 3.5: Mean ± standard deviation of participant characteristics in the control 
(CTRL), FSHD, BMD and LGMD groups. 
 
 CTRL FSHD BMD LGMD 
n 10 9 7 6 
Age (years) 46.8 ± 10.1 46.7 ± 11.2 42.1 ± 7.6 47.3 ± 11.3 
Body mass (kg) 79.4 ± 12.3 88.2 ± 18.4 93.0 ± 16.7 82.0 ± 19.4 
Stature (cm) 174.4 ± 7.5 181.4 ± 6.3 179.9 ± 9.4 170.9 ± 9.0 
Lean body mass (kg) 56.1 ± 11.7 60.8 ± 13.9 62.0 ± 6.9 54.0 ± 15.4 
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3.3.1.2 Knee Flexion MVC Torque  
There was an overall main effect of group on knee flexion MVC torque (p ≤ .01; 
Figure 3.7). Knee flexion MVC torque was lower in each MD group compared to the 
control group, by 47.1% in the FSHD (p =.022), by 72.9% in the BMD (p ≤ .001) and 
by 74.8% in the LGMD group (p ≤ .001), with no differences evident between the 
MD groups (p > .05).  
 
Figure 3.7: Knee flexion MVC torque for the control (CTRL), FSHD, BMD and LGMD 
group. Bars represent the mean and error bars represent the standard deviation. * 
represents a significant difference from the control group.
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3.3.1.3 Knee Extension MVC Torque 
There was an overall main effect of group on knee extension MVC torque (p ≤ .001; 
Figure 3.8). Knee extension MVC torque was lower in each MD group compared to 
the control group, by 41.0% in the FSHD (p = .039), by 89.4% in the BMD (p ≤ .001) 
and 78.7% in the LGMD group (p ≤ .001). Furthermore, knee extension MVC torque 
was 82% less in the BMD than the FSHD group (p ≤ .01) with no other differences 
between the MD groups (p > .05). 
 
 
Figure 3.8: Knee extension MVC torque for the control (CTRL), FSHD, BMD and 
LGMD group. Bars represent the mean and error bars represent the standard 
deviation. * represents a significant difference from the control group and $ 
represents a significant difference from the FSHD group.
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3.3.1.4 Strength Tests 
The absolute MVC torque values for each strength test are presented in Table 3.6 
and described below. In Figure 3.9, the MVC torque for each strength test are 
presented visually and quantitatively, relative to the control group values. 
There was an overall main effect of group on MVC torque during dorsi flexion (p ≤ 
.01). Post hoc tests showed that dorsi flexion MVC torque was reduced by 66.7% in 
the FSHD (p ≤ .001), by 65.7% in the BMD (p ≤ .001) and by 75.3% in the LGMD group 
(p ≤ .001), compared to the control group. There were no differences between the 
three MD groups (p > .05). 
There was an overall main effect of group on MVC torque during plantar flexion (p 
< .05). Post hoc tests showed plantar flexion MVC torque did not differ between 
then BMD and the control group (p > .05) but was reduced by 60.5% in the FSHD (p 
= .022) and by 70.4% in the LGMD (p ≤.01) group, compared to the control group. 
There were no differences between the three MD groups (p > .05). 
There was an overall main effect of group on MVC torque during hip abduction (p ≤ 
.001). Post hoc tests showed that hip abduction MVC torque was not significantly 
different between the FSHD and control group (p = .056) but was reduced by 66.5% 
in the BMD (p ≤ .01) and by 80.3% in the LGMD group (p ≤ .001), compared to the 
control group. In addition, there was 65.9% less hip abduction MVC torque in the 
LGMD than the FSHD group (p ≤ .01). There were no other differences between the 
MD groups (p > .05). 
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There was an overall main effect of group on MVC torque during hip adduction (p ≤ 
.001). Post hoc tests showed that hip adduction MVC torque was 52.5% smaller in 
the FSHD (p ≤ .01), 70.5% smaller in the BMD (p ≤ .001) and 77.6% smaller in the 
LGMD (p ≤ .001) group, compared to the control group. In addition, hip adduction 
MVC torque was smaller in the BMD and LGMD groups compared to the FSHD group 
by 38% (p = .038) and 52.8% (p = .025), respectively. 
There was an overall main effect of group on MVC torque during hip flexion (p ≤ 
.001). Post hoc tests showed that hip flexion MVC torque was reduced by 53.0% in 
the FSHD (p ≤ .01), by 72.3% in the BMD (p ≤ .001) and by 76.9% in the LGMD group 
(p ≤ .001), compared to the control group. There were no differences between the 
three MD groups (p > .05). 
There was an overall main effect of group on MVC torque during elbow flexion (p ≤ 
.01). Post hoc tests showed that elbow flexion MVC torque did not differ between 
the control and FSHD group (p = .89) but was 52.8% smaller in the BMD (p = .037) 
and 61.9% smaller in the LGMD group (p = .017) compared to the control group. 
There were no differences between the three MD groups (p > .05). 
There was an overall main effect of group on MVC torque during hip extension (p ≤ 
.001). Post hoc tests showed that hip extension MVC torque was reduced by 51.7% 
in the FSHD (p ≤ .01) and by 84.2% in the BMD (p ≤ .001), compared to the control 
group. In addition, hip extension MVC torque was 16.2% less in the BMD than the 
FSHD group (p = .026).
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Table 3.6: Mean ± standard deviation of MVC torque during seven strength tests, in the control (CTRL), FSHD, BMD and LGMD groups. * represents a significant 
difference from the control (CTRL) group and $ represents a significant difference from the FSHD group. 
 Dorsi 
Flexion 
(N.m) 
Plantar 
Flexion 
(N.m) 
Hip 
Abduction 
(N.m) 
Hip 
Adduction 
(N.m) 
Hip 
Flexion 
(N.m) 
Hip 
Extension 
(N.m) 
Elbow 
Flexion 
(N.m) 
CTRL 41.7 ± 13.2 31.1 ± 23.8 132.8 ± 92.8 116.8 ± 48.5 146.1 ± 55.3 153.5 ± 56.2 51.5 ± 24.5 
FSHD 13.9 ± 13.2* 12.3 ± 6.6* 76.9 ± 26.6 55.5 ± 29.9* 68.6 ± 38.2* 74.2 ± 38.6* 29.0 ± 12.8 
BMD 14.3 ± 10.4* 15.8 ± 8.7 44.5 ± 31.7* 34.4 ± 26.4*$ 40.4 ± 23.3* 24.3 ± 21.1*$ 24.3 ± 21.1* 
LGMD 10.3 ± 8.2* 9.2 ± 3.0* 26.2 ± 16.7*$ 26.2 ± 17.2*$ 33.7 ± 14.7* ~30.7 19.6 ± 12.5* 
Note: Hip Extension MVC torque in the LGMD group was not completed in enough participants to enable statistical analysis. The value presented represents 
data from one LGMD participant. 
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Figure 3.9:  Visual representation of MVC torque in the FSHD, LGMD and BMD groups as a percentage of the control (CTRL) MVC torque, represented by the 
change in colour gradient, (decreasing colour gradient with decreasing percentage of MVC torque). Numerical percentages are presented beside each key. 
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3.3.1.4 Six-minute Walk Distance 
There was an overall main effect of group on six-minute walk distance (p ≤ .01; 
Figure 3.10). Six-minute walk distance was reduced in each MD group compared to 
the control group, by 21.3% in the FSHD (p =.017), by 35.3% in the BMD (p ≤ .001) 
and by 45.6% in the LGMD group (p ≤.01). In addition, six-minute walk distance was 
27% less in the LGMD than the FSHD group (p ≤.051). No further differences 
between the MD groups were found (p > .05). 
 
Figure 3.10:  Six-minute walk distance for the control (CTRL), FSHD, BMD and LGMD 
groups.  Bars represent the mean and error bars represent the standard deviation. 
* represents a significant difference from the control group and $ represents a 
significant difference from the FSHD group.
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3.3.2 Part B – Effects of RT 
Two participants dropped out of the RT programme (2 out of 19). One after 
completion of the second exercise session and the second after the fifth exercise 
session. The reasons stated for dropping out were 1) a lack of time and 2) flare up 
of an injury that was sustained before the RT programme. On average, 23 ± 1.5 of 
24 exercise sessions were completed, totalling a mean adherence rate of 96%. Other 
than the flare up of a pre-existing injury, no other adverse events were reported to 
investigators, but one participant fell during a training session. However, the 
participant sustained no lasting injuries and continued with the programme the 
following week. All data presented represent the 17 participants who completed all 
elements of the training study. 
3.3.2.1 Knee Flexion MVC Torque  
There was an overall main effect of time on knee flexion MVC torque (p ≤ .01; Figure 
3.11).  Post hoc tests showed no difference between PRE1 and PRE2 (p > .05), a 
15.4% increase from PRE1 to POST (p ≤ .01) and a 12.6% increase from PRE2 to POST 
(p ≤ .001).  
3.3.2.2 Knee Extension MVC Torque  
There was no overall main effect of time on knee extension MVC torque (p = .084; 
Figure 3.12).
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Figure 3.11: Knee flexion MVC torque at PRE1, PRE2 and POST the RT programme. Bars 
represent the mean and error bars represent the standard deviation. * represents a 
significant difference from PRE1 and $ represents a significant difference from PRE2. 
 
Figure 3.12: Knee extension MVC torque at PRE1, PRE2 and POST the RT programme. Bars 
represent the mean and error bars represent the standard deviation.  
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3.3.2.3 Strength Tests 
The absolute values for MVC torque during each strength tests are presented in 
Figure 3.13 and described below. 
There was no overall main effect of time on MVC torque during elbow flexion (p > 
.05) or hip adduction (p = .059). 
There was an overall main effect of time on MVC torque during hip flexion (p ≤ .001). 
There was no difference in MVC torque between PRE1 and PRE2 (p >.05) but a 33.8% 
increase from PRE1 to POST (p ≤ .001) and a 27.3% increase from PRE2 to POST (p ≤ 
.01). 
There was an overall main effect of time on MVC torque during hip abduction (p ≤ 
.01, Ꞃp2 = .25), with an observed power of .80. There was no difference in MVC 
torque between PRE1 and PRE2 or between PRE1 and POST (p >.05), but a 20.1% 
increase in MVC torque between PRE2 and POST (p = .02).  
There was an overall main effect of time on MVC torque during plantar flexion (p ≤ 
.001). There was an 11.4% reduction in MVC torque between PRE1 and PRE2 (p = 
.045), a 46.2% increase from PRE1 to POST (p ≤ .001), and a 65.0% increase from 
PRE2 to POST (p ≤ .001) 
There was an overall main effect of time on MVC torque during dorsi flexion (p < 
.05). There was no difference in MVC torque between PRE1 and PRE2 (p > .05) but 
a 47.2% increase from PRE1 to POST (p ≤ .01) and a 27.9% increase from PRE2 to 
POST (p ≤ .01). 
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There was an overall main effect of time on MVC torque during hip extension (p ≤ 
.01). There was no difference in MVC torque between PRE1 and PRE2 (p > .05), but 
a 62.5% increase from PRE1 to POST (p ≤ .01) and a 22.8% increase from PRE2 to 
POST (p ≤ .01).
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Figure 3.13:  MVC torque during seven strength tests at PRE1, PRE2 and POST the RT programme. Bars represent means and error bars represent the standard 
deviation.  * represents a significant difference to PRE1 and $ represents a significant difference to PRE2.
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3.3.2.4 Six-minute Walk Distance 
There was an overall main effect of time on six-minute walk distance (p ≤ .01, Ꞃp2 = 
.38; Figure 3.14), with an observed power of .88. Post hoc tests showed no 
difference in walk distance between PRE1 and PRE2 (p > .05), a 9.3% increase from 
PRE1 to POST (p = .016) and a 4.0% increase from PRE2 to POST (p = .028).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: Six-minute walk distance at PRE1, PRE2 and POST completion of the RT 
programme. Bars represent the mean and error bars represent the standard deviation. * 
represents a significant difference from PRE1 and $ represents a significant difference from 
PRE2. 
3.3.2.5 Functional Tests 
Time to complete each functional test between PRE1, PRE2 and POST the RT 
programme are presented in Table 3.7 and described below. 
There was an overall main effect of time on balance time (p ≤ .01). Post hoc tests 
showed that balance time was increased by 4.2% between PRE1 and PRE2 (p = .031) 
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and by 29.1% between PRE1 and POST (p = .016). In addition, balance time was 
increased by 24% between PRE2 and POST (p = .016). There were no differences 
between PRE1 or PRE2 and Mid-Train or between Mid-Train and POST (p > .05). 
There was an overall main effect of time on sit to stand time (p < .001, Ꞃp2 = .35), 
with an observed power of .96. Post hoc tests showed that sit to stand time did not 
differ between PRE1 and PRE2 or between PRE1 and Mid-Train (p > .05) but was 
30.1% quicker at POST compared to PRE1 (p ≤ .001). In addition, sit to stand time 
did not differ between PRE2 and Mid-Train (p > .05) but was 35.9% quicker at POST 
than PRE2 (p ≤ .01) and did not differ between Mid-Train and POST (p > .05). 
There was an overall main effect of time on stair ascend time (p < .05, Ꞃp2 = .22), 
with an observed power of .60. Post hoc tests showed that stair ascend time did not 
differ between PRE1 and PRE2 or between PRE1 and Mid-Train (p > .05), but that it 
was 20.1% quicker at POST than PRE1 (p ≤ .05). In addition, stair ascend time did 
not differ between PRE2 and Mid-Train (p > .05) but was 18.1% quicker at PRE2 than 
POST (p = .035), with no difference between Mid-Train and POST (p > .05). 
There was an overall main effect of time on stair descend time (p ≤ .001). Post hoc 
tests showed that stair descend time increased by 9.8% between PRE1 and PRE2 (p 
= .012), did not differ between PRE1 and Mid-Train (p > .05) but was reduced by 
15.7% between PRE1 and POST (p ≤ .01). In addition, stair descend time was reduced 
by 16.1% between PRE2 and Mid-Train (p ≤ .01), by 23.2% between PRE2 and POST 
(p ≤ .001) and by 8.5% from Mid-Train to POST (p ≤ .01). 
125 
 
 Table 3.7: Mean ± standard deviation of time to complete functional tests at PRE1, PRE2 
and POST the RT programme. * represents a significant difference form PRE1, $ represents 
a significant difference from PRE2 and # represents a significant difference 
 
 
Balance 
(s) 
Sit-Stand 
(s) 
Stair Ascend 
(s) 
Stair Descend 
(s) 
PRE1 19.1 ± 13.5 3.6 ± 1.6 7.4 ± 3.3 5.1 ± 2.0 
PRE2 19.9 ± 12.9* 3.9 ± 2.0 7.2 ± 3.4 5.6 ± 2.3* 
Mid-Train 23.9 ± 10.5 3.3 ± 2.1 6.6 ± 3.1 4.7 ± 1.5$ 
POST 24.7 ± 10.6*$ 2.5 ± 1.4*$ 5.9 ± 2.5*$ 4.3 ± 1.5*$# 
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3.4 Discussion 
3.4.1 Part A – MD versus Controls 
Part A of this study aimed to quantify the MVC torque of 8 lower-limb muscle groups 
and the physical function, via a 6-minute walk test, of adults with FSHD, BMD and 
LGMD, compared to an age-matched control group. Overall, significant muscle 
weakness was identified in a variety of muscle groups, along with reduced physical 
function across all 3 types of MD, compared to the control group.  
There are few previous quantitative measures of MVC torque in FSHD, BMD and 
LGMD, compared to non-dystrophic control groups. This study is novel in the 
assessment of MVC torque in four previously unquantified lower-limb muscle 
groups in these populations; the hip flexors, hip extensors, hip abductors and hip 
adductors. Interestingly, significant muscle weakness was established in the 
majority of muscles for all MD groups compared to the control group, except for the 
hip abductors which were spared in the FSHD group and the plantar flexors, which 
did not differ between the BMD and the control group. These findings concur with 
previous research showing significant muscle weakness in the knee extensors of 
individuals with FSHD (Jacques et al., 2018; Marra et al., 2018; Skalsky et al., 2008; 
Bachasson et al., 2014), BMD (Jacques et al., 2018) and LGMD (Jacques et al., 2018), 
in the knee flexors of individuals with FSHD (Skalsky et al., 2008), in the dorsi flexors 
of individuals with LGMD (Lokken et al., 2016) and BMD (Lokken et al., 2016), and 
in the plantar flexors of individuals with LGMD (Jacques et al., 2018; Lokken et al., 
2016) and FSHD (Jacques et al., 2018). However, the current study findings disagree 
with those of two previous studies that have shown significant weakness in the 
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plantar flexor muscles of 52% (Lokken et al., 2016) and 51% (Jacques et al., 2018), 
in adults with BMD compared to age-matched control groups. It is possible that the 
reason for this discrepancy is due to differences in condition severity, as 44% of 
BMD participants were non-ambulatory in the latter study (Jacques et al., 2018) 
whereas all participants were ambulant in the current study. However, this is not 
the case for the former study (Lokken et al., 2016), as all participants were also 
ambulatory and younger than in the present study.   
Of the muscle groups measured in the previous literature (knee flexors, knee 
extensors, plantar flexors and dorsi flexors), there is fairly little agreement between 
the current study and previous ones regarding relative severity of muscle weakness. 
The likely reasons for these differences in weakness severity may be attributed to 
the heterogeneity of the conditions, differences in measurement technique, 
differences in joint angle, differences in participant ages, participant sex differences 
and/or differences in the matching of control groups to experimental groups, but 
each muscle group will be discussed individually.  
Knee flexion MVC torque was 47% weaker in the FSHD group, 72% weaker in the 
BMD group and 75% weaker in the LGMD group, compared to the control group 
within the current study. This is the first study to quantify knee flexion MVC torque 
in adults with BMD and LGMD, but one study has previously measured knee flexion 
MVC torque in adults and children with FSHD (Skalsky et al., 2008), reporting a 56% 
reduction compared to a sex, height and mass-matched control group. The small 
difference in weakness severity between the current study and Skalsky et al. (2008) 
is likely due to the heterogeneity of FSHD, participant ages (adults only were 
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included within the present study) or differences in knee joint angle (tested at 45° 
knee flexion previously, versus 70° knee flexion in the present study). 
This study established that knee extension MVC torque was 40% weaker in the 
FSHD, 79% weaker in the LGMD and 89% weaker in the BMD group, compared to 
the control group. These strength deficits are higher than those reported previously 
for BMD and LGMD (Jacques et al., 2018) of 41% and 43%, respectively, compared 
to controls. The almost two-fold increase in knee extension weakness severity in the 
LGMD and BMD group compared to Jacques et al. (2018) could be due to the 
heterogenous nature of these conditions, or sex differences in the LGMD groups 
(both male and female in the current study versus an all-male population). In FSHD, 
the 40% lower MVC torque from the current study sits centrally within deficit values 
previously reported for this population of 25% (Jacques et al., 2018), 42% (Skalsky 
et al., 2008), 45% (Bachasson et al., 2014) and 66% (Marra et al., 2018). The more 
severe weakness of 66% (Marra et al., 2018) is likely a result of the 20.5-year age 
difference between the control group and the experimental group within that study. 
At the other end of the scale, the less severe knee extensor weakness of 25% 
reported in Jacques et al. (2018) likely differs to the current study due to sex 
differences (a mixed sex population was utilised in the current study compared to 
an all-male population).  population).   
Dorsi flexion MVC torque was 67% lower in the FSHD group, 66% lower in the BMD 
and 75% lower in the LGMD group, compared to the control group within this study. 
Dorsi flexion MVC torque has not previously been reported in FSHD but was shown 
to be reduced by 41% in BMD (Lokken et al., 2016) and 39% in LGMD (Lokken et al., 
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2016). The severity of dorsi flexion weakness in the current study is much higher 
than previously reported by Lokken et al. (2016). This could be attributed to 
differences in measurement technique and joint angles, as an isokinetic 
dynamometer was used with a knee flexion angle of 140°, compared to a strain-
gauge and an extended knee angle of 0° within the current study.  
Plantar flexion MVC torque did not differ between the BMD and control group but 
was reduced by 61% in the FSHD and 70% in the LGMD group. These reductions in 
strength are almost double the severity of those reported previously in FSHD of 35% 
(Jacques et al., 2018), and in LGMD of 38% (Lokken et al., 2016) and 58% (Jacques 
et al., 2018). The disparity in findings regarding plantar flexion strength in BMD were 
discussed earlier. The greater severity of plantar-flexor muscle weakness for LGMD 
and FSHD in the current study compared to previous data could be attributed to 
heterogeneity within the conditions, participant sex differences compared to 
Jacques et al. (2018) and differences in measurement technique with Lokken et al. 
(2016) (isokinetic dynamometer with 140° knee flexion versus a strain-gauge with 
90° knee flexion).  
An important consideration of this study is the comparison of quantitative data to 
the pre-existing clinical classifications of weakness distribution in FSHD, BMD and 
LGMD (Emery, 2002; Mercuri and Muntoni, 2013). Using the MVC torque data 
relative to the MVC torque in the age-matched control group, it is possible to 
establish which muscle groups exhibited the most pronounced weakness within 
each MD group. This was visually presented in Figure 3.9. Accordingly, in the FSHD 
group, the distal dorsi flexor and plantar flexor muscle groups, followed by the 
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proximal hip flexor and hip adductor muscle groups experienced the highest relative 
weakness severity. This agrees somewhat with the clinical classifications of 
weakness distribution in FSHD, although the current data provide detail regarding 
important proximal muscle weakness in this population. In the BMD group, the 
proximal knee extensor, hip extensor, hip flexor and knee flexor muscle groups 
demonstrated the most pronounced weakness severity, respectively. This echoes 
the pre-existing clinical classifications of descending weakness distribution from 
proximal to distal regions in BMD (Emery, 2002). However, this was closely followed 
by a severe weakness in the dorsi flexor muscle group which was 65% lower than 
the control group strength. Finally, in the LGMD group, the hip abductor, hip 
extensor, knee extensor and hip adductor muscle groups presented the most 
pronounced weaknesses. This was closely followed by a severe weakness in the 
dorsi flexor muscle group of 25% of the control group strength. Again, this finding 
parallels the clinical classification of predominantly proximal muscle weakness in 
this MD population, but it provides a more detailed insight into which proximal 
muscles are most affected.  
Previous studies quantifying MVC torque in MD have demonstrated discrepancies 
with the clinical descriptions of weakness in MD, such as a more severe distal muscle 
weakness than proximal muscle weakness in both LGMD and BMD (Jacques et al., 
2018). The current study does not replicate those findings. Although it is extremely 
important to note that whilst certain muscle groups did not exhibit the highest 
strength deficits, they were often almost as weak as the weakest muscles. For 
example, the plantar flexors were not one of the four weakest muscle groups in the 
LGMD group, but their strength was still significantly reduced by 75% compared to 
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the control group. Therefore, it is important that the pre-existing clinical 
classifications of weakness distribution are taken as areas of principal muscle 
weakness only. The additional information provided by the measures of MVC torque 
during hip flexion, hip extension, hip abduction and hip adduction provide 
additional detail to the pre-existing descriptions of weakness distribution in FSHD, 
BMD and LGMD. In particular, it is clear that the hip abductors and hip extensors 
are the most limited of the proximal muscle groups in the LGMD population.  
Concerning physical function, the distance walked during the 6-minte walk test was 
significantly reduced in all MD groups compared to the control group, by 22% in the 
FSHD group, by 35% in the BMD group and by 43% in the LGMD group.  Hence, the 
LGMD group were the most limited of the MDs with regards to physical function, 
which is unsurprising given that they were the weakest of all 3 MD groups in 5 of 
the 8 lower-limb muscle groups measured, and the second weakest in the remaining 
3 lower-limb muscle groups. 
Part A of this chapter quantified muscle strength in 8 lower limb muscle groups and 
6-minute walk distance across three MD groups. The data contribute to the 
currently under-reported, but clinically described, physiological and functional 
understanding of FSHD, BMD and LGMD, and provide support for the pre-existing 
clinical classifications of weakness distribution in these populations.   
3.4.2 Part B – Effects of RT 
Part B of this study demonstrated that a 12-week, twice a week, programme of RT 
was both feasible and beneficial in ambulatory adults with FSHD, BMD and LGMD. 
The average adherence rate of 96% is more than satisfactory. The single adverse 
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event that occurred throughout the study caused no lasting injury and the two cases 
of participant drop out were both due to circumstances external to the RT 
programme. Overall, positive changes in both muscle strength and physical function 
as a result of the RT programme were evident.  
In our study, knee flexion MVC torque increased by 12.6% from immediately before 
to post completion of the RT programme, with stable values during the initial 12-
week control period. However, no change in knee extension MVC torque was 
evident, although the direction of change was positive it did not reach significance.  
The latter finding is in contrast to Sveen et al. (2013), who reported an approximate 
35% increase in knee extension strength with RT in adults with BMD and LGMD. 
However, muscle strength was quantified via 1-repetition maximum strength 
compared to isometric MVC torque in the current study and the RT programme 
lasted for 24-weeks compared to 12-weeks within the current study. Of particular 
note is the large standard deviation in the knee extension MVC torque in the present 
study, due to the heterogeneity of these MD conditions. This likely contributed 
towards the lack of a significant difference found in this variable. In addition, there 
was a potential ceiling effect with this muscle group for some individuals who had 
greater strength before the training programme. As seen in part A of this study, the 
knee extension MVC torque was higher within the FSHD group than the BMD and 
LGMD group. Hence, the inclusion of FSHD in the current study compared to only 
BMD and LGMD in Sveen et al. (2013) may have constrained the overall change in 
knee extension MVC torque through a ceiling effect. 
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MVC torque was increased by variable amounts in all other muscle groups, except 
for the hip adductors and elbow flexors (ranging from 27% in the hip flexors, 20% in 
the hip abductors, 28% in the dorsi flexors, 65% in the plantar flexors and 23% in 
the hip extensors), with stable values in the control period for each muscle group. 
The only study to have previously assessed the effect of a RT programme on any of 
these muscle groups in either FSHD, BMD or LGMD was Van der Kooi et al. (2004), 
who examined the effect of 52-weeks of RT on dorsi flexor muscle strength in adults 
with FSHD, but reported no change to dorsi flexion MVC torque post RT. However, 
it is important to note that the RT programme was unsupervised and the frequency 
of the RT programme was three times per week, compared to two supervised 
training sessions per week in current study. It is possible that the lack of supervision 
hindered the RT or that the higher frequency was excessive in the MD population.  
It is unsurprising that the elbow flexor MVC torque was unchanged in the current 
study, as this muscle was not trained as part of the RT programme. However, it is 
unclear why the hip adductor muscle group was unchanged post completion of the 
RT programme. It is possible that this muscle group is resistant to the effects of RT 
in at least one or all of the types of MD studied, although this seems unlikely given 
the response to RT across the other muscle groups. Alternatively, it may be due to 
the difficulty that was experienced by the investigators in training this muscle group, 
both in a gravity neutral position and through its full range of movement.  In other 
words, if participants were either too unstable or weak to train this muscle group in 
a single leg stance position (by adducting their leg across the front of their body), 
the exercise was completed whilst laying supine. The first exercise option in this 
lying position was often intolerable for participants as it required them to first lift 
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their leg higher than their body by flexing at the hip joint for the entirety of the 
exercise, which was often not possible. The alternative exercise involved squeezing 
a ball of progressive rigidities between the knees whilst lying supine, although this 
was possible it was limited in the range of movement it required. This limitation did 
not apply to any other muscle group.  
Functionally, the RT programme within this study was extremely positive in this 
population of adults with FSHD, BMD and LGMD. The distance walked during the 6-
minute walk test remained stable between PRE1 and PRE2, with a 4% increase from 
immediately before to after completion of the RT programme. This improvement in 
walking capacity is fairly small relative to the increases in muscle strength 
presented, but never the less, such an increase demonstrates an improved walking 
capacity. In the additional functional tests, much larger improvements were found 
between the PRE2 time point and completion of the RT programme, ranging from 
24% increase in balance time, a 36% reduction in sit to stand time, an 18% reduction 
in the time taken to climb stairs and a 23% reduction in the time taken to descend 
stairs. Hence, the increase in muscle strength in these individuals was successfully 
translated into improvements in physical function. With this in mind, it is highly 
possible that the benefits of RT may spread further than muscle strength and 
functional ability in these populations. Walking speed over the 6-minute walk test 
was improved, which suggests that the more detailed parameters of gait may also 
be influenced by RT in this population. Future research should seek to quantify the 
gait alterations that may occur with RT in MD. 
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Overall, the RT programme positively influenced the muscle strength and physical 
function of this MD group. Almost all variables of muscle strength and physical 
function were improved, and importantly, the few that were not improved 
remained unchanged. This is important to consider as maintenance of muscle 
strength or function in this progressive condition is a positive outcome in itself. 
These findings dispute the historical perspective that RT should be avoided in 
individuals with MD. The clinical implications of this research are that ambulatory 
adults with these forms of MD can safely undertake RT programmes similar to the 
one described in this study, and effectively improve lower-limb muscle strength and 
physical function as a result.  
This study has a noteworthy limitation; although the three types of MD examined 
in this study are functionally similar, the combination of the different types of MD 
may have concealed differences in the response to RT between the conditions. 
Future investigations with a larger sample size would benefit from examining 
whether the individual forms of MD differ in their responses to RT. In addition, 
future research should examine the influence of RT programme frequency and 
intensity in these populations. It would be advantageous to determine if a higher or 
lower frequency and intensity of RT are also beneficial in these populations. This 
study showed that a RT programme can feasibly be undertaken in adults with FSHD, 
BMD and LGMD, but an important question remains regarding how much RT is too 
much in these conditions. In order to provide detailed advice to patients with these 
forms of MD regarding the appropriate frequency and intensity of RT, future 
research should seek to examine these factors in more detail.  
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In conclusion, this study provides quantitative data on the strength of eight lower-
limb muscle groups in ambulatory adults with FSHD, BMD and LGMD. A 
comprehensive comparison between the current data and the pre-existing clinical 
classifications of weakness distribution in MD highlights agreement between the 
two. This is the first study to demonstrate the feasibility and beneficial effects of a 
programme of RT compared to a control period, across a wide range of lower-limb 
muscles and functional tests in ambulatory adults with FSHD, BMD and LGMD. 
Despite previous medical concerns, these findings provide support for RT in these 
forms of MD and highlight that RT is a viable option within the management and 
treatment programmes of adults with these MDs. RT is an innovative approach to 
maintaining or improving muscle strength and physical independence in adults with 
these forms of MD. 
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Chapter 4 
Influence of resistance training on the 
kinematics of gait in adults with 
Facioscapulohumeral, Limb-girdle and 
Becker muscular dystrophy
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4.1 Introduction 
Muscular dystrophy (MD) is a group of over thirty neuromuscular conditions caused 
by a variety of genetic mutations (Huml, 2015). Each genetic mutation ultimately 
results in an altered expression of proteins that are typically located within muscle 
cells, which leads to progressive weakening and deterioration of the muscles 
(Mercuri and Muntoni, 2013). Subsequently, individuals with MD experience 
increasing levels of disability and reduced physical function (Huml, 2015). 
Duchenne MD is the most severe form of MD characterised by early childhood 
onset, rapid progression, loss of ambulation in childhood and premature death 
(Bushby et al., 2010). Other types of MD vary between childhood and adult onset, 
progress more slowly and typically the ability to walk is not compromised at least 
until adulthood (Emery, 2002; Mercuri and Muntoni, 2013). Three common types 
of MD that fit the latter description are Facioscapulohumeral MD (FSHD), Limb-
girdle MD (LGMD) and Becker MD (BMD), which are described clinically to remain 
ambulant until at least the second decade of life (Huml, 2015), although precise 
measures of age at loss of ambulation are not available.  
4.1.1 Part A 
In Chapter 3 of this thesis, varying severities of lower-limb muscle weakness in 
adults with FSHD, BMD and LGMD were reported, in conjunction with a lower 
physical function through slower self-selected walking speed compared to a 
matched control group. Accordingly, these findings indicate that lower-limb muscle 
weakness likely influences gait in MD. Clinically it is well recognised that functional 
tasks, such as a person’s ability to walk, are diminished in adults with FSHD, BMD 
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and LGMD (Emery, 2002; Huml, 2015) and quantitative descriptions of gait 
consistently report slower self-selected walking speeds and reduced stride lengths 
in FSHD (Aprile et al., 2012; Iosa et al., 2007; Iosa et al., 2010; Rijken, van Engelen, 
de Rooy, et al., 2015; Rijken, van Engelen, Geurts, et al., 2015) compared to control 
participants or normative reference data. In addition, some of those studies also 
reported an increased stance duration (Iosa et al., 2007) and reduced cadence (Iosa 
et al., 2010) in FSHD compared to control groups. Although clinical knowledge of 
impaired gait in FSHD, BMD and LGMD exists, no spatial-temporal analysis of gait in 
humans with BMD and LGMD exists. In addition, very few quantitative studies of 
the lower-limb joint kinematics during gait have been conducted in BMD, LGMD or 
FSHD, with the majority of kinematic analysis occurring in adults with Myotonic MD 
or children with Duchenne MD. 
Three studies have described gait and lower-limb joint kinematics in adults with 
Myotonic MD and four for children with Duchenne MD. Numerous sagittal plane 
kinematic abnormalities have been reported in both of these MDs, including 
excessive anterior pelvic tilt (Galli et al., 2012; Doglio et al., 2011; D'Angelo et al., 
2009), inadequate hip extension in stance (Galli et al., 2012; Gaudreault et al., 2010; 
Sutherland et al., 1981), a lack of knee flexion or hyper-extension in stance (Galli et 
al., 2012; D'Angelo et al., 2009) and additional knee flexion in the swing phase (Galli 
et al., 2012; D'Angelo et al., 2009; Doglio et al., 2011). In addition, limited plantar 
flexion in the stance phase (Galli et al., 2012) was also reported in adults with 
Myotonic MD. In children with Duchenne MD, excessive hip flexion in the swing 
phase (D'Angelo et al., 2009; Gaudreault et al., 2010; Sutherland et al., 1981) and 
reduced dorsi flexion at initial contact have also been found (D'Angelo et al., 2009; 
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Doglio et al., 2011). In the frontal and transverse plane, excessive external pelvic 
rotation, increased pelvic obliquity and early abduction of the hip joint during the 
stance phase of gait have been reported in children with Duchenne MD (Doglio et 
al., 2011). These kinematic abnormalities however cannot be directly applied to 
ambulatory adults with FSHD, BMD and LGMD. This is because Myotonic MD differs 
widely from the other eight types of MD as nearly all systems in the body are 
affected, and Duchenne MD has a severe childhood onset that renders children 
wheelchair bound by adolescence (Emery, 2002). Furthermore, the differences in 
lower-limb weakness distribution between the MDs presented in Chapter 3 of this 
thesis likely predispose adults with FSHD, BMD and LGMD to employ different 
compensatory mechanisms during ambulation. 
One study has measured lower-limb joint kinematics during gait in adults with FSHD 
(Iosa et al., 2007). To date there appear to be no published studies that have 
measured the kinematics of gait in humans with LGMD or BMD. Iosa et al. (2007) 
assessed sagittal plane joint kinematics during self-selected walking in the hip, knee 
and ankle joint of adults with FSHD. They found reduced ankle dorsi flexion at initial 
contact, insufficient knee flexion during the stance phase and reduced hip extension 
at toe-off, compared to non-dystrophic controls. In addition, dorsi flexion angle at 
initial contact and hip extension angle at toe-off were negatively associated with an 
MRI score of fat infiltration in the tibialis anterior and hip extensor muscles, 
respectively, indirectly alluding to a relationship between these gait abnormalities 
and muscle strength. A more complete description of joint kinematics, including the 
pelvis joint and variables within the frontal and/or transverse plane would provide 
a more detailed insight into FSHD gait. 
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The kinematic gait deviations previously presented in MD populations may have 
implications for physiological variables in MD, such as the metabolic cost of walking. 
Given the importance of maintaining physical independence in adults with MD, 
quantifying the metabolic cost of walking is of particular importance. However, this 
is yet to be done in FSHD, BMD or LGMD.  
The first aim of this study is to describe the spatial-temporal variables, the lower-
body angular kinematics and the metabolic cost of gait in adults with FSHD, LGMD 
and BMD, compared to a matched control group.  
4.1.2 Part B 
Alongside descriptions of gait in adults with FSHD, BMD and LGMD, of particular 
interest to this study is the suitability of resistance training (RT) as an intervention 
for kinematic abnormalities in these populations. RT is a form of exercise that has 
previously been shown to alter spatial-temporal variables of gait and joint 
kinematics in a range of clinical populations that commonly exhibit gait 
abnormalities. In individuals with multiple sclerosis, RT resulted in increased walking 
speeds and step lengths, along with reductions in double support time (Manca et 
al., 2017; Kierkegaard et al., 2016; Gutierrez et al., 2005). In children with cerebral 
palsy, programmes of RT have increased stride length and reduced cadence (Eek et 
al., 2008), along with reducing the severity of crouch gait (knee flexion angle) during 
the stance phase (Engsberg et al., 2006). Furthermore, Cao et al. (2007) reported an 
increase in total ankle range of motion during gait,  plantar flexion angle at toe-off 
and maximum dorsi flexion angle in the swing phase following an exercise 
programme that included RT in elderly women. Alongside these experimental 
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studies, positive associations between lower-limb muscle strength and walking 
speed have been demonstrated in older adults (Buchner et al., 1996), a population 
that also experiences muscle weakness, and adults with Myotonic MD (Lindeman et 
al., 1998). We have presented evidence in Chapter 4 that RT increases lower-limb 
muscle strength in adults with FSHD, BMD and LGMD and therefore, RT may also 
influence gait and joint kinematics in these individuals.   
The influence of RT is relatively un-reported in MD due to historical concerns that it 
should be avoided in adults living with MD. These concerns were based on indirect 
evidence that RT was detrimental to dystrophic muscle cells (Ansved, 2001; Petrof, 
1998). To the contrary, Sveen et al. (2013) presented the first evidence of a 
beneficial effect of RT in MD; a 35% increase in knee extensor muscle strength post 
24-weeks’ RT in adults with BMD and LGMD. Furthermore, Chapter 3 of this thesis 
presents increased maximum voluntary contraction (MVC) torque in six lower-limb 
muscle groups post 12-weeks’ RT in adults with FSHD, BMD and LGMD. In addition 
to these strength gains, RT may also influence gait in individuals with MD but only 
one study has previously investigated this notion.   
Missaoui et al. (2010) investigated the effect of 6-weeks’ rehabilitation training on 
adults with Myotonic MD. The program consisted of stretching and balance 
exercises, resistance exercises and aerobic treadmill training. Knee extension and 
knee flexion MVC torque increased by 18% and 32%, respectively, together with 
improvements in the functional reach test, timed up and go test, and a 6% increase 
in fast walking speed. Unfortunately, the more detailed parameters of gait, such as 
the spatial-temporal parameters of the gait cycle, joint angular displacements and 
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oxygen cost were not measured. Hence it remains unknown if a programme of 
lower-body RT influences key gait parameters in adults with MD. 
The second aim of this study is to investigate the influence of a 12-week, twice a 
week, lower-body RT programme on spatial-temporal parameters, joint kinematics 
and the metabolic cost of gait in a group of ambulatory adults with MD (FSHD, BMD 
and LGMD).
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4.2 Method 
4.2.1 Participants & Study Design 
The experimental design for this study is presented in two parts. Part A presents group 
comparisons between adults with FSHD (9), BMD (7), LGMD (6) and a group of 10 
control adults matched in age, stature and body mass.  
Part B is a within-participant design, involving a group of 17 adults with MD, inclusive 
of FSHD (6), BMD (5) and LGMD (6). Data were collected at three time points: PRE1 
(before a 12-week control period), PRE2 (immediately after the 12-week control 
period) and POST (immediately after a 12-week RT programme). All 17 MD participants 
completed a 12-week, twice a week, RT programme.  
Detailed descriptions of the study design, participants and RT programme are provided 
in Chapter 3.2 Method. 
Manchester Metropolitan University Ethics Committee granted ethical approval and 
all participants provided written informed consent after which data collection took 
place at Manchester Metropolitan University on all occasions. 
4.2.2 Procedures 
Testing procedures and data collection for anthropometric and body composition 
measures are provided in Chapter 3.2 Method. 
4.2.2.1 Gait Analysis 
4.2.2.1.1 Equipment 
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A Vicon motion capture system (Oxford Metrics Ltd., Oxford, UK) was used to collect 
data during gait. The system consisted of 14 infrared Vicon cameras (MX-T Series) 
and two Bonita video cameras, with two floor mounted AMTI force platforms (AMTI, 
Watertown, MA, USA), a Dell computer (Precision T1650) and Vicon Nexus software 
(Version 1.7) to capture and process data (Figure 4.1). 
The 14 infrared cameras were positioned on a metal frame around the edge of the 
capture volume, at a height of ~2.4 m above the ground. The Bonita video cameras 
were mounted on tripods within the capture volume, which measured ~ 170 m3 
(length x width x height: 10 x 7 x 2.4 m). One video camera was positioned 
perpendicular to the walking direction and the second was positioned parallel to the 
walking direction, offering a sagittal and coronal view of the participants. The Vicon 
and Bonita cameras were connected via Ethernet cables to one of two Vicon 
connectivity units (MX-Giganet), which contained a 64-channel analogue-digital 
converter. The primary connectivity unit was connected via Ethernet cable to a Dell 
computer (Precision T1650) that used Vicon Nexus software to obtain kinematic and 
video data at 100 Hz. The secondary connectivity unit was connected to the primary 
unit via an MX Giganet cable, to carry synchronisation signals to the secondary unit.  
The two AMTI force platforms were located side by side in the centre of the capture 
volume. Each platform measured 46.7 x 51.0 cm and was mounted flush to the 
laboratory floor. Each force platform was connected via a 26-pin connector cable to 
an amplifier, which was connected via the amplifier output cable to a Vicon 
connectivity unit (MX-Giganet). All force data were sampled at 1000 Hz through a 64-
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channel analogue-digital converter, which was connected to a Dell computer 
(Precision T1650) that used Vicon Nexus software to obtain kinetic data. 
Muscle activity of four muscles in the dominant limb: tibialis anterior (TA), medial 
gastrocnemius (GM), vastus lateralis (VL) and bicep femoris (BF) was measured. Data 
were captured using wireless surface electrodes (Trigno™ Wireless System, Delsys, Inc, 
Boston, USA). The electrodes measured 27.6 x 24.1 x 12.7 mm and consisted of a four-
bar formation with a 10 mm distance between the bars. Raw signals were detected via 
a Bluetooth receiver in the Delsys unit and collected by Delsys EMGworks® Acquisition 
software on a HP computer (ProBook 4320), at a sampling frequency of 1000 Hz.  
Force data were collected simultaneously with motion data using Vicon Nexus 
software. To enable time synchronisation of data collection between the motion 
capture and EMG data acquisition systems, a Delsys Trigger Module (SP-U02) was 
used. This acted as an independent push button device that was connected to the 
Vicon connectivity unit and the Delsys unit, to start both EMGworks acquisition and 
Vicon Nexus simultaneously.  
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Figure 4.1: Schematic showing the Vicon, AMTI force platforms and Delsys equipment set-up in the gait laboratory. 
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4.2.2.1.2 System Calibration 
Before the collection of data, the Vicon system was calibrated and a residual of equal 
to or less than .2 mm for each camera was accepted. An L frame Vicon active wand 
with five LEDs was used according to the manufacturer’s guidelines. Firstly, a dynamic 
calibration was undertaken, in which the investigator waved the L frame within the 
estimated capture volume in a variety of positions and orientations, until each camera 
had viewed a variety of wand positions. Next, the origin of the global coordinate 
system was defined. The L frame was placed flat in the top corner of the right AMTI 
force plate, to define the laboratory origin. The lab coordinate system was defined as 
Y-axis: anterior-posterior, X-axis: medial-lateral and Z-axis: superior-inferior. Force 
platform signals were zeroed using the automatic zero function in Vicon Nexus.  
4.2.2.1.3 Marker and Electrode Placement  
Vicon infrared camera lenses contain a set of diodes that emit light; this light is 
reflected back by retro-reflective markers on the participant’s body to track their 
motion. Thirty-nine markers were positioned on specific landmarks on the 
participant’s body, according to the standard Vicon plug in gait model marker set 
(Vicon, 2010), which is demonstrated in Appendix 2.1. The plug in gait model is the 
Vicon’s variation of the conventional gait model, which was designed by Davis et al. 
(1991) and describes the calculations that are used to define each body segment and 
subsequently to define each joint centre location. Mainly, the markers were secured 
to the participant’s skin, to avoid movement artefacts from moveable clothing. A single 
investigator located markers by palpating the skin to identify specific bony landmarks. 
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An example of one participant with all 39 markers located on the body is presented in 
Figure 4.2 
Upper body markers were placed whilst participants were seated to avoid fatigue in 
participants with limited mobility. Markers were secured onto a headband so that they 
were positioned over the left and right temple at the front of the head and on the left 
and right side of the back of the head. Markers were also placed on the spinous process 
of the 7th cervical and the 10th thoracic vertebra, on the jugular notch where the 
clavicles meet the sternum, on the xiphoid process of the sternum and anywhere on 
the right scapula. Bilateral upper body markers were positioned on the acromio-
clavicular joints, on the upper lateral third of the arms, on the lateral epicondyle of the 
elbows, on the lower lateral third of the forearms, on either side of the wrist at the 
xiphoid process of the radius and ulna and on the hands proximal to the middle 
knuckle.  
Lower body markers were placed whilst participants were stood, holding onto a 
walking aid or support where required. Markers were placed bilaterally over anterior 
superior iliac spines, posterior superior iliac spines, lateral distal third of the thigh (in 
line with the hip and knee joint centres), on the lateral epicondyle of the femur, lateral 
distal third of the shank (in line with the ankle and knee joint centres), lateral 
malleolus, and at the point of the calcaneus and head of the second metatarsal on the 
participant’s shoe. Due to MD participants reporting feelings of reduced stability and 
walking confidence when walking barefoot, gait analysis was completed shod. 
Participants were instructed to wear comfortable shoes that they would typically wear 
to walk outside of their home. Of note is that the sole of most footwear typically 
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introduces a vertical difference between the toe and the heel marker, despite 
participants achieving a flat foot with respect to the footwear. Thus, a measure of sole 
delta was recorded (described in Chapter 3.2 Anthropometry) and the height of the 
heel marker in comparison to the toe marker was adjusted accordingly within the 
Vicon Nexus software.  
 
 
 
 
 
 
 
 
 
Figure 4.2: Example of marker placement on participants from an anterior (left) and 
posterior (right) view. 
EMG sensors were attached onto the skin at the belly of each muscle, according to the 
SENIAM guidelines (Hermens et al., 2000). Before application, the surrounding skin 
was shaved and cleaned with an alcohol wipe to ensure optimal electrical 
conductance. For the TA muscle, the sensor was placed at one third of the distance 
between the tip of the fibula and the tip of the medial malleolus and it was orientated 
in the direction of this line. For the GM muscle, the sensor was positioned on the most 
protruding part of the muscle, in the direction of the limb. For the VL muscle, the 
sensor was placed at two thirds of the distance between the anterior spina iliaca 
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superior to the lateral side of the patella and it was orientated in the direction of the 
muscle fibres. For the BF, the sensor was placed mid-way between the ischial 
tuberosity and the lateral epicondyle of the tibia and it was orientated along this line.  
4.2.2.1.4 Protocol 
Throughout the gait analysis assessment, participants wore their own shoes and 
minimal non-reflective clothing, inclusive of shorts for men and shorts and a sports bra 
or tight fitted vest top for women. In instances where a top was worn, it was rolled up 
so that markers could be attached directly onto the skin. The instructions given to 
participants regarding their shoes was that they should be comfortable to walk in and 
reflect typical shoes that they wear regularly, for example shoes that would be worn 
to go shopping. Shoes were deemed appropriate if they were non-slip, suitable to be 
worn outside and flat without a significant sole wedge (for example trainers). Trials 
were completed with or without personal walking aids (if applicable; crutch or walking 
stick), dependant on whether these were typically used to walk short distances (e.g. 
to walk around their home). 
Initially, a static calibration was completed. Participants stood with one foot on each 
force platform within the capture volume, facing forward with their arms raised away 
from their body. Static marker data were collected and together with anatomical 
measurements were utilised to define each body segment and establish the location 
of each joint centre, relative to the coordinate system. Details of the calculations used 
to estimate lower body joint centre locations are described by Davis et al. (1991).  
Participants completed a minimum of five practise trials. This enabled them to become 
familiar with their surroundings and to establish a starting position that rendered a 
152 
 
clean foot strike on the force platform with their dominant leg. Subsequently, 
participants completed four successful walking trials. Participants were instructed to 
walk at their self-selected walking pace; for example, the speed that they would 
typically use to walk to the shop. They walked along a 10 m level walkway but starting 
position was modified to make sure that the foot strike on the force platform was 
clean. Participants were offered as much rest as they required between walking trials, 
particularly those with severely reduced mobility and functional ability.   
4.2.2.2 Oxygen Consumption   
Expired gases were collected during a six-minute walk test, which was conducted in 
the control group and a subgroup of MD participants who self-reported confidence in 
their ability to walk for 6 minutes.  A portable breath by breath gas analyser (Metmax 
3B, Cortex, Leipzig Germany) was used to collect VO2 (mL∙min-1), via indirect 
calorimetry. Before use, the system was calibrated to the manufacturer’s guidelines, 
using known concentrations of gas. The system comprised of a fitted face mask with a 
gas sensor and turbine, a Polar Bluetooth heart rate monitor and a portable unit that 
was carried in a material harness around the participant’s chest and back. The unit 
weighed ~1 kg and was secured with Velcro straps. Data were collected using MetaSoft 
Studio software on an HP computer that used a Bluetooth receiver.  
An adapted version of the 6-minute walk test protocol set out by the American 
Thoracic Society (2002) was utilised. Participants were instructed to walk at a steady 
self-selected pace instead of as far as possible as specified in the protocol devised by 
the American Thoracic Society (2002). This was due to safety concerns in the current 
population and to ensure steady state was achieved. The test took place along a flat 
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straight corridor. Each end of the 25 m course was marked with tape on the ground. 
Participants were instructed to turn clockwise at each end and walk in a straight line. 
One investigator walked behind the participant keeping at least a 1.5 m distance to 
provide encouragement (in accordance with The American Thoracic Society 
guidelines), to assess fall risk and to place markers on the course at each minute for 
the calculation of minute-distance splits. Participants were instructed to use their 
walking aids during the test if they did so during 3D gait analysis.  
Before the test, participants rested for 5 minutes in a seated position.  To start the test, 
participants were readied at the start line and the timer was started once they began 
to walk. Participants were instructed to stop walking at six minutes and were 
subsequently seated until fully recovered. Expired gases were measured for the 
entirety of the rest period and the 6-minute walk test. 
4.2.3 Data Processing and Analysis  
Unless otherwise stated, data are presented as means and standard deviations for 
the control group, FSHD, BMD and LGMD group in part A, and means and standard 
deviations for the MD group at each time point (PRE1, PRE2 and POST) in part B.  
4.2.3.1 Joint Kinematics  
Processing of each walking trial was completed using Vicon Nexus software. The 
markers were reconstructed and then their trajectories labelled. Gait events (initial 
contact and toe-off) were determined via vertical ground reaction forces on the 
dominant side with force plate contact, using a force threshold of 20 N. On the non-
dominant side or without force platform contact, gait events were determined 
manually via frame by frame visual inspection. For each trial, the stride that 
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occurred in the centre of the capture volume over the force platform was selected 
for analysis. Gaps (≤ 10 frames) in the marker trajectories were filled using a cubic 
spline interpolation. The dynamic plug-in gait model (Vicon, 2010) was then applied 
to each walking trial to calculate marker trajectories and joint kinematics. Data were 
smoothed using a low-pass 4th order Butterworth filter, with a cut off frequency of 
6 Hz. 
Spatial and temporal data and lower-limb angular displacements in the dominant 
leg were averaged across four trials and used for further analysis. Kinematic data 
for a full gait cycle were time normalised to 100 data points using a cubic spline 
interpolation method in Microsoft Excel, representing initial contact at 0% and the 
following foot contact on the same side at 100%.  
The selection of discrete dependant variables was guided by Beneditti et al. (1998). 
Ensemble average graphs for angular displacement of the pelvis, hip, knee and ankle 
were produced in Microsoft Excel and are presented in the results section, along 
with the mean ± standard deviation for each discrete variable. Statistical analysis 
was completed on all discrete variables. The spatial and temporal variables chosen 
for analysis are presented in Table 4.1 and the discrete kinematic variables chosen 
for analysis are presented in Table 4.2.   
The root mean square difference in joint angle between each MD group and the 
control group and between the time points of PRE1 compared to PRE2 and PRE2 
compared to POST were calculated at the pelvis, hip, knee and ankle in the sagittal 
plane. This was calculated during the stance phase, the swing phase and the over 
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the entire gait cycle as a descriptive measure of the global difference in joint angle 
during gait.  
4.2.3.2 Additional Kinematic Analysis 
In part B, additional analysis was completed on a sub-group of MD participants that 
exhibited excessive hyper-extension of the knee joint during the stance phase 
(defined as an angle that was ≤ -3° in the stance phase) and another subgroup of 
participants who exhibited limited dorsi flexion of the ankle joint during the swing 
phase (defined as a mean ankle angle that was ≤ -1° during the swing phase). This 
was done to establish the effect of RT on these specific kinematic abnormalities 
during gait. Eight participants were involved in the former sub-group and eleven in 
the latter sub-group.   
Table 4.1: Definition of spatial and temporal gait variables. 
Variable Definition 
Gait speed (m/s) Stride length divided by the total time over one stride 
Stride length (m) Anterior distance from toe marker position at initial 
ground contact and at the second ipsilateral ground 
contact 
Step width (m) Lateral distance between the toe marker position and 
the contralateral toe marker position at initial ground 
contact  
Cadence (strides/minute) Number of strides per minute 
Stance time (% of gait cycle) Time between initial ground contact and toe-off, 
expressed as a percentage of total gait cycle time 
Double support time (% of 
gait cycle) 
Total duration during one gait cycle that both feet are 
in contact with the floor simultaneously 
 
156 
 
Table 4.2: Numerical system for discrete kinematic variables.  
 Pelvis (°)  Hip (°) 
P1 
P2 
P3 
P4 
P5 
P6 
P7 
Mean pelvic tilt 
Max anterior tilt in stance 
Max anterior tilt in swing 
Max pelvic rise in stance 
Max pelvic drop in swing 
Max internal rotation 
External rotation at toe-off 
H1 
H2 
H3 
H4 
H5 
H6 
H7 
H8 
Hip flexion at initial contact 
Max hip extension 
Hip extension at toe-off 
Max flexion in swing 
Mean adduction in stance 
Max abduction in swing 
Internal rotation at initial contact 
External rotation at toe-off 
    
 Knee (°)  Ankle (°) 
K1 
K2 
K3 
K4 
K5 
K6 
K7 
Flexion at initial contact 
Max flexion in early stance 
Max extension in stance 
Max flexion in swing 
Max extension in swing 
Mean varus in stance 
Varus angle at toe-off 
A1 
A2 
A3 
A4 
A5 
A6 
A7 
A8 
A9 
Angle at initial contact 
Max dorsiflexion in stance 
Max plantar flexion in stance 
Plantar flexion at toe-off 
Max dorsi-flexion in swing 
Mean dorsi flexion in late swing 
Inversion at initial contact 
Eversion at toe-off 
 Abduction at initial contact 
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4.2.3.3 Oxygen Cost 
Oxygen consumption (VO2) and heart rate data were averaged over the final minute 
of seated rest and the 4th minute of the walk test. Steady state was confirmed by a 
respiratory exchange ratio less than 1, and a visual plateau of heart rate and VO2 
(Reeves et al., 2004).  Data were recorded as a rolling average of six measurements 
every 10 seconds. Net VO2 (ml/kg/min) was calculated by subtracting the average 
VO2 collected during the final minute of rest from the average VO2 collected during 
the 4th minute of the 6-minute walk test. This was then normalised to walking speed 
by calculating the oxygen cost; net VO2 was divided by the distance covered during 
the 4th minute of the test (ml/kg/m). Net VO2 and oxygen cost were subsequently 
normalised to lean body mass (net VO2; ml/kgLBM/min, oxygen cost: ml/kgLBM/m).  
4.2.4 Statistical Analysis  
All statistical analyses were completed using IBM SPSS Statistics 25 software. The 
critical level of significance was set at p ≤ .05. 
4.2.4.1 Part A – MD versus Controls 
Data were compared between the FSHD, BMD, LGMD and control group. All data 
were checked against the parametric assumptions and data that satisfied the 
assumptions were assessed using a one-way ANOVA with least significant difference 
post hoc pairwise comparisons where required. The following variables were non-
parametric: stride length, stride width, cadence, P1, P2, P3, P5, P7, H2, H3, H5, K2, 
A3 and A7. In these cases, Kruskall Wallis tests were conducted with Mann-Whitney 
U post-hoc comparisons (least significant difference) where necessary. Analysis of 
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oxygen cost data were conducted in sub-groups of MD participants (7 FSHD, 5 BMD 
and 5 LGMD). 
4.2.4.2 Part B – Effects of RT 
Data were compared between the time points (PRE1, PRE2 and POST) in the MD 
group. All data were checked against the parametric assumptions and data that 
satisfied these assumptions were assessed using a one-way repeated measures 
ANOVA. If the data did not pass Mauchly’s test of sphericity (P < .05), a Greenhouse-
Geisser correction was applied. From the ANOVA, both the retrospective observed 
power and the effect size, calculated as partial eta squared (Ꞃp2), were reported. 
Post hoc analysis was completed using least significant difference pairwise 
comparisons where appropriate. Data that were non-parametric (stride width, K7, 
H4, H8, A8 and A9) were analysed using a Friedman’s ANOVA, followed by post-hoc 
analysis using Wilcoxon-signed rank tests (least significant difference) where 
required. Analysis of net VO2 and oxygen cost were conducted in a sub-group of 14 
MD participants (5 FSHD, 4 BMD and 5 LGMD). Data from the sub-group of 
participants that demonstrated hyper-extension of the knee joint and excessive 
plantar flexion of the ankle joint were checked for parametricity and subsequently 
analysed as described above. 
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4.3 Results  
4.3.1 Part A – MD versus Controls 
4.3.1.1 Participant Characteristics 
There were no differences between the groups for age, body mass, stature or lean 
body mass (p > .05; Table 4.3). Individual participant characteristics, including use 
of walking aids and completion of the 6-minute walk test, are provided in Table 4.4. 
Table 4.3: Mean ± standard deviation of participant characteristics in the control 
(CTRL), FSHD, BMD and LGMD group. 
 CTRL FSHD BMD LGMD 
n 10 9 7 6 
Age (years) 46.8 ± 10.1 46.7 ± 11.2 42.1 ± 7.6 47.3 ± 11.3 
Body mass (kg) 79.4 ± 12.3 88.2 ± 18.4 93.0 ± 16.7 82.0 ± 19.4 
Stature (cm) 174.4 ± 7.5 181.4 ± 6.3 179.9 ± 9.4 170.9 ± 9.0 
Lean body mass (kg) 56.1 ± 11.7 60.8 ± 13.9 62.0 ± 6.9 54.0 ± 15.4 
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Table 4.4:  Individual MD participant characteristics, use of walking aids during gait 
analysis and completion of the 6-minute walk test (6MWT). Y = yes, N = no. 
 Sex MD Walking Aid 6MWT 
MD1 F FSHD Stick (1) Y 
MD2 M FSHD None Y 
MD3 M FSHD None Y 
MD4 F FSHD None Y 
MD5 M FSHD Stick (1) N 
MD6 M FSHD Stick (1) Y 
MD7 F FSHD None Y 
MD8 M FSHD None Y 
MD9 M FSHD Stick (1) N 
MD10 M BMD None Y 
MD11 M BMD None N 
MD12 M BMD None N 
MD13 M BMD None Y 
MD14 M BMD Stick (2) Y 
MD15 M BMD None Y 
MD16 M BMD None Y 
MD17 M LGMD Crutches (2) Y 
MD18 M LGMD None Y 
MD19 F LGMD None N 
MD20 F LGMD Stick (1) Y 
MD21 F LGMD Crutches (2) Y 
MD22 M LGMD None Y 
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4.3.1.2 Spatial and Temporal Variables 
There was an overall main effect of group on gait speed (p ≤ .001), stride length (p 
≤ .01), stride width (p < .05), cadence (p ≤ .001), double support time (p ≤ .01) and 
stance time (p< .05). All spatial and temporal values are presented in Table 4.5.  
Post hoc tests revealed that gait speed was slower in the FSHD, BMD and LGMD 
group compared to the control group by 26.4% (p ≤ .05), 33.3% (p ≤ .01) and 44.4% 
(p ≤ .001), respectively. No differences in gait speed were found between the MD 
groups (p > .05). 
Post hoc tests revealed that stride length was shorter in the FSHD, BMD and LGMD 
groups compared to the control group by 12.9% (p ≤ .05), 16.7 % (p ≤ .01) and 36.1% 
(p ≤ .001), respectively. Stride length was 26.6% shorter in the LGMD group than the 
FSHD group (p < .05). No other differences in stride length were found between the 
MD groups (p > .05). 
Post hoc tests revealed that stride width was greater in the BMD group compared 
to the control group by 80.0% (p ≤ .01). No differences in stride width were evident 
between any other groups (p > .05). 
Post hoc tests revealed that cadence was lower in the FSHD, BMD and LGMD group 
by 16.0% (p ≤ .01), 19.6 % (p ≤ .001) and 27.7% (p ≤ .001) compared to the control 
group. No differences in cadence were found between the MD groups (p > .05).  
Post hoc tests revealed that double support time lasted 12% longer in the LGMD 
group than the control group (p ≤ .001) and 39.1% longer in the LGMD than the BMD 
group (p < .05). No other differences in double support time were found between 
the groups (p > .05).  
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Post hoc tests revealed that stance time was 4% longer in the LGMD group than the 
control group (p ≤ .05) and the FSHD group (p < .05). No other differences in stance 
time were found between the groups (p > .05).  
Table 4.5: Mean ± standard deviation of spatial and temporal gait variables of self-
selected walking in the FSHD, BMD, LGMD and control (CTRL) group. * represents a 
significant difference from the control group. $ represents a significant difference 
from FSHD. # represents a significant difference from BMD.  
 
4.3.1.3 Joint kinematics 
Angular displacement of the pelvis, hip, knee and ankle joint during the gait cycle 
are presented as ensemble averages in the sagittal, frontal and transverse planes 
for the FSHD, BMD and LGMD group in Figures 4.3, 4.4 and 4.5. 
 CTRL FSHD BMD LGMD 
Gait speed 
(m/s) 
1.44 ± 0.23 1.06 ± 0.34* 0.96 ± 0.23* 0.80 ± 0.20* 
Stride length 
(m) 
1.55 ± 0.21 1.35 ± 0.22* 1.29 ± 0.22* 1.20 ± 0.14*$ 
Cadence  
(steps/minute) 
112 ± 9 94 ± 15* 90 ± 9* 81 ± 15* 
Step width (m) 0.10 ± 0.02 0.15 ± 0.07 0.18 ± 0.04* 0.14 ± 0.04 
Stance time 
 (%) 
62 ± 2 62 ± 3 63 ± 4 66 ± 3*$ 
Double support 
(%) 
20 ± 5 24 ± 6 23 ± 6 32 ± 6*# 
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Figure 4.3:  Pelvis, hip, knee and ankle angle during the gait cycle in the sagittal (top row), frontal (middle row) and transverse (bottom row) planes. The white line and grey 
band represents the control group mean ± 1 standard deviation, and the black line and the blue band represents the FSHD group mean ± 1 standard deviation. On the x-axis, 
0% represents initial contact and 100% the following ipsilateral contact. 
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Figure 4.4: Pelvis, hip, knee and ankle angle during the gait cycle in the sagittal (top row), frontal (middle row) and transverse (bottom row) planes. The white line and grey 
band represents the control group mean ± 1 standard deviation, and the black line and the blue band represents the BMD group mean ± 1 standard deviation. On the x-axis, 
0% represents initial contact and 100% the following ipsilateral contact.
165 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Pelvis, hip, knee and ankle angle during the gait cycle in the sagittal (top row), frontal (middle row) and transverse (bottom row) planes. The white line and grey 
band represents the control group mean ± 1 standard deviation, and the black line and the blue band represents the LGMD group mean ± 1 standard deviation. On the x-
axis, 0% represents initial contact and 100% the following ipsilateral contact.
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The root mean square difference in joint angle over the entire gait cycle and in the 
stance and swing phase compared to the control group are presented in Table 4.6.  
Table 4.6: Root mean square difference in joint angle over the entire gait cycle, in 
the stance phase and in the swing phase, compared to the control group. 
 
  FSHD BMD LGMD 
Pelvic Tilt (°)    
Gait cycle  7.5 9.5 2.0 
Stance phase  7.4 9.4 2.0 
Swing phase 7.5 9.8 2.0 
Hip Flexion (°)    
Gait cycle 8.2 8.9 6.8 
Stance phase  7.9 7.6 8.0 
Swing phase  8.8 11.2 4.6 
Knee Flexion (°)    
Gait cycle 5.1 6.3 15.6 
Stance phase 6.4 8.9 19.7 
Swing phase 3.1 2.0 8.0 
Ankle Flexion (°)    
Gait cycle 3.5 4.1 6.2 
Stance phase 2.5 4.0 7.7 
Swing phase 5.0 4.0 3.4 
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Discrete variables at the pelvis, hip, knee and ankle joint for each group are 
presented in Table 4.7, 4.8, 4.9 and 4.10, respectively. 
Pelvis 
Table 4.7: Mean ± standard deviation of discrete kinematic variables (°) of the pelvis 
during the gait cycle. * represents a significant difference from the control group 
(CTRL). 
Note: P1 = mean pelvic tilt, P2 = max. anterior tilt in stance, P3 = max. anterior tilt in 
swing, P4 = max. pelvic rise in stance, P5 = max. pelvic drop in swing, P6 = max. 
internal rotation, P7 = external rotation at toe-off. 
There was a significant main effect of group on mean pelvic tilt, max. anterior tilt in 
stance, max. anterior tilt in swing and external rotation at toe-off (p < .05). No main 
effect of group was found for max. pelvic rise in stance, max. pelvic drop in swing or 
max. internal rotation (p > .05).  
 
 CTRL FSHD BMD LGMD 
P1 (°) 9.7 ± 4.6 17.1 ± 8.2* 19.2 ± 6.2* 9.8 ± 9.2 
P2 (°) 11.6 ± 4.6 19.2 ± 8.4* 21.9 ± 6.4* 13.4 ± 10.9 
P3 (°) 10.1 ± 4.6 17.3 ± 8.0* 21.2 ± 6.4* 13.5 ± 10.7 
P4 (°) 4.2 ± 1.8 3.3 ± 1.8 5.2 ± 2.4 5.6 ± 2.2 
P5 (°) -5.5 ± 1.4 -4.0 ± 2.1 -4.6 ± 3.1 -3.1 ± 4.2 
P6 (°) 4.6 ± 2.9 7.3 ± 8.0 4.5 ± 4.2 5.7 ± 7.8 
P7 (°) -2.1 ± 3.8 -6.4 ± 4.9* -10.7 ± 4.3* -7.8 ± 9.2* 
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Post hoc tests showed that mean pelvic tilt did not differ between the LGMD and 
control group (p > .05) but was greater in the FSHD group by 7.4° (p < .05) and in 
the BMD group by 9.5° (p < .01) compared to the control group.  
Post hoc tests showed that max. anterior tilt in stance did no differ between the 
LGMD and control group (p > .05) but was greater in the FSHD group by 7.6° (p < 
.05) and in the BMD group by 10.3° (p < .01) compared to the control group.  
Post hoc tests showed that max. anterior tilt in swing did no differ between the 
LGMD and control group (p > .05) but was greater in the FSHD group by 10.2° (p < 
.05) and in the BMD group by 11.1° (p < .01) compared to the control group.  
Post hoc tests showed that max. external rotation at toe-off was 4.3° greater in the 
FSHD group (p < .05), 8.6° greater in the BMD group (p < .001) and 5.7° greater in 
the LGMD group (p < .05) compared to the control group.  
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Hip 
Table 4.8: Mean ± standard deviation of discrete variables (°) of the hip joint during 
the gait cycle. * represents a significant difference from the control group (CTRL). 
Note: H1 = flexion at initial contact, H2 = max. extension, H3 = extension at toe-off, 
H4 = max flexion in swing, H5 = mean adduction in stance, H6 = max. abduction in 
swing, H7 = internal rotation at initial contact, H8 = external rotation at toe-off. 
At the hip, there was a significant main effect of group on max. hip extension, hip 
extension at toe-off and max. hip abduction in swing (p < .05). No main effect of 
group was found for hip flexion at initial contact, max. hip flexion in swing, mean 
hip adduction in stance, internal rotation at initial contact or external rotation at 
toe-off (p > .05).  
Post hoc tests showed that max. hip extension did not differ between the control 
and LGMD group (p > .05), but that H2 was 7° lower in the FSHD group (p < .05) and 
10.5° lower in the BMD group (p < .05) than the control group.  
 CTRL FSHD BMD LGMD 
H1 (°) 37.7 ± 8.1 42.0 ± 9.0 40.3 ± 6.7 28.6 ± 14.7 
H2 (°) -9.9 ± 8.7 2.9 ± 16.8* 0.6 ± 7.2* -13.8 ± 12.0 
H3 (°) 0.4 ± 9.7 11.8 ± 15.6* 14.6 ± 8.7* -1.0 ± 10.9 
H4 (°) 38.1 ± 7.2 45.3 ± 11.0 47.1 ± 7.2 35.8 ± 12.6 
H5 (°) 4.7 ± 2.0 4.8 ± 2.3 1.4 ± 4.4 3.0 ± 4.0  
H6 (°) -5.7 ± 2.5 -6.1 ± 4.1 -11.4 ± 3.2* -10.1 ± 5.2* 
H7 (°) -17.3 ± 10.5 -5.9 ± 14.8 -9.1 ± 9.4 -13.1 ± 15.7 
H8 (°) 1.2 ± 9.4 12.0 ± 14.1 0.4 ± 10.9 5.4 ±20.2 
170 
 
Post hoc tests showed that hip extension at toe-off did not differ between the 
control and LGMD group (p > .05), but that H3 was 11.4° lower in the FSHD group 
(p < .05) and 14.2° lower in the BMD group (p<.05) than the control group. 
Post hoc tests showed that max. hip abduction in swing did not differ between the 
control and FSHD group (p > .05), but that H3 was 5.7° greater in the BMD group (p 
< .05) and 4.4° greater in the LGMD group (p < .05) than the control group. 
Knee 
Table 4.9: Mean ± standard deviation of discrete variables (°) of the knee joint 
during gait. * represents a significant difference from the control group (CTRL). 
Note: K1 = flexion at initial contact, K2 = max. flexion in early stance, K3 = max. 
extension in stance, K4 = max. flexion in swing, K5 = max. extension in swing, K6 = 
mean varus in stance, K7 = varus angle at toe-off. 
There was a significant main effect of group on knee flexion at initial contact (p ≤ 
.001), max. flexion in early stance (p ≤ .001), max. extension in stance (p ≤ .001), 
 CTRL FSHD BMD LGMD 
K1 (°) 8.9 ± 4.4 4.0 ± 5.9* 4.8 ± 3.3 -1.9 ± 3.8* 
K2 (°) 23.7 ± 7.7 14.5 ± 11.5 5.8 ± 3.9* 0.5 ± 5.9* 
K3 (°) 5.1 ± 6.1  0.6 ± 8.1 1.3 ± 4.7 -11.5 ± 11.4* 
K4 (°) 67.2 ± 3.9 66.1 ± 6.5 68.5 ± 8.5 58.6 ± 14.0 
K5 (°) 4.3 ± 3.6 -0.1 ± 5.4* 3.2 ± 3.5 -4.0 ± 3.9* 
K6 (°) -0.7 ± 3.4 1.4 ± 5.9 -1.7 ± 5.4 0.7 ± 6.0 
K7 (°) 2.8 ± 7.2 10.4 ± 11.0* -1.9 ± 5.9 9.4 ± 9.7* 
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max. extension in swing (p ≤ .01) and varus angle at toe-off (p < .05). No main effect 
of group was found for max. knee flexion in swing or mean varus in stance (p > .05). 
Post hoc tests showed that knee flexion at initial contact did not differ between the 
control and BMD group (p > .05), but that it was 4.9° lower in the FSHD group (p < 
.05) and 10.8° lower in the LGMD group (p ≤ .001) than the control group. 
Post hoc tests showed that max. knee flexion in early stance did not differ between 
the control and FSHD group (p > .05), but that K2 was 17.9° lower in the BMD group 
(p ≤ .01) and 23.2° lower in the LGMD group (p ≤ .01) than the control group. 
Post hoc tests showed that max. knee extension in stance did not differ between 
the FSHD and control group or between the BMD and control group (p > .05) but 
was 16.6° lower in the LGMD group (p ≤ .001) than the control.  
Post hoc tests showed that max. knee extension in swing did not differ between the 
control and BMD group (p > .05) but was 4.4° lower in the FSHD group (p < .05) and 
8.3° lower in the LGMD group (p ≤ .001) than the control group. 
Post hoc tests showed that varus angle at toe-off did not differ between the control 
and BMD group (p > .05), but was 7.6° higher in the FSHD group (p < .05) and 6.6° 
higher in the LGMD group (p ≤ .001) than the control group. 
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Ankle 
Table 4.10: Mean ± standard deviation of discrete variables (°) of the ankle during 
the gait cycle. * represents a significant difference from the control group (CTRL). 
Note: A1 = angle at initial contact, A2 = max. dorsiflexion in stance, A3 = max. plantar 
flexion in stance, A4 = plantar flexion at toe-off, A5 = max. dorsiflexion in swing, A6 
= mean dorsi flexion in late swing, A7 = inversion angle at initial contact, A8 = 
eversion at toe-off, A9 = abduction at initial contact. 
 At the ankle there was a significant main effect of group on ankle angle at initial 
contact and mean dorsi flexion in late swing (p ≤ .05). No main effect of group was 
found for max. dorsi flexion in stance, max. plantar flexion in stance, plantar flexion 
at toe-off, max. dorsi flexion in swing, inversion angle at initial contact, eversion at 
toe-off or abduction at initial contact (p > .05).  
 CTRL FSHD BMD LGMD 
A1 (°) 5.0 ± 5.3 -3.3 ± 9.3* -4.0 ± 5.6* -4.5 ± 7.4* 
A2 (°) 14.6 ± 4.5 16.9 ± 6.1 16.1 ± 7.2 15.5 ± 8.8 
A3 (°) -13.8 ± 5.1 -13.4 ± 5.1 -14.5 ± 7.6 -13.7 ± 9.3 
A4 (°) -13.6 ± 4.5 -10.6 ± 8.4 -10.0 ± 13.0 -9.8 ± 11.6 
A5 (°) 8.8 ± 4.0 2.7 ± 8.1 1.9 ± 7.3 3.2 ± 8.0 
A6 (°) 6.7 ± 4.0 0.1 ± 7.7* -0.4 ± 7.5* -1.5 ± 6.9* 
A7 (°) 17.6 ± 10.5 15.9 ± 14.7 6.2 ± 13.7 6.0 ± 10.6 
A8 (°) -5.7 ± 11.4 -2.1 ± 15.7 -3.8 ± 17.5 -0.7 ± 8.9 
A9 (°) -4.2 ± 2.8 -5.3 ± 7.0 -2.2 ± 3.0 -1.9 ± 3.0 
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Post hoc tests showed that ankle angle at initial contact was 8.3° lower in the FSHD 
group (p < .05), 9.0° lower in the BMD group (p < .05) and 9.5° lower in the LGMD 
group (p < .05) than the control group. 
Post hoc tests showed that mean dorsi flexion in late swing was 6.6° lower in the 
FSHD group (p < .05), 7.1° lower in the BMD group (p < .05) and 8.2° lower in the 
LGMD group (p ≤ .05) than the control group. 
4.3.1.4 Metabolic Cost of Walking 
There was a main effect of group on oxygen cost normalised to body mass (p ≤ .01; 
Figure 4.6 A) and lean body mass (p ≤ .01; Figure 4.6 B). Post hoc tests showed an 
83% higher oxygen cost (ml/kg/m) in the LGMD than the control group (p ≤ .01) and 
the FSHD group (p ≤ .01). No other differences in oxygen cost normalised to body 
mass were found between the groups (P > .05). Post hoc tests showed oxygen cost 
normalised to lean body mass in the LGMG group was double that of the control 
and FSHD group (p ≤ .01). No other differences in oxygen cost normalised to lean 
body mass were found between the groups (p > .05). 
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Figure 4.6:  Oxygen cost during steady state walking normalised to body mass (A) 
and lean body mass (B). Bars represent means and error bars represent standard 
deviation. * represents a significant difference from the control (CTRL) group and $ 
represents a significant difference from the FSHD group. 
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4.3.2 Part B – Effects of RT 
4.3.2.1 Participant Characteristics 
Individual participant characteristics, including use of walking aids and completion 
of the 6-minute walk test, are provided in Table 4.11.  
Table 4.11:  Use of walking aids during gait analysis and completion of the 6-minute 
walk test (6MWT)
 Sex MD Walking Aid 6MWT 
MD1 F FSHD Stick (1) Y 
MD2 M FSHD None Y 
MD3 M FSHD None Y 
MD5 M FSHD Stick (1) N 
MD7 F FSHD None Y 
MD8 M FSHD None Y 
MD10 M BMD None Y 
MD12 M BMD None N 
MD14 M BMD Stick (2) Y 
MD15 M BMD None Y 
MD16 M BMD None Y 
MD17 M LGMD Crutches (2) Y 
MD18 M LGMD None Y 
MD19 F LGMD None N 
MD20 F LGMD Stick (1) Y 
MD21 F LGMD Crutches (2) Y 
MD22 M LGMD None Y 
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4.3.2.2. Spatial and Temporal Variables 
There was an overall main effect of time on gait speed (p ≤ .001), stride length (p ≤ 
.001), cadence (p < .05), and stride width (p < .05). No overall effect was found for 
double support time or stance time (p > .05). Data are presented in Table 4.12. 
Post hoc tests showed that gait speed did not change between PRE1 and PRE2 (p > 
.05) but that it increased by 8.1% from PRE 1 to POST (p ≤ .001) and by 7.9% from 
PRE2 to POST (p ≤ .001).  
Post hoc tests showed that stride length did not change between PRE1 and PRE2 (p 
> .05), but that it increased by 4.3% from PRE 1 to POST (p ≤ .01) and by 4.0% from 
PRE2 to POST (p ≤ .001).  
Post hoc tests showed that cadence did not change between PRE1 and PRE2 (p > 
.05) or between PRE1 and POST (p = .07), but that it increased by 4.4% from PRE2 
to POST (p ≤ .01).  
Post hoc tests showed that stride width increased by 7.1% from PRE1 to PRE2 (p < 
.05) and decreased by 7.1% from PRE2 to POST (p < .05) with no difference in-
between PRE1 and POST (p> .05). 
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Table 4.12: Mean ± standard deviation of spatial and temporal variables of self-
selected walking at PRE1, PRE2 and POST. * represents a significant difference from 
PRE1 and $ from PRE2.  
 
4.3.2.3 Joint Kinematics 
Angular displacement of the pelvis, hip, knee and ankle joint during the gait cycle 
are presented as ensemble averages in the sagittal, frontal and transverse planes 
for each time point (PRE1, PRE2 and POST) in Figure 4.7. The root mean square 
difference in joint angle between PRE1 and PRE2 and between PRE2 and POST over 
the entire gait cycle and in the stance and swing phase are presented in Table 4.13.
 PRE1 PRE2 POST 
Gait speed (m/s) 0.96 ± 0.25 0.97 ± 0.26 1.04 ± 0.24*$ 
Stride length (m) 1.30 ± 0.18 1.31 ± 0.17 1.36 ± 0.17*$ 
Cadence  
(steps/minute) 
88.4 ± 15.4 87.5 ± 16.4 91.4 ± 16.4$ 
Step width (m) 0.14 ± 0.05 0.15 ± 0.04* 0.14 ± 0.04* 
Stance time (%) 64 ± 4 64 ± 3 63 ± 4 
Double support (%) 26 ± 7 27 ± 7 26 ± 7 
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Figure 4.7: Mean pelvis, hip, knee and ankle angle during the gait cycle in the sagittal (top row), frontal (middle row) and transverse (bottom row) planes. The white line and 
grey band represents control data mean ± 1 standard deviation and the blue line represents the mean of the MD group at PRE1, the green line represents the mean at PRE2, 
and the red line represents the mean at POST. On the x-axis, 0% represents initial contact and 100% the following ipsilateral contact.
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Table 4.13: Root mean square difference in joint angle compared to the control 
group over the entire gait cycle, in the stance phase and in the swing phase at 
PRE1, PRE2 and POST. 
 
 
 
 
 
 
 
 
 
 
 
  PRE1-PRE2 PRE2-POST 
Pelvic Tilt (°)   
Gait cycle 1.0 0.8 
Stance phase 1.2 0.8 
Swing phase 0.8 0.9 
Hip Flexion (°)   
Gait cycle 0.4 2.7 
Stance phase 0.3 2.3 
Swing phase 0.4 3.6 
Knee Flexion (°)   
Gait cycle 0.5 2.8 
Stance phase 0.5 2.9 
Swing phase 0.5 2.8 
Ankle Flexion (°)   
Gait cycle 0.4 1.0 
Stance phase 0.3 1.1 
Swing phase 0.5 0.9 
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Discrete kinematic variables for PRE1, PRE2 and POST are presented in Table 4.14, 
4.15, 4.16 and 4.17 for the pelvis, hip, knee and ankle joint, respectively.  
Pelvis 
Table 4.14: Mean ± standard deviation of discrete kinematic variables (°) of the 
pelvis during the gait cycle. * represents a significant difference from PRE1 and $ 
represents a significant difference from PRE2. 
 PRE1 PRE2 POST 
P1 (°) 15.1 ± 8.4 14.0 ± 10.1 14.8 ± 8.2 
P2 (°) 17.9 ± 8.8 16.6 ± 10.6 17.3 ± 8.6 
P3 (°) 17.2 ± 8.3 16.4 ± 10.0 17.1 ± 8.2 
P4 (°) 5.0 ± 2.4 4.4 ± 3.1 4.4 ± 2.9 
P5 (°) -3.8 ± 3.2 -4.1 ± 2.5 -4.2 ± 2.6 
P6 (°) 5.8 ± 6.6 5.5 ± 6.3 5.3 ± 5.6 
P7 (°) -7.4 ± 6.8 -7.1 ± 5.4 -7.6 ± 5.7 
Note: P1 = mean pelvic tilt, P2 = max. anterior tilt in stance, P3 = max. anterior tilt in 
swing, P4 = max. pelvic rise in stance, P5 = max. pelvic drop in swing, P6 = max. 
internal rotation, P7 = external rotation at toe-off. 
No main effect of time was found in in any of the discrete pelvic variables, with the 
retrospective observed power for these comparisons ranging between .06 and .16.
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Hip 
Table 4.15: Mean ± standard deviation of discrete kinematic variables (°) of the hip 
joint during the gait cycle. * represents a significant difference from PRE1 and $ 
represents a significant difference from PRE2. 
 PRE1 PRE2 POST 
H1 (°) 37.0 ± 11.9 36.9 ± 13.1 39.4 ± 11.2 
H2 (°) -4.0 ± 13.8 -3.8 ± 14.6 -2.0 ± 13.6 
H3 (°) 9.1 ± 15.9 8.8 ± 16.9 9.8 ± 14.2 
H4 (°) 42.4 ± 10.7 42.2 ± 11.5 45.9 ± 10.8 
H5 (°) 3.6 ± 3.1 3.3 ± 3.0 4.6 ± 2.9*$ 
H6 (°) -8.9 ± 5.1 -8.6 ± 5.1 -8.0 ± 4.8 
H7 (°) -7.3 ± 14.0 -5.4 ± 16.5  -10.7 ± 17.7 
H8 (°) 5.3 ± 16.2 4.1 ± 16.1 3.5 ± 12.4 
 Note: H1 = flexion at initial contact, H2 = max. extension, H3 = extension at toe-off, 
H4 = max flexion in swing, H5 = mean adduction in stance, H6 = max. abduction in 
swing, H7 = internal rotation at initial contact, H8 = external rotation at toe-off. 
There was a significant main effect of time on mean hip adduction in stance (p < .05, 
Ꞃp2 = .19) with a retrospective observed power of .65.  No main effect of time was 
found in any other discrete hip variable, with the retrospective observed power for 
these comparisons ranging between .07 and .27.  
Post hoc tests showed that mean hip adduction in stance did not differ between 
PRE1 and PRE2 (P > .05) or between PRE1 and POST (p = .055) but was increased by 
1.3° from PRE2 to POST (p <.05).  
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Knee 
Table 4.16: Mean ± standard deviation of discrete kinematic variables (°) of the knee 
joint during the gait cycle. * represents a significant difference from PRE1 and $ 
represents a significant difference from PRE2. 
 PRE1 PRE2 POST 
K1 (°) 2.6 ± 5.9 2.5 ± 7.6 5.0 ± 6.0*$ 
K2 (°) 7.6 ± 10.0 7.6 ± 11.7 9.9 ± 10.6*$ 
K3 (°) -3.1 ± 10.8 -2.6 ± 11.7 -0.1 ± 9.7*$ 
K4 (°) 64.9 ± 11.3 65.9 ± 10.5 68.9 ± 10.3*$ 
K5 (°) -0.6 ± 5.6 -1.0 ± 6.3 1.6 ± 5.6*$ 
K6 (°) 0.2 ± 5.4 0.8 ± 3.9 1.9 ± 4.9 
K7 (°) 5.4 ± 17.1 5.6 ± 13.2 4.4 ± 13.0 
Note: K1 = flexion at initial contact, K2 = max. flexion in early stance, K3 = max. 
extension in stance, K4 = max. flexion in swing, K5 = max. extension in swing, K6 = 
mean varus in stance, K7 = varus angle at toe-off. 
There was a significant main effect of time on knee flexion at initial contact (p ≤ 
.001, Ꞃp2  = .38), max. flexion in early stance (p ≤ .01, Ꞃp2  = .31), max. extension in 
stance (p ≤ .001, Ꞃp2  = .35), max. flexion in swing (p < .05, Ꞃp2  = .22) and max. 
extension in swing (p ≤ .001, Ꞃp2  = .36), with the retrospective observed powers 
ranging from .73 to .97. No main effect of time was found for mean varus in stance 
or varus angle at toe-off (observed power = .27).  
Post hoc tests showed that knee flexion at initial contact did not differ between 
PRE1 and PRE2 (P > .05) but that it increased by 2.4° from PRE1 to POST (p ≤ .01) 
and 2.5° from PRE2 to POST (p ≤ .01). 
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Post hoc tests showed that max. flexion in early stance did not differ between PRE1 
and PRE2 (P > .05) but that it increased by 2.3° from PRE1 to POST (p ≤ .01) and 2.3° 
from PRE2 to POST (p ≤ .01). 
Post hoc tests showed that max. extension in stance did not differ between PRE1 
and PRE2 (P > .05) but that it decreased by 3° from PRE1 to POST (p ≤ .01) and 
decreased by 2.5° from PRE2 to POST (p ≤ .01). 
Post hoc tests showed that max. flexion in swing did not differ between PRE1 and 
PRE2 (P > .05) but that it increased by 4° from PRE1 to POST (p < .05) and increased 
by 3° from PRE2 to POST (p < .05). 
Post hoc tests showed that max. extension in swing did not differ between PRE1 and 
PRE2 (P > .05) but that it decreased by 2.2° from PRE1 to POST (p ≤ .01) and 
decreased by 2.6° from PRE2 to POST (p ≤ .01). 
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Ankle 
Table 4.17: Mean ± standard deviation of discrete kinematic variables (°) of the 
ankle joint during the gait cycle. * represents a significant difference from PRE1 and 
$ represents a significant difference from PRE2. 
 PRE1 PRE2 POST 
A1 (°) -5.0 ± 6.0 -4.3 ± 5.5 -2.1 ± 6.3*$ 
A2 (°) 15.0 ± 7.2 14.8 ± 6.8 15.8 ± 6.9 
A3 (°) -14.7 ± 7.0 -14.8 ± 7.0 -14.6 ± 7.4 
A4 (°) -11.0 ± 9.7 -10.4 ± 9.7 -9.1 ± 13.2 
A5 (°) 2.1 ± 5.9 1.8 ± 5.2 4.1 ± 6.6*$ 
A6 (°) -0.8 ± 5.8 -1.4 ± 4.8 0.5 ± 5.7*$ 
A7 (°) 6.5 ± 10.8 3.3 ± 10.3 13.1 ± 12.3*$ 
A8 (°) -6.6 ± 12.0 -10.4 ± 12.2 -1.5 ± 15.4$ 
A9 (°) -2.0 ± 2.6 -1.7 ± 2.1 -2.5 ± 2.9 
Note: A1 = angle at initial contact, A2 = max. dorsiflexion in stance, A3 = max. plantar 
flexion in stance, A4 = plantar flexion at toe-off, A5 = max. dorsiflexion in swing, A6 
= mean dorsi flexion in late swing, A7 = inversion angle at initial contact, A8 = 
eversion at toe-off, A9 = abduction at initial contact. 
There was a significant main effect of time on ankle angle at initial contact (p ≤ .01, 
Ꞃp2  = .36), max. dorsi flexion in swing (p < .05, Ꞃp2  = .24), mean dorsi flexion in late 
swing (p < .05, Ꞃp2  = .24), inversion angle at initial contact (p < .05, Ꞃp2  = .24) and 
eversion angle at toe-off (p < .05), with the retrospective observed power for these 
comparisons ranging from .65 to .87.  No main effect of time was found for max. 
dorsi flexion in stance, max. plantar flexion in stance, plantar flexion at toe-off or 
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abduction at initial contact, with the retrospective observed power for these 
comparisons ranging between .05 and .13. 
Post hoc tests showed that ankle angle at initial contact did not differ between PRE1 
and PRE2 (P > .05) but that it increased by 2.9° from PRE1 to POST (p ≤ .01) and 
increased by 2.2° from PRE2 to POST (p < .05). 
Post hoc tests showed that max. dorsi flexion in swing did not differ between PRE1 
and PRE2 (P > .05) but that it increased by 2° from PRE1 to POST (p < .05) and 
increased by 2.3° from PRE2 to POST (p < .05). 
Post hoc tests showed that mean dorsi flexion in late swing did not differ between 
PRE1 and PRE2 (P > .05) but that it increased by 1.3° from PRE1 to POST (p < .05) 
and increased by 1.9° from PRE2 to POST (p < .05). 
Post hoc tests showed that inversion angle at initial contact did not differ between 
PRE1 and PRE2 (P > .05) or between PRE1 and POST (p = .06) but that it increased 
by 9.8° from PRE2 to POST (p ≤ .01). 
Post hoc tests showed that eversion angle at toe-off did not differ between PRE1 
and PRE2 (P > .05) or between PRE1 and POST (p = .09) but that it decreased by 8.9° 
from PRE2 to POST (p < .05). 
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4.3.2.4 Additional Kinematic Analysis - knee hyperextension  
Knee angle in the sagittal plane for the sub-group of participants that displayed 
excessive hyperextension of the knee in the stance phase is presented in Figure 4.8, 
and discrete data from this analysis are presented in Table 4.18. 
There was a significant main effect of time on knee flexion at initial contact (p ≤ .01, 
Ꞃp2= .53, observed power = .89) and max. extension in stance (p ≤ .01, Ꞃp2= .51, 
observed power = .87). No main effect of time on max. extension in swing was found 
(p = .087, power = .48).  
Post hoc analysis showed that knee flexion at initial contact did not differ between 
PRE1 and PRE2 (p > .05) but that the angle was increased by 2.7° from PRE1 to POST 
(p ≤ .01) and increased by 3.9° from PRE2 to POST (p < .05).  
Post hoc analysis showed that max. extension in stance did not differ between PRE1 
and PRE2 (p > .05) but that the angle was increased by 4.3° from PRE1 to POST (p ≤ 
.05) and increased by 4.1° from PRE2 to POST (p < .05).
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Figure 4.8: Mean knee flexion (+) and extension (-) angle during the gait cycle in individuals 
with MD who hyper-extend the knee at PRE1 (blue line), PRE2 (green line) and POST (red 
line) completion of a RT programme. The grey line (± grey band) represents control group 
data mean (± 1 standard deviation) for visual comparison. On the x-axis, 0% represents 
initial ground contact and 100% the following ipsilateral ground contact. 
 
Table 4.18: Mean ± standard deviation of discrete knee angle data for a sub-group 
of participants that exhibited excessive hyperextension of the knee during stance. * 
represents a significant difference from PRE1 and $ represents a significant 
difference from PRE2. 
 PRE1 PRE2 POST 
K1 (°) -1.9 ± 3.4 -3.1 ± 5.5 0.8 ± 3.6*$ 
K3 (°) -11.2 ± 9.5 -11.0 ± 11.1 -6.9 ± 8.4*$ 
K5 (°) -2.9 ± 4.4 -4.8 ± 5.2 -1.8 ± 3.8 
Key: K1 = flexion at initial contact, K3 = max. extension in stance, K5 = max. extension 
in swing. 
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4.3.2.5 Additional Kinematic Analysis – limited dorsi flexion   
Ankle angle in the sagittal plane for the sub-group of participants that displayed 
excessive plantar flexion of the ankle during the swing phase is presented in Figure 
4.9, and discrete kinematic variables from this analysis are presented in Table 4.19. 
There was a significant main effect of time on ankle angle at initial contact (p ≤ .05, 
Ꞃp2= .39, observed power = .85) and mean dorsi flexion in late swing (p ≤ .05, Ꞃp2= 
.38, observed power = .78). No main effect of time on max. dorsi flexion in swing 
was found (p = .123, power = .36).  
Post hoc analysis showed that ankle angle at initial contact did not differ between 
PRE1 and PRE2 (p > .05) but that the angle was increased by 2.8° from PRE1 to POST 
(p ≤ .05) and increased by 1.9° from PRE2 to POST (p < .05).  
Post hoc analysis showed that mean dorsi flexion in late swing did not differ 
between PRE1 and PRE2 (p > .05) but the angle was increased by 2.3° from PRE1 to 
POST (p ≤ .05) and increased by 2.4° from PRE2 to POST (p < .05). 
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Figure 4.9: Mean ankle dorsi flexion (+) and plantar flexion (-) angle during the gait cycle in 
individuals with MD who exhibit limited dorsi flexion in the swing phase, at PRE1 (blue line), 
PRE2 (green line) and POST (red line) completion of a RT programme. The grey line (± grey 
band) represents control group data mean (± 1 standard deviation) for visual comparison. 
On the x-axis, 0% represents initial ground contact and 100% the following ipsilateral 
ground contact. 
 
Table 4.19: Mean ± standard deviation of discrete ankle angle data for a sub-group 
of participants that exhibited limited ankle dorsi flexion during swing. * represents 
a significant difference from PRE1 and $ represents a significant difference from 
PRE2. 
 PRE1 PRE2 POST 
A1 (°) -7.6 ± 5.5 -6.7 ± 4.8 -4.8 ± 5.8*$ 
A5 (°) -1.0 ± 4.8 -1.0 ± 3.7 1.1 ± 4.7 
A6 (°) -3.6 ± 5.0 -3.7 ± 3.8 -1.3 ± 4.3*$ 
Key:  A1 = angle at initial contact, A5 = max. dorsiflexion in swing, A6 = mean 
dorsiflexion in late swing. 
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4.3.2.4 Metabolic Cost of Walking 
There was a main effect of time on oxygen cost normalised to body mass (p ≤ .05; 
Figure 4.10 A). Post hoc tests showed a 9.1% increase from PRE1 to PRE2 (p = .025) 
but no difference between PRE2 and POST or PRE1 and POST (p > .05). No effect of 
time on oxygen cost normalised to lean body mass was found (p > .05; Figure 4.10 
B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Oxygen cost during steady state walking normalised to body mass (A) 
and lean body mass (B). Bars represent means and error bars represent standard 
deviation.  * represents a significant difference from PRE1. 
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4.4. Discussion  
4.4.1 Part A – MD versus Controls 
This study is novel in the description of spatial-temporal variables, lower-body 
angular kinematics and the metabolic cost of gait in adults with BMD and LGMD. It 
is also novel in the presentation of angular kinematics at the pelvis and in the 
transverse and frontal plane as well as the metabolic cost of gait in adults with FSHD. 
Adults with FSHD, BMD and LGMD walked at a slower self-selected pace, with 
reduced stride length and reduced cadence compared to the control group. Adults 
with BMD walked with a greater stride width and adults with LGMD spent a greater 
proportion of the stride in the stance phase and in double support than controls did. 
In addition, numerous kinematic gait abnormalities were evident in the MD groups 
compared to the controls and the oxygen cost of gait was 2 times greater in the 
LGMD group than the control and FSHD group.  
4.4.1.1 Spatial and Temporal Variables 
In agreement with most previous research in MD, self-selected gait speed was 
slower in all MD groups compared to controls, ranging from 26-44% slower. With 
regards to gait speed, the LGMD group were the most impaired followed by the 
BMD and subsequently the FSHD group. Slower gait speed resulted from both 
shorter stride lengths and reduced cadence in all MD groups. The finding of shorter 
stride length is in accordance with most previous gait studies in MD (Aprile et al., 
2012; Iosa et al., 2007; Iosa et al., 2010; Rijken, van Engelen, de Rooy, et al., 2015; 
Rijken, van Engelen, Geurts, et al., 2015). Reduced cadence on the other hand is not 
a common finding in MD gait but has previously been reported in one study of adults
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with FSHD (Iosa et al., 2010). Gait speed is an important clinical indicator of physical 
function and independence and offers a functional perspective on the health status 
of individuals (Fritz and Lusardi, 209). In our study, gait speeds of 1.1, 1.0 and 0.8 
m/s were found for the FSHD, BMD and LGMD groups, respectively, compared to 
1.4 m/s in the controls. Thus, it is clear that each MD group was considerably 
impaired. 
Stride width was greater in the BMD group, but not in the FSHD or LGMD group, 
compared to the controls. Previously, greater stride width has been reported in 
children with Duchenne MD (Sutherland et al., 1981), whilst several studies in adults 
with FSHD found no difference in stride width compared to controls  (Iosa et al., 
2010; Aprile et al., 2012; Rijken, van Engelen, Geurts, et al., 2015). It is interesting 
to note that as BMD is a less severe variant of Duchenne MD, gait patterns in BMD 
have previously been presumed to be similar to Duchenne MD. This finding provides 
evidence of similar gait patterns between these two populations. The greater stride 
width in adults with BMD may be due to a number of reasons. It may be a functional 
compensatory mechanism to improve lateral stability by increasing the base of 
support, but in the absence of an increased double support phase duration it is 
uncertain whether this is the cause. Alternatively, greater stride width may reflect 
a mechanical mechanism rather than a functional one. It may be an adaptation that 
occurs in response to altered trunk mechanics that are described later in this 
discussion. Essentially, due to an excessive lateral trunk lean towards the stance 
limb (qualitative observation), a wider stride may be required to ensure that the 
centre of mass remains within the base of support. 
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Despite the differences in gait speed, temporal variables were similar between the 
FSHD and control and BMD and control group. The LGMD group however spent 4% 
more time in the stance phase and 12% more time in a double support phase than 
the control group. This gait pattern reflects an avoidance of single support loading 
during gait, which may be a compensatory mechanism for reduced lateral stability 
during gait or alternatively it could be a mechanism for pain reduction during single 
limb stance. 
4.4.1.2 Angular Kinematics 
Kinematic gait abnormalities at the hip, knee and ankle joint have previously been 
reported in adults with FSHD in the sagittal plane, but gait patterns have not 
previously been described for adults with BMD or LGMD. The current study found 
numerous kinematic abnormalities that were similar between all three MD groups 
as well as kinematic abnormalities that were specific to the individual types of MD. 
Although direct associations between these kinematic abnormalities and muscle 
strength were not conducted as part of this study, some potential reasons behind 
such abnormalities are proposed. 
At the level of the pelvis, greater anterior tilt was found throughout the gait cycle in 
both the FSHD and BMD group compared to the controls. Excessive anterior pelvic 
tilt has previously been reported in both adults with Myotonic MD and children with 
Duchenne MD (Galli et al., 2012; Doglio et al., 2011; D'Angelo et al., 2009). Whilst 
lower-limb gait kinematics have previously been described in adults with FSHD (Iosa 
et al., 2007) kinematics at the level of the pelvis have not. With regards to BMD, this 
finding (greater anterior tilt) supports the previously presumed notion of similar gait 
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abnormalities between BMD and Duchenne MD. The most likely cause of the 
excessive pelvic tilt in these groups is a combination of the weak hip extensor and 
knee flexor muscles presented in Chapter 3 and, potentially, tight hip flexor muscles 
that cause a forward shift in the position of the pelvis. It makes sense that the BMD 
group present a more severe anterior pelvic tilt than the FSHD group given the 
greater strength deficits found in these muscles (Chapter 3). It is interesting that the 
LGMD group did not present with excessive anterior pelvic tilt despite greater 
strength deficits in the hip extensor and knee flexor muscle groups than the FSHD 
group and similar strengths to the BMD group. It is possible that this is due to muscle 
tightness in the hip extensor and/or knee flexor muscles of individuals with LGMD, 
which logically would act to pull the pelvis backwards into a more neutral position 
despite hip extensor and knee flexor muscle weakness. This mechanism is seen in 
other clinical populations such as cerebral palsy (de Morais Filho et al., 2018), were 
surgical hamstring lengthening often results in an anterior shift of the pelvis.  
An additional abnormality found at the level of the pelvis was greater external 
rotation of the pelvis at toe-off in all MD groups compared to controls. Pelvic 
rotation has not previously been measured in FSHD, but increased external pelvic 
rotation has been reported in children with Duchenne MD (Doglio et al., 2011). This 
excessive rotation may serve as an attempt to preserve stride length by gaining 
additional forward advancement through pelvic rotation.   
At the hip joint, maximum hip extension and hip extension at toe-off were reduced 
in the FSHD and BMD group compared to controls. This has previously been 
reported in Myotonic MD (Galli et al., 2012), Duchenne  MD (Sutherland et al., 1981; 
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Gaudreault et al., 2010) and importantly FSHD (Iosa et al., 2007). It is likely that this 
insufficient hip motion results from strength deficits in the hip extensor muscles in 
combination with the excessive anterior pelvic tilt seen in these individuals.  
Abnormalities in hip motion were expected in the frontal plane for the BMD and 
LGMD groups, due to the strength deficits that were found in the hip abductor 
muscles, as reported in Chapter 3. As such, a Trendelenburg gait pattern was 
expected to be found in these groups. Trendelenburg gait refers to excessive pelvic 
drop on the contralateral side during the stance phase, which is due to hip abductor 
muscle weakness or impairment (Pai, 1996). This typically results in severe 
adduction of the hip joint throughout the stance phase. However, no difference in 
mean hip adduction during stance was evident in any of the MD groups compared 
to controls. Instead, excessive abduction of the hip joint was found during the swing 
phase in the BMD and LGMD groups and noticeably in Figures 4.4 and 4.5 earlier 
abduction of the hip joint occurred during stance. This kinematic pattern suggests 
that a compensated Trendelenburg gait pattern (Vroome et al., 2016) was evident 
in these MDs (a visual representation of this is provided in Appendix 3.1). That is, in 
order to counteract pelvic drop on the contralateral side to the stance limb, 
participants abducted the hip joint using a lateral trunk lean towards the stance 
limb, which was confirmed via video and can be observed in Appendix 3.2. This 
finding agrees with a study in children with Duchenne MD by Gaudreault et al. 
(2010); the only other study to previously report frontal plane hip kinematics in MD 
gait. Essentially, excessive adduction of the hip joint during stance is not observed 
in the data due to the compensatory lateral trunk lean utilised by participants. 
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Despite this it is still evident that the stability of the pelvis during gait is 
compromised in these groups.   
At the knee joint, numerous gait abnormalities were evident for the MD groups 
compared to the control. Reduced knee flexion at initial contact and greater knee 
extension/hyperextension during the late swing phase, was found in both the FSHD 
and LGMD groups compared to controls. Furthermore, reduced maximum flexion in 
stance was evident in the BMD and LGMD groups compared to controls. The two 
former variables have not previously been reported in an FSHD population, but Iosa 
et al. (2007) did find reduced maximum knee flexion during stance in adults with 
FSHD compared to controls. Although our study contradicts this finding, as 
maximum knee flexion in the FSHD group did not significantly differ to controls, 
qualitatively the magnitude of knee flexion during stance was noticeably smaller in 
FSHD than controls (Figure 4.3). Importantly, the abnormalities in knee angle during 
stance in the BMD and LGMD groups were not as simple as a reduced magnitude of 
knee flexion during the loading response. Instead, there was a complete lack of knee 
flexion or hyperextension of the knee joint throughout the stance phase in BMD and 
LGMD, respectively. This kinematic pattern has previously been reported in children 
with Duchenne MD (D'Angelo et al., 2009). Visual examples of the knee 
extension/hyperextension that were observed in our study are provided in 
Appendix 3.3. 
The lack of knee flexion or hyperextension during stance in the BMD and LGMD 
groups may be due to the knee extensor strength deficits that were presented in 
Chapter 3. This likely results in an inability of the knee extensors to eccentrically 
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control knee flexion whilst weightbearing. An extended knee position likely 
increases the knee extensor moment during stance through a more anterior 
direction of the ground reaction force relative to the knee joint, thereby creating a 
more stable knee position during the loading response (Gaudreault et al., 2010). 
However, it is unclear why the severity of this abnormality was greater in the LGMD 
than the BMD group, given the similarities in knee extensor and knee flexor muscle 
strength deficits between these groups (Chapter 3). This difference may be 
associated with variances in the direction and/or magnitude of the knee 
flexion/extension moment between the groups. Alternatively, it is possible that 
differences in soft tissue properties between the two MDs, such as ligament laxity 
or tendon stiffness, play a role in this discrepancy.   
In agreement with previous studies in children with Duchenne MD (D'Angelo et al., 
2009; Doglio et al., 2011; Sutherland et al., 1981), this study found that the ankle 
was more plantar flexed at initial contact and that dorsi flexion was limited during 
the swing phase (these abnormalities are defined as drop foot), in all MD groups 
compared to controls. Whilst reduced dorsi flexion at initial contact has previously 
been reported in adults with FSHD (Iosa et al., 2007), no comparison of discrete 
ankle kinematics to a control group in the swing phase has been undertaken. 
Although significant deficits in dorsi flexor MVC torque were found for each MD 
group (Chapter 3), the severity of drop foot between the MD groups does not mirror 
the severity of dorsi flexor muscle weakness (i.e. the BMD group demonstrated the 
least severe strength deficit in dorsi flexor MVC torque but not the least severe drop 
foot). Thus, it is likely that both dorsi flexor muscle strength and the presence of 
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plantar flexor muscle tightness/contractures influence this kinematic abnormality 
in MD. 
4.4.1.3 Oxygen Cost 
Oxygen cost during gait was 83% greater in the LGMD group than both the control 
and the FSHD group and, once it was normalised to lean body mass, oxygen cost 
was found to be double that of the control and FSHD group. Although not directly 
assessed in this study there are a plethora of potential reasons for the heightened 
oxygen cost in the LGMD group. The measure of oxygen cost accounts for gait speed 
and was further normalised to lean body mass. Therefore, other factors must be 
associated with the heightened oxygen cost in this group.  
Some of the kinematic abnormalities found in this study, either in isolation or in 
combination, may be associated with the greater oxygen cost of gait in LGMD. 
Excessive movements that occur during gait may have the potential to increase the 
oxygen cost of gait through an increased mechanical effort. In this study greater 
external pelvic rotation, greater hip abduction with a lateral trunk lean and 
excessive hyperextension of the knee joint were found. It has previously been 
shown that excessive hip and pelvic motion during gait in children with spina bifida 
were significantly related to the oxygen cost of gait (Bare et al., 2001). Thus, it is 
highly likely that the increased hip abduction found within our study contributes 
towards the greater oxygen cost of gait in the LGMD group. In addition, previous 
research has  demonstrated that ankle range of motion in gait has a strong negative 
association to energy expenditure during cerebral palsy gait (Ballaz et al., 2010). In 
our study, limited ankle dorsi flexion was noted in all MD groups and to the greatest 
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severity in the LGMD group. We proposed that this is due to dorsi flexor muscle 
weakness in combination with plantar flexor muscle tightness. If the latter is correct, 
the material properties of the Achilles tendon may also be altered, which has the 
potential to contribute towards the greater oxygen cost of gait. This is because 
tendons control the storage and release of elastic energy during movement 
(Lichtwark and Wilson, 2008).  
Alternatively, the greater oxygen cost in LGMD may be associated with physiological 
mechanisms. Although muscle mass is not a potential factor as it was accounted for, 
the quality of muscle in LGMD may have influenced oxygen cost during gait. This is 
because lean muscle mass did not differ between the MD groups but the LGMD 
were the weakest overall (Chapter 3), signifying a reduced quality of muscle tissue 
in LGMD. Additionally, it may be related to excessive co-activations of antagonistic 
muscles in MD. This is considered as increased co-contraction of the knee flexors 
and knee extensors during gait has previously been shown to be associated with a 
greater oxygen cost of gait in elderly men (Mian et al., 2006). Although muscle 
activation patterns during gait have not directly been measured in adults with FSHD, 
BMD or LGMD, heightened co-contraction between the knee extensor and knee 
flexor muscles during gait has been demonstrated in children with Duchenne MD 
(Ropars et al., 2016).  
4.4.1.4 Clinical Implications 
This study demonstrates numerous kinematic abnormalities in individuals with 
FSHD, BMD and LGMD compared to controls. These abnormalities have numerous 
clinical implications including the potential for increased pain, excessive forces at 
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the joints, increased fall and injury risk, fatigue and psychological implications. For 
example, excessive anterior pelvic tilt may result in low back pain through greater 
stresses and loads placed on the intervertebral disks in the spine (Keller et al., 2006), 
and hyperextension of the knee may result in pain and damage through excessive 
compressive forces at the structures of the knee joint, including the posterior and 
anterior cruciate ligaments (Meyer et al., 2011). Furthermore, the presence of drop 
foot suggests that fall risk is a substantial hazard in these MD groups. In order to 
minimise these risks, strength training, regular stretching and physiotherapy should 
be a key element within the management of these conditions. In advanced cases of 
drop foot, the use of orthotics may be required to enable the continuation of safe 
ambulation. Finally, it is important to recognise that the greater oxygen cost of 
walking in MD, particularly in the LGMD group, likely impact levels of fatigue and 
therefore quality of life. 
This study identified the key kinematic gait abnormalities in adults with BMD, LGMD 
and FSHD and alluded to the potential primary reasons for such abnormalities. 
Future research should seek to establish direct associations between these 
kinematic abnormalities and measures of muscle strength. 
4.4.1.5 Conclusion 
Kinematic abnormalities are evident at all lower-limb joint levels in these MD 
groups. Some of these abnormalities are similar between the MDs, such as reduced 
dorsiflexion of the ankle joint at initial contact and during the swing phase, whilst 
some abnormalities were specific to individual types of MD, such as hyperextension 
of the knee joint in the LGMD group. It is clear that such gait abnormalities may have 
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a huge impact on physical function, daily life and independence. Therefore, 
resistance training that is designed to target these primary gait deviations may be 
advantageous in these individuals.  
4.4.2 Part B -Effects of RT 
This is the first study to examine the effect of a RT programme on key gait 
parameters in individuals with MD. Several changes in spatial and temporal 
variables of gait were found after completion of the RT programme including 
increased self-selected gait speed, stride length and cadence. In addition, numerous 
kinematic parameters were improved at the hip, knee and ankle joint. Despite these 
changes, no difference in oxygen cost post completion of the RT programme was 
evident. 
4.4.2.1 Spatial and Temporal Variables 
Gait speed increased by 8% from immediately before to after completion of the RT 
programme, with stable values in the control period. Even though this increase is 
relatively small, the ability to ambulate at a speed closer to control participants may 
influence daily life considerably, particularly as this may continue to rise with 
sustained participation in RT. Furthermore, this percentage increase in gait speed is 
similar to the 9% increase found in adults with multiple sclerosis following 
completion of a 12-week RT programme (Kierkegaard et al., 2016). The increase in 
gait speed came from a 4% increase in both stride length and cadence but no change 
in the temporal parameters of gait were found. However as demonstrated in part A 
of this study, differences in temporal variables were evident in one of the three 
types of MD only; stance duration and double support time were increased in 
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LGMD. As the effect of RT was not measured in each type of MD individually, it is 
unknown whether differences in temporal parameters of gait may have occurred 
with separate analysis.  
4.4.2.2 Angular Kinematics 
Numerous changes in the hip, knee and ankle kinematics were found post 
completion of the RT programme. The root mean square differences, which 
provides an insight into the global change in sagittal plane joint angles, were 
greatest in the hip joint during the swing phase, the knee joint during the stance 
phase and the ankle joint during the stance phase. In addition, numerous discrete 
kinematic parameters were improved post completion of the RT programme, 
compared to stable values in the initial control period. Notably, the discrete 
variables in which significant differences were found displayed sufficient statistical 
power, but a few of the variables that did not differ were found to have a low 
retrospective statistical power (between .05 and .27). Thus, it is viable that a greater 
sample size would reveal additional differences alongside the ones found in this 
study. 
No change in any of the discrete variables at the pelvis were evident post the RT 
programme. At the hip however, a 1.3° increase in mean hip adduction angle during 
the stance phase was found. This brought the hip adduction angle closer to that of 
the control group and likely occurred in combination with a reduction in the 
compensatory trunk lean that was discussed in Part A of this study. This finding 
signifies an improved stability at the hip joint and pelvis and is most likely associated 
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with the increase in hip abduction muscle strength presented in Chapter 3 of this 
thesis.  
Several improvements in the kinematics of the knee were found post completion of 
the RT programme. Knee angle at initial contact was unchanged in the control 
period but increased by 2.5° to a more flexed position post RT. In addition, the 
maximum knee flexion angle in the stance phase increased by 2.3° post RT. These 
changes occurred in the opposite direction those previously found in individuals 
with cerebral palsy post RT (Engsberg et al., 2006) but the adaptations reported in 
both studies are relative to the initial impairments. These being a reduction in 
excessive crouch gait in cerebral palsy and an increase in insufficient knee flexion in 
MD. Importantly, the adaptation in knee angle found in our study shifted the flexion 
angle time curve closer to that of the control population and demonstrates an 
improved loading response at the knee joint during stance. Although no significant 
increase in the knee extensor MVC torque was found in this group post RT (Chapter 
3) there was a clear trend for an increase (p = .08). Additionally, completion of the 
RT programme may have improved confidence in gait, such that the increase in knee 
flexion angle may have occurred as a conscious adaptation due to improved 
confidence in the knee extensors to eccentrically control this motion. Changes in 
knee flexion angle were also found in the swing phase of the gait cycle. Maximum 
knee flexion increased by 3° to an angle comparable to the control group. This is 
likely a result of the 13% increase in knee flexor MVC torque post completion of the 
RT programme. Regarding maximum knee extension or hyperextension, significant 
reductions were found in both the stance and terminal swing phase of 2.5° and 2.6°, 
respectively, post RT. The latter finding signifies an improved ability of the knee 
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flexor muscles to control and slow down the advancing lower leg during terminal 
swing and therefore likely results from the increase in knee flexor MVC torque found 
in this group (Chapter 3).   
At the ankle joint, an increase in dorsiflexion of 2.2° at initial contact was found after 
completion of the RT programme. This increase demonstrates a movement towards 
a more dorsi flexed position at ground contact, similar to the control group. In 
addition, the maximum dorsiflexion angle during swing and the mean angle during 
the late swing phase increased by 2.3° and 1.9°. respectively. The latter finding 
agrees with a previous investigation into RT in community dwelling elderly women 
(Cao et al., 2007), who reported a 4° increase in peak dorsiflexion angle during the 
swing phase. This adaptation is important as it may reduce the risk of falls in the 
current population. This is suggested as an increase in dorsiflexion during the swing 
phase will increase the clearance distance between the ground and the foot and 
subsequently lower the potential for a trip to occur. In fact, the frequency of falls 
was reduced by almost half (47%; Appendix 3.4) post completion of the RT 
programme. These gait adaptations parallel the 28% increase in dorsiflexion MVC 
torque presented in Chapter 3.  
Kinematic adaptations in ankle position were also evident in the transverse plane. 
Inversion at initial contact increased by 9.8° and eversion at toe-off increased by 
8.9° post the RT programme, thereby bringing the ankle kinematics closer to that of 
the control group. The primary dorsiflexor muscles are also involved in these 
movements and therefore it is likely that the increase in dorsiflexion MVC torque 
contributed towards these adaptations.  
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Additional analysis was completed on the knee kinematics in the sagittal plane in 
those participants who presented with severe hyperextension of the knee joint in 
stance, and on the sagittal plane ankle kinematics in those participants who 
presented with severe foot drop in the swing phase. Both of these parameters were 
primary gait abnormalities rather than compensatory mechanisms. This analysis 
was undertaken to provide an insight into the effect of RT on those individuals with 
the most severe gait abnormalities.  
The additional analysis completed on those participants categorised as having knee 
hyperextension, found that knee angle at initial contact increased by 3.9° from 
immediately before to post completion of the RT programme. This increase shifted 
the knee angle from a negative angle (knee extension) to a slightly positive angle 
(knee flexion). Additionally, the maximum hyperextension that occurred during 
mid-stance was reduced by 4.1° from before to after the RT programme, with no 
difference between PRE1 and PRE2. Although hyperextension of the knee remained 
evident in mid-stance, the severity of this abnormality was reduced considerably. A 
photographic example of this is presented in Appendix 3.5. This reduction may be 
due to changes in the magnitude of the knee flexor/extensor moment. 
Alternatively, the reduction in knee hyperextension may be caused by adaptations 
in the material properties of the internal structures at the knee, such as ligament 
laxity, as a result of RT. This is suggested as previous research has demonstrated 
adaptations in the material properties of the patella tendon post 14 weeks’ RT in 
elderly individuals (Reeves et al., 2003). 
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The additional analysis that was completed on participants who demonstrated 
severe foot drop showed that ankle angle at initial contact increased by 1.9°, and 
the mean ankle angle during the swing phase increased by 2.4°. These adaptations 
demonstrate an increased dorsiflexion of the ankle joint as it contacts the ground 
and moves throughout the terminal swing phase. It is most likely that these 
adaptations occurred as a result of the increase in dorsiflexor MVC torque 
presented in Chapter 3. As discussed in part A of this study, limited dorsiflexion at 
the ankle during swing is likely a combination of weakness in the dorsiflexor muscles 
and reduced range of motion due to muscle tightness or contractures. Therefore, 
alongside the increase in MVC torque the exercises completed within the RT 
programme may have also improved the range of motion at the ankle joint, thereby 
allowing a greater dorsiflexion angle to be achieved. 
It is clear that kinematic gait abnormalities in MD can be improved through the use 
of RT. In addition, it is important to note that in cases of severe gait impairment the 
positive effects of RT appear to be even larger, at least for hyperextension of the 
knee joint and foot drop throughout the swing phase.  
4.4.2.3 Oxygen Cost 
Despite the changes in gait kinematics with RT found in this study, no change in the 
oxygen cost of gait was found. Whilst this is surprising there are various potential 
explanations for this outcome. There is a strong possibility that participants who 
used walking aids relied less on these aids post completion of the RT programme, 
and therefore increased weight acceptance on the legs during gait and in turn, 
oxygen cost. Although this would not reduce the oxygen cost of gait, it would 
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demonstrate a more independent gait. Additionally, alterations in other 
biomechanical factors may have occurred post RT which influenced the oxygen cost 
of gait. Examples include alterations in muscle co-contraction, energy transfer 
between the segments and energy storage in the tendons. It is also important to 
consider that the mode of exercise utilised in our study was focused on increasing 
muscle strength rather than achieving cardiorespiratory adaptations. With this in 
mind, future exercise interventions aimed at improving the oxygen cost of gait in 
MD may benefit from the addition of an aerobic element to the training 
programme. Importantly, the oxygen cost of gait was no worse post RT in our study. 
Walking is a complex skill, so in order to see improvements in oxygen cost it may be 
necessary to provide guidance alongside RT. That is, once muscle strength has 
improved, gait re-training may be a useful technique to assist individuals to walk 
more economically. 
4.4.2.4 Clinical Implication 
The implication of these findings is that RT is a practical option to help maintain and 
improve walking ability in adults living with MD. As an intervention, RT has the 
potential to improve walking speed and reduce the risk of pain, stress on the joints 
and fall risk during gait, all of which are important in everyday life and towards the 
maintenance of physical independence. 
4.4.2.5 Limitations 
Although this study examined the lower-limb gait impairments in individuals with 
MD, the plug-in-gait model does not provide detailed data on the kinematics in the 
foot (Carty et al., 2015). This is because the model assumes the foot to be one rigid 
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segment (Davis et al., 1991). Therefore, it is unknown whether abnormal motion in 
the foot during gait is evident in individuals with FSHD, BMD or LGMD. Future 
research would benefit from applying a multi segment foot model alongside lower-
body models in order to assess foot motion in greater detail, such as the Oxford 
Foot Model (Carsona et al., 2001). 
It is clear that RT results in changes to some of the lower-limb kinematics of gait in 
MD, but the causes behind these changes are unknown. The next chapter will 
examine the effect of RT on the kinetic parameters of gait in these individuals.   
4.4.2.6 Conclusion 
In conclusion, this is the first study to demonstrate positive effects of a 12-week RT 
programme on a number of kinematic impairments in adults with FSHD, BMD and 
LGMD. Improvements included increased gait speed, stride length and cadence, 
increased knee flexion at initial contact and during the loading response, increased 
knee flexion during the swing phase, a reduction in the severity of hyperextension 
during the stance phase, increased dorsiflexion at initial contact and during the 
swing phase and increased ankle inversion at initial contact and eversion at toe-off. 
Overall, RT is an innovative approach to maintaining ambulation in adults with 
FSHD, BMD and LGMD, particularly for those with more severe gait abnormalities 
as the improvements observed in these individuals were greater. 
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Chapter 5 
Influence of resistance training on the 
kinetics of gait in adults with 
Facioscapulohumeral, Limb-girdle and 
Becker muscular dystrophy
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5.1 Introduction 
Muscular Dystrophies (MD) are inherited disorders with condition specific 
manifestations, yet they are all characterised by progressive muscle deterioration 
and weakness (Mercuri and Muntoni, 2013). This muscle weakness results in 
progressive disability and impaired physical function and with those, a reduction in 
physical independence (Huml, 2015). 
The severity of MD varies both within and between the different types of the 
condition. Boys with Duchenne MD become wheelchair bound by adolescence 
(Bushby et al., 2010), whilst other types of MD may not surface until adulthood and 
may never require the use of a wheelchair (Mercuri and Muntoni, 2013). FSHD, BMD 
and LGMD are types of MD that fit the latter description. These types of MD are less 
severe than Duchenne MD (Emery, 2002) and are considered clinically to remain 
ambulatory until at least the second or third decade of life (Huml, 2015), although 
precise measures of age at loss of ambulation are not available.  
5.1.1 Part A 
In clinical environments it is well recognised that walking is impaired in adults with 
FSHD, BMD and LGMD, with the potential for individuals to completely lose the 
ability to walk (Emery, 2002; Huml, 2015). Chapters 3 and 4 of this thesis present 
evidence of impaired walking in these populations compared to a matched control 
group. As such, those adults who remain ambulatory walk slower and experience 
debilitating kinematic gait abnormalities, such as a lack of knee flexion or even 
hyper-extension of the knee joint during loading in the stance phase and limited 
dorsi flexion of the ankle at initial contact and throughout the swing phase, to name 
211 
 
a few. Whilst spatial and temporal variables and joint kinematic profiles describe 
the nature of movement abnormalities in gait, kinetic variables offer an insight into 
the causes behind gait abnormalities. However, very few studies of lower-limb joint 
kinetics of gait have been undertaken in MD, with the majority conducted in 
children with Duchenne MD (D'Angelo et al., 2009; Gaudreault et al., 2009; 
Gaudreault et al., 2010).  
Three published studies have compared the gait and lower-limb joint kinetics of 
individuals with Duchenne MD to control groups. Abnormalities in joint powers, 
joint moments and ground reaction forces have been reported. Concerning joint 
powers, lower maximum plantar flexion power generation in the stance phase was 
consistently reported (D'Angelo et al., 2009; Gaudreault et al., 2009; Gaudreault et 
al., 2010), along with lower hip extensor generation power during the stance phase,  
lower hip flexor generation power at toe-off (Gaudreault et al., 2010), and lower 
maximum knee extensor absorption power at toe-off (Gaudreault et al., 2010), in 
children with Duchenne MD compared to controls.    
Joint moments and ground reaction forces have also been found to differ in children 
with Duchenne MD compared to control groups. D'Angelo et al. (2009) described a 
knee extensor moment over almost the entire stance phase in children with 
Duchenne MD, compared to an initial extensor moment followed by a flexor 
moment in the control group, although statistical analysis of this difference was not 
undertaken. Similarly, Gaudreault et al. (2010) found greater peak knee extensor 
moments in the stance phase in Duchenne MD than controls. In addition, 
Gaudreault et al. (2010) reported a smaller hip flexor moment in the early stance 
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phase, a smaller hip extension moment at toe-off and a smaller plantar flexor 
moment in stance, in Duchenne MD compared to controls. Furthermore, peak 
ground reaction forces were smaller in the vertical, posterior and anterior direction 
compared to self-selected walking in a control group, but no differences in these 
variables were evident when controls walked at a slow pace (Gaudreault et al., 
2010). On the other hand, medial peak forces were significantly higher in the 
Duchenne MD group than control group, regardless of walking pace. These reported 
kinetic gait abnormalities however cannot be presumed to be the same in 
ambulatory adults with other forms of MD, as Duchenne MD is highly disabling from 
the very early years of life (Emery, 2002). In addition, differences in lower-limb 
muscle weakness distribution between adults with FSHD, BMD and LGMD (shown 
in Chapter 3) may result in the use of different compensatory mechanisms during 
gait between these conditions.  
In the MDs specific to this study, two studies have reported lower-limb joint 
moments and/or powers during gait in adults with FSHD (Rijken, van Engelen, de 
Rooy, et al., 2015; Iosa et al., 2007) but only one of those compared gait to a control 
population (Iosa et al., 2007). To date there appear to be no published studies that 
have measured the kinetics of gait in humans with LGMD or BMD and ground 
reaction forces remain un-reported in FSHD. Iosa et al. (2007) found no significant 
differences in the sagittal plane joint moments at the hip, knee or ankle joint during 
level walking in adults with FSHD compared to a control group. However, the study 
was limited to mild-moderate presentations of FSHD. This was evidenced as no 
participants required the use of walking aids and 5 of the 12 participants were 
categorised as exhibiting no pelvic or lower-limb muscle weakness through a score 
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of 5 out of a possible 5 on manual muscle tests (5 = movement through a full range 
of motion against gravity and able to hold against resistance).  
Descriptions of ground reaction forces and joint powers during gait in FSHD, BMD 
and LGMD compared to a control population are un-reported. In addition, 
descriptions of joint moments in FSHD are limited to the sagittal plane and adults 
with mild-moderate presentations of the condition. Therefore, the first aim of this 
study is to describe the ground reaction forces, joint moments and joint powers 
during gait in adults with FSHD, LGMD and BMD, compared to a control group 
matched for age, stature and body mass.  
5.1.2 Part B 
In addition to describing the joint kinetics during gait in adults with FSHD, BMD and 
LGMD, this study is interested in the effectiveness of RT as an intervention for 
impaired gait in MD. RT is an exercise modality that has previously altered measures 
of joint kinematics and joint kinetics during gait in numerous populations that 
exhibit gait abnormalities. In individuals with multiple sclerosis, RT resulted in 
increased walking speeds and step lengths, along with reductions in double support 
time (Manca et al., 2017; Kierkegaard et al., 2016; Gutierrez et al., 2005). In children 
with cerebral palsy, a programme of RT increased stride length, reduced cadence 
and increased the maximum ankle power generation during the late stance phase 
(Eek et al., 2008). In addition, Chapter 4 of this thesis demonstrates that a 
programme of RT in adults with FSHD, BMD and LGMD resulted in increased self-
selected gait speed and adaptions to numerous kinematic abnormalities, such as 
increased knee flexion during stance, increased knee flexion in swing, increased 
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dorsi flexion at initial contact and during the swing phase and a reduction in the 
severity of hyper-extension at the knee joint during stance. Whilst gait speed and 
kinematic profiles provide information on the nature of gait adaptations with RT, 
they provide little insight into the kinetics behind these adaptations. As such, in 
order to fully assess the influence of RT on gait in MD, the kinetics of gait should 
also be analysed.  
Thus, the second aim of this study is to investigate the influence of a 12-week, twice 
a week, lower-body RT programme on ground reaction forces, joint moments and 
joint powers during gait in a group of ambulatory adults with MD (FSHD, BMD and 
LGMD). 
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5.2 Method 
5.2.1 Participants & Study Design 
The experimental design for this study is presented in two parts. Part A presents group 
comparisons between adults with FSHD (9), BMD (7), LGMD (6) and a group of 10 
control adults matched in age, stature and body mass.  
Part B is a within-participant design, involving a group of 17 adults with MD, inclusive 
of FSHD (6), BMD (5) and LGMD (6). Data were collected at three time points: PRE1 
(before a 12-week control period), PRE2 (immediately after the 12-week control 
period) and POST (immediately after a 12-week RT programme). All 17 MD participants 
completed a 12-week, twice a week, RT programme.  
Detailed descriptions of the study design, participants and RT programme are provided 
in Chapter 3.2 Method. 
Manchester Metropolitan University Ethics Committee granted ethical approval and 
all participants provided written informed consent after which data collection took 
place at Manchester Metropolitan University on all occasions. 
5.2.2 Procedures 
Testing procedures and data collection for anthropometric, body composition and 3D 
gait analysis measures are provided in Chapter 3.2 Method. 
5.2.3 Data Processing and Analysis  
Unless otherwise stated, all data are presented as means and standard deviations 
for the control group, FSHD, BMD and LGMD group in part A, and for the combined 
MD group at each time point (PRE1, PRE2 and POST) in part B. 
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5.2.3.1 Lower-Limb Joint Kinetics  
Processing of each walking trial was completed using Vicon Nexus software. The 
plug-in gait marker set was used as a kinematic model to obtain lower-limb joint 
kinematics, centre of mass kinematics using the inertial properties described by 
Dempster (Dempster, 1995) and lower-limb kinetics. The markers were reconstructed 
and then the marker trajectories were labelled. Gait events (initial contact and toe-
off) were determined via vertical ground reaction forces on the dominant side with 
force plate contact, using a force threshold of 20 N. On the non-dominant side or 
without force platform contact, gait events were determined manually via frame by 
frame visual inspection. For each trial, the stride that occurred in the centre of the 
capture volume over the force platform was selected for analysis. Gaps (≤ 10 
frames) in the marker trajectories were filled using a cubic spline interpolation. The 
dynamic plug-in gait model (Vicon, 2010) was then applied to each walking trial to 
calculate marker trajectories, joint kinematics and joint kinetics. Data were 
smoothed using a low-pass 4th order Butterworth filter, with a cut off frequency of 
6 Hz. 
Joint moments and joint powers (joint moment x angular velocity) were calculated 
via inverse dynamics, using the joint kinematic data, ground reaction force data and 
segment inertial data described by Dempster (Dempster, 1995). Kinetic data were 
normalised to body mass (kg).  
Joint moments are presented as net external joint moments as Vicon calculates joint 
moments using the local coordinate frame of the distal segment and exports 
external joint moments (Vicon, 2010). Vicon Plug-in Gait specifies the following 
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conventions for external joint moments (ankle: dorsiflexor, adduction and internal 
rotation moment = positive; knee: flexion, varus and internal rotation moment = 
positive and hip: flexion, adduction and internal rotation moment = positive) (Vicon, 
2016). This convention is often used in clinical gait analysis (Baker, 2013; Dicharry, 
2010). The net external moment is produced by external forces acting on the joint 
(Robertson et al., 2013). For example, during the stance phase of gait a net external 
knee flexion moment acts on the knee joint, which is counteracted by a net internal 
knee extensor moment produced mainly by the quadricep muscles. Another 
example during midstance is when the ankle is in dorsiflexion and an external 
dorsiflexor moment acts to dorsiflex the ankle, which is counteracted by a net 
internal plantarflexor moment to maintain the position of the ankle at that time 
(Dicharry, 2010).  
Ground reaction forces and lower-limb joint external moments and powers from 
the dominant leg were averaged across four trials and used for further analysis. Data 
were time normalised to 100 data points using a cubic spline interpolation method 
in Microsoft Excel, representing initial contact at 0% and the following foot contact 
at 100%.  
The selection of discrete dependant variables was guided by Beneditti et al. (1998). 
Ensemble average graphs for ground reaction forces, joint moments of the hip, knee 
and ankle and joint powers of the hip knee and ankle were produced in Microsoft 
Excel and are presented in the results section, along with the mean ± standard 
deviation for each discrete variable. Statistical analysis was completed on all 
discrete variables. The discrete ground reaction force variables and the joint 
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moment and joint power variables chosen for analysis are presented in Table 5.1 in 
addition to visual representations of each discrete ground reaction force and joint 
power variable in Figure 5.1. 
The root mean square difference in joint moments between each MD group and the 
control group and between the time points of PRE1 compared to PRE2 and PRE2 
compared to POST were calculated at the hip, knee and ankle in the sagittal plane. 
This was calculated as a descriptive measure of the global difference in joint 
moments during gait.  
5.2.3.2 Additional Kinetic Analysis 
Additional analysis was completed in part B of this study on a sub-group of MD 
participants who in Chapter 4, exhibited excessive hyper-extension of the knee joint 
(defined in the Chapter 4). This was done to establish the effect of RT on the knee 
moment in cases of severe knee hyperextension during the stance phase. Eight 
participants were included in this sub-group. 
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Table 5.1: Numerical system for discrete variables of ground reaction forces (GRF), external 
joint moments and joint powers. Max = maximum, mom = moment, gen = generation, abs 
= absorption.  
 GRF  Hip  
Fz1 
Fz2 
Fz3      
Fy1 
Fy2 
Fx1 
Fx2 
Fx3 
Max. vertical force in loading 
Min. vertical force in mid-stance 
Max. vertical force in terminal 
stance 
Max. braking force 
Max. propulsive force 
Max. lateral force in loading 
Max. medial force in mid-stance 
Max. medial force in terminal 
stance 
HM1 
HM2 
HM3       
. 
HM4                                                                   
,                 
HM5 
HM6 
Hp1 
Hp2 
Hp3 
Max. hip flexor mom. in stance 
Max. hip extensor mom. in stance 
1st Max. hip adductor mom. in 
stance 
2nd Max. hip adductor mom. in
stance 
Max. external hip rotation mom. 
Max. internal hip rotation mom. 
Max. hip extensor gen. power 
Max. hip flexor abs. power 
Max. hip flexor gen. power 
      Knee   Ankle  
KM1          
KM2                                                                      
KM3       
x        
KM4       
KM5       
x 
Kp1 
Kp2 
Kp3          
Kp4 
1st Max. extension mom. in stance 
Max. flexor mom. in stance
2nd Max. extension mom. in 
stance 
1st Max. varus mom. in stance 
2nd Max. knee varus mom. in 
stance 
Max. knee extension abs. power 
Max. knee extension gen. power  
Max. knee extension abs. power 
Max. knee flexion abs. power 
AM1 
AM2 
AM3 
AM4 
Ap1 
Ap2 
 
 
 
Max. plantarflexion mom. in stance 
Max. dorsiflexor mom. in stance 
Max. ankle eversion mom. 
Max. ankle inversion mom. 
Max. plantarflexion abs. power 
Max. plantarflexion gen. power 
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Figure 5.1: Visual example of each discrete ground reaction force and joint power 
variables as described in Table 5.1. 
5.2.4 Statistical Analysis  
All statistical analysis were completed using IBM SPSS Statistics 25 software. The 
critical level of significance was set at p ≤ .05. 
5.2.4.1 Part A -MD versus Controls 
Data were compared between the FSHD, BMD, LGMD and control group. All data 
were checked against the parametric assumptions and data that satisfied these 
assumptions were assessed using a one-way ANOVA, with least significant 
difference post hoc pairwise comparisons where required. The following variables 
were non-parametric: Fz1, Fz2, Fy1, Fx1, HP1, KP1, KP2, KP3, KP4, AP2, HM5, KM5, 
AM1 and AM3. In these cases, Kruskall Wallis tests were conducted with Mann-
Whitney U post-hoc comparisons (least significant difference) where necessary.  
 
 
Hp1 
Hp2 
Hp3 
Kp1 
Kp2 
Kp3 
Kp4 
Ap1 
Ap2 
Fz1 
Fz2 
Fz3 
Fy1 
Fy2 
Fx1 
Fx2 Fx3 
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5.2.4.2 Part B - Effects of RT 
Data were compared between the time points (PRE1, PRE2 and POST) in the MD 
group. All data were checked against the parametric assumptions and data that 
satisfied these assumptions were assessed using a repeated measures ANOVA. If 
the data did not pass Mauchly’s test of sphericity (P < .05), a Greenhouse-Geisser 
correction was applied. From the ANOVA, both the retrospective observed power 
and the effect size, calculated as partial eta squared (Ꞃp2), were reported. Post hoc 
analysis was completed using the least significant difference pairwise comparisons 
where appropriate. Data that were non-parametric (Fz1, Fz2, Fz3, Fx1, Fx3, Hp1, 
Hp2, Kp1, Kp2, Kp3, Kp4, Ap1, HM1, HM5, KM2, KM5, AM2 and AM3) were analysed 
using a Friedman’s ANOVA, followed by post-hoc analysis using Wilcoxon-signed 
rank tests (least significant difference) where required. Data from the sub-group of 
participants that demonstrated hyper-extension of the knee joint in Chapter 4 were 
checked for parametricity and subsequently analysed as described above. 
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5.3 Results  
5.3.1 Part A – MD versus Controls  
5.3.1.1 Participant Characteristics 
There was no differences between the groups for age, body mass, stature or lean 
body mass (p > .05; Table 5.2). Details of walking aid use for each participant is 
provided in Table 4.4 in Chapter 4. 
Table 5.2: Mean ± standard deviation participant characteristics in the control 
(CTRL), FSHD, BMD and LGMD groups. 
 
 
 
 
 
 
 
 
 
 
 
 CTRL FSHD BMD LGMD 
n 10 9 7 6 
Age (years) 46.8 ± 10.1 46.7 ± 11.2 42.1 ± 7.6 47.3 ± 11.3 
Body mass (kg) 79.4 ± 12.3 88.2 ± 18.4 93.0 ± 16.7 82.0 ± 19.4 
Stature (cm) 174.4 ± 7.5 181.4 ± 6.3 179.9 ± 9.4 170.9 ± 9.0 
Lean body mass (kg) 56.1 ± 11.7 60.8 ± 13.9 62.0 ± 6.9 54.0 ± 15.4 
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5.3.1.2 Ground Reaction Forces 
 Ground reaction forces in the vertical, anterior-posterior and medial-lateral 
direction during the stance phase of the gait cycle are presented as ensemble 
averages for the FSHD (blue), BMD (red) and LGMD (green) group in Figure 5.2. 
Discrete variables for the control, FSHD, BMD and LGMD group are presented in 
Table 5.3. 
Figure 5.2: Vertical (left), anterior-posterior (middle) and medial-lateral (right) ground 
reaction force during the stance phase. The white line and grey band represents the control 
group mean ± 1 standard deviation, and the black line and the coloured band represents 
the FSHD (blue), BMD (red) or LGMD (green) group mean ± 1 standard deviation. On the x-
axis, 0% represents initial contact and 100% represents toe-off. 
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Table 5.3: Mean ± standard deviation of discrete ground reaction force variables (N/kg). * 
represents a significant difference from the control group (CTRL). 
Key: Fz1= Max. vertical force in loading, Fz2 = Min. vertical force in mid-stance, Fz3 = Max. 
vertical force in terminal stance, Fy1 = Max. braking force, Fy2 = Max. propulsive force, Fx1 
= Max. lateral force in loading, Fx2 = Max. medial force in mid-stance, Fx3 = Max. medial 
force in terminal stance. 
A main effect of group was found in the max. vertical force in loading, max. vertical force in 
terminal stance, max. propulsive force, and max. medial force in terminal stance (p < .05). 
No main effect of group was found for min. vertical force in mid-stance, max. braking force, 
max. lateral force in loading or max medial force in mid-stance (p > .05).  
Post hoc tests showed that the max. vertical force in loading was 8.3% smaller in FSHD (p ≤ 
.01), 10.6% smaller in the BMD (p < .05) and 26.5% smaller in the LGMD group (p ≤ .01) 
compared to controls.  
Post hoc tests showed that max. vertical force in terminal stance did not significantly differ 
between FSHD and controls or BMD and controls (p > .05) but that it was 18.9% smaller in 
LGMD (p ≤ .01) compared to controls.  
 CTRL FSHD BMD LGMD 
Fz1 (N/kg) 1.32 ± 0.16 1.21 ± 0.14* 1.18 ± 0.16* 0.97 ± 0.35* 
Fz2 (N/kg) 0.77 ± 0.16 0.91 ± 0.10 0.91 ± 0.10 0.83 ± 0.29 
Fz3 (N/kg) 1.27 ± 0.09 1.23 ± 0.09 1.26 ± 0.15 1.03 ± 0.30* 
Fy1 (N/kg) -0.20 ± 0.07 -0.17 ± 0.08 -0.17 ± 0.06 -0.11 ± 0.07 
Fy2 (N/kg) 0.23 ± 0.04 0.19 ± 0.07 0.18 ± 0.06 0.10 ± 0.05* 
Fx1 (N/kg) 0.04 ± 0.03 0.04 ± 0.06 0.02 ± 0.04 0.02 ± 0.01 
Fx2 (N/kg) -0.05 ± 0.03 -0.06 ± 0.01 -0.05 ± 0.05 -0.04 ± 0.03 
Fx3 (N/kg) -0.03 ± 0.02 -0.06 ± 0.02 -0.07 ± 0.04* -0.03 ± 0.02 
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Post hoc tests showed that max. propulsive force did not differ between FSHD and controls 
or BMD and controls (p = .07) but that it was 91.9% smaller in the LGMD group compared 
to the control group (p ≤ .001). 
Post hoc tests showed that max. medial force in terminal stance did not differ between the 
controls and FSHD or controls and LGMD (p > .05) but that it was 13% greater in the BMD 
group compared to the controls (p ≤ .01).  
5.3.1.3 External Joint Moments 
External joint moments at the hip, knee and ankle joint in the sagittal, frontal and 
transverse planes during the gait cycle are presented as ensemble averages for the 
FSHD, BMD and LGMD group in Figures 5.3, 5.4 and 5.5. 
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Figure 5.3: Hip, knee and ankle external moment during the gait cycle in the sagittal (top 
row), frontal (middle row) and transverse (bottom row) planes. The white line and grey 
band represents the control group mean ± 1 standard deviation, and the black line and the 
blue band represents the FSHD group mean ± 1 standard deviation. On the x-axis, 0% 
represents initial contact and 100% the following ipsilateral contact.
FSHD 
HIP KNEE ANKLE 
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Figure 5.4: Hip, knee and ankle external moment during the gait cycle in the sagittal (top 
row), frontal (middle row) and transverse (bottom row) planes. The white line and grey 
band represents the control group mean ± 1 standard deviation, and the black line and the 
red band represents the BMD group mean ± 1 standard deviation. On the x-axis, 0% 
represents initial contact and 100% the following ipsilateral contact. 
BMD 
HIP KNEE ANKLE 
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Figure 5.5: Hip, knee and ankle external moment during the gait cycle in the sagittal (top 
row), frontal (middle row) and transverse (bottom row) planes. The white line and grey 
band represents the control group mean ± 1 standard deviation, and the black line and the 
green band represents the LGMD group mean ± 1 standard deviation. On the x-axis, 0% 
represents initial contact and 100% the following ipsilateral contact.  
 
 
 
 
 
 
 
LGMD 
HIP KNEE ANKLE 
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The root mean square differences in the sagittal plane hip, knee and ankle joint 
external moments compared to the control group are presented in Table 5.4. 
 
 
Table 5.4: Root mean square difference in joint moment over the gait cycle and 
during the stance phase compared to the control group. 
 
 
 
 
 
 
 
  FSHD BMD LGMD 
Hip (Nm/kg)    
Gait cycle 0.28 0.22 0.22 
Stance phase 0.37 0.26 0.27 
    
Knee (Nm/kg)    
Gait cycle 0.24 0.19 0.29 
Stance phase 0.34 0.25 0.41 
    
Ankle (Nm/kg)    
Gait cycle 0.09 0.09 0.10 
Stance phase 0.14 0.13 0.15 
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Discrete variables for the joint moments at the hip, knee and ankle for each group 
are presented in Table 5.5, 5.6 and 5.7, respectively.  
External Hip Moments 
Table 5.5: Mean ± standard deviation of discrete external moments (Nm/kg) at the hip 
during the gait cycle. * represents a significant difference from the control group (CTRL). 
Key: HM1 = Max. hip flexor moment in stance, HM2 = Max. hip extensor moment in stance, 
HM3 = 1st Max. hip adductor moment in stance, HM4 = 2nd Max. hip adductor moment in 
stance, HM5 = Max. external hip rotation moment, HM6 = Max. internal hip rotation 
moment.  
There was a main effect of group on the max. hip flexor moment in stance, max. hip 
extensor moment in stance, 1st max. hip adductor moment in stance and max. 
external hip rotation moment in stance (p < .05). No main effect of time was found 
at any other variables at the hip (p > .05). 
Post hoc tests showed that the max. hip flexor moment in stance did not differ 
between the control and FSHD group (p = .08) but that it was 41.3% smaller in the 
BMD (p ≤ .01) and 32.9% smaller in the LGMD group (p ≤ .05) compared to the 
control group, respectively.  
 CTRL FSHD BMD LGMD 
HM1 (Nm/kg) 1.25 ± 0.40 0.97 ± 0.39 0.54 ± 0.16* 0.54 ± 0.28* 
HM2 (Nm/kg) -1.67 ± 0.38 -0.98 ± 0.53* -1.43 ± 1.64 -1.12 ± 0.30* 
HM3 (Nm/kg) 1.18 ± 0.16 0.92 ± 0.26* 0.96 ± 0.32 0.73 ± 0.34* 
HM4 (Nm/kg) 0.97 ± 0.1 0.98 ± 0.23 0.95 ± 0.25 0.79 ± 0.36 
HM5 (Nm/kg) -0.27 ± 0.08 -0.16 ± 0.11* -0.07 ± 0.07* -0.02 ± 0.01* 
HM6 (Nm/kg) 0.14 ± 0.06 0.16 ± 0.07 0.15 ± 011 0.10 ± 0.07 
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Post hoc tests showed that the max. hip extensor moment in stance did not differ 
between the control and BMD group (p > .05) but that it was 41.3% smaller in the 
FSHD (p ≤ .01) and 32.9% smaller in the LGMD group (p ≤ .01) compared to the 
control group, respectively.  
Post hoc tests showed that the 1st max. hip adductor moment in stance did not differ 
between the BMD and control group (p > .05) but was 22.0% smaller in the FSHD 
group compared to the control (p < .05) and 38.1% smaller in the LGMD group than 
the control (p < .05). 
Post hoc tests showed that max. external hip rotation moment in stance was 
reduced in the FSHD, BMD and LGMD group compared to the control group (p < .05) 
by 40.7%, 74.0% and 92.6%, respectively.  
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External Knee Moments 
Table 5.6: Mean ± standard deviation of discrete external moments (Nm/kg) at the knee 
during the gait cycle. * represents a significant difference from the control group (CTRL). 
Key: KM1 = 1st Max. extension moment in loading, KM2 = Max. flexor moment in stance, 
KM3 = 2nd Max. extension moment in stance, KM4 = 1st Max. varus moment in stance, KM5 
= 2nd Max. varus moment in stance. 
There was a significant main effect of group on the max. knee flexor moment in 
stance (p ≤.01). No differences were found in the other knee moment variables (p > 
.05). 
Post hoc tests showed that the max. knee flexor moment in stance was smaller in 
the FSHD, BMD and LGMD group compared to the control (p < .05) by 68.7%, 73.5% 
and 88.0%, respectively. 
 
 CTRL FSHD BMD LGMD 
KM1 (Nm/kg) -0.48 ± 0.16 -0.50 ± 0.24 -0.36 ± 0.15 -0.37 ± 0.25 
KM2 (Nm/kg) 0.83 ± 0.44 0.26 ± 0.33* 0.22 ± 0.34* 0.10 ± 0.24* 
KM3 (Nm/kg) -0.01 ± 0.18 -0.25 ± 0.38 -0.01 ± 0.44 -0.24 ± 0.36 
KM4 (Nm/kg) 0.57 ± 0.26 0.41 ± 0.21 0.43 ± 0.28 0.38 ±0.18 
KM5 (Nm/kg) 0.46 ± 0.13 0.39 ± 0.18 0.36 ± 0.28 0.33 ± 0.16 
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External Ankle Moments 
Table 5.7: Mean ± standard deviation of discrete external moments (Nm/kg) at the ankle 
during the gait cycle. * represents a significant difference from the control group (CTRL). 
Key: AM1 = Max. plantarflexion moment in stance, AM2 = Max. dorsiflexor moment in 
stance, AM3 = Max. ankle eversion moment, AM4 = Max. ankle inversion moment. 
There was a significant main effect of group on the max. plantarflexion moment in 
stance (p <. 05). No other differences in ankle moments were found at the ankle 
joint (p > .05). 
Post hoc tests showed that the max. plantarflexion moment in stance was smaller 
in the FSHD, BMD and LGMD group than the control group by 90%, 80% and 65% (p 
< .05), respectively. 
 
 CTRL FSHD BMD LGMD 
AM1 (Nm/kg) -0.20 ± 0.12 -0.02 ± 0.06* -0.04 ± 0.10* -0.07 ±0.07* 
AM2 (Nm/kg) 1.52 ± 0.19 1.43 ± 0.26 1.50 ± 0.43 1.20 ± 0.41 
AM3 (Nm/kg) -0.02 ± 0.02 -0.06 ± 0.06 -0.02 ± 0.02 -0.02 ± 0.02 
AM4 (Nm/kg) 0.19 ± 0.09 0.18 ±0.09 0.17 ± 0.05 0.17 ± 0.04 
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5.3.1.4 Joint Powers 
Joint powers of the hip, knee and ankle joint during the gait cycle are presented as 
ensemble averages for the FSHD, BMD and LGMD group in Figure 5.6. Discrete 
kinetic variables for the control, FSHD, BMD and LGMD group are presented in Table 
5.8, 5.9 and 5.10 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Hip, knee and ankle joint powers during the gait cycle of the FSHD (top row), 
BMD (middle row) and LGMD (bottom row) groups. The white line and grey band represents 
the control group mean ± 1 standard deviation, and the black line and coloured band 
represents the MD group mean ± 1 standard deviation. On the x-axis, 0% represents initial 
contact and 100% the following ipsilateral contact.  
 
 
HIP KNEE ANKLE 
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Hip Power 
Table 5.8: Mean ± standard deviation of discrete hip power variables (W/kg) during the gait 
cycle. * represents a significant difference from the control group (CTRL). 
Key: Hp1 = Max. hip extensor generation power in early stance, Hp2 = Max. hip flexor 
absorption power in mid-stance, Hp3 = Max. hip flexor generation power in pre-swing. 
There was a significant main effect of group on the max. hip extensor generation 
power in early stance (p ≤ .01) and the max. hip flexor generation power in pre-
swing (p < .05). No effect of group on the max. hip flexor absorption power in mid-
stance was found (p > .05). 
Post hoc tests showed that the max. hip extensor generation power in early stance 
did not differ between the control and FSHD group (p > .05) but that it was 72.2% 
smaller in the BMD group (p ≤ .01) and 79.4% smaller in the LGMD group (p ≤ .01) 
than the control group.  
Post hoc tests showed that the max. hip flexor generation power in pre-swing was 
39.9% smaller in the FSHD group (p < .05), 33.7% smaller in the BMD group (p < .05) 
and 53.4% smaller in the LGMD group (p ≤ .01) compared to the control group.  
 
 CTRL FSHD BMD LGMD 
Hp1 (W/kg) 1.26 ± 0.73 0.84 ± 0.49 0.35 ± 0.32* 0.26 ± 0.40* 
Hp2 (W/kg) -1.44 ± 0.70 -0.73 ± 0.53 -0.99 ± 0.71 -0.75 ± 0.26 
Hp3 (W/kg) 1.93 ± 0.68 1.16 ± 0.61* 1.28 ± 0.55* 0.90 ± 0.50* 
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Knee Power 
Table 5.9: Mean ± standard deviation of discrete knee power variables during the gait 
cycle. * represents a significant difference from the control group (CTRL). 
Key: Kp1 = Max. knee extensor absorption power in early stance, Kp2 = Max. knee extensor 
generation power in mid-stance, Kp3 = Max. knee extensor absorption power in pre-swing, 
Kp4 = Max. knee flexor absorption power in late swing. 
There was a significant main effect of group on the max. knee extensor generation 
power in mid-stance, the max. knee extensor absorption power in pre-swing and 
the max. knee flexor absorption power in late swing (p ≤ .01). No effect of group 
was found for the max. knee extensor absorption power in early stance (p > .05). 
Post hoc tests showed that the max. knee extensor generation power in mid-
stance was smaller in the FSHD, BMD and LGMD group compared to the control 
group (p < .05), by 63.7%, 87.3% and 67.6% respectively.  
Post hoc tests showed that the max. knee extensor absorption power in pre-swing 
was 47.0% smaller in the FSHD group (p ≤ .01), 39.3% smaller in the BMD group (p 
< .05) and 76.3% smaller in the LGMD group (p ≤ .01).  
Post hoc tests showed that the max. knee flexor absorption power in late swing 
did not differ between the control and the FSHD group (p > .05) but was 52.7% 
 CTRL FSHD BMD LGMD 
Kp1 (W/kg) -1.12 ± 1.43 -0.50 ± 0.59 -0.28 ± 0.10 -0.40 ± 0.29 
Kp2 (W/kg) 1.02 ± 1.12 0.37 ± 0.35* 0.13 ± 0.06* 0.33 ± 0.37* 
Kp3 (W/kg) -3.00 ± 0.73 -1.59 ± 0.91* -1.82 ± 1.39* -0.71 ± 0.34* 
Kp4 (W/kg) -1.31 ± 0.42 -1.08 ± 0.49 -0.62 ±0.67* -0.55 ± 0.38* 
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smaller in the BMD group (p ≤ .01) and 58.0% smaller in the LGMD group (p ≤ .01) 
than controls. 
Ankle Power 
Table 5.10: Mean ± standard deviation of discrete ankle power variables during the gait 
cycle. * represents a significant difference from the control group (CTRL). 
Key: Ap1 = Max. plantarflexion absorption power in early stance, Ap2 = Max. plantarflexion 
generation power in stance.  
A main effect of group was found on max. plantarflexion generation power in the 
stance phase (p ≤ .01). No main effect of group was found in max. plantarflexion 
absorption power in early stance (p > .05).  
A post hoc test showed that max. plantarflexion generation power in stance was 
smaller in the FSHD, BMD and LGMD group compared to the control group by 
33.8%, 29.0% and 63.0% (p ≤ .01), respectively. 
 CTRL FSHD BMD LGMD 
Ap1 (W/kg) -0.93 ± 0.32 -0.81 ± 0.33 -0.94 ± 0.43 -0.99 ± 0.42 
Ap2 (W/kg) 4.11 ± 0.84 2.72 ± 1.37* 2.92 ± 1.83* 1.52 ± 0.84* 
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5.3.2 Part B – Effects of RT 
5.3.2.1 Participant Characteristics 
Individual participant characteristics, including use of walking aids during gait 
analysis are provided in Table 4.11 in Chapter 4.  
5.3.2.2 Ground Reaction Forces 
Ground reaction forces in the vertical, anterior-posterior and medial-lateral 
direction during the stance phase of the gait cycle are presented as ensemble 
averages for each time point (PRE1, PRE2 and POST) in Figure 5.7. Discrete ground 
reaction force variables for PRE1, PRE2 and POST are presented in Table 5.11. 
Figure 5.7: Vertical (left), anterior-posterior (middle) and medial-lateral (right) ground 
reaction force during the stance phase. The black line and grey band represents control 
data mean ± 1 standard deviation, and the coloured lines represent the MD group mean at 
PRE1 (blue), PRE2 (green) and POST (red). On the x-axis, 0% represents initial contact and 
100% represents toe-off. 
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Table 5.11: Mean ± standard deviation of discrete ground reaction force variables (N/kg). * 
represents a significant difference from PRE1 and $ represent a significant difference from 
PRE2. 
Key: Fz1= Max. vertical force in loading, Fz2 = Min. vertical force in mid-stance, Fz3 = Max. 
vertical force in terminal stance, Fy1 = Max. braking force, Fy2 = Max. propulsive force, Fx1 
= Max. lateral force in loading, Fx2 = Max. medial force in mid-stance, Fy3 = Max. medial 
force in terminal stance. 
There was a significant main effect of time on the min. vertical force in mid-stance 
(p ≤ .01), max. braking force (p ≤ .01, Ꞃp2 = .28) and max. propulsive force (p < .05, 
Ꞃp2  = .23), with the retrospective observed powers ranging from .75 to .86). No 
other significant effects were found for ground reaction variables (P > .05). 
Post hoc tests showed that the min. vertical force in mid-stance did not differ 
between PRE1 and PRE2 (P > .05) but was increased by 2.3% from PRE1 to POST (p 
< .05) and from PRE2 to POST (p ≤ .01). 
 PRE1 PRE2 POST 
Fz1 (N/kg) 1.12 ± 0.24 1.13 ± 0.23 0.13 ± 0.23 
Fz2 (N/kg) 0.88 ± 0.18 0.88 ± 0.18 0.86 ± 0.17*$ 
Fz3 (N/kg) 1.18 ± 0.22 1.18 ±0.22 1.18 ± 0.23 
Fy1 (N/kg) -0.15 ±0.07 -0.15 ± 0.06 -0.17 ± 0.06*$ 
Fy2 (N/kg) 0.16 ± 0.07 0.16 ± 0.08 0.17 ± 0.08* 
Fx1 (N/kg) 0.02 ± 0.03 0.03 ± 0.03 0.02 ± 0.03 
Fx2 (N/kg) -0.05 ± 0.04 -0.04 ± 0.04 -0.05 ± 0.04 
Fx3 (N/kg) -0.05 ± 0.03 -0.05 ± 0.03 -0.05 ± 0.03 
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Post hoc tests showed that the max. braking force did not differ between PRE1 and 
PRE2 (p > .05) but was increased from PRE1 to POST and from PRE2 to POST by 
13.3% (p ≤ .01). 
Post hoc tests showed that the max. propulsive force did not differ between PRE1 
and PRE2 (p > .05) or between PRE2 and POST (P = .095) but was increased by 6.3% 
from PRE1 to POST (p < .05). 
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5.3.2.3 External Joint Moments  
External joint moments of the hip, knee and ankle joint in the sagittal, frontal and 
transverse planes, along with the hip, knee and ankle powers during the gait cycle 
are presented as ensemble averages for each time point (PRE1, PRE2 and POST), in 
Figure 5.8. The root mean square differences in sagittal plane external joint 
moments between PRE1 and PRE2 and between PRE2 and POST are presented in 
Table 5.12. 
Figure 5.8: Hip (top row), knee (middle row) and ankle (bottom row) joint external moment 
during the gait cycle in the sagittal (left column), frontal (middle column) and transverse 
(right column) planes. The black line and grey band represents control data mean ± 1 
standard deviation, and the coloured lines represents the MD group mean at PRE1 (blue), 
PRE2 (green) and POST (red). On the x-axis, 0% represents initial contact and 100% 
represents toe-off. 
 
242 
 
 
Table 5.12: Root mean square difference in external joint moment between PRE1 
and PRE2 and between PRE2 and POST over the entire gait cycle and in the stance 
phase. 
 
 
 
 
 
 
 
 
 
  PRE1-PRE2 PRE2-POST 
Hip Extensor Moment 
(Nm/kg) 
  
Gait cycle 0.04 0.04 
Stance phase 0.05 0.04 
   
Knee Flexor Moment 
(Nm/kg) 
  
Gait cycle 0.01 0.04 
Stance phase 0.02 0.06 
   
Ankle Plantarflexion 
Moment (Nm/kg) 
  
Gait cycle 0.02 0.03 
Stance phase 0.04 0.05 
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Discrete variables at PRE1, PRE2 and POST are presented in Table 5.13, 5.14 and 
5.15, for the hip joint, knee joint and ankle joint respectively.  
External Hip Moments 
Table 5.13: Mean ± standard deviation of discrete external moments (Nm/kg) at the hip 
during the gait cycle. * represents a significant difference from PRE1 and $ represents a 
significant difference from PRE2. 
Key: HM1 = Max. hip flexor moment in stance, HM2 = Max. hip extensor moment in stance, 
HM3 = 1st Max. hip adductor moment in stance, HM4 = 2nd Max. hip adductor moment in 
stance, HM5 = Max. external hip rotation moment, HM6 = Max. internal hip rotation 
moment.  
No significant main effect of time was found for any of the discrete hip moment 
variables (p > .05), with the retrospective observed power for these comparisons 
ranging between .12 and .42. 
 
 
 
 PRE1 PRE2 POST 
HM1 (Nm/kg) 0.71 ± 0.40 0.72 ± 0.36 0.84 ± 0.60 
HM2 (Nm/kg) -1.22 ± 0.53 -0.11 ± 0.51 -0.19 ± 0.53 
HM3 (Nm/kg) 0.91 ± 0.31 0.85 ± 0.31 0.96 ± 0.36 
HM4 (Nm/kg) 0.94 ± 0.30 0.87 ± 0.33 0.96 ± 0.33 
HM5 (Nm/kg) -0.08 ± 0.07 -0.09 ± 0.08 -0.11 ± 0.11 
HM6 (Nm/kg) 0.15 ± 0.16 0.14 ± 0.06 0.13 ± 0.07 
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External Knee Moments 
Table 5.14: Mean ± standard deviation of discrete external moments (Nm/kg) at the knee 
during the gait cycle. * represents a significant difference from PRE1 and $ represents a 
significant difference from PRE2. 
Key: KM1 = 1st Max. extension moment in stance, KM2 = Max. flexor moment in stance, KM3 
= 2nd Max. extension moment in stance, KM4 = 1st Max. varus moment in stance, KM5 = 2nd 
Max. knee varus moment in stance. 
A significant main effect of time was found for the maximum knee flexor moment 
during the stance phase (p < .05). Post hoc tests showed that no difference between 
PRE1 and PRE2 was evident (p > .05) but a 40% increase from PRE1 to POST (p < .05) 
and a 31.2% increase from PRE2 to POST was found (p < .05).  
No significant main effect of time was found for any other discrete knee moment 
variable (p > .05). The retrospective observed powers for these comparisons ranged 
between .11 and 25.  
 
 
 
 
 PRE1 PRE2 POST 
KM1 (Nm/kg) -0.41 ± 0.23 -0.45 ± 0.25 -0.44 ± 0.28 
KM2 (Nm/kg) 0.15 ± 0.25 0.16 ± 0.27 0.21 ± 0.31*$ 
KM3 (Nm/kg) -0.21 ± 0.37 -0.23 ± 0.38 -0.15 ± 0.34 
KM4 (Nm/kg) 0.41 ± 0.22 0.40 ± 0.20 0.48 ± 0.25 
KM5 (Nm/kg) 0.34 ± 0.19 0.33 ± 0.20 0.37 ± 0.25 
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External Ankle Moments 
Table 5.15: Mean ± standard deviation of discrete external moments (Nm/kg) at the ankle 
during the gait cycle. * represents a significant difference from PRE1 and $ represents a 
significant difference from PRE2. 
Key: AM1 = Max. plantarflexion moment in stance, AM2 = Max. dorsiflexor moment in 
stance, AM3 = Max. ankle eversion moment, AM4 = Max. ankle inversion moment. 
There was a significant main effect of time on the max. plantarflexion moment in 
early stance (p < .05, Ꞃp2 = .24), with an observed power of .78. No main effects of 
time were found for the other discrete ankle moment variables (p > .05). 
Post hoc tests showed that max. plantarflexion moment in early stance did not differ 
between PRE1 and PRE2 (p > .05) but was increased by 125% from PRE1 to POST (p 
≤ .01) and from PRE2 to POST (p ≤.01). 
 
 
 
 
 
 
 
 PRE1 PRE2 POST 
AM1 (Nm/kg) -0.04 ± 0.08 -0.04 ± 0.05 -0.09 ± 0.09*$ 
AM2 (Nm/kg) 1.38 ± 0.39 1.44 ± 0.41 1.42 ± 0.40 
AM3 (Nm/kg) -0.04 ± 0.05 -0.04 ± 0.02 -0.05 ± 0.04 
AM4 (Nm/kg) 0.17 ± 0.07 0.15 ± 0.06 0.16 ± 0.07 
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5.3.2.4 Joint Powers 
Joint powers of the hip, knee and ankle joint at PRE1, PRE2 and POST are presented 
as ensemble averages of the gait cycle in Figure 5.9. Discrete variables at PRE1, PRE2 
and POST are presented in Table 5.16, 5.17 and 5.18 for the hip, knee and ankle 
joint respectively.  
Figure 5.9: Hip (left), knee (middle) and ankle (right) joint power during the gait cycle in the 
sagittal plane. The black line and grey band represents control data mean ± 1 standard 
deviation. Coloured lines represent the MD group mean at PRE1 (blue), PRE2 (green) and 
POST (red). On the x-axis, 0% represents initial contact and 100% represents toe-off. 
Hip Power 
Table 5.16: Mean ± standard deviation of discrete hip power variables (W/kg) during the 
gait cycle. * represents a significant difference from PRE1 and $ represents a significant 
difference from PRE2. 
Key: Hp1 = Max. hip extensor generation power in early stance, Hp2 = Max. hip flexor 
absorption power in mid-stance, Hp3 = Max. hip flexor generation power in pre-swing. 
No significant main effect of time was found for any discrete hip power variable (p > .05), 
with retrospective observed powers ≤ .15. 
 PRE1 PRE2 POST 
Hp1 (W/kg) 0.55 ± 0.52 0.54 ± 0.47 0.69 ± 0.77 
Hp2 (W/kg) -0.82 ± 0.56 -0.80 ± 0.62 -0.84 ± 0.79 
Hp3 (W/kg) 1.11 ± 0.60 1.18 ± 0.71 1.21 ± 0.62 
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Knee Power 
Table 5.17: Mean ± standard deviation of discrete knee power variables during the gait 
cycle. * represents a significant difference from PRE1 and $ represents a significant 
difference from PRE2. 
Key: Kp1 = Max. knee extensor absorption power in early stance, Kp2 = Max. knee extensor 
generation power in mid-stance, Kp3 = Max. knee extensor absorption power in pre-swing, 
Kp4 = Max. knee flexor absorption power in late swing. 
A significant main effect of time on the max. knee flexor absorption power in late 
swing was found (p<.05). No significant main effect was evident in any other 
discrete knee power variable (p > .05).  
Post hoc tests showed that max. knee flexor absorption power did not differ 
between PRE1 and PRE2 (p > .05) but was significantly increased by 15.8% from 
PRE1 to POST (p ≤ .01) and by 29.4% from PRE2 to POST (p < .05).  
 
 
 
 
 
 PRE1 PRE2 POST 
Kp1 (W/kg) -0.33 ± 0.23 -0.37 ± 0.32 -0.43 ± 0.39 
Kp2 (W/kg) 0.27 ± 0.27 0.25 ± 0.22 0.27 ± 0.23 
Kp3 (W/kg) -1.48 ± 1.11 -1.46 ± 1.47 -1.60 ± 0.99 
Kp4 (W/kg) -0.76 ± 0.48 -0.68 ± 0.65 -0.88 ± 0.52*$ 
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Ankle Power 
Table 5.18: Mean ± standard deviation of discrete ankle power variables during the gait 
cycle. * represents a significant difference from PRE1 and $ represents a significant 
difference from PRE2. 
Key: Ap1 = Max. plantarflexion absorption power in early stance, Ap2 = Max. plantarflexion 
generation power in stance.  
 A significant main effect of time was found in the max. plantarflexion generation 
power during stance (p < .05, Ꞃp2 = .23), with an observed retrospective power of 
.76. No main effect of time was found for the max. plantarflexion absorption power 
in early stance (p >.05). 
Post hoc tests showed that max. plantarflexion generation power did not differ 
between PRE1 and PRE2 (P > .05) but increased by 9.4% from PRE1 to POST (p < .05) 
and increased by 9.0% from PRE2 to POST (p < .05).  
 
 
 PRE1 PRE2 POST 
Ap1 (W/kg) -0.98 ± 0.38 -0.94 ± 0.45 -0.86 ± 0.56 
Ap2 (W/kg) 2.55 ± 1.66 2.56 ± 1.52 2.79 ± 1.72*$ 
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5.3.2.5 Additional Kinetic Analysis – Knee Moment and Knee Power 
The knee flexion-extension moment and power for the sub-group of participants 
categorised as hyperextending the knee joint in Chapter 4 (see Chapter 4 for more 
details) are presented in Figure 5.10 and 5.11, respectively. Discrete knee moment 
and knee power variables from this data set are presented in Table 5.19 and 5.20, 
respectively.  
A main effect of time was found in the 2nd max. extension moment during stance 
(p <.05, Ꞃp2 = .42), with an observed retrospective power of .73. No main effect of 
time was found for the 1st max. extension moment in stance or the max flexor 
moment in stance (p>.05), with observed powers of .21 and .18, respectively. 
Post hoc tests showed that there was no difference in the 2nd max. extension 
moment during stance between PRE1 and PRE2 (p > .05) but that it decreased by 
30.4% from PRE1 to POST and 37.3% from PRE2 to POST (p < .05). 
There was a main effect of time on the max. knee extensor absorption power at pre-
swing (p < .01, Ꞃp2 = .49), with an observed retrospective power of .86. No significant 
main effect of time was found in the max. knee extensor absorption power in early 
stance, the max. knee extensor generation power in mid-stance or the max. knee 
flexor absorption power in late swing (p > .05), with observed powers between .11 
and .26. 
Post hoc tests showed that the max. knee extensor absorption power at pre-swing 
did not differ between PRE1 and PRE2 (p > .05) but that it increased by 49.2% from 
PRE1 to POST and 30.0% from PRE2 to POST (p < .05). 
250 
 
Figure 5.10: Mean knee flexion (+) and extension (-) external moment during the gait cycle 
in MD participants categorised as hyperextending the knee, at PRE1 (blue line), PRE2 (green 
line) and POST (red line) completion of a RT programme. The grey line (± grey band) 
represents control data mean (± 1 standard deviation) for visual comparison. On the x-axis, 
0% represents initial ground contact and 100% the following ipsilateral ground contact. 
Table 5.19: Mean ± standard deviation of discrete external knee moment data for the sub-
group of MD participants that exhibited excessive hyperextension of the knee during 
stance. * represents a significant difference from PRE1 and $ represents a significant 
difference from PRE2. 
 PRE1 PRE2 POST 
KM1 (Nm/kg) -0.47 ± 0.25 -0.48 ± 0.25 -0.39 ± 0.20 
KM2 (Nm/kg) -0.02 ± 0.10 -0.02 ± 0.10 0.02 ± 0.15 
KM3 (Nm/kg) -0.46 ± 0.27 -0.51 ± 0.26 -0.32 ± 0.19*$ 
Key: KM1 = 1st Max. extension moment in stance, KM2 = Max. flexor moment in stance, KM3 
= 2nd Max. extension moment in stance. 
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Figure 5.11: Mean knee power during the gait cycle in MD participants categorised as 
hyperextending the knee, at PRE1 (blue line), PRE2 (green line) and POST (red line) 
completion of a RT programme. The grey line (± grey band) represents control data mean 
(± 1 standard deviation) for visual comparison. On the x-axis, 0% represents initial ground 
contact and 100% the following ipsilateral ground contact. 
Table 5.20: Mean ± standard deviation of discrete knee power data for the sub-group of 
MD participants that exhibited excessive hyperextension of the knee during stance. * 
represents a significant difference from PRE1 and $ represents a significant difference from 
PRE2. 
 PRE1 PRE2 POST 
Kp1 (W/kg) -0.31 ± 0.19 -0.26 ± 0.14 -0.27 ± 0.20 
Kp2 (W/kg) 0.15 ± 0.14 0.13 ± 0.15 0.16 ± 0.17 
Kp3 (W/kg) -0.61 ± 0.40 -0.70 ± 0.35 -0.91 ± 0.43*$ 
Kp4 (W/kg) -0.54 ± 0.32 -0.31 ± 0.59 -0.67 ± 0.34 
Key: Kp1 = Max. knee extensor absorption power in early stance, Kp2 = Max. knee extensor 
generation power in mid-stance, Kp3 = Max. knee extensor absorption power in pre-swing, 
Kp4 = Max. knee flexor absorption power in late swing.
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5.4 Discussion 
5.4.1 Part A- MD versus Controls 
This study is novel in the description of the kinetics of gait in adults with BMD and 
LGMD, along with the presentation of ground reaction forces and joint powers 
during FSHD gait compared to controls. Several peak vertical and anterior-posterior 
ground reaction forces were small in one or all of the MD groups compared to the 
controls. Specifically, peak vertical ground reaction force in loading in all MD groups; 
peak vertical force in terminal stance in LGMD and peak propulsive force in LGMD. 
Peak lateral force in terminal stance however, was greater in the BMD group than 
the controls. Numerous differences in joint moments between the MD groups and 
the control group were evident at the hip in the sagittal, frontal and transverse 
planes, along with differences in the knee and ankle moments in the sagittal plane. 
In addition, deviations in joint powers were found in the MD groups compared to 
the controls, including; a smaller maximum hip extensor generation power in BMD 
and LGMD; a smaller maximum hip flexor generation power in all MD groups; a 
smaller maximum knee extensor generation power in all MD groups; a smaller 
maximum knee extension absorption power in all MD groups; a smaller maximum 
knee flexor absorption power in BMD and LGMD and a smaller maximum 
plantarflexion generation power in all MD groups. 
5.4.1.1 Ground Reaction Forces 
It is unsurprising that numerous peak ground reaction forces in the vertical and 
horizontal direction were smaller in one or some of the MD groups in comparison 
to the controls, given the slower self-selected gait speed of the MD groups 
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presented in Chapter 5 (control: 1.44 m/s, FSHD: 1.06 m/s, BMD: 0.96 m/s, LGMD: 
0.80 m/s). 
In the vertical direction, peak force during loading was smaller in all MD groups than 
in the control group. In terminal stance, peak vertical force was smaller in all MD 
groups but only reached significance in the LGMD group. Interestingly, peak force 
in loading was 3% lower than body weight in LGMD (1 = body weight). This suggests 
that full weightbearing on the legs at loading did not happen in this group. It is likely 
that a proportion of bodyweight was supported by the upper body in some 
individuals through their walking aids.  Thus, in the LGMD group the centre of mass 
may not be accelerated upwards as much as controls; at least not by the lower body. 
This evidence provides some support for the explanation that was proposed in 
Chapter 5 regarding no change to the oxygen cost of gait post RT. Similar findings to 
these (lower peak vertical forces) have previously been shown in children with 
Duchenne MD compared to controls (Gaudreault et al., 2010), however the 
differences in vertical ground reaction forces were dissipated once control gait 
speed was matched to MD gait speed. Typically, the vertical ground reaction force 
decreases from the initial peak to mid-stance as the knee flexes and the vertical lift 
in the centre of mass decelerates (Chung and Wang, 2010). No significant difference 
in this minimum vertical force at mid-stance was found between the groups, but the 
decrease in vertical force from the initial peak to mid-stance was observably smaller 
in all MD groups than the control. This parallels the reduced, or lack of knee flexion 
in mid-stance that was presented in Chapter 5 in the MD groups.   
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In the anterior-posterior direction, the peak braking force was smaller in all MD 
groups than controls, but this difference did not reach significance. The peak 
propulsive force however was significantly smaller in LGMD than controls, which 
parallels the slowest gait speed in this group. Numerous studies have shown that 
the plantar flexor muscles are the main contributor towards forward propulsion of 
the mass centre during late stance in normal walking (Liu et al., 2006; Gottschall and 
Kram, 2003; Neptune et al., 2001). Therefore, the smaller propulsive force in LGMD 
is likely related to the weak plantar flexor MVC torque presented in Chapter 4, which 
was the most severe in LGMD than all other groups.   
Interestingly, peak medial ground reaction force during terminal stance was 13% 
greater in the BMD group than the control group, despite the slower gait speed in 
BMD. This finding agrees with a study by Gaudreault et al. (2010), which also 
reported a greater peak medial force during stance in Duchenne MD compared to 
controls walking at both their natural and a matched gait speed to the MD group. 
This finding provides evidence towards the previously presumed notion of similar 
gait patterns between Duchenne MD and BMD. It is important to note the greater 
step width reported in the BMD group compared to controls in Chapter 5, as this 
may be related to the greater medial ground reaction force found in this group. This 
is suspected as the medial ground reaction force during terminal stance acts to 
transfer body weight onto the opposite foot (Browning and Kram, 2007). Therefore, 
the greater step width in BMD likely requires a greater force to complete this 
transition. Furthermore, enforced increases in step width have previously been 
shown to increase peak medial ground reaction forces during stance in healthy 
adults (Donelan et al., 2001). 
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5.4.1.2 External Joint Moments 
Differences in hip joint moments were found in the MD groups compared to 
controls. Most notable was the reduced maximum hip extensor moment in late 
stance, which was 41% lower in the FSHD and 33% lower in the LGMD group than 
controls. However, no significant difference in this variable was evident in BMD 
compared to controls. Similar findings of a lower hip extensor moment in late stance 
have previously been reported in other populations, such as elderly individuals 
compared to young adults (Monaco et al., 2009). 
The smaller hip extensor moment in FSHD than controls coincides with the lack of 
hip extension at toe-off in the FSHD group reported in Chapter 4. The combination 
of a reduced hip extensor moment acting on the hip joint, and the weakness of the 
hip extensor muscles, as reported in Chapter 3, likely limits the degree of hip 
extension that is achievable. In BMD however, no difference in maximum hip 
extensor moment was evident, yet a lack of hip extension at toe-off was also found 
in this group (Chapter 3). Thus, these findings demonstrate that the lack of hip 
extension at toe-off in the BMD group is not a function of low hip extensor moments 
acting on the hip joint. Instead, the reduced hip extension position in BMD must be 
related to an alternative abnormality. One such alternative may be tightness in the 
muscles that are anterior to the hip, such as the hip flexors, which may reduce the 
degree of hip extension that is attainable. Although it is not possible to verify this 
explanation from our study, it is clear that the magnitude of the hip extensor 
moment in stance is not the cause of limited hip extension in BMD.   
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Deviations in the knee flexor/extensor moment during the gait cycle, for each MD 
group compared to the control group, are observable in Figures 5.3, 5.4 and 5.5. The 
root mean square difference in knee moment shows considerable differences 
between each MD group and the controls over the stance phase as a whole (FSHD: 
0.34 Nm/kg, BMD: 0.25 Nm/kg, LGMD: 0.41 Nm/kg). In addition, analysis of discrete 
variables demonstrate significantly lower knee flexor moments during the loading 
response compared to controls by 69%, 74% and 88%, in FSHD, BMD and LGMD, 
respectively. Furthermore, although no significant difference was found in the 
maximum knee extensor moment during mid-stance, it was 0.24 Nm/kg and 0.23 
Nm/kg greater in the FSHD and LGMD group than the controls. However, no 
difference in the maximum knee extensor moment was evident between BMD and 
controls (-0.01 versus -0.01), which disagrees with previous studies in children with 
Duchenne MD that reported greater peak knee extensor moments during stance 
compared to controls (D'Angelo et al., 2009; Gaudreault et al., 2010). This 
discrepancy highlights that gait patterns between children with Duchenne MD and 
adults with BMD are not entirely alike, which is most likely a function of the greater 
severity and progression of Duchenne MD than BMD.  
 In Chapter 4 we proposed that the greater severity of knee 
extension/hyperextension during midstance in LGMD than BMD despite similar 
strength deficits, was either a function of greater abnormalities in the knee 
flexor/extensor moment, or a reduced resistance to hyperextension from the 
internal structures of the knee. The findings from this study confirm that the LGMD 
group experience a lower knee flexor moment acting on the knee joint at loading 
than the BMD group, and a greater knee extensor moment acting on the knee joint 
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during mid-stance than the BMD group. Thus, it appears that the greater severity of 
hyperextension in LGMD than BMD is a function of a larger external extensor 
moment acting on the knee joint during stance.  
The smaller knee flexor moments during loading in FSHD, BMD and LGMD than 
controls coincides with less flexed knee positions during loading that were reported 
in Chapter 4 for these groups. In addition, the heightened knee extensor moment 
during mid-stance in LGMD coincides with the hyperextension of the knee joint that 
was reported in LGMD (Chapter 4). However, a high knee extensor moment during 
stance was also found in the FSHD group, but hyperextension of the knee was not 
evident in this group, as shown in Chapter 4. Thus, both the LGMD and FSHD group 
experienced an excessive external knee extensor moment during mid-stance but it 
appears that the FSHD group were able to counter this external knee extensor 
moment to keep the knee in a slightly flexed position. This reflects the less severe 
strength deficits (in the knee flexors and knee extensors) of the FSHD group than 
the LGMD group (as shown in Chapter 3).  
At heel contact with the ground, the vertical projection of the ground reaction force 
is typically located posterior to the ankle joint, which results in an external 
plantarflexion moment during early stance (Webster and Darter, 2019). This 
plantarflexion moment can be seen in the control group in Figure 5.3. However, 
there is a complete absence of this external moment in the FSHD, BMD and LGMD 
group, which is observable in Figures 5.3, 5.4 and 5.5, respectively. As such, the 
maximum plantarflexion moment in early stance was 90%, 80% and 65% lower in 
the FSHD, BMD and LGMD group respectively compared to controls. This finding 
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coincides with the lack of dorsiflexion at initial contact (flat foot) that was reported 
in the MD groups in Chapter 4. With this flat foot position at initial contact, an 
immediate dorsiflexor moment occurs instead. This abnormality has previously 
been reported in children with Duchenne MD (Gaudreault et al., 2010). 
5.4.1.3 Joint Powers  
It is clear that the propulsive generating capacity during late stance is impaired in 
all MD groups. This is demonstrated at the hip, knee and ankle. The maximum hip 
flexor generation power in late stance was 40%, 34% and 53% smaller in the FSHD, 
BMD and LGMD groups compared to controls, respectively. In addition, the knee 
extensor generation power in stance was 34%, 87% and 68% smaller in the FSHD, 
BMD and LGMD groups compared to controls. Finally, the maximum plantarflexion 
generation power in late stance was 34%, 29% and 63% lower in the FSHD, BMD 
and LGMD group, respectively. The greater deficit in hip flexor power generation 
and plantarflexion generation power in the LGMD group compared to FSHD and 
BMD parallels the smaller maximum propulsive force reported in LGMD. This is 
particularly pertinent as numerous studies have shown that the plantar flexors are 
the main contributor towards forward propulsion during late stance in normal 
walking (Liu et al., 2006; Gottschall and Kram, 2003; Neptune et al., 2001). 
Previous studies that have measured joint powers in other types of MD, namely 
Duchenne MD, have reported similar findings to ours. These findings include lower 
plantar flexion generation powers in late stance (D'Angelo et al., 2009; Gaudreault 
et al., 2009; Gaudreault et al., 2010) and a lower hip flexor generation power in late 
stance (Gaudreault et al., 2010), compared to controls. In addition, reduced 
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plantarflexion generation power in late stance is well documented in elderly 
populations compared to young (Schloemer et al., 2017; Monaco et al., 2009; Silder 
et al., 2008), and has been reported in a study involving adults with Myotonic MD 
(Galli et al., 2012). However, in the latter two populations (elderly and Myotonic 
MD) a greater hip flexor generation power compared to controls was also reported 
(Galli et al., 2012; Schloemer et al., 2017; Monaco et al., 2009; Silder et al., 2008). 
This strategy demonstrates a proximal compensation for the reduced plantar flexion 
generation power in elderly individuals and adults with Myotonic MD. However, this 
compensatory shift is not evident in our populations of FSHD, BMD or LGMD as hip 
flexor generation power was also lower than it was in the control group.   
5.4.1.4 Clinical Implications  
This study demonstrates numerous kinetic abnormalities in individuals with FSHD, 
BMD and LGMD compared to controls. These abnormalities have numerous clinical 
implications including the potential for increased pain and damage through 
excessive forces acting on the joints. For example, the lower knee flexor moment in 
loading and the heightened knee extensor moment in mid-stance in the MD groups, 
LGMD in particular, exposes the internal structures of the knee joint to excessive 
forces during the stance phase. Another clinical implication is the deterioration of 
gait speed due to a reduced capacity to generate propulsion. The inferior joint 
powers at the hip, knee and ankle joint from mid-stance to terminal stance indicate 
that the capacity to generate propulsion is diminished proximally and distally for all 
MD groups. Therefore, a full lower-body RT programme may be advantageous 
towards maintaining ambulation in these types of MD.  
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5.4.1.5 Conclusion 
In conclusion, several peak vertical and horizontal ground reaction forces differed 
to controls. Peak vertical force in loading was smaller in all MD groups, peak vertical 
force in terminal stance and propulsive force was smaller in LGMD and peak lateral 
force in terminal stance was greater in BMD. In addition, deviations in joint 
moments were evident at all lower-limb joint levels (hip, knee and ankle) between 
the MD groups and controls, with the most striking abnormalities occurring in the 
knee flexor/extensor moment and the plantarflexor/dorsiflexor moment in each 
MD group. On the other hand, hip moment abnormalities varied between the MD 
groups, with only the FSHD and LGMD group demonstrating an inferior hip extensor 
moment compared to controls. Despite these differences between the MD groups, 
propulsive force generating capacity was diminished in all MD groups at the ankle, 
knee and hip joint. Overall, these findings suggests that several kinetic abnormalities 
are common to all three types of MD whereas others are individual to the specific 
groups. Thus, individualised RT programmes would be advantageous in these 
individuals.  
5.4.2 Part B – Effects of RT 
This is the first study to examine the effect of a RT programme on key kinetic gait 
parameters in individuals with MD. Alongside the increase in gait speed and changes 
in numerous kinematic variables presented in Chapter 4, several kinetic variables 
were altered after completion of the RT programme. Peak vertical and horizontal 
ground reaction forces including the minimum vertical force in mid-stance, the 
maximum braking force and the maximum propulsive force increased post RT. In 
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addition, adaptations were also found in several joint moments, including an 
increase in the maximum plantarflexion moment during early stance and the 
maximum knee flexor moment in stance. The only change in joint power occurred 
at the ankle joint as an increase in maximum plantarflexion generation power in late 
stance. Importantly the additional analysis completed in the subgroup of MD 
participants that hyperextended the knee during stance, found that the maximum 
knee extensor moment during mid-stance was reduced in these individuals post RT.  
It is important to note, as mentioned in Chapter 4 of this thesis, the discrete kinetic 
variables in which significant differences were found post RT all showed sufficient 
retrospective statistical power (between .75 and .86). However, some of the 
variables that did not differ were found to have insufficient retrospective observed 
power (between .11 and .42). Thus, it is viable that a greater sample size would 
reveal additional kinetic differences alongside the ones found in this study, but the 
key finding that RT does influence variables of gait in a positive direction remains 
valid.  
5.4.2.1 Ground Reaction Forces 
Increases in peak vertical and horizontal ground reaction forces were found in the 
MD group post RT. In the vertical direction, the minimum vertical force during mid-
stance increased by 2.3% (i.e. a lower magnitude of force), shifting the vertical force 
curve closer to that of non-dystrophic controls. This reduction in vertical force 
coincides with the increased knee flexion that occurred in this group post RT 
(Chapter 4). A 13% Increase in maximum braking force during early stance was also 
found, which makes sense given the increase in gait speed that occurred post RT. In 
262 
 
addition, a 6.3% increase in maximum propulsive force during late stance was found 
from PRE1 to POST RT. This finding signifies that RT improved the propulsive force 
generating capacity of this MD group. As already mentioned, it has previously been 
shown that the plantar flexor muscles are the main contributors towards forward 
propulsion in late stance (Liu et al., 2006). Thus, the 65% increase in plantarflexion 
MVC torque that was found post RT (Chapter 3) is in line with this. 
5.4.2.2 External Joint Moments  
The root mean square difference in sagittal plane external joint moments offers a 
value of the global difference in joint moment over the gait cycle as a whole, and 
over the stance phase as a whole rather than at discrete time points or peaks. The 
mean variance in the hip flexor/extensor moment was relatively equal between the 
control period and post completion of the RT programme, both over the entire gait 
cycle (0.04 versus 0.04 Nm/kg) and over the stance phase (0.04 versus 0.05 Nm/kg). 
This demonstrates that on the whole the hip flexor/extensor moment did not 
change considerably post RT, relative to the variance within the initial control 
period. The largest difference in overall joint moment post RT occurred in the knee 
flexor/extensor external moment, which differed by a mean of 0.04 Nm/kg overall 
and 0.06 Nm/kg in the stance phase post RT, compared to small variances of 0.01 
and 0.02 Nm/kg in the control period. The mean difference in plantarflexion 
moment post RT was only slightly greater than the variance observed in the control 
period (0.03 versus 0.02 Nm/kg, respectively). Therefore, the overall ankle 
plantarflexion moment did not differ considerably between the control period and 
post RT. Overall, only the knee flexion/extension moment changed post RT when 
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analysed over the entire gait cycle, but additional adaptations were evident in 
discrete variables which will be now be discussed. 
Analysis of discrete variables at the hip found no change in hip moments in the 
sagittal, frontal or transverse planes. However, it is important to note the low 
observed powers in these comparisons (between .12 and .42).  Thus, a greater 
sample size and in turn a greater statistical power may detect adaptations in hip 
moments post RT.   
Most notable among the adaptations in external joint moments was the 31.2% 
increase in maximum knee flexor moment during stance, post completion of the RT 
programme. This finding parallels the increase in the knee flexion position during 
mid-stance that was found post RT and is presented in Chapter 4. These adaptations 
also coincide with the greater reduction in vertical ground reaction force following 
the initial peak in vertical force, which was described above. Together these findings 
demonstrate a superior attenuation of the vertical forces acting on the body during 
mid-stance. Additionally in the sub-group of participants that hyperextended at the 
knee joint, a 37.3% reduction in the maximum external knee extensor moment 
during mid-stance was found. This finding parallels the 4.1° (38.4%) reduction in the 
severity of hyperextension during mid-stance that was presented in Chapter 4. We 
noted that this reduction in knee hyperextension may be related to changes in the 
knee extensor moment or other adaptations such as an increased resistance to 
hyperextension from the internal structures of the knee. The findings from this 
study confirm that the reduction in the severity of hyperextension is a function of a 
reduced external knee extensor moment acting on the knee joint during mid-stance. 
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Although it is possible that an increase in internal resistance to hyperextension also 
occurred post RT, it is not possible to determine this from our study,  
At the ankle, an increase in maximum plantarflexion moment in early stance was 
found post RT, with stable values in the control period. This adaptation occurs in 
parallel with the 2.2° increase in ankle dorsiflexion at initial contact presented in 
Chapter 4. This greater dorsiflexed position at initial contact, together with the 
increase in plantarflexion moment during loading, reflects a more posterior 
trajectory of the vertical ground reaction force in relation to the ankle joint during 
loading (Webster and Darter, 2019).  
5.4.2.3 Joint Powers 
An increase in the propulsive generating capacity at push-off was observed post RT. 
Specifically, the maximum plantarflexion generation power increased by 9% post 
completion of the RT programme, with stable values in the initial control period. 
This finding represents an increase in the propulsive generating capacity of 
individuals with MD during the late stance phase, which is observable in the 
increased propulsive ground reaction force post RT that was described earlier in this 
discussion. This increase in ankle power corresponds well with, and may be related 
to, the 65% increase in plantarflexion MVC torque that was presented in Chapter 3. 
Interestingly, similar findings have previously been reported in children with 
cerebral palsy following a programme of 8 weeks’ individually designed RT (Eek et 
al., 2008). No other changes in joint powers were found post completion of the RT 
programme, but it should be noted that although not significantly different, the 
maximum hip extensor generation power in early stance increased by 27.8% and is 
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noticeably larger in Figure 5.9. This variable had a considerably low retrospective 
statistical power and therefore may significantly differ in future studies with a 
greater sample size.  
Overall, analysis of joint powers pre and post the RT programme demonstrated that 
adaptations occurred predominantly in the distal joints at the push-off phase of gait 
rather than the proximal joints.  
5.4.2.4 Clinical Implication 
The implication of these findings is that RT is a practical option to help improve 
walking ability in adults living with MD. As an intervention, RT has the potential to 
reduce excessive forces at the joints during gait which often result in abnormal joint 
positions. For instance, the excessive knee extension moment observed during mid-
stance in this MD population was reduced. In addition, RT also has the potential to 
improve walking speed in MD through an increase in propulsive generating capacity, 
such as the increase in plantarflexion generation power at push-off shown within 
this study. 
5.4.2.5 Limitations 
This study has a key limitation that cannot be ignored. Whilst statistical power was 
sufficient for some of the variables of interest in this study, low retrospective 
statistical power was observed in quite a few other kinetic variables, particularly 
those at the hip. Therefore, it is highly likely that adaptations occurred in additional 
kinetic variables post RT in this population but were concealed due to this limitation. 
Whilst statistical power was sufficient for variables of MVC torque presented in 
Chapter 4, and the vast majority of kinematic variables presented in Chapter 4, 
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greater power would have been advantageous in this study. Nevertheless, the 
variables that were sufficiently powered in this study demonstrate that RT is a 
successful intervention for gait adaptations in MD. 
5.4.2.6 Conclusion 
In conclusion, this is the first study to demonstrate positive effects of a 12-week RT 
programme on a number of kinetic gait abnormalities in adults with MD. Overall, RT 
is an innovative approach to improving gait abnormalities and to enhancing 
propulsive capacity in MD, which was shown specifically by an increase in the 
maximum external knee flexor moment during stance, a reduction in the excessive 
external knee extensor moment during stance and an increase in peak plantarflexor 
power generation during late stance.  
267 
 
Chapter 6 
Influence of resistance training on quality of 
life and mental health in adults with 
Facioscapulohumeral, Limb-girdle and 
Becker muscular dystrophy
268 
 
6.1 Introduction 
MD encompasses a number of neuromuscular conditions which are caused by a 
variety of genetic mutations (Huml, 2015). Such mutations give rise to a reduced or 
absent expression of proteins within the muscle cell which ultimately causes 
progressive weakening and deterioration of the muscles (Mercuri and Muntoni, 
2013). This results in increasing levels of disability and reduced physical function 
(Huml, 2015). In addition, chronic conditions, such as MD, may result in not just 
physical but also mental challenges. A higher prevalence of poor mental health has 
previously been demonstrated in a variety of groups with chronic medical 
conditions (Katon, 2011).  
Duchenne MD is the most severe form of MD, characterised by an absence of the 
protein dystrophin (Koenig et al., 1989), early childhood onset, rapid progression, 
loss of ambulation in childhood and premature death (Bushby et al., 2010). Other 
types of MD vary between childhood and adult onset, progress more slowly and do 
not typically lead to a loss of ability to walk, at least until the second decade of life  
and onwards (Emery, 2002). Three common types of MD that fit the latter 
description are FSHD, LGMD and BMD (Emery, 2002). Similar to Duchenne MD, BMD 
is also due to a defect in the dystrophin protein, but the protein is reduced or 
dysfunctional rather than absent (Koenig et al., 1989), rendering BMD a less severe 
variant of Duchenne MD with the loss in ambulation typically occurring from the 
second decade of life onwards (Mercuri and Muntoni, 2013) . FSHD and LGMD are 
both heterogeneous conditions with various subtypes in each condition that affect 
different proteins at several molecular levels of the muscle cell (Sacconi et al., 2015; 
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Liewluck and Milone, 2018). FSHD and LGMD typically occur in adulthood, with the 
loss in ability to walk occurring much later in life, if at all (Emery, 2002). 
6.1.1 Part A 
Understanding quality of life (QoL) and mental health in MD is of vital importance. 
QoL has of late become a major focal point in long-term disease management, as 
lower QoL has been demonstrated across a variety of muscle diseases (Graham et 
al., 2011). In MD populations the research is conflicting. Some studies have reported 
reduced QoL (both physical and mental dimensions), in children and adults with 
Duchenne MD (Davis et al., 2010; Uzark et al., 2012; Landfeldt et al., 2016; Lue et 
al., 2016), a combined group of children and adults with Duchenne MD, BMD and 
LGMD (Grootenhuis et al., 2007), adults with Myotonic MD (Antonini et al., 2006) 
and adults with FSHD (Winter et al., 2010; Padua et al., 2009). In contrast, other 
studies have reported that whilst physical aspects of QoL are impaired, QoL in the 
mental domain is similar between individuals with Duchenne MD and control 
groups or normative reference values (Kohler et al., 2005; Pangalila, van den Bos, 
Bartels, Bergen, Kampelmacher, et al., 2015; Elsenbruch et al., 2013). The latter 
findings reflect the disability paradox phenomenon (Albrecht and Devlieger, 1999) 
where perceived QoL is high despite substantial physical disability.  
The relationship between MD and QoL is clearly complicated, and it is likely 
mediated by additional factors. Previous investigations have shown that numerous 
disease-specific parameters are related to QoL in MD in the physical domain, 
including current age (Uzark et al., 2012), disease severity (Landfeldt et al., 2016; 
Padua et al., 2009; Otto et al., 2017; Peric et al., 2018), functional status (Lue et al., 
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2016), wheelchair use (Wei et al., 2016) and age at disease onset (Peric et al., 2018). 
Other variables are negatively associated with both domains (physical and mental) 
of QoL in MD; pain (Padua et al., 2009; Abresch et al., 2002) and fatigue (Wei et al., 
2016; Kalkman, 2005; Pangalila, van den Bos, Bartels, Bergen, Stam, et al., 2015).  
Interestingly, these two variables are aspects of the condition that may be 
manageable through interventions such as medication. Of particular interest to this 
study is the relationship of QoL to variables that may be managed to some extent 
through RT, such as physical activity level, depressive symptoms, anxiety and self-
esteem. 
The relationships between physical activity and QoL and between self-esteem and 
QoL remain un-investigated in individuals with MD. On the other hand, negative 
relationships have been presented between anxiety and both domains of QoL, and 
between depression and the physical domain of QoL, in Duchenne MD (Pangalila, 
van den Bos, Bartels, Bergen, Stam, et al., 2015). Furthermore,  Peric et al. (2018) 
established a negative association between depression and total QoL score in adults 
with LGMD, but details regarding individual QoL subscales were not provided. The 
relationship of depression and anxiety with QoL is yet to be investigated in FSHD or 
BMD, and nothing is known of the relationship between anxiety and QoL in LGMD. 
It is known that poor mental health is often present in individuals with long-term 
physical disease. Moussavi et al. (2007) established that between 9.3% and 18.1% 
of individuals with a physical disease exhibit depression, which was significantly 
higher than the 4.4% in the general population with no physical condition. Similarly, 
higher levels of moderate depression have been established in adults with 
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Duchenne MD (18%), compared to a control group (8%;(Pangalila, van den Bos, 
Bartels, Bergen, Stam, et al., 2015). However, investigation of mental health in 
FSHD, BMD and LGMD is particularly limited. Caregivers of non-ambulatory males 
with BMD perceived that depression and anxiety were present in 18% and 26% of 
their patients, respectively (Latimer et al., 2017). In addition, the frequency of 
anxiety and depression experienced by adults with BMD and LGMD does not differ 
(Melo et al., 1995), but in adults with Myotonic MD the severity of depression was 
higher than in adults with FSHD (Alschuler et al., 2012). Studies quantifying anxiety 
and depression in comparison to control or normative reference data have yet to 
be conducted in FSHD, LGMD and BMD. 
Investigation into levels of self-esteem in MD are also extremely limited, with only 
two examinations of this being published to date. Authors reported lower levels of 
self-esteem in children with LGMD compared to an age and sex-matched control 
group (Miladi et al., 1999), whilst no difference in self-esteem was established 
between adults with Myotonic MD and normative reference data (Bertrand et al., 
2015). It has previously been established that self-esteem increases from 
adolescence to adulthood in healthy populations (Huang, 2010). Thus, age may play 
a role in the mediation of self-esteem in MD too, but the research is too sparse to 
confirm this. What is more, these studies were limited to measures of global self-
esteem. Given the multidimensional nature of self-esteem (Raustorp et al., 2005), 
domain-specific levels of self-worth may be more sensitive to investigation. In 
particular, physical self-worth is of interest in individuals with MD due to the typical 
influence of MD on physical elements of the body and function. However, this is yet 
to be investigated in any form of MD.  
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It has been shown that individuals with FSHD, BMD and LGMD experience a high 
frequency of body pain that is symptomatic of their condition (Jacques et al., 2019). 
Kinesiophobia is consistently elevated in other populations with chronic pain, such 
as those with low back pain, (Ishak et al., 2017), chronic musculoskeletal pain 
(Bränström and Fahlström, 2008), neck pain (Demirbüken et al., 2015) and  post-
surgery disk herniation (Svensson et al., 2011). Kinesiophobia describes an elevated 
fear of physical movement or injury/re-injury (Woby et al., 2005) and is commonly 
measured using The Tampa Scale of Kinesiophobia (Miller et al., 1991). However, 
kinesiophobia remains un-investigated in individuals with FSHD, BMD and LGMD. 
Given the presence of significant pain in these populations, it is possible that 
kinesiophobia is also elevated which may have important implications for MD 
management techniques, such as physiotherapy, and long-term physical activity 
limitations. 
Thus, the first aim of this study is to quantify QoL and the mental health profiles 
(depressive symptoms, trait anxiety, global self-esteem and physical self-worth) of 
adults living with MD (FSHD, BMD and LGMD), compared to age-matched control 
adults. In addition, the physical activity and mental health factors that may be 
related to QoL in these individuals will be examined, along with the severity of 
kinesiophobia. 
6.1.2 Part B 
Along with the quantification of QoL and mental health in adults with MD, of 
particular interest is the suitability of RT as an intervention for these areas. RT is a 
form of exercise that has previously been shown to positively influence QoL and 
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mental health in a range of clinical populations.  QoL was improved post RT in adults 
with Parkinson’s disease (Ferreira et al., 2018), older adults (Kekalainen et al., 2018) 
and patients with chronic heart failure (Lans et al., 2018). In addition, systematic 
reviews and meta-analyses have revealed that RT programmes positively influence 
anxiety, depression and self-esteem. O' Connor et al. (2010) revealed a moderate 
effect of RT on the reduction of anxiety symptoms across older adults, breast cancer 
patients and adults with osteoarthritis, with a large effect when older adults were 
analysed independently. Furthermore, Mead et al. (2010) reported large reductions 
in the severity of depressive symptoms post RT amongst clinically depressed 
patients. Reductions have also been established in participants with fibromyalgia 
(Jones et al., 2002; Hakkinen et al., 2001), spinal cord injury (Hicks et al., 2003) and 
osteoarthritis (O' Reilly et al., 1999), whilst results in older adults are inconclusive. 
Some studies have found a positive effect of RT in older adults, (Cassilhas et al., 
2007; Timonen et al., 2002; Singh et al., 1997), whilst other studies have reported 
no change in depression with RT in elderly populations (Jette et al., 1996; Sims et 
al., 2006; Chin A Paw et al., 2004; Penninx et al., 2002). However, low adherence 
rates (ranging from 58-71%) were evident in the latter group of studies. With regard 
to self-esteem, Spence et al. (2005) found a small effect of RT on improvements in 
global self-esteem. More recently, improvements in global self-esteem post 12 
weeks’ RT were shown to be accompanied by larger improvements in physical self-
worth in obese women (Megakli et al., 2015).  
Based on previous research in other populations, RT may also elicit beneficial effects 
on mental health and QoL in individuals with MD. However this is yet to be 
investigated, which is likely due to historical discouragement of RT in adults living 
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with MD. This  discouragement was due to claims that RT may be harmful to the 
muscle cells of individuals with MD (Ansved, 2001). However, the evidence for this 
is limited to anecdotal case reports of overwork weakness in FSHD (Johnson and 
Braddom, 1971) and scapuloperoneal MD (Wagner et al., 1986), and murine 
evidence in MDX mice (Weller et al., 1990; Petrof et al., 1993). MDX mice represent 
one type of MD only (Duchenne) and in any case, the replicability of the MDX 
mutation to Duchenne MD is limited (Partridge, 2013) . Given the stark differences 
in genotype and severity of Duchenne MD compared to other types of MD, along 
with questionable applicability of MDX mice to humans, it is illogical to presume 
that RT should be avoided in all types of MD. Yet, there remains a serious lack of 
experimental investigation into RT in individuals with MD.  
A meta-analysis conducted by Gianola et al. (2013) was unable to determine 
whether RT was beneficial or not in MD, due to there being only four studies that 
investigated maximum voluntary contraction (MVC) strength following a period of 
RT in individuals with MD (Lindeman et al., 1995; Tollback et al., 1999; Van der Kooi 
et al., 2004; de Lateur and Giaconi, 1979). Nevertheless, the authors did establish 
that despite no overall effect of RT, the direction of the effect in each of the studies 
was positive (Gianola et al., 2013). It remains uncertain from published research 
whether RT can increase muscle strength in MD, but it does appear that RT is at the 
very least not harmful to adults living with MD, with likely benefits to muscle 
strength. 
Results presented in Chapter 3 of this thesis show a significant increase in MVC 
torque in six out of a possible eight lower limb muscle groups following RT, in adults 
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with FSHD, BMD and LGMD. In addition to these strength gains from RT in FSHD, 
BMD and LGMD, there may be other benefits of a RT programme in these adults 
that are equally as important to health. More specifically, the positive influence of 
RT on QoL and mental health already discussed may apply to adults with MD too, 
but this is yet to be investigated in any depth. One experimental study has 
considered this in adults with Myotonic MD (Kierkegaard et al., 2011), but it was 
limited to the measure of QoL. Nevertheless, the authors reported no effect of a 14-
week RT programme. The influence of RT on QoL in adults with FSHD, LGMD and 
BMD, along with the effects of RT on the more detailed measures of mental health 
in these populations, remain unknown. 
Thus, the second aim of this study is to examine whether a 12-week programme of 
supervised RT influences QoL and aspects of mental health (depressive symptoms, 
trait anxiety, global self-esteem, physical self-worth and fear of movement), in 
ambulatory adults with MD (FSHD, BMD and LGMD).
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6.2 Method 
6.2.1 Participants & Study Design 
The experimental design for this study is presented in two parts. Part A presents group 
comparisons between adults with FSHD (9), BMD (7), LGMD (6) and a group of 10 
control adults matched in age, stature and body mass.  
Part B is a within-participant design, involving a group of 17 adults with MD, inclusive 
of FSHD (6), BMD (5) and LGMD (6). Data were collected at three time points: PRE1 
(before a 12-week control period), PRE2 (immediately after the 12-week control 
period) and POST (immediately after a 12-week RT programme). All 17 MD participants 
completed a 12-week, twice a week, RT programme. One additional testing session 
took place halfway through the RT programme (Mid-Train), in which questionnaire 
data were also collected. 
Detailed descriptions of the study design, participants and the RT programme are 
provided in Chapter 3.2 Method. 
Manchester Metropolitan University Ethics Committee granted ethical approval and 
all participants provided written informed consent after which data collection took 
place at Manchester Metropolitan University on all occasions. 
6.2.2 Procedure  
6.2.2.1 Part A - MD versus Controls 
Participants were given seven questionnaires (outlined below) which were each 
explained by one investigator. Participants were asked to complete the 
questionnaires in their own time and to return them to the investigators within one-
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two weeks. The participants were able to ask questions about each questionnaire if 
required and were informed that the investigator was available via phone or email 
should they require assistance.  
6.2.2.2 Part B - Effects of RT 
Participants were given seven questionnaires on four different occasions: PRE1, 
PRE2, Mid-Train and POST. They were asked to complete the questionnaires 
(outlined below) in their own time and to return the questionnaires to the 
investigators within one week. The participants were able to ask questions about 
each questionnaire if required and were informed that the investigator was 
available via phone or email should they require assistance. 
6.2.3 Measures 
Seven questionnaires that assessed QoL and multiple aspects of mental health, 
along with one questionnaire that quantified physical activity levels, were included 
within this study. Appendix 4 contains copies of the questionnaires. Each measure 
is described below: 
6.2.3.1 The 36-item Short Form Health Survey   
The 36-item Short Form Health Survey is a self-report generic survey that covers 36 
questions on functional health and wellbeing to assess QoL, from the participant’s 
perspective (Ware, 2000). Each question has a multiple-choice Likert scale on which 
participants rate themselves. The answers are summarised into a physical 
component health score and a mental component health score, such that higher 
scores indicate better health. The scale has excellent test-retest reliability in both 
components, with a correlation coefficient above .80 (Ware, 2000).  
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6.2.3.2 Beck Depression Inventory 
The Beck Depression Inventory is a 21 question, multiple choice, self-report 
questionnaire that measures depressive symptoms. It has good reliability, with test-
retest correlation coefficients of .96 (Sprinkle et al., 2002).  The questionnaire 
includes items relating to symptoms of depression and participants score each 
question from 0 (least) to 3 (most), with a total sum score indicating overall 
depressive symptoms from 0-63. Higher scores indicate increased severity of 
depressive symptoms. The cut scores for the Beck Depression Inventory are as 
follows: ≤ 10 indicates zero to minimal depressive symptoms, 11-20 indicates mild 
depressive symptoms, 21-30 indicates moderate depressive symptoms, and ≥ 31 
indicates severe depressive symptoms. 
6.2.3.3 State-Trait Anxiety Inventory 
The trait sub-scale of the State-Trait Anxiety Inventory (Spielberger et al., 1983) is a 
20 question, multiple choice, self-report questionnaire that measures trait-anxiety, 
which is a predisposition to long-lasting and persistent feelings of anxiety that are 
not restricted to particular circumstances. The trait scale has excellent test-retest 
reliability, with a correlation coefficient of .86 (Spielberger et al., 1983). The scale 
includes statements for participants to score between 1 (not at all) to 4 (very much 
so). Total scores can range between 20-80, with higher scores indicating more 
severe anxiety symptoms.  
6.2.3.4 Rosenberg Self-Esteem Survey 
The Rosenberg Self-Esteem Scale is a measure of global self-esteem (Rosenberg, 
1965) with excellent reliability (correlation coefficient of .90; (Sinclair et al., 2010). 
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The scale has 10 questions that assess both the positive and negative feelings 
towards the self. Participants rate themselves on a 4-point Likert scale, with total 
scores ranging from 10 to 40. The higher the score the higher the self-esteem.  
6.2.3.5 Physical Self-Perception Profile 
The Physical Self-Perception Profile is a reliable (test-retest correlation coefficient 
between .74 and .91) (Fox and Corbin, 1989) self-report questionnaire that is 
comprised of thirty questions that assess physical self-worth in the global domain 
and self-perceptions in four sub-scales: sport competence, body attractiveness, 
physical strength and physical conditioning and exercise. An additional eight 
questions relate to perceived importance in the four sub-scales (sport competence, 
body attractiveness, physical strength and physical conditioning and exercise) and 
provide a measure of importance attached by the participant to the respective sub-
scale.   
6.2.3.6 Tampa Scale of Kinesiophobia 
The Tampa Scale of Kinesiophobia is a self-report, multiple choice questionnaire 
that evaluates fear of movement or injury in individuals who experience chronic 
pain (Miller et al., 1991). The questionnaire has 17-items which participants answer 
using a Likert scale ranging from strongly agree to strongly disagree. The scale has 
good test-retest reliability, with a correlation coefficient ≥ .82 (Woby et al., 2005). 
Total score can range between 17 and 68, with higher scores indicating a higher fear 
of movement. An exact cut-off value for high kinesiophobia has not been 
established, but values used consistently within the literature to define high 
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kinesiophobia range from ≥ 35 to 37 (Larsson et al., 2016; Demirbüken et al., 2015; 
Mahmood et al., 2018).  
6.2.3.7 Physical Activity Score for Individuals with Physical Disability 
The Physical Activity Scale for Individuals with Physical Disability measures levels of 
participation in physical activities over the last 7 days, in individuals with physical 
disabilities (Washburn et al., 2002), with good (ICC = .77) test-retest reliability (van 
der Ploeg et al., 2007). The scale assesses engagement in leisure activities, light, 
moderate and strenuous sport and recreation, exercise for muscle strength and 
endurance, household activities, home repairs, gardening, caring for others and 
non-sedentary occupational activities. Participants state the amount of days over 
the last 7 that they participated in each activity, including never, seldom (1-2 days 
per week), sometimes (3-4 days per week) or often (5-7 days per week), and how 
many hours they typically participated in each activity per day, ranging from < 1 
hour, 1 but < 2 hours, 2-4 hours and > 4 hours.  
6.2.4 Data Analysis 
Each questionnaire was scored according to the relevant manual and analysed in 
Microsoft Excel. In part A, data are presented as means and standard deviations for 
the control group, overall MD group and the MD sub-groups: FSHD BMD and LGMD, 
but statistical analysis is restricted to comparison between the overall MD group 
and control group. For part B, data are presented as means and standard deviations 
for the overall MD group at four-time points: PRE1, PRE2, Mid-Train and POST, but 
statistical analysis is limited to comparison between PRE1, PRE2 and POST. In all 
instances, two data points were missing from the Mid-Train time point. As the 
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Tampa Scale of Kinesiophobia is designed for individuals with chronic pain, data 
were not collected in the healthy control group. In MD participants, kinesiophobia 
data were collected in thirteen participants (6 FSHD and 7 BMD) for part A and in 9 
MD participants (4 FSHD and 5 BMD) for part B, due to an error in the questionnaire 
packs provided for participants. 
6.2.5 Statistical Analysis 
All statistical analysis was completed using IBM SPSS Statistics 22 software. The 
critical level of significance was set at p ≤ .05. 
6.2.5.1 Part A – MD versus Controls 
For all dependent variables that passed the parametric assumptions, independent 
samples t-tests were performed between the control and overall MD group, except 
for kinesiophobia. For all dependent variables that did not pass the parametric 
assumptions, Mann-Whitney U tests were performed. The following dependent 
variables did not satisfy the parametric assumptions: physical and mental health 
quality of life, depressive symptoms, global physical self-worth, body physical self-
perception, strength physical self-perception and all four importance domains of 
the physical self-perception profile. For analysis of kinesiophobia, an independent 
samples t-test was performed between the FSHD and BMD group.  
To investigate any associations between QoL (in both the physical and mental health 
components) and physical activity, depressive symptoms, trait anxiety, global self-
esteem, global physical self-worth and kinesiophobia, Pearson’s correlation 
coefficients were conducted using data for the overall MD group. In cases where 
data were non-parametric, Kendall Tau correlations were conducted. 
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6.2.5.1 Part B – Effects of RT 
For all dependant variables that passed the parametric assumptions, a one-way 
repeated measures ANOVA was performed between the time points. If the data did 
not pass Mauchly’s test of sphericity (P < .05), a Greenhouse-Geisser correction was 
applied. From the ANOVA, both the retrospective observed power and the effect 
size, calculated as partial eta squared (Ꞃp2), were reported. Post hoc analysis was 
completed using least significant difference pairwise comparisons. Data that were 
not normally distributed were analysed using a Friedman’s ANOVA, followed by post 
hoc analysis using Wilcoxon-signed rank tests (least significant difference). The 
following dependent variables did not satisfy the parametric assumptions: sport 
physical self-perception, strength physical self-perception, body physical self-
perception and all four domains of the importance physical self-perception profile.  
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6.3 Results 
6.3.1 Part A – MD versus Controls 
Participant characteristics, including age, stature and body mass, for the control, 
MD group and subdivided MD groups (FSHD, BMD and LGMD) are presented in 
Chapter 3.2 Method. No significant differences (p > .05) in age, stature or body mass 
were found between any of the groups. 
6.3.1.1 Quality of Life 
QoL scores in the physical domain were 38.5% lower (p ≤ .001) in the MD compared 
to the control group (Figure 6.1). QoL scores in the mental domain were not 
significantly different (p > .05) between the MD and the control group (Figure 6.1). 
Figure 6.1:  Physical health and mental health quality of life (QoL) scores for the control 
(CTRL) and MD group, along with the MD subgroups: FSHD, BMD and LGMD. Bars represent 
the mean and error bars represent the standard deviation. * represents a significant 
difference from the control group. 
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6.3.1.2 Depressive Symptoms 
All control participants scored ≤ 10 on the Beck Depression Inventory, which is 
categorised as zero to minimal depressive symptoms. Of the MD participants, 36.4% 
scored between 11 and 20 (mild depressive symptoms), and 4.5% scored between 
21-30 (moderate depressive symptoms) and 4.5% scored ≥ 31 (severe depressive 
symptoms) on this inventory. Severity of depressive symptom scores were 14% 
greater (p ≤ .01) in the MD than the control group (Figure 6.2). 
 
Figure 6.2: Beck Depression scores for the control CTRL) and MD group, along with the MD 
subgroups: FSHD, BMD and LGMD. Bars represent the mean and error bars represent the 
standard deviation. * represents a significant difference from the control group. 
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6.3.1.3 Trait Anxiety 
Trait anxiety scores were 22.7% greater in the MD than the control group but this 
was not significantly different (p = .054; Figure 6.3).  
 
Figure 6.3: Trait anxiety scores for the control (CTRL) and MD group, along with the 
subdivided MD groups: FSHD, BMD and LGMD. Bars represent the mean and error bars 
represent the standard deviation.  
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6.3.1.4 Self-Esteem 
Rosenberg self-esteem scores were not significantly different between the control 
and MD group (p = .095; Figure 6.4). 
 
Figure 6.4: Rosenberg self-esteem scores for the control (CTRL) and MD group, along with 
the MD subgroups: FSHD, BMD and LGMD. Bars represent the mean and error bars 
represent the standard deviation.  
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6.3.1.5 Physical Self-Perception Profile 
Physical self-perception profile score in the global domain was 35.3% lower (p 
≤.001) in the MD compared to the control group (Figure 6.5). Physical self-
perception profile scores were lower in the sport, condition and strength domains 
by 35.3% (p ≤ .01), 28% (p ≤ .01) and 42.9% (p ≤ .001), respectively, in the MD 
compared to the control group (Table 6.1). There was no difference between the 
MD and control group in the body domain or any of the importance domains (p > 
.05; sport importance, condition importance, body importance or strength 
importance). 
 
Figure 6.5:  Global physical self-worth scores for the control (CTRL) and MD group, along 
with the MD subgroups: FSHD, BMD and LGMD. Bars represent the mean and error bars 
represent the standard deviation. * represents a significant difference from the control 
group. 
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Table 6.1:  Physical Self-Perception Profile scores in the sport, condition body and strength domains for the control (CTRL) and MD group, along with the MD 
subgroups: FSHD, BMD and LGMD. * represents a significant difference from the control group (CTRL). S = score, I = Importance. 
 
 
 
 
 
 
 Sport Condition Body Strength 
 S I S I S I S I 
CTRL 15.6 ± 5.0 4.7 ± 1.7 16.4 ± 4.4 5.9 ± 1.7 13.5 ± 2.8 4.5 ± 1.4 15.4 ± 3.9 5.1 ± 2.0 
MD 10.1 ± 3.6* 4.3 ± 1.0 11.8 ± 3.2* 5.4 ± 1.2 11.0 ± 3.2 4.8 ± 1.1 8.8 ± 3.0* 5.1 ± 1.1 
FSHD 12.4 ± 2.7 4.4 ± 0.5 12.5 ± 1.8 5.5 ± 1.3 10.9 ± 3.6 5.0 ± 0.8 9.6 ± 3.0 4.8 ± 0.9 
LGMD 9.2 ± 4.2 4.8 ± 2.6 12.0 ± 5.3 5.2 ± 2.6 10.3 ±2.7 5.0 ± 2.6 7.8 ± 2.6 5.2 ± 2.6 
BMD 7.6 ± 1.8 3.4 ± 0.5 10.4 ± 1.7 5.4 ± 0.9 12.0 ± 3.4 4.4 ± 1.5 8.8 ± 3.1 5.6 ± 1.5 
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6.3.1.6 Tampa Scale of Kinesiophobia 
A high level of kinesiophobia (≥ 35) was present in 54% of the MD participants 
overall. There was no difference in severity of kinesiophobia between the FSHD and 
BMD group (p > .05), with mean scores of 36 ± 5 and 36 ± 6 in each group, 
respectively (Figure 6.6).  
 
Figure 6.6:  Scores on the Tampa scale of kinesiophobia for the FSHD and BMD group. Bars 
represent the mean and error bars represent the standard deviation.  
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6.3.1.6 Correlations with QoL 
6.3.1.6.1 Physical Activity  
Physical activity score was not related to QoL in the physical (r = .168, p > .05; Figure 
6.7) or the mental health domain (r = -.191, p > .05; Figure 6.8). 
 Figure 6.7: Physical activity score and physical health QoL in MD participants. 
 
Figure 6.8: Physical activity score and mental health QoL in MD participants. 
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6.3.1.6.2 Depressive Symptoms 
Depression was not related to QoL in the physical health domain (r =-.068, p > .05; 
Figure 6.9). Depression was significantly negatively related to QoL in the mental 
health domain (r= -.706, p ≤ .001; Figure 6.10). 
Figure 6.9: Depression score and physical health QoL in MD participants. 
Figure 6.10: Depression score and mental health QoL in MD participants 
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6.3.1.6.3 Anxiety 
Anxiety was not related to QoL in the physical health domain (r =-.154, p > .05; 
Figure 6.11). Anxiety was significantly negatively related to QoL in the mental health 
domain (r = -.638, p ≤ .001; Figure 6.12). 
Figure 6.11: Trait anxiety and physical health QoL in MD participants. 
Figure 6.12: Trait anxiety and mental health QoL in MD participants. 
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6.3.1.6.4 Self-Esteem  
Self-esteem was not related to QoL in the physical health domain (r =-.096, p > .05; 
Figure 6.13). Self-esteem was significantly positively related to QoL in the mental 
health domain (r = .521, p ≤ .001; Figure 6.14). 
Figure 6.13: Self-esteem score and physical health QoL in MD participants. 
Figure 6.14: Self-esteem score and mental health QoL in MD participants. 
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6.3.1.6.5 Physical Self-Perception (Global) 
Global physical self-perception was not related to QoL in the physical health domain 
(r =-.258, p > .05; Figure 6.15) but it was significantly positively related to QoL in the 
mental health domain (r = .594, p = .007; Figure 6.16). 
Figure 6.15: Physical self-perception profile in the global domain and physical health QoL in 
MD participants. 
Figure 6.16: Physical self-perception profile in the global domain and mental health QoL in 
MD participants 
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6.3.1.6.6 Tampa Scale 
Tampa scores were not related to QoL in the physical health domain (r = .415, p > 
.05; Figure 6.17) or in the mental health domain (r = .042, p = > .05; Figure 6.18). 
 
Figure 6.17: Tampa score and physical health QoL in MD participants 
 
Figure 6.18: Tampa score and mental health QoL in MD participants
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6.3.2 Part B – Effects of RT 
6.3.2.1 Quality of Life 
There was an overall main effect of time on physical health QoL scores (p = .024, 
Ꞃp2 = .21; Figure 6.19), with an observed power of .70. Post hoc analysis revealed 
that physical health QoL scores did not differ between PRE1 and PRE2 (p >.05) but 
significantly increased by 11.5% from PRE1 to POST the RT programme (P =.017) and 
by 10.5% from PRE2 and POST (P =.022).  
There was an overall main effect of time on mental health QoL scores (p = .048, Ꞃp2 
= .17; Figure 6.19), with an observed power of .60. Post hoc analysis revealed that 
mental health QoL scores did not differ between PRE1 and PRE2 (p >.05), but 
significantly increased by 11.6% from PRE1 to POST (p = .038) with no difference 
between PRE2 and POST (p = .071), although the p value was close to the 
significance threshold of < .05.  
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Figure 6.19: Quality of life scores in the physical health and mental health domains at PRE1, 
PRE2, Mid-Train and POST completion of the RT programme. Bars represent the mean and 
error bars represent the standard deviation. * represents a significant difference from PRE1 
and $ represents a significant difference from PRE2. 
6.3.2.2 Depressive Symptoms 
There was a main effect of time on depression (p ≤ .01, Ꞃp2 = .32; Figure 6.20), with 
an observed power of .79. Post hoc analysis showed that depression symptom 
severity decreased between PRE1 and PRE2 by 8.7% (p <.05), and by 26.2% from 
PRE1 to POST (P ≤ .01), with a 19.2% reduction from PRE2 to POST (p =.049). The 
number of participants that scored ≤ 10 (no depressive symptom), between 11-20 
(mild depressive symptoms), between 21-30 (moderate depressive symptoms) are 
≥ 31 (severe depressive symptoms) are presented in Table 6.2. 
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Figure 6.20: Depression scores at PRE1, PRE2, Mid-Train and POST completion of the RT 
programme. Bars represent the mean and error bars represent the standard deviation. * 
represents a significant difference from PRE1 and $ represents a significant difference 
from PRE2. 
 
Table 6.2: Number (percentage) of participants that scored no depressive symptoms (≤ 10, 
mild symptoms (11-20), moderate symptoms (21-30) and severe depressive symptoms (≥ 
31) on the Beck Depression Inventory Scale.  
 PRE1 PRE2 POST 
≤ 10 8 (47) 8 (47) 11 (65) 
11-20 7 (41) 7 (41) 4 (23) 
21-30 1 (6) 1 (6) 2 (12) 
≥ 31 1 (6) 1 (6) 0 (0) 
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6.3.2.3 Trait Anxiety 
There was an overall main effect of time on trait anxiety (p ≤ .01, Ꞃp2 = .27; Figure 
6.21), with an observed power of .83. Post hoc analysis showed that anxiety scores 
did not significantly differ between PRE1 and PRE2 (p ≥.05), but significantly 
decreased by 11.5% from PRE1 to POST (P = .016) and by 11.2% from PRE2 to POST 
(p =.021) completion of the RT programme. 
 
 
Figure 6.21: Trait anxiety scores at PRE1, PRE2, Mid-Train and POST completion of the RT 
programme. Bars represent the mean and error bars represent the standard deviation. * 
represents a significant difference from PRE1 and $ represents a significant difference from 
PRE2. 
 
 
 
 
0
10
20
30
40
50
60
PRE1 PRE2 Mid-Train POST
Tr
ai
t 
A
n
xi
et
y
* $ 
300 
 
6.3.2.4 Self-Esteem 
There was an overall main effect of time on self-esteem (p < .01, Ꞃp2 = .37; Figure 
6.22), with an observed power of .89. Post hoc analysis showed that self-esteem 
scores did not significantly differ between PRE1 and PRE2 (p >.05) but significantly 
increased by 9.6% between PRE2 and POST (p =.036) and increased by 14.0% from 
PRE1 to POST completion of the RT programme (P ≤ .001). 
Figure 6.22: Rosenberg Self-Esteem Scale scores at PRE1, PRE2, Mid-Train and POST 
completion of the RT programme. Bars represent the mean and error bars represent the 
standard deviation. * represents a significant difference from PRE1 and $ represents a 
significant difference from PRE2. 
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6.3.2.5 Physical Self-Perception Profile 
There was an overall main effect of time on global physical self-perception profile 
(p = .023, Ꞃp2 = .22; Figure 6.23), with an observed power of .70. Post hoc analysis 
showed that scores did not significantly differ between PRE1 and PRE2 (p >.05) but 
did increase by 14.5% from PRE2 to POST (p = .023) and by 14.5% between PRE1 
and POST (p = .043). 
 
Figure 6.23: Physical self-worth scores in the global domain at PRE1, PRE2, Mid-Train and 
POST completion of the RT programme. Bars represent the mean and error bars represent 
the standard deviation. * represents a significant difference from PRE1 and $ represents a 
significant difference from PRE2. 
There was no overall main effect of time on sport physical self-perception profile (p 
> .05; Table 6.3).  
There was an overall main effect of time on condition physical self-perception 
profile (p ≤ .001, Ꞃp2 = .43; Table 6.3), with an observed power of .98. Post hoc 
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analysis showed that scores did not differ between PRE1 and PRE2 (p > .05) but were 
increased by 20.8% (p = .004) from PRE1 to POST and by 22.3% (p = .001) from PRE2 
to POST. 
There was an overall main effect of body physical self-perception profile (p = .012; 
Table 6.3). Post hoc analysis showed that scores did not differ between PRE1 and 
PRE2 (p > .05) or between PRE1 and POST (p = .073) but increased by 13.2% (p = 
.014) from PRE2 to POST. 
There was no overall main effect of strength physical self-perception profile (p = 
.101; Table 6.3).  
There was an overall main effect of time on physical self-perception profile score in 
the sport importance domain (p = .004; Table 6.3). Post hoc analysis showed that 
scores decreased by 7.2% between PRE1 and PRE2 (p = .023), increased by 14.2% 
between PRE2 and POST (p = .016) and did not differ between PRE1 and POST (p = 
.102). 
There was no overall main effect of time on physical self-perception profile score in 
the condition importance domain (p = .124, Table 6.3), the body importance domain 
(p = .276, Table 6.3), or the strength importance domain (p = .629, Table 6.3). 
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Table 6.3:  Physical self-perception profile scores in the sport, condition, body and strength domains for PRE1, PRE2, Mid-Train and POST. * represents a 
significant difference from the same variable in PRE1 and $ represents a significant difference from the same variable in PRE2.  S = score, I = Importance. 
 
 
 
 
 
 
 
 
 
 Sport Condition Body Strength 
 S I S I S I S I 
PRE1 9.3 ± 3.1 4.1 ± 1.0 11.1 ± 2.8 5.3 ± 1.3 10.6 ± 3.0 4.7 ± 1.1 8.2 ± 2.7 5.2 ± 1.2 
PRE2 9.2 ± 2.3 3.9 ± 1.2* 11.0 ± 2.3 5.4 ± 1.2 11.1 ± 2.5 4.4 ± 0.8 8.5 ± 2.6 4.9 ± 1.2 
Mid-Train 10.6 ± 2.8 4.1 ± 0.9 12.4 ± 2.1 5.6 ± 1.3 11.8 ± 2.6 4.8 ± 0.7 8.9 ± 2.5 5.4 ± 1.1 
POST 10.4 ± 3.1 4.4 ± 1.0$ 13.4 ± 2.3*$ 5.6 ± 1.4 11.9 ± 3.0$ 5.0 ± 0.7 9.7 ± 3.0 5.3 ± 1.2 
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6.3.2.6 Tampa Scale of Kinesiophobia 
There was no overall main effect of time on Tampa score (p =.738, Ꞃp2 = .04; 
Figure 6.24), with an observed power of .09. 
 
Figure 6.24: Scores from the Tampa Scale of Kinesiophobia at PRE1, PRE2, Mid-Train and 
POST completion of the RT programme. Bars represent the mean and error bars represent 
the standard deviation.  
6.3.2.7 Participant comments 
Throughout the RT programme, numerous participants expressed their feelings 
towards the RT programme. Such conversations were encouraged by the 
investigators but never prompted. Participants regularly spoke about how they felt 
the RT was influencing/had influenced their life. A variety of comments that stood 
out to the investigators are presented in Appendix 4.8. 
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6.4 Discussion 
6.4.1 Part A – MD versus Controls 
Part A of this study examined the mental health and QoL profiles of a group of adults 
with MD (FSHD, BMD and LGMD), compared to an age-matched control group, 
along with the severity of kinesiophobia in adults with FSHD and BMD. In addition, 
relationships between physical activity level, numerous mental health variables and 
QoL were examined. Overall, various aspects of mental health and wellbeing were 
poorer in the MD compared to the control group, including physical QoL, the 
severity of depressive symptoms and physical self-worth, and the severity of 
kinesiophobia was high in both the FSHD and BMD sub-groups. In addition, clear 
associations between depressive symptoms and trait anxiety along with self-esteem 
and physical self-worth were found with QoL in the mental domain. 
As expected, QoL in the physical domain was lower in the MD than control group, 
and QoL in the mental domain was similar between the two groups. This latter result 
is in accordance with previous studies that also reported no difference in the mental 
subscale of QoL, between individuals with Duchenne MD and non-dystrophic 
control populations (Kohler et al., 2005; Pangalila, van den Bos, Bartels, Bergen, 
Kampelmacher, et al., 2015; Elsenbruch et al., 2013). These results reflect the 
disability paradox phenomenon (Albrecht and Devlieger, 1999) where, despite the 
presence of severe disability, perceived QoL in the mental domain is high. This 
phenomenon has not previously been reported in FSHD, BMD and LGMD. In fact, 
the opposite (lower QoL than control groups) has previously been established in a 
group of children and adults with Duchenne MD, BMD and LGMD (Grootenhuis et 
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al., 2007) and adults with FSHD (Winter et al., 2010; Padua et al., 2009). Based on 
the previous research, we initially thought that the disability paradox may be 
exclusive to the Duchenne form of MD, perhaps due to the earlier onset of disease 
in this form. However, this study demonstrates that ambulatory adults with FSHD, 
BMD and LGMD also demonstrate a high perceived QoL in the mental domain. In 
order to understand why some individuals with these types of MD perceive a high 
QoL in the mental domain whilst other do not, the factors that mediate QoL were 
also examined in this study. 
No association between physical activity, kinesiophobia or any aspect of mental 
health with QoL in the physical domain was found in this study. Conversely, negative 
associations between QoL in the mental domain with the severity of depressive 
symptoms and anxiety, and positive associations between QoL in the mental 
domain with self-esteem and physical self-worth, were found. Whilst it has 
previously been established that numerous disease-specific parameters are related 
to QoL in various forms of MD, such as current age (Uzark et al., 2012), disease 
severity (Landfeldt et al., 2016; Padua et al., 2009; Otto et al., 2017; Peric et al., 
2018) and age at disease onset (Peric et al., 2018), these variables are not open to 
treatment or intervention. This is the first study to demonstrate an association 
between QoL and self-esteem, physical self-worth and anxiety in FSHD, BMD and 
LGMD, and between QoL and the severity of depressive symptoms in FSHD and 
BMD. Importantly, these variables may be susceptible to change through treatment 
or interventions such as RT, and they likely contribute towards the contradicting 
research findings surrounding QoL in the mental domain of individuals with MD.  
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The severity of trait anxiety did not differ between the study’s participant groups, 
but the severity of depressive symptoms was significantly higher in the MD group 
than the control group, by 14%. In addition, 36.4% of the MD population exhibited 
mild depressive symptoms, with 4.5% and 4.5% exhibiting moderate and severe 
depressive symptoms. The burden of MD itself may cause enough stress to prompt 
or exacerbate depressive symptoms, or conversely, there may be a joint pathway 
between the pathogenesis of MD and depressive symptoms. Similarly, higher 
frequencies of moderate depression have previously been reported in adults with 
Duchenne MD compared to a control population (18% versus 8%), but to a greater 
extent than within the current study (Pangalila, van den Bos, Bartels, Bergen, Stam, 
et al., 2015). This may be due to the more severe presentation of Duchenne MD 
than FSHD, BMD and LGMD, or there could be a direct link between the 
pathophysiology of Duchenne MD and symptoms of depression, which is either less 
pronounced or not present in FSHD, BMD and LGMD.  
Global self-esteem did not differ between the MD and the control group in the 
current study. This agrees with Bertrand et al. (2015), who also assessed self-esteem 
using the Rosenberg Self-esteem Scale in adults with Myotonic MD, and reported 
no difference compared to normative reference data. However, this finding differs 
to that of Miladi et al. (1999), who subjectively scored lower levels of self-esteem in 
children with LGMD compared to a control group, as a consequence of their 
response to projective cards depicting real life situations. This disparity in findings 
could be related to the different measures of self-esteem utilised or the difference 
in participant age between the studies, as both studies that reported no difference 
between the populations utilised The Rosenberg Self-Esteem Scale and were 
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conducted in an adult MD population. It is well known that self-esteem typically 
increases from adolescence to adulthood (Huang, 2010). Therefore, self-esteem 
may be unaffected in adults with MD, but children with MD may exhibit lower self-
esteem compared to control children due to an already vulnerable self-esteem. On 
the other hand, measures of global self-esteem may not provide sufficient detail 
into the self-worth of individuals with MD. Self-esteem is a multidimensional 
construct (Raustorp et al., 2005), said to be influenced by various domain levels of 
self-worth, such as physical, academic, cognitive and social. Thus, high self-worth in 
some areas may conceal limitations in the self-worth in other areas.  
This is the first study to demonstrate that despite no difference in global self-esteem 
between the populations, physical self-worth was reduced in individuals with MD 
compared to an age-matched control group. Specifically, lower physical self-worth 
was found in the sport competence domain, physical condition domain and physical 
strength domain, with no differences found in the body attractiveness domain or 
the importance of any of those domains. Thus, the MD group exhibited lower 
perceptions of the self in these areas, but they did not place any higher importance 
on these areas. This information may be useful when designing interventions aimed 
at improving physical self-worth in this population. Such interventions could focus 
either on increasing self-perceptions in each physical domain, or on decreasing the 
level of importance placed on each domain. However, given that the importance 
placed on each physical domain was no higher than the control group in the current 
study, it would be far more advantageous to target physical self-perceptions over 
importance in this population.  
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Before now, kinesiophobia had not been examined in adults with FSHD, BMD or 
LGMD, despite evidence that these individuals frequently experience body pain 
(Jacques et al., 2019), and the knowledge that other chronic pain populations 
consistently exhibit high levels of kinesiophobia  (Ishak et al., 2017; Bränström and 
Fahlström, 2008; Demirbüken et al., 2015; Svensson et al., 2011). The Tampa Scale 
of Kinesiophobia revealed that on the whole, kinesiophobia was high in this 
population (FSHD and BMD), with the mean score topping the cut-off value of 35. 
In addition, 54% of participants scored equal to or above the cut-off value for a high 
kinesiophobia score (35). This information is important as high levels of 
kinesiophobia may have important implications for the management and treatment 
of MD. For example, fear of movement may influence a person’s engagement in 
physical activity, it may have an effect on adherence to exercise programmes and it 
may also influence compliance with physiotherapy treatment.  
Overall, the severity of depressive symptoms and level of physical self-worth were 
both afflicted in this population of adults with FSHD, BMD and LGMD. This poor 
mental health in comparison to non-dystrophic control adults may have important 
Implications for the management of MD and was shown to be directly associated 
with QoL in this population. These findings add to the pre-existing research that 
demonstrates higher frequencies of poor mental health in individuals with physical 
diseases (Moussavi et al., 2007). Taken together, this evidence suggests that mental 
health treatment pathways tailored specifically for individuals with physical 
conditions, including MD, would be advantageous. The regular mental health 
treatment route, alongside individuals with no physical condition, may not be 
available or specific enough for individuals with MD. It is clear that parameters of 
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mental health, including the severity of depressive symptoms and anxiety and the 
level of self-esteem and physical self-worth directly influence perceived QoL in 
adults with FSHD, BMD and LGMD.   
6.4.2 Part B – Effects of RT 
Part B of this study examined the influence of a 12-week, twice a week, RT 
programme on mental health and wellbeing in a group of ambulatory adults with 
MD (FSHD, BMD and LGMD). Beneficial effects of the RT programme were evident 
across various areas of mental health and wellbeing, including QoL, the severity of 
depressive symptoms and trait anxiety and levels of self-esteem and physical self-
worth.  
The improvement in QoL in both the physical and mental domain following 
completion of the RT programme, in conjunction with stable values during the 12-
week control period, is supportive of RT in adults with MD. This finding is in 
opposition to Kierkegaard et al. (2011), who reported no change to QoL score post 
12-weeks of RT in adults with Myotonic MD. This discrepancy may be due to a 
number of factors including the type of MD studied. It is well accepted that 
Myotonic MD differs vastly from the other 8 types of MD because it affects nearly 
every system in the body (Emery, 2002). Alternatively, the discrepancy  may be due 
to the relatively low level of adherence (75%) reported by Kierkegaard et al. (2011), 
compared to the high level of adherence achieved in the current study.  
In the current study, both depressive and trait anxiety symptoms were significantly 
improved after completion of RT. The severity of trait anxiety was reduced by 11.2% 
after the RT programme, in conjunction with stable values during the 12-week 
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control period. This concurs with previous studies that have demonstrated a 
beneficial effect of RT on anxiety in other pathological populations, such as older 
adults, cancer patients and osteoporotic patients (O' Connor et al., 2010).  
The severity of depressive symptoms was reduced by 26.2% from PRE1 to POST 
competition of the RT programme. There was, however, an 8.7% reduction in 
symptoms of depression within the initial 12-week control period, but it is 
important to note that an additional 19.2% reduction in depressive symptom 
severity was evident between PRE2 and POST. Hence, it appears that depressive 
symptoms were initially reduced purely by being part of the study itself, but 
depressive symptoms were reduced by a far greater amount after completion of the 
RT programme. Interestingly, the average depression symptom score immediately 
prior to the start of the RT programme (PRE2) was 11.3, which, according to the 
Beck Depression Inventory classification system, sits within the mild depressive 
symptom category. After completion of the RT programme, the average score was 
reduced to 9.1, which sits within the normal category reflecting minimal to zero 
depressive symptoms. The proportion of participants situated in the normal 
depressive symptom category increased from 47.1% to 64.7% after the RT 
programme. Overall, it is clear that the RT programme was highly beneficial towards 
reducing the severity of depressive symptoms in this population. This finding is in 
line with previous studies that have reported a reduction in the severity of 
depression with RT in other pathological populations, such as fibromyalgia (Jones et 
al., 2002; Hakkinen et al., 2001), spinal cord injury (Hicks et al., 2003) and 
osteoarthritis (O' Reilly et al., 1999) and those studies in older adults that exhibit 
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adequate adherence to the RT programme (Cassilhas et al., 2007; Timonen et al., 
2002; Singh et al., 1997). 
Concerning self-esteem and physical self-worth, the RT programme had an overall 
positive influence on this population, which agrees with previous investigation into 
the effect of RT on self-esteem and physical self-worth in other clinical populations 
(Spence et al., 2005; Megakli et al., 2015). In this study, global self-esteem was 
stable during the initial control period, followed by a 9.6% improvement after 
completion of the RT programme. Interestingly, physical self-worth, as measured by 
the global domain of The Physical Self-Perception Profile, was also stable between 
the initial control period, with a greater increase of 14.5% after completion of the 
RT programme. This increase stemmed from a 22.3% and 13.2% increase in self-
perceptions of physical condition and body attractiveness, respectively. In addition, 
the importance placed on each of these sub-domains of physical self-worth was 
unchanged, highlighting that physical self-perceptions in these areas were improved 
but the relative importance placed on these domains remained the same. This led 
to an overall improvement in physical self-worth. On the other hand, the 
importance placed on the sport competence domain increased by 14.2%, with no 
change to the self-perception of this domain. Thus, perceptions of sport 
competence were unchanged, but participants perceived this domain with a higher 
importance after completion of the RT programme. Independently, this finding 
would negatively influence physical self-worth, but in conjunction with the 
increases found in self-perceptions of physical condition and body attractiveness, 
the overall effect of RT on physical self-worth was positive. It not clear why the 
importance placed on the sport competence domain increased, but it was perhaps 
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the result of being exposed to an active environment whilst taking part in the RT 
programme. In any case, the current author does not perceive this increase with 
negative connotations, as in conjunction with the improvements in physical self-
perceptions in the other domains, it may actually contribute to the continuation of 
RT long-term, given that participants now place more importance on an area related 
to sport.  
There was no overall influence of RT on fear of movement, measured via the 
severity of kinesiophobia, which is somewhat surprising given the highly positive 
changes in other areas of mental health and wellbeing found in the current study. 
The direction of change in kinesiophobia did show a reduction but the observed 
power for this comparison was exceptionally low (.09) due to analysis of data in a 
subgroup of the participants only. Therefore, this finding should be regarded 
circumspectly. This is an important limitation within the current study and future 
research should seek to investigate the influence of RT on kinesiophobia in a larger 
sample size with adequate study power.  
It is important to note the limitations of the current study. Firstly, the influence of 
the RT programme was assessed in a mixed group of adults with FSHD, BMD and 
LGMD, which may have concealed differences between the different types of MD. 
In addition, there were potential ceiling effects for some of the variables within the 
present study. For example, although the severity of depressive symptoms were 
greater than in the control group, only 2 participants were situated in the moderate 
or severe category for depressive symptoms. Therefore, a different response to RT 
may occur in a MD population with more severe depressive symptoms. Finally, a 
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major limitation of the current study is that it provides no insight into whether the 
improvements in mental health that were found remained following completion of 
the study. Numerous participants did continue to follow the RT programme upon 
completion of the study, at least once a week, but as the RT programme was 
staggered it was logistically not possible to include follow-up tests within the 
current study. 
The current results support the inclusion of a RT programme in the management 
and treatment of ambulatory adults with FSHD, BMD and LGMD. It is extremely 
disappointing that RT has previously been discouraged in these populations, as the 
clinical implications of the current findings are that RT is an innovative and 
alternative approach to improving mental health and wellbeing in adults with MD. 
From a holistic perspective, RT is an effective tool to enhance the overall health of 
adults living with MD. In future, researchers should seek to understand the 
mechanisms behind such improvements in mental health in these populations. In 
addition, future research should explore whether the benefits are maintained in the 
long-term and/or continue to improve with continued training. Furthermore, with 
examination of a larger sample size it would be advantageous to examine whether 
certain subtypes of MD differ in their response to RT.  
In conclusion, this study highlights that poorer mental health is evident in adults 
with FSHD, BMD and LGMD, compared to age-matched control adults, shown 
specifically by higher severity of depressive symptoms and a lower level of physical 
self-worth. Furthermore, these parameters were directly related to the perceived 
QoL in these individuals. This is the first study to demonstrate positive effects of a 
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12-week RT programme on mental health and QoL in a population of adults living 
with MD (FSHD, LGMD and BMD). These findings highlight that RT is a viable option 
within the management of MD in adults, particularly where mental health and QoL 
are low. It is imperative that a change in the outdated perspective, that RT should 
not be encouraged in individuals with MD, takes place. These findings go some way 
towards helping to catalyse that change.
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Chapter 7 
Epilogue 
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7.1 Summary of Findings 
7.1.1 Muscle Strength 
The first data chapter (Chapter 3) within this thesis aimed to compare lower-limb 
muscle strength and physical function, between adults with FSHD, BMD and LGMD, 
to matched control adults. The data showed varying severities of muscle weakness 
across the MDs in most of the lower-limb muscle groups that were tested. These 
strength deficits paralleled the pre-existing clinical classifications of weakness 
distribution patterns in these MD groups, although caution was advised when 
interpreting the areas of muscle weakness that were highlighted as predominant by 
clinical classifications. This is because muscle groups that were not categorised as 
areas of predominant weakness based on the clinical classifications were often still 
severely weak in comparison to the matched control group.  
The second aim of Chapter 3 was to examine the effect of a 12-week lower-limb RT 
programme on muscle strength and physical function, in a combined group of adults 
with MD (FSHD, BMD and LGMD). Importantly, RT improved MVC torque in six of 
the eight muscle groups that were assessed, and timed performances on the 
functional tests were improved across the board. In addition, comfortable walking 
speed increased which was demonstrated by an increase in the distance walked 
during a 6-minute walk test. Thus, despite previous medical concerns, this RT 
programme was highly beneficial to muscle strength and physical function in the 
individuals involved. The success of the RT programme within this study compared 
to the lack of an effect found in previous investigations is most likely a result of the 
supervision in our training programme, the complete lower-body nature of our 
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training programme as opposed to training one or two individual muscle groups in 
previous studies, and the individualised nature of our RT programme. This study 
offers the first convincing evidence that RT increases muscle strength in adults with 
these types of MD.  
7.1.2 Gait 
Chapters 4 and 5 of this thesis aimed to compare gait in adults with FSHD, BMD and 
LGMD with age-matched control adults. Chapter 4 described the kinematic 
abnormalities of gait in these groups of MD, and Chapter 5 described the kinetic 
abnormalities of gait in these groups of MD.  
Chapter 4 highlighted numerous kinematic abnormalities at the pelvis, hip, knee and 
ankle joint in each of the MD groups. These abnormalities were evident in the 
sagittal, coronal and transverse planes. Numerous abnormalities were found in all 
of the MD groups, including slower gait speed, reduced stride length, reduced 
cadence, excessive external pelvic rotation and limited ankle dorsiflexion at initial 
contact and during the swing phase. However, other kinematic abnormalities were 
isolated to one or two of the individual MD groups, such as a greater anterior pelvic 
tilt and limited hip extension in stance and at toe-off in the FSHD and BMD groups, 
and greater hip abduction in swing and a lack of knee flexion or hyperextension of 
the knee joint in the BMD and LGMD groups. Importantly, the oxygen cost of gait 
was heightened two-fold in the LGMD group.  
Chapter 5 highlighted numerous kinetic abnormalities at the hip, knee and ankle 
joint along with differences in ground reaction forces in the MD groups compared 
to controls. Several peak vertical and anterior-posterior ground reaction forces 
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were smaller in one or all of the MD groups, including peak vertical ground reaction 
force in loading in all MD groups, peak vertical force in terminal stance in LGMD and 
peak propulsive force in LGMD. Whereas peak lateral force in terminal stance was 
greater in the BMD group than controls. Kinetic abnormalities in external joint 
moments included smaller hip flexor moments during stance in BMD and LGMD, 
smaller hip extensor moments during late stance in FSHD and LGMD, smaller hip 
adductor moments during early stance in FSHD and LGMD, reduced knee flexor 
moments in loading in all MD groups, greater knee extensor moments in mid-stance 
in FSHD and LGMD and a lack of a plantarflexor moment during loading in all MD 
groups. Finally, deviations in several joint powers were noted in the MD groups 
compared to controls, which specifically highlighted a reduced capacity to generate 
propulsion during late stance in all MD groups. These included a smaller maximum 
hip flexor generation power in late swing, a smaller maximum knee extensor 
generation power and a smaller maximum plantarflexion generation power in late 
stance. 
The second aim of Chapter 4 and Chapter 5 was to examine the effect of a 12-week 
lower limb RT programme on the kinematics and kinetics of gait in a combined 
group of adults with MD (FSHD, BMD and LGMD). These studies are the first to 
assess the effects of RT on gait in a MD population and, importantly, the findings 
reveal that RT is a highly beneficial technique to improve gait in these individuals.  
Kinematic improvements included increased gait speed, stride length and cadence, 
increased knee flexion at initial contact and during the loading response, increased 
knee flexion during the swing phase, a reduction in the severity of hyperextension 
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during the stance phase, increased dorsiflexion at initial contact and during the 
swing phase and increased ankle inversion at initial contact and eversion at toe-off. 
Moreover, the improvements found in those individuals with more severe gait 
abnormalities, including hyperextension of the knee and limited dorsiflexion in the 
swing phase, were even larger.  
Kinetic adaptations showed that RT improved several gait abnormalities and 
enhanced propulsive capacity in MD, shown specifically by an increase in the 
maximum external knee flexor moment during stance, a reduction in the excessive 
external knee extensor moment during stance, an increase in the maximum 
plantarflexion moment in early stance and an increase in peak plantarflexor power 
generation during late stance.   
The adaptations discussed above contribute towards the faster gait speed and likely 
contribute towards reduce stress at the joints and reduced fall risk in individuals 
with MD, all of which are highly desirable towards maintaining ambulation, physical 
function and physical independence. Although the oxygen cost of gait was not 
improved in this population post completion of the RT programme, several 
suggestions were provided that may aid future studies with the aim of improving 
this aspect of gait. 
7.1.3 Mental Health  
Chapter 6 of this thesis aimed to compare the mental health and perceived QoL of 
adults with MD (FSHD, BMD and LGMD). The findings highlight that poorer mental 
health is evident in adults with MD (FSHD, BMD and LGMD) compared to age-
matched control adults. This was shown specifically by a higher severity of 
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depressive symptoms and a lower level of physical self-worth in the MD compared 
to the control group. Furthermore, these parameters were directly related to the 
perceived QoL in these individuals.  
This study is novel in the investigation of the effect of a 12-week lower-limb RT 
programme on variables of mental health and QoL in MD. Positive effects of the RT 
programme on mental health and QoL were found in a population of adults living 
with MD (FSHD, LGMD and BMD). Specifically, the severity of depressive symptoms 
and anxiety were reduced, and self-esteem, physical self-worth and perceived QoL 
were improved after completion of the RT programme, compared to stable values 
during the 12-week control period. These findings highlight that RT is a viable option 
within the management of MD in adults, particularly where mental health and QoL 
are low. 
7.1.4 Global Summary 
Muscular, gait and mental health impairments were described in adults with FSHD, 
BMD and LGMD. Importantly, RT was found to be highly feasible and beneficial 
towards managing many of these limitations in adults living with MD. Not only did 
RT positively increase lower limb muscle strength, but the benefits stretched 
beyond this into areas of gait, mental health and QoL. Previous medical 
apprehension towards RT in adults living with FSHD, BMD and LGMD are 
unsubstantiated and in fact, evidence from this thesis strongly contradicts the 
concerns that RT should be avoided, at least in adults with these types of MD. The 
key message from these findings is that RT is an innovative means of improving 
muscle strength, gait and mental health in ambulatory adults with MD. In addition, 
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supplementary to the quantitative findings of this study, the anecdotal outcomes 
from this study truly encapsulate the positive impact that the RT programme had 
on this group of individuals. As demonstrated in Appendix 4.8, the unprompted 
statements from participants surrounding their participation in the RT programme 
are extremely encouraging, such as “I feel more confident when I am moving around 
now”, “I am finding it much easier to kick the ball for my dog”,  “It was the highlight 
of my year” , “I tripped but was able to stop myself from falling over” “I continued 
training after completing the programme and went on to complete my first disability 
triathlon” and “It has given me that boost that I needed to be more physically 
active”.  
7.2 Clinical Implications 
The findings from this thesis contribute towards the understanding of muscle 
strength deficits, gait abnormalities and mental health in adults with FSHD, BMD 
and LGMD. In addition, the findings enhance understanding of the effects of RT in 
adults with FSHD, BMD and LGMD. As a result, a number of key clinical implications 
were identified.  
Deficits in lower-body muscle strength and physical function compared to a non-
dystrophic age-matched control group were quantified in adults with FSHD, BMD 
and LGMD. These data contribute to the currently under-reported, but clinically 
described, physiological and functional understanding of FSHD, BMD and LGMD, 
and provide some support for the pre-existing clinical classifications of muscle 
weakness distribution in these populations. Importantly though, these data provide 
greater detail of muscle weakness than the pre-existing clinical descriptions of 
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weakness distribution, through the assessment of individual muscle groups. The 
findings demonstrate that clinicians should interpret clinical descriptions of 
weakness distribution in FSHD, BMD and LGMD cautiously, as muscles not 
categorised as regions of predominant weakness in clinical descriptions were often 
still severely weak compared to control adults.   
Kinematic and kinetic abnormalities of gait compared to control adults were 
identified in FSHD, BMD and LGMD. The clinical implications of these abnormalities 
are extensive, including increased risk of pain, excessive forces at the joints, 
increased fall and injury risk, increased fatigue and psychological implications. For 
example, the excessive anterior pelvic tilt that was identified may result in low back 
pain through greater stresses and loads placed on the spine, hyperextension of the 
knee likely leads to pain and damage through excessive compressive forces at the 
structures of the knee joint and the presence of foot drop in the swing phase likely 
heightens the risk of falls in these MD groups. Notably, all of these primary 
implications have the potential to cause additional abnormalities and a domino 
effect. Thus, participation in strength training and a specialised programme of 
physiotherapy should be a crucial element within the management of these MD 
conditions. Furthermore, in advanced abnormalities such as severe foot drop, the 
use of orthotic devices may be appropriate to provide further support towards the 
maintenance of safe ambulation in MD.  
The examination of psychological variables in adults with MD highlight poor mental 
health compared to age-matched control adults. The severity of depressive 
symptoms and level of physical self-worth were both afflicted in this population of 
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adults with MD and were directly associated with perceived quality of life. These 
findings have direct implications for the care of, and service delivery to adults living 
with MD. Mental health treatment should form a key aspect of the management of 
MD and mental health pathways tailored specifically for adults living with MD would 
be advantageous. The regular mental health treatment route, alongside individuals 
with no physical condition, may not be suitable for individuals with physical 
disabilities such as MD. 
The findings within this thesis demonstrate highly beneficial effects of a 12-week 
lower-body RT programme in a combined group of adults with FSHD, BMD and 
LGMD. RT is an effective tool that increased lower-limb muscle strength and 
physical function, improved walking ability through an increase in gait speed and a 
reduction in various kinematic and kinetic abnormalities, and improved mental 
health and quality of life through a reduction in the severity of depressive symptoms 
and anxiety and an increase in self-esteem, physical self-worth and perceived 
quality of life. The clinical implications of these findings are that RT is an innovative 
approach to maintaining or improving physical and mental independence in 
individuals with MD, and should therefore be considered within the management 
of MD. From a holistic perspective, RT is a practical treatment that can enhance the 
overall health of adults living with MD.  
Historically, health care professions were apprehensive about RT in individuals with 
MD. Some individuals were strongly advised not to participate in RT and other 
activities that may physically exert their muscles, whilst others were discouraged 
from doing so but were not categorically directed not to participate in such 
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activities. To date, although physical activity is now generally accepted as beneficial 
in MD, whether RT is harmful, null or beneficial in individuals with MD remains 
ambiguous. However, the findings within this thesis provide evidence that RT is 
beneficial in adults with MD and the clinical implications of this are that supervised 
RT should be actively promoted in individuals with MD.  
Further to the benefits of RT to participants themselves, the RT programme 
completed within this thesis had implications for the physiotherapy department at 
the Neuromuscular Centre in terms of time and resources. All participants who 
underwent the 12-week RT programme became knowledgeable about their training 
programme overtime and eventually became capable of continuing their training in 
a semi-supervised manner, once their participation in this study came to an end. For 
the physiotherapy department this brought about a welcomed easement, freeing 
up valuable time and resources to be expended elsewhere in the department. For 
participants, they gained greater autonomy in managing their condition.  
7.3 Limitations 
Inevitably, this thesis has some key limitations that should be considered. The 
individual studies have some limitations that are specific to that study, but the key 
limitations of this thesis are shared between each study.  
The heterogeneous nature of the MD conditions, particularly LGMD, is visible within 
the data by the often-large standard deviation. This large standard deviation likely 
contributed towards the low power in some of the kinetic variables within Chapter 
6, and therefore may have concealed additional differences between the groups or 
as a function of the RT programme. However, variance within the MD groups is 
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typical of the nature of these conditions and therefore the groups within this study 
represent these MDs well.  
A second important limitation of this thesis is that three different types, although 
functionally similar, of MD were combined to examine the effect of the RT 
programme. The consequence of this is that the effect of RT cannot be separated 
between the different types of MD. For example, differences in the magnitude of 
effects may exist between the MDs. However, combining the participant groups 
provided sufficient power for the majority of dependant variables. Ideally, a greater 
sample size would have been utilised to enable analysis of the effect of RT on FSHD, 
BMD and LGMD individually, but this was not logistically feasible. The importance 
of establishing the potential role of RT in ambulatory adults with MD outweighed 
this limitation. Thus, it was deemed appropriate to combine the participants groups 
in order to do so.  
A third key limitation of this thesis was that no follow-up analysis was completed. 
The implication of this is that no knowledge of whether the training effects 
remained, continued or diminished post completion of the RT programme was 
captured. It may have been insightful to incorporate some long-term follow up of 
the participants within these studies, particularly as approximately ten of the 17 
participants that completed the RT programme continue to undertake RT at least 
once a week. However, a long-term follow-up to these studies was not feasible 
within the time frame.   
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7.4 Future Research Directions 
The outcomes of this thesis have prompted several future research directions that 
would further add to the understanding of physical and mental challenges in MD, 
and to the role of RT in individuals with MD. 
A clear outcome from this thesis is a greater knowledge of both the physical and 
mental benefits of RT in adults living with FSHD, BMD and LGMD. This thesis 
provides the first convincing evidence that RT increases muscle strength in adults 
with these conditions. Future studies should aim to establish the influence of RT 
programme frequency and intensity. It would be advantageous to determine the 
optimal frequency and intensity of RT in FSHD, BMD and LGMD, as understandably, 
this may differ to that of non-dystrophic individuals. Although this thesis provides 
evidence of a positive effect of RT in MD, an important question remains; how much 
RT is too much in these MD conditions? To enable health professionals to give 
detailed advice regarding the frequency and intensity of RT to individuals with MD, 
future research should seek to establish thresholds between which RT is beneficial.  
A second future research direction that emanated from the outcomes of this thesis 
is the association between the identified gait abnormalities and muscle strength. 
Such associations were not directly assessed within this thesis, but they were 
proposed numerous times. Of course, it is possible that other factors contributed 
towards, or were responsible for the gait adaptations found within Chapters 5 and 
6. Therefore, it would be advantageous for future studies to examine these 
potential associations, as this would provide greater direction for the design of 
future RT programmes in MD.     
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Numerous gait adaptations from the RT programme were found in this thesis, but 
no change in the oxygen cost of gait was found. This result prompted an exciting 
future research direction. Studies should continue to investigate the influence of RT 
programmes on gait in MD, with the addition of a gait re-training element. This is 
suggested as although numerous gait adaptations were found, gait re-training 
alongside RT may produce greater or even additional adaptations. Importantly, the 
inclusion of a gait re-training element may enable researchers to prompt gait 
adaptations that lead to a lower cost of gait in MD.  
An important finding within this thesis was the greater severity of depressive 
symptoms and lower levels of physical self-worth within adults with MD, compared 
to the age-matched control adults. Research studies that utilise qualitative methods 
would enable a greater, more in-depth analysis of mental health and wellbeing in 
MD. In addition, qualitative investigation into the effects of RT in individuals with 
MD may provide a reference or insight into the mechanisms behind the improved 
mental health that was found within this thesis.  
Finally, the positive impact of RT in adults with MD that is demonstrated by this 
thesis promotes RT as an evolving area of research in MD. The findings incite a 
plethora of research questions, such as how the proximity between participation in 
RT and the onset of the condition influences the overall effect. In addition, the 
knowledge that RT does improve muscle strength in FSHD, BMD and LGMD opens 
up new avenues that involve enabling individuals with MD to partake in RT 
programmes more easily. One avenue to do this involves eliminating some of the 
barriers to RT that are experienced by individuals with MD. For example, the design 
329 
 
of accessible RT equipment that provides the user with adjustable levels of support 
and/or assistance whilst completing exercises, such as the squat bed that was 
designed and used in this thesis. 
7.5 Global Conclusion 
It is overwhelmingly evident that individuals with FSHD, BMD and LGMD display 
strength deficits of varying severity and distributions in the lower-limb muscles. In 
addition, gait is slower, and a multiplicity of kinematic and kinetic abnormalities 
exist throughout the gait cycle. Furthermore, mental health and wellbeing is 
compromised in adults with MD, particularly in the areas of depressive symptoms 
and physical self-worth. The findings from this thesis reveal persuasively the 
effectiveness of RT as an intervention, to both improve and manage the debilitating 
physical and mental limitations experienced daily in adults living with MD. RT is 
shown to be highly beneficial; it is economical; it is most certainly value for money 
in terms of time and resources, and it is an innovative treatment option. That is, it 
enables adults with MD to actively partake in improving their physical and mental 
health and is of itself therapeutic and beneficial towards maintaining independence. 
It is therefore imperative that the outdated view, that RT should not be encouraged 
in individuals with MD, is changed. The findings of this thesis go some way towards 
helping to inform and catalyse that change.  
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Abstract Submission 
Gait & Posture, Volume 65, Supplement 1 (2018) pp. 166-167 
Is progressive resistance training an effective intervention in adults with Muscular 
Dystrophy? 
D. O’Dowd*, C. Morse, E. Bostock, D. Smith and C. Payton 
Manchester Metropolitan University 
 
Introduction 
Muscular dystrophies (MD) are inherited disorders with condition specific 
manifestations, yet they are all characterised by progressive muscle deterioration. 
This deterioration results in weakness, pain and impaired walking or potentially a loss 
of ability to walk and with it, independence. Those who remain ambulatory walk 
slower and experience debilitating and painful gait characteristics (D'Angelo et al., 
2009), one of the most apparent is knee hyperextension. Resistance training (RT) has 
previously been shown to increase six-minute walk (6MW) distance in adults with 
Myotonic MD (Gianola et al., 2013). However, the detailed gait improvements that 
may accompany the increase in walking speed with RT are yet to be reported. 
Research Question 
Does RT improve walking capacity and gait kinematics, specifically knee 
hyperextension, in adults with Limb-girdle and Facioscapulohumeral MD? 
Methods 
 Seven adults with MD (2 with Facioscapulohumeral and 5 with Limb-girdle MD; 44.7 
± 13.1 yrs.) completed testing immediately before (PRE1) and after (PRE2) a 12-week 
control period, then after completion of a 12-week (two sessions per week) supervised 
RT programme (POST). Gait analysis was performed at a self-selected pace, using a 3D 
motion capture system (VICON) with AMTI force plates, from which spatial and 
temporal parameters and sagittal plane knee joint kinematics were extracted. 
Additionally, the 6MW test was completed. For comparison, knee angle data are 
presented from four age-matched controls without MD. 
Results 
Walking speed and 6MW distance significantly increased from PRE1 and PRE2 to 
POST, and stride length from PRE1 to POST (Table 1). A significant reduction in 
minimum knee angle during the stance phase (PRE1: -8.8 ± 11.3°, PRE2: -10.4 ± 12.3°, 
POST: -5.4 ± 8.8°), swing phase (PRE1: -1.6 ± 3.8°, PRE2: -3.5 ± 4.2°, POST: 1.3 ± 3.7°) 
and at heel strike (PRE1: -1.4 ± 4.6°, PRE2: -2.5 ± 5.7°, POST: .98 ± 2.9°) was found, 
POST RE compared to PRE1 and PRE2 (Figure 1).  
Discussion 
 These results offer support for RT as a treatment approach in adults with Limb-girdle 
and Facioscapulohumeral MD. RT improved walking performance and the severity of 
knee hyperextension whilst walking. This reduction in excessive motion at the knee 
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may reduce the risk of damage to the knee joint and surrounding ligamentous 
structures. Future work will consider additional gait deviations to help promote the 
benefits of RT in MD. The clinical implications of these findings are that RT is an 
innovative approach to maintaining or improving physical independence in 
individuals with MD.  
Table 1: Mean ± SD spatial and temporal walking parameters for MD participants at PRE1, 
PRE2 and POST completion of the RT programme. Significant differences from PRE1 and 
PRE2 are denoted by * and #, respectively. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Mean knee flexion (+) and extension (-) angle during the gait cycle in individuals 
with MD at PRE1 (dotted line), PRE2 (dashed line) and POST (line) completion of RT. The grey 
band (± 1 standard deviation) represents control group data. On the x-axis, 0% represents 
heel strike and 100% the following ipsilateral heel strike. 
 
PRE1 PRE2 POST % Change 
 (PRE2-POST) 
Walking speed (m/s) 0.81 ± 0.2 0.81 ± 0.2 0.87 ± 0.2*# +7.4 
Stride length (m) 1.17 ± 0.1 1.20 ± 0.1 1.27 ± 0.1* +5.8 
Stride width (m) 0.16 ± 0.04 0.14 ± 0.02 0.14 ± 0.02 0 
Cadence (s/m) 83 ± 16.5 81 ± 16.0 83 ± 15.5 +2.5 
6MWD (m) 261 ± 88 271 ± 75 292 ± 70*# +7.7 
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Appendix 2 
Plug in Gait model 
 & 
Resistance Training 
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A 2.1 Vicon Plug in Gait  marker set and descriptions 
Figure A2.1 and Figure A2.2 (Vicon, 2010) provide a visual example of the position 
of the 39 markers accroding to the Vicon plug in gait marker set. Table A2.1 provides 
written descriptions of the marker positions on the body, in accordance with the 
Vicon plug in gait model (Vicon, 2010).  
 
Figure  A2.1:  Anterior view of the Vicon plug in gait marker set, taken from Vicon 
(2010). 
 
 
Figure  A2.2: Posterior view of the Vicon plug in gait marker set, taken from Vicon 
(2010). 
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A 2.2 - Consistent Resistance Exercises 
Table A.2.2 describes the six consistent elements of the exercise programme for all participants. Equipment used for the cardiovascular warm-
up was interchangeable depending on preference and a mixture of the Wi-Fit balance games were completed for between 5-10 minutes.  The 
step-up exercise was completed at various progressive heights, ranging between 3 cm, 6 cm, 9 cm, 12 cm and 15 cm above the ground. One 
variation of the squat, knee flexion and knee extension exercise was completed based on the strength and physical function of the participant.   
Table A.2.2: Description of the six exercises that were consistently included in all training programmes, along with the specific variations of each 
exercise and the progressive variations in training load. 
Exercise Variations Description Training Load Progression 
Aerobic Warm-up    
 Cycle 
Ergometer 
Rowing 
Machine 
Seated cross-
trainer 
Five minutes of cardiovascular exercise was performed at a 
moderate intensity 
• Level between 12-14 on 
the Borg Rating of 
Perceived Exertion Scale 
Wi-Fit Balance Games 
 
 
 
 
 Table Tilt   With the feet placed on a balance board, participants were 
required to move their centre of mass in order to tilt marbles on 
top of a moving platform into holes.  
Parallel bars were placed either side of the participant for safety 
but they were encouraged not to use them unless required. 
 
• Beginner 
• Advanced 
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 Downhill 
Skiing 
With the feet placed on a balance board, participants were 
required to move their centre of mass between the gates of a 
skiing slalom course.  
  
 Football 
Heading 
With the feet placed on a balance board, participants were 
required to move their centre of mass in order to head footballs 
coming from different directions. 
 
 
Step-up     
 Exercise Block  
 
 
 
With the feet positioned hip distance apart, participants stepped 
up onto an exercise block with one leg. Keeping the heel planted 
on the box and the torso erect, participants lifted their body up 
and placed the opposite foot onto the platform. Participants 
then stepped down with one foot and followed with the back 
leg.  
 
Step height was selected based on ability to perform the 
movement with the correct posture throughout the exercise. 
Parallel bars were placed either side of the participant for safety, 
but they were encouraged not to use them unless required. 
 
 
 
 
 
 
 
 
• Body weight  
• Body weight + dumbbells 
• Body weight + dumbbells 
+ increased step height 
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Squat     
 
 
 
 
 
 
 
 
 
Free Standing Participants flexed their hips, knees and ankle whilst maintaining 
a flat or slightly lordosis back position and kept their heels on 
the floor. Participants continued the descent until their thighs 
were parallel with the ground, after which they extended their 
hips and knees into a standing position. Participants extended 
their arms out in front to aid balance if required. 
 
If participants were unable to complete the movement or unable 
to balance, an alternative exercise variation was utilised. 
 
• Body weight 
• Body weight + plate 
weights/kettlebells 
 
 
 
 
 
 
 
 
 
 
 
Standing with 
Swiss Ball 
Participants stood with a Swiss exercise ball between their lower 
back and a wall. They flexed their hips, knees and ankle whilst 
continually pushing back into the ball and kept their heels on the 
floor. Participants continued the descent until their thighs were 
parallel with the ground after which they extended their hips 
and knees into a standing position. 
 
If participants were unable to complete the movement due to 
muscle weakness, an alternative exercise variation was utilised. 
• Body weight 
• Body weight + plate 
weights/kettlebells 
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Squat Bed 
 
 
 
 
 
 
 
 
 
 
 
Participants lay supine on the squat bed plinth with their hips 
and knees at 90 ° and the feet secured to the footplate. 
Participants extended their hips, knees and ankle whilst keeping 
their heels on the footplate until they reached full extension, or 
slightly before, of the knees and hips. Participants then flexed at 
the hip knee and ankle until their knees returned to at a 90° 
angle.    
 
If participants were unable to keep their heels flat on the 
footplate, a wedge was secured under the heels. 
• Plinth angle 
Knee Flexion 
   
 
 
 
 
 
 
Leg Curl  Participants were seated on a leg curl and extension machine 
(Pro Heavy Duty, XS Sports). The seat was adjusted so the latera 
epicondyle of the knee joint was in line with the axis of rotation 
and the back was firmly against the back pad. The lower legs 
were placed on top of the padded lever so that the legs were at 
90° to the torso. Participants bent their knees to curl their heels 
downwards through a 90° range of motion. Participants then 
straightened their knees to return to a starting position.  
 
If participants were unable to complete the movement due to the 
additional weight of the lever, the exercise was completed in a 
gravity neutral position.  
 
• Weight of lever arm  
• Plate weights 
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Side-Lying  Participants lay on their side with their knees extended on a 
physiotherapy bed. They flexed their top knee to bring their heel 
to their buttocks. 
 
 
 
 
 
 
 
 
 
 
• Gravity neutral  
• Resistive rubber bands 
• Progress to leg curl 
machine  
Knee Extension    
 
 
 
 
 
 
 
 
 
 
Knee 
Extension  
Participants were seated on a knee extension machine (Pro 
Heavy Duty, XS Sports). The seat was adjusted so the lateral 
epicondyle of the knee joint was in line with the axis of rotation 
and the back was firmly against the back pad. The anterior 
aspect of the lower legs was placed behind the padded lever, 
which was positioned at 90 ° to the horizontal. Participants 
extended their lower legs to full extension and then lowered the 
legs back down to the starting position.  
 
If participants were unable to complete the movement due to 
the additional weight of the lever, the exercise was completed in 
a gravity neutral position.  
• Weight of lever arm  
• Plate weights 
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Side-lying 
 
 
 
 
 
 
 
 
 
Participants lay on their side on a physiotherapy bed with their 
bottom knee extended and their top knee flexed at 90°. They 
extended their top knee until the leg was parallel with their 
bottom leg. 
 
 
• Gravity neutral 
• Resistive rubber bands  
• Progress to knee 
extension machine 
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2.3 – Individual Resistance Exercises 
Table A.2.3 describes the variations of exercises and progressive training loads that were available for each muscle group (dorsi-flexor, plantar-
flexor, hip flexor, hip extensor, hip abductor, hip adductor, hip internal rotator, hip external rotator, abdominal and lower back muscles). The 
specific exercise that was selected for each muscle group was dependent upon the functional ability and initial strength of the participant. The 
training load was progressive but in cases of severe weakness the load was initially reversed, so that the exercise was either assisted or completed 
in a gravity neutral or gravity assisted position. 
Table A.2.3: Description of individual exercises and training load progressions for each muscle group. 
Muscle Group Variations Description Training Load  
Ankle Dorsi-Flexors    
 
Lay Supine  Participants lay supine on a physiotherapy bed with their knees slightly 
flexed and a foam roller underneath. Participants lay with their ankle 
(2 cm proximal to their medial malleolus) hanging over the end of the 
bed to allow movement of the calcaneus. Participants dorsi-flexed 
their ankle through a full range of motion and then extended back to a 
neutral ankle position.  Resistive bands were secured around the 
forefoot and attached to a wall hook. Ankle weights were fasted 
around the forefoot. 
 
 
 
 
 
 
 
 
• Assistive rubber 
bands 
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands  
• Cable machine 
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Ankle Plantar-Flexors 
 
 
 
 
 Standing     
 
 
 
 
 
 
 
 
Participants stood with both feet placed on the edge of an exercise 
block, ensuring that the balls of their feet were firmly planted on the 
step and their heels were lowered. Participants raised up onto their 
toes, through a full range of motion and then lowered back down into 
the starting position.  
 
If balance was particularly poor or hyperextension occurred at the 
knees, a seated or lay alternative was utilised. 
 
• Body weight  
• Body weight + 
dumbbells/plate 
weights 
 
 
 
Seated  Participants were seated on a chair with their ankles, knees and hips at 
a 90° angle. Starting with both feet placed flat on the ground, 
participants raised their heels through a full range of motion and then 
lowered their heels back to the starting position. Plate weights were 
placed on the thighs and secured in place by participants during the 
lift. 
 
 
 
• Limb weight  
• Limb weight + plate 
weight  
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Lay Supine  Participants lay supine on a physiotherapy bed with their knees slightly 
flexed and a foam roller placed underneath both knees. Participants 
lay with their ankle (from 2 cm proximal to their medial malleolus) 
hanging freely over the end of the bed, to allow free movement of the 
calcaneus. Participants plantar-flexed their ankle through a full range 
of motion and then relaxed back to a dorsi-flexed ankle position.  
Resistive bands were secured around the forefoot and a hook on the 
wall. 
 
 
• Gravity assistance  
• Resistive rubber 
bands 
• Cable machine  
Hip Flexors     
 
 
 
 
 
 
 
 
Standing 
 
 
Participants stood up straight with the cable lever or rubber bands 
attached around their ankle (if in use), posterior to their body. They 
stood a distance away to ensure that there was tension in the 
resistance, with their hip in a slightly extended position. Participants 
paced their body weight onto one leg and on the opposite side, they 
flexed their hip joint with a bent knee, to lift their knee up and bring 
the thigh parallel with the floor. Participants then extended their knee 
and hip to return the leg back to the starting position.  
 
If excessive movement was evident at the torso due to muscle 
weakness or single leg stance could not be achieved, an alternative 
exercise position was utilised.  
• Limb weight  
• Ankle Weights 
• Resistive rubber 
bands 
• Cable machine 
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Lay Supine Participants lay supine on a physiotherapy bed with their knees fully 
extended. They flexed at the hip joint with their knee bent to bring 
one knee towards their chest and then they extended their hip and 
knee to place the leg flat on the bed again.  
 
If participants were unable to keep their back flat on the bed and 
instead arched their back during the lift due to muscle weakness of 
their core and/or lower back, a side-lying position was utilised instead. 
• Limb weight  
• Ankle weights 
• Resistive rubber 
bands 
• Cable machine 
 
Side-lying  Participants lay on their side in a straight line with their pelvis and 
shoulders in vertical alignment. The top leg was lifted up (abducted), 
until it was at the same height as the pelvis. From this position, 
participants flexed at the hip to bring the knee towards the chest. 
 
If participant were unable to keep the pelvis still, the exercise was 
completed against a wall for support. 
• Gravity neutral  
• Resistive rubber 
bands 
• Ankle weights 
• Cable machine 
Hip Extensors (Gluteus 
Maximus) 
   
 
 
Standing Participants stood up straight with the cable lever or rubber bands 
attached around their ankle (if in use), anterior to their body. They 
stood a distance away to ensure that there was tension in the 
resistance, with their hip in a slightly flexed position. Keeping the torso 
upright and the working leg straight, participants extended their hip to 
take the leg back to maximum hip extension and then returned back to 
the starting position.  
 
If participants were unable to keep the back flat and instead arched at 
the back or hyperextension at the stance knee occurred, an alternative 
exercise position was used. 
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands 
• Cable machine  
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Kneeling 
Prone  
(Glute 
Kickback) 
Participants were in a knelt position on a physiotherapy bed, with their 
arms extended in front of them (perpendicular to the torso), in a 
kneeling push up position. The knees were bent at 90° to the thigh. 
Participants lifted one leg so that the heel moved towards the ceiling 
and the knee remained bent at 90°, until the thigh was level with the 
back. Participants then lowered the leg back to the starting position.  
 
If participants were unable to hold bodyweight through their upper 
body, an alternative exercise was chosen.  
 
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands 
• Cable machine 
 
 
 
Lay supine 
(Glute 
Bridge)  
 
Participants lay supine on a physiotherapy bed, with their knees bent, 
their feet flat and their arms down by the sides. Participants raised 
their pelvis towards the ceiling using the glute muscles, keeping the 
back flat with no arching of the back. Participants then lowered their 
pelvis back down onto the bed.  
 
If participants were unable to keep the back flat and instead arched 
their back during the movement, an alternative exercise was selected.  
• Body weight  
• Weighted barbell  
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Side-lying Participants lay on their side in a straight line, with their pelvis and 
shoulders in vertical alignment. The top leg was lifted up (abducted) 
until it was at the same height as the pelvis. From this position, 
participants extended at the hip to bring the leg backwards. 
 
If significant weakness in the abductors was present, manual 
assistance was given to keep the leg abducted. 
 
• Gravity neutral 
• Ankle weights 
• Resistive rubber 
bands 
• Cable machine  
Hip Abduction (Glute Medius) 
   
 Standing Participants stood with one foot on a step to give clearance to the 
working leg. Keeping the toes upwards, participants moved their leg 
laterally away from their body, keeping the knee straight. Participants 
then lowered the leg back to the starting position. Participants held 
onto a wall or the cable machine for stability. 
  
If participants were unable to complete the exercise without leaning 
the upper body into the opposite direction of movement or single limb 
stance was not achievable, an alternative exercise was utilised. 
 
• Limb weight 
• Ankle weights 
• Resistive rubber  
bands 
• Cable machine 
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Side-lying  Participants lay on their side on a physiotherapy bed in a straight line, 
with their pelvis and shoulders in vertical alignment. The top leg was 
lifted, keeping the knees straight and ensuring that no rotation 
occurred at the pelvis. Participants then lowered the leg back down to 
the starting position.  
 
If participants were unable to complete the movement due to the 
weight of their leg or without rotating the pelvis backwards, an 
alternative exercise was chosen. 
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands 
• Cable machine  
 
 
Side-lying 
(clamshell) 
Participants lay on their side on a physiotherapy bed with their 
shoulders and pelvis in vertical alignment, with the knees bent, hips 
flexed and heels together. Keeping the heels together and the upper 
body and pelvis still, participants rotated the hip to raise the knee of 
the top leg until it was parallel with the hip. Participants then lowered 
the knee back to the starting position.  
 
If participants were unable to complete the exercise without rolling the 
pelvis backwards, it was completed against a wall for support or a 
gravity neutral exercise was utilised.  
• Limb weight 
• Resistance bands 
 
370 
 
 
Lay Supine  Participants lay supine on a physiotherapy bed with their knees fully 
extended and feet hip distance apart. Participants lifted the leg off the 
surface of the bed by flexing the hip slightly and then abducted the hip 
to move the leg away from the body, keeping the knees straight and 
the foot vertical.  
 
A slide board was placed under the foot if participants were unable to 
lift the leg from the surface of the bed due to hip flexor weakness. 
 
• Gravity neutral 
• Ankle weight 
• Resistive rubber 
bands 
• Cable machine  
 
 
Hip Adduction    
 
 
 
 
 
 
 
Standing 
 
Participants stood up straight with their feet shoulder width apart and 
holding onto bars or the cable machine for support, they placed all 
their weight onto one leg. They lifted the opposite leg of the floor and 
keeping the ankle dorsi-flexed, they pulled their leg towards the 
midline of their body and continued until the ankle passed the stance 
leg. They then returned the leg to the starting position.  
If participants were unable to keep their back flat without arching it, or 
were unable to stand on one leg, an alternative was chosen. 
 
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands 
• Cable Machine 
 Lay Supine  
 
 
 
 
 
 
 
 
Participants lay supine on a physiotherapy bed, with their arms down 
by their sides, their knees bent, and feet flat on the bed. A ball was 
placed between their knees and they were instructed to squeeze the 
ball to compress its shape and then release back to the starting 
position.  
 
Once participants were able to deform the shape of the softball they 
progressed to the exercise above. 
 
• Softball 
• Progress to exercise 
above 
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Lay Supine  Participants lay supine on a physiotherapy bed with their knees fully 
extended and one leg abducted out at 30°. Participants lifted the leg of 
the surface of the bed slightly and then adducted the hip to move the 
leg towards the midline of the body, until the legs were hip distance 
apart, keeping the knees straight and the foot vertical. Participants 
then returned the leg back to the starting position.   
 
A slide board was placed under the foot, if participants were unable to 
lift the leg from the surface of the bed  
• Gravity neutral 
• Ankle weights 
• Resistive rubber 
bands 
• Cable machine  
Hip External Rotators 
   
 
Seated 
 
 
 
 
 
 
 
Participants were seated on a chair or bench with their non-involved 
foot placed slightly in front. Keeping the knee bent at 90° and the 
ankle dorsi-flexed to give clearance from the ground, participants 
pulled their lower leg under the thigh of the non-involved leg, by 
externally rotating the hip. Participants then returned the leg to the 
starting position.   
 
If participants were unable to externally rotate the hip due to the 
weight of their lower leg, the alternative exercise was utilised.  
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands 
• Cable Machine 
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Lay Prone  
 
Participants lay prone on a physiotherapy bed with their legs hips 
distance apart, one knee fully extended and the working knee bent at 
90°. Keeping the knee bent, participants pulled their foot towards the 
thigh of the opposite leg by externally rotating at the hip. Participants 
then returned to the starting position.  
 
 
 
• Gravity assisted 
• Resistive rubber 
bands 
• Cable machine 
Hip Internal Rotators    
 
Seated 
 
Participants were seated on a chair or bench with their non-involved 
foot placed slightly in front. Keeping the knee bent at 90° and the 
ankle dorsi-flexed to give clearance from the ground, the participant 
pushed their lower leg away from the non-involved leg, by internally 
rotating the hip. Participants then returned the leg to the starting 
position.   
 
If participants were unable to internally rotate the hip in this position, 
the alternative exercise was utilised. 
 
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands 
• Cable Machine 
    
 
Lay Supine  Participants lay supine on a physiotherapy bed with their knees fully 
extended and their legs hip distance apart. Their hips were relaxed and 
externally rotated so that the participant’s feet were not vertical. 
Participants rotated the entire leg medially, so that their feet moved 
past a vertical position into an internally rotated hip position and then 
returned to the starting position.  
 
 
 
• Assistive rubber 
bands 
• Limb weight 
• Ankle weights 
• Resistive rubber 
bands 
• Cable machine 
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Abdominals    
 Seated  Participants were seated on a bench with their feet hip distance apart 
and planted on the ground and their back against the back support. 
The back support of the bench could be inclined at numerous angles to 
the seat. The angles were 90°, 101°, 113°, 124°, 135°, 146° 158°, 169° 
and 180°, which enabled the range of movement of the exercise to be 
decreased in circumstances of severe weakness. The back angle was 
set at 135°, unless participants were unable to complete the 
movement, in which case it was reduced. Participants pulled their 
torso forwards, flexing at the hips so that the shoulders moved 
towards the thighs and then returned to the starting position. 
Participants crossed their arms across their chest and, if applicable, 
held the resistance bands/cable stirrups in both hands. 
 
If the bench was too low for participants to sit down onto and/or stand 
up from, an alternative exercise was utilised. 
 
• Reduced back angle 
• Body weight 
• Resistive rubber 
bands 
• Cable machine  
 
 
Lay Supine  Participants lay supine on a physiotherapy bed with their knees bent 
and feet flat. Participants flexed to raise their upper torso from the 
bed as high as possible whilst keeping the lower back in contact with 
the bed. Participants then returned to the starting position. 
 
 
 
 
 
 
 
• Body weight 
• Plate weight 
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Lower-Back     
 
Lap Prone on 
Swiss ball  
Participants lay prone on a Swiss ball, with their feet hip distance apart 
on the floor or against the base of a wall for support. They crossed 
their arms across their chest and raised their torso off the ball to 
extend the back. Participants then returned to the starting position.  
 
If participants were unable to steady the ball, an alternative exercise 
was utilised.  
 
• Assistive rubber 
bands 
• Body weight 
• Plate weights  
 
 
Lay Prone Participants lay prone on a physiotherapy bed, with their legs 
extended and their arms extended out in front of them. Participants 
raised their upper body and arms off the surface of the bed and then 
returned to the starting position.  
• Assistive rubber 
bands 
• Body weight 
• Plate weights 
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Appendix 3 
Gait Kinematics 
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A3.1 Trendeleberg gait and compensated Trendeleberg gait  
 
 
 
 
 
 
 
 
 
 
Figure A3.1: Visual representation of a normal pelvic position during gait (left image), a 
positive Trendeleberg pelvic position during gait (middle image) and a compensated 
Trendeleberg pelvic position during gait (right image). 
A3.2: Lateral trunk lean examples  
Figure A3.2: Examples of compensatory lateral trunk lean towards the support side 
during the gait cycle in this study. 
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A3.3 Lack of Knee Flexion in stance/hyperextension examples 
 
  
 
 
 
 
 
Figure A3.3: Examples of the lack of knee felxion during the loading response in the 
stance phase and hyperextension in the stance phase found in our study. 
A3.4 Effects of RT on Fall Frequency 
Table A3.4: Mean ± standard deviation of self reported fall frequency in the previous 
12 weeks, measured at PRE1, PRE2 and POST completion of the RT programme. 
PRE1 PRE2 POST 
9.9 ± 33.7 10.4 ± 34.7 5.5 ± 20.5 
A3.5 Effects of RT on Knee Hyperextension  
 
 
 
 
 
 
 
 
Figure A3.5:  Example of the reduction in the severity of hyperextension at mid-
stance from before completion of the RT programme (left image) to afterwards 
(right image).
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Appendix 4 
Questionaires and 
Participant Comments 
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A 4.1 Short Form 36-item Health Survey 
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A 4.2 Beck Depression Inventory 
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A 4.3 State-Trait Anxiety Inventory for Adults 
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A 4.4 Rosenberg Self-Esteem Scale 
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A 4.5 Physical Self-Perception Profile  
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A 4.6 Tampa Scale of Kinesiophobia 
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A 4.7 Physical Activity Scale for Individuals with Physical Disability  
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A 4.8 Participant Comments 
 
 
 
 
 
 
 
